0001628280-23-038279.txt : 20231109 0001628280-23-038279.hdr.sgml : 20231109 20231109163135 ACCESSION NUMBER: 0001628280-23-038279 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 107 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cibus, Inc. CENTRAL INDEX KEY: 0001705843 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 271967997 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38161 FILM NUMBER: 231393121 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 450-0008 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Calyxt, Inc. DATE OF NAME CHANGE: 20170504 10-Q 1 cbus-20230930.htm 10-Q cbus-20230930
000170584312-312023Q3falsehttp://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602MemberP3Y0.10.2P3YP3YP3YP30D00017058432023-01-012023-09-300001705843us-gaap:CommonClassAMember2023-11-08xbrli:shares0001705843us-gaap:CommonClassBMember2023-11-0800017058432023-09-30iso4217:USD00017058432022-12-310001705843us-gaap:RelatedPartyMember2023-09-300001705843us-gaap:RelatedPartyMember2022-12-310001705843us-gaap:NonrelatedPartyMember2023-09-300001705843us-gaap:NonrelatedPartyMember2022-12-310001705843us-gaap:CommonClassAMember2022-12-31iso4217:USDxbrli:shares0001705843us-gaap:CommonClassAMember2023-09-300001705843us-gaap:CommonClassBMember2023-09-300001705843us-gaap:CommonClassBMember2022-12-3100017058432023-07-012023-09-3000017058432022-07-012022-09-3000017058432022-01-012022-09-3000017058432023-06-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-06-300001705843us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-06-300001705843us-gaap:AdditionalPaidInCapitalMember2023-06-300001705843us-gaap:TreasuryStockCommonMember2023-06-300001705843us-gaap:RetainedEarningsMember2023-06-300001705843us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001705843us-gaap:RetainedEarningsMember2023-07-012023-09-300001705843us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-07-012023-09-300001705843us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-09-300001705843us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-09-300001705843us-gaap:AdditionalPaidInCapitalMember2023-09-300001705843us-gaap:TreasuryStockCommonMember2023-09-300001705843us-gaap:RetainedEarningsMember2023-09-300001705843us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-06-300001705843us-gaap:AdditionalPaidInCapitalMember2022-06-300001705843us-gaap:TreasuryStockCommonMember2022-06-300001705843us-gaap:RetainedEarningsMember2022-06-3000017058432022-06-300001705843us-gaap:RetainedEarningsMember2022-07-012022-09-300001705843us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-07-012022-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-09-300001705843us-gaap:AdditionalPaidInCapitalMember2022-09-300001705843us-gaap:TreasuryStockCommonMember2022-09-300001705843us-gaap:RetainedEarningsMember2022-09-3000017058432022-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-12-310001705843us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-310001705843us-gaap:AdditionalPaidInCapitalMember2022-12-310001705843us-gaap:TreasuryStockCommonMember2022-12-310001705843us-gaap:RetainedEarningsMember2022-12-310001705843us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001705843us-gaap:RetainedEarningsMember2023-01-012023-09-300001705843us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-01-012023-09-300001705843us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-01-012023-09-300001705843us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001705843us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001705843us-gaap:AdditionalPaidInCapitalMember2021-12-310001705843us-gaap:TreasuryStockCommonMember2021-12-310001705843us-gaap:RetainedEarningsMember2021-12-3100017058432021-12-310001705843us-gaap:RetainedEarningsMember2022-01-012022-09-300001705843us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-01-012022-09-300001705843us-gaap:AdditionalPaidInCapitalMembercbus:AtTheMarketOfferingMember2022-01-012022-09-300001705843cbus:AtTheMarketOfferingMember2022-01-012022-09-300001705843us-gaap:CommonClassAMemberus-gaap:CommonStockMembercbus:FollowOnPublicOfferingMember2022-01-012022-09-300001705843us-gaap:AdditionalPaidInCapitalMembercbus:FollowOnPublicOfferingMember2022-01-012022-09-300001705843cbus:FollowOnPublicOfferingMember2022-01-012022-09-3000017058432021-01-012021-12-310001705843us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001705843srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-3100017058432023-05-31cbus:class_of_stock0001705843us-gaap:CommonClassAMember2023-05-310001705843us-gaap:CommonClassBMember2023-05-310001705843cbus:CalyxtIncMember2023-05-300001705843us-gaap:CommonClassAMember2023-05-312023-05-310001705843cbus:RestrictedCommonClassAMember2023-05-312023-05-310001705843us-gaap:CommonClassBMembercbus:CibusGlobalMember2023-05-312023-05-310001705843cbus:CalyxtIncMember2023-05-31xbrli:pure0001705843cbus:CibusGlobalMember2023-05-310001705843srt:MinimumMember2023-09-300001705843srt:MaximumMember2023-09-30cbus:reporting_unit0001705843cbus:CommonWarrantsMember2023-01-012023-09-300001705843us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001705843us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001705843us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001705843us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001705843us-gaap:PerformanceSharesMember2023-01-012023-09-300001705843us-gaap:PerformanceSharesMember2022-01-012022-09-300001705843us-gaap:RestrictedStockMember2023-01-012023-09-300001705843us-gaap:RestrictedStockMember2022-01-012022-09-300001705843us-gaap:WarrantMember2023-01-012023-09-300001705843us-gaap:WarrantMember2022-01-012022-09-300001705843cbus:PreFundedWarrantsMember2022-02-230001705843cbus:CommonWarrantsMember2022-02-2300017058432023-09-302023-09-30cbus:segment0001705843cbus:CalyxtIncMember2023-04-242023-04-2400017058432023-05-312023-05-310001705843cbus:CibusGlobalMember2023-05-312023-05-310001705843cbus:CibusGlobalMember2023-05-310001705843us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-09-302023-09-300001705843us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-05-312023-05-310001705843us-gaap:CommonClassAMembercbus:CibusGlobalMember2023-05-312023-05-310001705843us-gaap:RestrictedStockMembercbus:CibusGlobalMember2023-05-312023-05-310001705843us-gaap:RelatedPartyMembercbus:CibusGlobalMember2023-05-310001705843us-gaap:NonrelatedPartyMembercbus:CibusGlobalMember2023-05-310001705843us-gaap:InProcessResearchAndDevelopmentMembercbus:CibusGlobalMember2023-05-310001705843us-gaap:DevelopedTechnologyRightsMembercbus:CibusGlobalMember2023-05-310001705843us-gaap:DevelopedTechnologyRightsMembercbus:CibusGlobalMember2023-05-312023-05-310001705843us-gaap:TradeNamesMembercbus:CibusGlobalMember2023-05-310001705843us-gaap:TradeNamesMembercbus:CibusGlobalMember2023-05-312023-05-310001705843cbus:CibusGlobalMember2022-01-012023-09-300001705843cbus:CibusGlobalMember2022-01-012022-12-310001705843cbus:CibusGlobalMember2023-01-012023-09-300001705843us-gaap:SellingGeneralAndAdministrativeExpensesMembercbus:CibusGlobalMember2023-01-012023-09-300001705843us-gaap:ResearchAndDevelopmentExpenseMembercbus:CibusGlobalMember2023-01-012023-09-300001705843cbus:CibusGlobalMember2023-07-012023-09-300001705843cbus:CibusGlobalMember2022-07-012022-09-300001705843cbus:CibusGlobalMember2022-01-012022-09-300001705843us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-09-300001705843us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2023-09-300001705843us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2023-09-300001705843us-gaap:MoneyMarketFundsMember2023-09-300001705843us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001705843us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2022-12-310001705843us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001705843us-gaap:MoneyMarketFundsMember2022-12-310001705843us-gaap:FairValueInputsLevel1Member2023-09-300001705843us-gaap:FairValueInputsLevel2Member2023-09-300001705843us-gaap:FairValueInputsLevel3Member2023-09-300001705843us-gaap:FairValueInputsLevel1Member2022-12-310001705843us-gaap:FairValueInputsLevel2Member2022-12-310001705843us-gaap:FairValueInputsLevel3Member2022-12-310001705843cbus:CommonWarrantsMemberus-gaap:FairValueInputsLevel1Member2023-09-300001705843us-gaap:FairValueInputsLevel2Membercbus:CommonWarrantsMember2023-09-300001705843us-gaap:FairValueInputsLevel3Membercbus:CommonWarrantsMember2023-09-300001705843cbus:CommonWarrantsMember2023-09-300001705843cbus:CommonWarrantsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001705843us-gaap:FairValueInputsLevel2Membercbus:CommonWarrantsMember2022-12-310001705843us-gaap:FairValueInputsLevel3Membercbus:CommonWarrantsMember2022-12-310001705843cbus:CommonWarrantsMember2022-12-310001705843cbus:CommonWarrantsMember2023-01-012023-09-300001705843us-gaap:MeasurementInputRiskFreeInterestRateMember2023-09-300001705843us-gaap:MeasurementInputRiskFreeInterestRateMember2022-12-310001705843us-gaap:MeasurementInputOptionVolatilityMember2023-09-300001705843us-gaap:MeasurementInputOptionVolatilityMember2022-12-310001705843us-gaap:MeasurementInputExpectedTermMember2023-09-30utr:Y0001705843us-gaap:MeasurementInputExpectedTermMember2022-12-310001705843us-gaap:BuildingMembersrt:MinimumMember2023-09-300001705843srt:MaximumMemberus-gaap:BuildingMember2023-09-300001705843us-gaap:BuildingMember2023-09-300001705843us-gaap:BuildingMember2022-12-310001705843us-gaap:LeaseholdImprovementsMember2023-09-300001705843us-gaap:LeaseholdImprovementsMember2022-12-310001705843us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2023-09-300001705843us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2023-09-300001705843us-gaap:FurnitureAndFixturesMember2023-09-300001705843us-gaap:FurnitureAndFixturesMember2022-12-310001705843cbus:ComputerEquipmentAndSoftwareMembersrt:MinimumMember2023-09-300001705843srt:MaximumMembercbus:ComputerEquipmentAndSoftwareMember2023-09-300001705843cbus:ComputerEquipmentAndSoftwareMember2023-09-300001705843cbus:ComputerEquipmentAndSoftwareMember2022-12-310001705843us-gaap:ConstructionInProgressMember2023-09-300001705843us-gaap:ConstructionInProgressMember2022-12-310001705843cbus:MeasurementInputInflationRateMember2023-09-3000017058432023-05-300001705843us-gaap:InProcessResearchAndDevelopmentMember2023-09-300001705843us-gaap:DevelopedTechnologyRightsMember2023-09-300001705843us-gaap:TradeNamesMember2023-09-300001705843us-gaap:OtherIntangibleAssetsMember2023-09-300001705843us-gaap:NotesPayableOtherPayablesMembercbus:AnnualLicensesMember2023-01-012023-09-300001705843us-gaap:NotesPayableOtherPayablesMembercbus:AnnualLicensesMember2023-09-300001705843us-gaap:NotesPayableOtherPayablesMembercbus:FinancedEquipmentMembersrt:MinimumMember2023-09-300001705843us-gaap:NotesPayableOtherPayablesMembersrt:MaximumMembercbus:FinancedEquipmentMember2023-09-300001705843us-gaap:NotesPayableOtherPayablesMembercbus:FinancedEquipmentMember2023-01-012023-09-300001705843us-gaap:NotesPayableOtherPayablesMembercbus:InsuranceNotesMember2023-09-300001705843us-gaap:NotesPayableOtherPayablesMembercbus:InsuranceNotesMember2023-01-012023-09-300001705843cbus:AnnualLicensesMember2023-09-300001705843cbus:FinancedEquipmentMember2023-09-300001705843cbus:InsuranceNotesMember2023-09-300001705843us-gaap:CommonClassAMembercbus:FollowOnPublicOfferingMember2022-02-232022-02-230001705843cbus:PreFundedWarrantsMembercbus:FollowOnPublicOfferingMember2022-02-230001705843cbus:CommonWarrantsMembercbus:FollowOnPublicOfferingMember2022-02-230001705843cbus:FollowOnPublicOfferingMember2022-02-230001705843cbus:FollowOnPublicOfferingMember2022-02-232022-02-230001705843cbus:CommonWarrantsMember2022-12-310001705843cbus:CommonWarrantsMember2023-09-300001705843cbus:AtTheMarketOfferingMember2022-01-012022-12-310001705843cbus:AtTheMarketOfferingMember2023-01-012023-09-300001705843cbus:CibusIncMember2023-09-300001705843cbus:ElectingMembersMember2023-09-300001705843cbus:TwoThousandSeventeenOmnibusPlanMember2023-09-300001705843us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001705843us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001705843us-gaap:EmployeeStockOptionMembersrt:MinimumMember2022-01-012022-09-300001705843us-gaap:EmployeeStockOptionMembersrt:MaximumMember2022-01-012022-09-300001705843us-gaap:EmployeeStockOptionMembersrt:MinimumMember2023-01-012023-09-300001705843us-gaap:EmployeeStockOptionMembersrt:MaximumMember2023-01-012023-09-3000017058432023-02-282023-02-2800017058432023-03-012023-03-010001705843us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001705843us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001705843us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001705843us-gaap:RestrictedStockMembersrt:MinimumMember2023-01-012023-09-300001705843srt:MaximumMemberus-gaap:RestrictedStockMember2023-01-012023-09-300001705843us-gaap:RestrictedStockMember2022-12-310001705843us-gaap:RestrictedStockMember2023-01-012023-09-300001705843us-gaap:RestrictedStockMember2023-09-300001705843us-gaap:RestrictedStockMember2023-07-012023-09-300001705843us-gaap:RestrictedStockMember2022-07-012022-09-300001705843us-gaap:RestrictedStockMember2022-01-012022-09-300001705843us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2023-01-012023-09-300001705843srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001705843us-gaap:RestrictedStockUnitsRSUMember2022-12-310001705843us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001705843us-gaap:RestrictedStockUnitsRSUMember2023-09-300001705843us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001705843us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001705843us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001705843us-gaap:RelatedPartyMembercbus:DeemedDividendsMember2023-07-012023-09-300001705843us-gaap:RelatedPartyMembercbus:DeemedDividendsMember2022-07-012022-09-300001705843us-gaap:RelatedPartyMembercbus:DeemedDividendsMember2023-01-012023-09-300001705843us-gaap:RelatedPartyMembercbus:DeemedDividendsMember2022-01-012022-09-300001705843us-gaap:PerformanceSharesMembercbus:TwoThousandSeventeenOmnibusPlanMember2023-05-242023-05-24cbus:employee0001705843us-gaap:PerformanceSharesMembercbus:TwoThousandSeventeenOmnibusPlanMembersrt:ExecutiveOfficerMember2023-05-242023-05-240001705843us-gaap:PerformanceSharesMembercbus:TwoThousandSeventeenOmnibusPlanMember2022-03-012022-03-310001705843us-gaap:PerformanceSharesMembercbus:TwoThousandSeventeenOmnibusPlanMembersrt:ExecutiveOfficerMember2022-03-012022-03-310001705843us-gaap:PerformanceSharesMembercbus:TwoThousandSeventeenOmnibusPlanMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-03-012022-03-010001705843us-gaap:PerformanceSharesMembercbus:TwoThousandSeventeenOmnibusPlanMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2023-05-312023-05-310001705843us-gaap:PerformanceSharesMembercbus:InducementPlanMember2021-07-012021-07-310001705843us-gaap:PerformanceSharesMembercbus:InducementPlanMember2023-05-312023-05-310001705843us-gaap:PerformanceSharesMember2022-06-012022-06-300001705843us-gaap:PerformanceSharesMember2022-12-310001705843us-gaap:PerformanceSharesMember2023-01-012023-09-300001705843us-gaap:PerformanceSharesMember2023-09-300001705843us-gaap:PerformanceSharesMember2023-07-012023-09-300001705843us-gaap:PerformanceSharesMember2022-07-012022-09-300001705843us-gaap:PerformanceSharesMember2022-01-012022-09-300001705843cbus:RosevilleMnLeaseMember2023-09-300001705843cbus:RosevilleMnLeaseMember2022-12-310001705843cbus:SanDiegoCaliforniaLaboratoryLeaseMember2023-09-300001705843cbus:SanDiegoCaliforniaLaboratoryLeaseMember2022-12-310001705843cbus:SanDiegoCaliforniaHeadquartersLeaseMember2023-09-300001705843cbus:SanDiegoCaliforniaHeadquartersLeaseMember2022-12-310001705843cbus:SanDiegoCaliforniaGreenhouseLeaseMember2023-09-300001705843cbus:SanDiegoCaliforniaGreenhouseLeaseMember2022-12-310001705843cbus:OtherLeasesMember2022-12-310001705843cbus:OtherLeasesMembersrt:MinimumMember2023-09-300001705843cbus:OtherLeasesMembersrt:MaximumMember2023-09-300001705843cbus:OtherLeasesMember2023-09-30cbus:option0001705843cbus:GreenhouseLeaseMember2023-09-300001705843cbus:WarehouseLeaseMember2023-09-3000017058432022-10-012022-12-3100017058432023-01-012023-03-310001705843cbus:WarrantExchangeAgreementMembersrt:ManagementMember2023-01-012023-09-300001705843cbus:WarrantExchangeAgreementMembersrt:ManagementMember2023-09-300001705843us-gaap:MeasurementInputDiscountRateMembersrt:ManagementMember2023-09-300001705843srt:ManagementMember2022-12-310001705843srt:ManagementMember2023-01-012023-09-300001705843srt:ManagementMember2023-09-300001705843us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001705843us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300001705843us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001705843us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-300001705843us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001705843us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300001705843us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001705843us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300001705843srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2022-09-300001705843cbus:InterimFundingAgreementMemberus-gaap:UnsecuredDebtMembercbus:CibusGlobalMembersrt:AffiliatedEntityMemberus-gaap:RevolvingCreditFacilityMember2023-03-150001705843cbus:InterimFundingAgreementMemberus-gaap:UnsecuredDebtMembercbus:CibusGlobalMembersrt:AffiliatedEntityMemberus-gaap:RevolvingCreditFacilityMember2023-03-152023-05-300001705843cbus:InterimFundingAgreementMemberus-gaap:UnsecuredDebtMembercbus:CibusGlobalMembersrt:AffiliatedEntityMemberus-gaap:RevolvingCreditFacilityMember2023-05-310001705843cbus:ProctorGambleMember2023-01-012023-09-300001705843us-gaap:RelatedPartyMembercbus:LeaseGuaranteeMembercbus:CellectisMember2023-09-300001705843us-gaap:RelatedPartyMembercbus:LeaseGuaranteeMembercbus:CellectisMember2022-10-012022-10-310001705843us-gaap:SubsequentEventMemberus-gaap:EmployeeSeveranceMember2023-10-170001705843us-gaap:SubsequentEventMemberus-gaap:EmployeeSeveranceMember2023-10-180001705843us-gaap:SubsequentEventMembercbus:BindingTermSheetMemberus-gaap:LineOfCreditMember2023-10-200001705843srt:ScenarioForecastMembercbus:BindingTermSheetMemberus-gaap:LineOfCreditMember2024-01-012024-03-010001705843srt:ScenarioForecastMembercbus:BindingTermSheetMemberus-gaap:LineOfCreditMember2023-10-212023-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 10-Q
_____________________
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023;
or
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from_________to_________
Commission file number 001-38161
Cibus_Logo_RGB.jpg
_____________________
Cibus, Inc.
(Exact name of registrant as specified in its charter)
_____________________
Delaware27-1967997
(State or other jurisdiction of
incorporation or organization)		(I.R.S. Employer
Identification No.)
 
6455 Nancy Ridge Drive
San Diego, CA
92121
(Address of principal executive offices)(Zip Code)
(858) 450-0008
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
_____________________
Securities registered pursuant to Section 12(b) of the Act.
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Class A Common Stock, $0.0001 par value per shareCBUSThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated fileroAccelerated filero
 
Non-accelerated filerxSmaller reporting companyx
 
  Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes x No
As of November 8, 2023, there were 16,699,948 shares of the registrant's Class A Common Stock, $0.0001 par value per share (Class A Common Stock) (excluding 901,044 restricted shares of Class A Common Stock, which remain subject to vesting), and 4,642,636 shares of the registrant's Class B Common Stock, $0.0001 par value per share, outstanding.

Terms

When the terms “Cibus,” the “Company” or “its” are used in this report, unless the context otherwise requires, those terms are being used to refer to Cibus, Inc. (formerly Calyxt, Inc.) and its consolidated subsidiaries (i) excluding Cibus Global, LLC and its consolidated subsidiaries, prior to the completion of the Merger Transactions (as defined under the heading “Explanatory Note” below) and (ii) the combined entity, including Cibus Global, LLC and its consolidated subsidiaries, as of and following the consummation of the Merger Transactions. When the term “Legacy Calyxt” is used, it is being used to exclusively refer to Calyxt, Inc. prior to the Merger Transactions. When the term “Cibus Global” is used, it is being used to refer to Cibus Global, LLC, both prior to and after the completion of the Merger Transactions. When the term “Cellectis,” is used, it is being used to refer to Cellectis S.A. (société anonyme), the Company’s largest shareholder prior to the completion of the Merger Transactions.

When the term “Class A Common Stock” is used, it is being used, unless the context requires otherwise, to refer prior to the Merger Transactions to Legacy Calyxt’s common stock, par value $0.0001 per share (Legacy Common Stock) and following the Merger Transactions to the Class A Common Stock, $0.0001 par value per share (Class A Common Stock). Each share of Legacy Common Stock existing and outstanding immediately prior to the Merger Transactions remained outstanding as a share of Class A Common Stock without any conversion or exchange thereof.

The Company owns or has the right to use the trademarks, service marks, and trade names that it uses in conjunction with the operation of its business. Some of the more important marks and names that it owns or has rights to use that may appear in this Quarterly Report on Form 10-Q include: “Cibus®,” “RTDS®,” “Rapid Trait Development SystemTM,” “NucelisTM,” “Trait MachineTM,” “PlantSpring,” and “BioFactory.” This report may also contain additional trade names, trademarks, and service marks belonging to other companies. The Company does not intend its use or display of other parties’ trademarks, trade names, or service marks to imply, and such use or display should not be construed to imply a relationship with, or endorsement or sponsorship of these other parties.

Explanatory Note

Completion of Merger Transactions

On May 31, 2023, the Company completed the business combination transactions contemplated by the Agreement and Plan of Merger, dated as of January 13, 2023, as amended by the First Amendment thereto dated as of April 14, 2023 (as amended, the Merger Agreement, and the transactions contemplated thereby, the Merger Transactions), by and among Legacy Calyxt; Calypso Merger Subsidiary, LLC, a Delaware limited liability company and wholly-owned subsidiary of Legacy Calyxt; Cibus Global; and certain blocker entities party thereto. Among other things, as part of the Merger Transactions, the Company’s amended and restated certificate of incorporation was further amended and restated (the Amended Certificate of Incorporation). The Company is organized in an “Up-C” structure, and the Company’s only material asset consists of membership units of Cibus Global. The Amended Certificate of Incorporation designated two classes of the Company’s common stock: (i) Class A Common Stock, par value $0.0001 per share (the Class A Common Stock), which shares have full voting and economic rights, and (ii) Class B Common Stock, par value $0.0001 per share (the Class B Common Stock), which shares have full voting, but no economic rights.

The financial information presented in this Quarterly Report on Form 10-Q for the nine months ended September 30, 2023, represents four months of Cibus, inclusive of Cibus Global, and five months of Legacy Calyxt results only, except where proforma figures are presented. All financial information prior to the completion of the Merger Transactions is that of Legacy Calyxt only.

Reverse Stock Splits

Prior to the Merger Transactions, Legacy Calyxt effected a one-for-ten reverse stock split (the First Reverse Stock Split) of the Legacy Common Stock, which became effective on April 24, 2023. The First Reverse Stock Split was reflected on the Nasdaq Capital Market beginning with the opening of trading on April 25, 2023.


Immediately prior to the Merger Transactions, the Company effected a one-for-five reverse stock split (the Second Reverse Stock Split and, together with the First Reverse Stock Split, the Reverse Stock Splits) of the Legacy Common Stock, which became effective on May 31, 2023. The Second Reverse Stock Split was reflected on the Nasdaq Capital Market beginning with the opening of trading of the Class A Common Stock on June 1, 2023.

No fractional shares were issued in connection with the Reverse Stock Splits and instead, fractional shares were rounded up to the nearest whole share number. The par value and authorized shares of Legacy Common Stock and preferred stock of the Company were not adjusted as a result of the Reverse Stock Splits.

Pursuant to the Amended Certificate of Incorporation, following the consummation of the Merger Transactions, the Company is authorized to issue 310,000,000 shares, consisting of (i) 300,000,000 shares of common stock, par value $0.0001 per share, divided into (A) 210,000,000 shares of Class A Common Stock and (B) 90,000,000 shares of Class B Common Stock and (ii) 10,000,000 shares of preferred stock, par value $0.0001 per share. Unless otherwise noted, all share and per share amounts in this Quarterly Report on Form 10-Q have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Splits.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended (the Securities Act) and the rules and regulations promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act) and the rules and regulations promulgated thereunder. The Company may also make forward-looking statements in other reports filed with the Securities and Exchange Commission (SEC), in materials delivered to stockholders, and in press releases. In addition, the Company’s representatives may from time-to-time make oral forward-looking statements.

The Company has made these forward-looking statements in reliance on the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the company believes the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance or achievements. In some cases, you can identify these statements by forward-looking words such as “anticipates,” “believes,” “continue,” “estimates,” “expects,” “intends,” “may,” “might,” “plans,” “predicts,” “projects,” “should,” “targets,” “will,” or the negative of these terms and other similar terminology. Forward-looking statements in this report include statements about the realization of anticipated benefits of the Merger Transactions; integration of the combined company; the Company’s future financial performance, including its liquidity and capital resources, cash runway, and its ability to continue as a going concern; the advancement, timing and progress of the Company’s platform development and trait development in crop platforms; the anticipated timing for the presentation of data related to trait development and other operational activities; the timeframes for transferring traits in customers’ elite germplasm; the timeframe for commercialization of germplasm with the Company’s traits by seed company customers; the timing for, and degree of, adoption by farmers of germplasm with the Company’s traits following commercialization; the capacity of the Company’s productivity traits to deliver competitive yield improvements; the ability of gene editing to address climate change at scale; the timing and nature of regulatory developments relating to gene editing; the market opportunity for the Company’s plant traits, including the number of addressable acres, and the trait fees that the Company expects to receive; and the Company’s ability to enter into and maintain significant customer collaborations. These and other forward-looking statements are predictions and projections about future events and trends based on the Company’s current expectations, objectives, and intentions and are premised on current assumptions. The Company’s actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: risks associated with the possible failure to realize certain anticipated benefits of the Merger Transactions; the effect of the completion of the Merger Transactions on the Company’s business relationships, operating results, and business generally; the outcome of any litigation related to the Merger Transactions; changes in expected or existing competition; challenges to the Company’s intellectual property protection and unexpected costs associated with defending intellectual property rights; increased or unanticipated time and resources required for the Company’s platform or trait product development efforts; the Company’s reliance on third parties in connection with its development activities; challenges associated with the Company’s ability to effectively license its productivity traits and sustainable ingredient products; the risk that farmers do not recognize the value in germplasm containing the Company’s traits or that farmers and processors fail to work effectively with crops containing the Company’s traits; challenges that arise in respect of the Company’s production of high-quality plants and seeds cost effectively on a large scale; the Company’s need for additional near term funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all; the Company’s dependence on distributions from Cibus Global to pay taxes and cover its corporate and overhead expenses; regulatory developments that disfavor or impose significant burdens on gene-editing processes or products; the Company’s ability to achieve commercial success; commodity prices and other market risks facing the agricultural sector; technological developments that could render our technologies obsolete; impacts of our headcount reductions and other cost reduction measures, which may include operational and strategic challenges; changes in macroeconomic and market conditions, including inflation, supply chain constraints, and rising interest rates; dislocations in the capital markets and challenges in accessing liquidity and the impact of such liquidity challenges on the Company’s ability to execute on its business plan; and other important factors discussed in “Risk Factors of Cibus, Inc.” filed as Exhibit 99.3 with the Company’s Current Report on Form 8-K, which was filed with the SEC on June 1, 2023, under the heading "Item 8.01 - Other Events - Supplemental Risk Factors" in the Company's Current Report on Form 8-K filed on October 18, 2023, and any additional “Risk Factors” identified in the Company’s other subsequent reports on Forms 10-Q and 8-K filed with the SEC, which should be considered an integral part of Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Any forward-looking statements made by the Company in this Quarterly Report on Form 10-Q are based only on currently available information and speak only as of the date of this report. Except as otherwise required by securities and other applicable laws, the Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change.
- 1 -

Market Data

Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning the Company’s industry and the markets in which it operates is based on information from various sources, including independent industry publications. In presenting this information, the Company has also made assumptions based on such data and other similar sources, and on its knowledge of, and its experience to date in, the potential markets for its products. The industry in which the Company operates is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the section entitled “Risk Factors of Cibus, Inc.” filed as Exhibit 99.3 with the Company’s Current Report on Form 8-K, which was filed with the SEC on June 1, 2023, under the heading "Item 8.01 - Other Events - Supplemental Risk Factors" in the Company's Current Report on Form 8-K filed on October 18, 2023, and other subsequent reports on Forms 10-Q and 8-K filed with the SEC. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by the Company.

Website Disclosure

The Company uses its website (www.cibus.com), its corporate Twitter account (@CibusGlobal) and its corporate LinkedIn account (https://www.linkedin.com/company/cibus-global) as routine channels of distribution of company information, including press releases, analyst presentations, and supplemental financial information, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor its website and its corporate Twitter and LinkedIn accounts in addition to following press releases, filings with the SEC, and public conference calls and webcasts.

Additionally, the Company provides notifications of announcements as part of its website. Investors and others can receive notifications of new press releases posted on the Company’s website by signing up for email alerts.

None of the information provided on the Company’s website, in its press releases or public conference calls and webcasts, or through social media is incorporated into, or deemed to be a part of, this Quarterly Report on Form 10-Q or in any other report or document it files with the SEC, and any references to its website or its corporate Twitter and LinkedIn accounts are intended to be inactive textual references only.
- 2 -
PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
CIBUS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited and in Thousands, Except Par Value and Share Amounts)
 September 30,
2023		December 31,
2022
Assets  
Current assets:  
Cash and cash equivalents$31,883 $3,427 
Restricted cash— 99 
Accounts receivable560 — 
Prepaid expenses and other current assets2,029 606 
Total current assets34,472 4,132 
Property, plant, and equipment, net17,197 4,516 
Operating lease right-of-use assets22,935 13,615 
Intangible assets, net134,921 158 
Goodwill585,266 — 
Other non-current assets1,444 — 
Total assets$796,235 $22,421 
Liabilities, redeemable noncontrolling interest, and stockholders’ equity  
Current liabilities:  
Accounts payable$6,281 $340 
Accrued expenses5,092 173 
Accrued compensation3,704 107 
Due to related parties— 175 
Deferred revenue1,637 107 
Current portion of notes payable1,165 — 
Current portion of financing lease obligations235 97 
Current portion of operating lease obligations5,436 367 
Class A common stock warrants1,512 291 
Other current liabilities17 5 
Total current liabilities25,079 1,662 
Notes payable, net of current portion629 — 
Financing lease obligations, net of current portion102 — 
Operating lease obligations, net of current portion18,844 13,447 
Royalty liability - related parties157,113 — 
Other non-current liabilities1,974 79 
Total liabilities203,741 15,188 
Commitments and contingencies (See Note 10)
Redeemable noncontrolling interest129,104 — 
Stockholders’ equity:  
Class A common stock, $0.0001 par value; 210,000,000 shares authorized; 17,656,831 shares issued and 16,659,996 shares outstanding as of September 30, 2023, and 275,000,000 shares authorized; 978,915 shares issued and 976,908 shares outstanding as of December 31, 2022
8 5 
Class B common stock, $0.0001 par value; 90,000,000 shares authorized; 4,642,636 shares issued and outstanding as of September 30, 2023, and no shares authorized; no shares issued and outstanding as of December 31, 2022
— — 
Additional paid-in capital727,821 220,422 
Class A common stock in treasury, at cost; 32,660 shares as of September 30, 2023, and 2,007 shares as of December 31, 2022
(1,785)(1,043)
Accumulated deficit(262,664)(212,151)
Accumulated other comprehensive income10 — 
Total stockholders’ equity463,390 7,233 
Total liabilities, redeemable noncontrolling interest, and stockholders' equity$796,235 $22,421 
See accompanying notes to these condensed consolidated financial statements.
- 3 -
CIBUS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited and in Thousands, Except Share and Per Share Amounts)
 Three Months Ended September 30,Nine Months Ended September 30,
 2023202220232022
Revenue:
Revenue$475 $42 $714 $115 
Total revenue475 42 714 115 
Operating expenses:    
Research and development17,521 3,016 28,159 9,207 
Selling, general, and administrative8,751 3,229 22,126 9,965 
Total operating expenses26,272 6,245 50,285 19,172 
Loss from operations(25,797)(6,203)(49,571)(19,057)
Royalty liability interest expense - related parties(8,136)— (10,753)— 
Other interest income (expense), net281 (47)359 (80)
Non-operating income (expenses)(876)300 (466)5,083 
Loss before income taxes(34,528)(5,950)(60,431)(14,054)
Income taxes— — — — 
Net loss$(34,528)$(5,950)$(60,431)$(14,054)
Net loss attributable to redeemable noncontrolling interest(8,099)— (9,918)— 
Net loss attributable to Cibus, Inc.$(26,429)$(5,950)$(50,513)$(14,054)
Basic and diluted net loss per share of Class A common stock$(1.59)$(6.36)$(6.33)$(15.56)
Weighted average shares of Class A common stock outstanding – basic and diluted16,641,127935,7027,979,132903,476












See accompanying notes to these condensed consolidated financial statements.
- 4 -
CIBUS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited and in Thousands)
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net loss$(34,528)$(5,950)$(60,431)$(14,054)
Foreign currency translation adjustments15 — 13 — 
Comprehensive loss(34,513)(5,950)(60,418)(14,054)
Comprehensive loss attributable to redeemable noncontrolling interest(8,096)— (9,915)— 
Comprehensive loss attributable to Cibus, Inc.$(26,417)$(5,950)$(50,503)$(14,054)






















See accompanying notes to these condensed consolidated financial statements.
- 5 -
CIBUS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY
(Unaudited and in Thousands, Except Shares Outstanding)
Class A Common StockClass B Common Stock
Three Months Ended
September 30, 2023		Redeemable Noncontrolling InterestSharesAmountSharesAmountAdditional
Paid-In
Capital		Shares
in
Treasury 		Accumulated
Deficit 		Accumulated Other Comprehensive Income (Loss)Total
Stockholders’
Equity
Balance at June 30, 2023$136,866 16,606,401$8 4,642,636$— $722,327 $(1,785)$(236,235)$(2)$484,313 
Net loss(8,099)—— —— — — (26,429)— (26,429)
Stock-based compensation— —— —— 5,828 — — — 5,828 
Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units— 53,608— —— — — — — — 
Shares withheld for net share settlement— (13)— —— — — — — — 
Change in value of redeemable noncontrolling interest334 (334)(334)
Foreign currency translation adjustments3 —— —— — — — 12 12 
Balance at September 30, 2023$129,104 16,659,996$8 4,642,636$— $727,821 $(1,785)$(262,664)$10 $463,390 
Three Months Ended
September 30, 2022		Class A Shares
Outstanding		Class A Common
Stock		Additional
Paid-In
Capital		Shares
in
Treasury 		Accumulated
Deficit 		Total
Stockholders’
Equity
Balance at June 30, 2022934,327$5 $218,161 $(1,043)$(203,364)$13,759 
Net loss—— — — (5,950)(5,950)
Stock-based compensation—— 1,035 — — 1,035 
Issuance of Class A common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units1,871— — — — — 
Balance at September 30, 2022936,198$5 $219,196 $(1,043)$(209,314)$8,844 












- 6 -
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY, CONT.
Class A Common StockClass B Common Stock
Nine Months Ended
September 30, 2023		Redeemable Noncontrolling InterestSharesAmountSharesAmountAdditional
Paid-In
Capital 		Shares
in
Treasury 		Accumulated
Deficit 		Accumulated Other Comprehensive IncomeTotal
Stockholders’
Equity
Balance at December 31, 2022$— 976,908$5 —$— $220,422 $(1,043)$(212,151)$— $7,233 
Net loss(9,918)—— —— — — (50,513)— (50,513)
Stock-based compensation— —— —— 11,670 — — — 11,670 
Issuance of common stock resulting from merger with Cibus Global, LLC— 15,508,2023 4,642,636— 634,748 — — — 634,751 
Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units— 207,546— —— — — — — — 
Shares withheld for net share settlement— (32,660)— —— — (742)— — (742)
Redeemable noncontrolling interest resulting from merger with Cibus Global, LLC138,685 —— —— (138,685)— — — (138,685)
Change in value of redeemable noncontrolling interest334 (334)(334)
Foreign currency translation adjustments3 —— —— — — — 10 10 
Balance at September 30, 2023$129,104 16,659,996$8 4,642,636$— $727,821 $(1,785)$(262,664)$10 $463,390 
Nine Months Ended
September 30, 2022		Class A Shares
Outstanding		Class A Common
Stock		Additional
Paid-In
Capital 		Shares
in
Treasury 		Accumulated
Deficit 		Total
Stockholders’
Equity
Balance at December 31, 2021775,480$4 $211,263 $(1,043)$(196,092)$14,132 
Net loss—— — — (14,054)(14,054)
Stock-based compensation—— 2,890 — — 2,890 
Issuance of Class A common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units5,518— — — — — 
Issuance of Class A common stock from ATM facility, net of offering expenses—— (7)— — (7)
Issuance of Class A common stock and pre-funded warrants in registered offering, net of $0.5 million of offering costs
77,6001 5,050 — — 5,051 
Issuance of Class A common stock upon exercise of pre-funded warrants77,600— — — — — 
Cumulative effect of adoption of lease accounting standard—— — — 832 832 
Balance at September 30, 2022936,198$5 $219,196 $(1,043)$(209,314)$8,844 

See accompanying notes to these condensed consolidated financial statements.
- 7 -
CIBUS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited and in Thousands)
 Nine Months Ended September 30,
 20232022
Operating activities  
Net loss$(60,431)$(14,054)
Adjustments to reconcile net loss to net cash used by operating activities:  
Royalty liability interest expense - related parties10,753 — 
Depreciation and amortization2,875 1,158 
Stock-based compensation11,670 2,890 
Change in fair value of liability classified Class A common stock warrants1,221 (5,009)
Other17 — 
Changes in operating assets and liabilities, net of acquisitions:  
Accounts receivable1,674 — 
Due to/from related parties(95)(34)
Prepaid expenses and other current assets1,111 297 
Accounts payable(61)(188)
Accrued expenses1,357 41 
Accrued compensation738 (166)
Deferred revenues340 (115)
Right-of-use assets and lease liabilities, net(28)154 
Other assets and liabilities, net(334)(575)
Net cash used by operating activities(29,193)(15,601)
Investing activities  
Cash acquired from merger with Cibus Global, LLC59,381 — 
Purchases of property, plant, and equipment(3,872)(1,509)
Net cash provided by (used) by investing activities55,509 (1,509)
Financing activities  
Proceeds from Class A common stock issuance— 11,209 
Costs incurred related to the issuance of Class A common stock— (962)
Proceeds from draws on revolving line of credit from Cibus Global, LLC2,500 — 
Payment of taxes related to vested restricted stock units(742)— 
Proceeds from issuance of notes payable1,287 — 
Repayments of financing lease obligations(242)(353)
Repayments of notes payable(760)— 
Net cash provided by financing activities2,043 9,894 
Effect of exchange rate changes on cash and cash equivalents(2)— 
        Net increase (decrease) in cash, cash equivalents, and restricted cash28,357 (7,216)
Cash, cash equivalents, and restricted cash – beginning of period3,526 14,421 
Cash, cash equivalents, and restricted cash – end of period$31,883 $7,205 
See accompanying notes to these condensed consolidated financial statements.
- 8 -
CIBUS, INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The unaudited condensed consolidated financial statements of Cibus, Inc. (Cibus or the Company) have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP or GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC) applicable to interim financial statements. In the Company’s opinion, the accompanying condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of its statements of financial position, results of operations, and cash flows for the periods presented but they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Except as otherwise disclosed herein, these adjustments consist of normal recurring items. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole or any other interim period.

For further information, refer to the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, as amended by the Company’s Form 10-K/A for the year ended December 31, 2022, filed with the SEC on March 2, 2023, and March 3, 2023, respectively (collectively, the Annual Report). The accompanying condensed consolidated balance sheets as of December 31, 2022, was derived from the audited consolidated financial statements. This Quarterly Report on Form 10-Q should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Annual Report.

Description of Business

Cibus, Inc. (formerly Calyxt, Inc.) completed the Merger Transactions (as defined below under “—Merger Transactions”) on May 31, 2023, with Cibus Global, LLC (Cibus Global), and the Company carries on its business through Cibus Global and its subsidiaries. Cibus is the sole managing member of Cibus Global and, as sole managing member, the Company operates and controls all of the business and affairs of Cibus Global. As a result, the Company consolidates the financial results of Cibus Global and its subsidiaries and reports redeemable noncontrolling interest representing the economic interest in Cibus Global held by the other members of Cibus Global.

Cibus Global, a Delaware limited liability company, was formed on May 10, 2019. Immediately prior to the effective date of this formation, Cibus Global was organized as a British Virgin Islands company (Cibus Global, Ltd.), which was formed on November 5, 2001. On May 10, 2019, Cibus Global was converted to be a Delaware limited liability company.

Cibus Global is a plant trait company using gene editing technologies to develop and license gene edited plant traits that improve farming productivity or produce renewable low carbon plant products.

Completion of Merger Transactions

On May 31, 2023, the Company completed the business combination transactions contemplated by the Agreement and Plan of Merger, dated as of January 13, 2023, as amended by the First Amendment thereto dated as of April 14, 2023 (as amended, the Merger Agreement, and the transactions contemplated thereby, the Merger Transactions), by and among Legacy Calyxt; Calypso Merger Subsidiary, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company; Cibus Global, LLC (Cibus Global); and certain blocker entities party thereto. Among other things, as part of the Merger Transactions, the Company’s amended and restated certificate of incorporation was further amended and restated (the Amended Certificate of Incorporation). The Company is organized in an “Up-C” structure, and the Company’s only material asset consists of membership units of Cibus Global. The Amended Certificate of Incorporation designated two classes of the Company’s common stock: (i) Class A Common Stock, par value $0.0001 per share (the Class A Common Stock), which shares have full voting and economic rights, and (ii) Class B Common Stock, par value $0.0001 per share (the Class B Common Stock), which shares have full voting, but no economic rights. Each share of Legacy Calyxt’s common stock, par value $0.0001 per share (Legacy Common Stock) existing and outstanding immediately prior to the Merger Transactions remained outstanding as a share of Class A Common Stock without any conversion or exchange thereof.

At the closing of the Merger Transactions, the Company contributed all of its assets and liabilities to Cibus Global, in exchange for Common Units. The Company issued an aggregate of 16,527,484 shares of Class A Common Stock (including 1,019,282 shares of restricted Class A Common Stock) and 4,642,636 shares of Class B Common Stock to Cibus Global equityholders, as consideration in the Merger Transactions, pursuant to the terms of the Merger Agreement. Upon closing, Legacy Calyxt stockholders held approximately 4.8 percent of the issued and outstanding common stock of the Company and legacy holders of membership units of Cibus Global (including profits interest units and warrants) held approximately 95.2 percent of the issued and outstanding common stock of the Company.

The primary purpose of the merger was to bring together the technology platforms and facilities of two pioneering companies to create a leading agricultural technology company for the development of productivity traits and to consolidated significant patented agricultural gene editing technology.

Reverse Stock Splits

Prior to the Merger Transactions, Legacy Calyxt effected a one-for-ten reverse stock split (the First Reverse Stock Split) of the Legacy Common Stock, which became effective on April 24, 2023. The First Reverse Stock Split was reflected on the Nasdaq Capital Market
- 9 -
beginning with the opening of trading on April 25, 2023.

Immediately prior to the Merger Transactions, the Company effected a one-for-five reverse stock split (the Second Reverse Stock Split and, together with the First Reverse Stock Split, the Reverse Stock Splits) of the Legacy Common Stock, which became effective on May 31, 2023. The Second Reverse Stock Split was reflected on the Nasdaq Capital Market beginning with the opening of trading of the Class A Common Stock on June 1, 2023.

No fractional shares were issued in connection with the Reverse Stock Splits and instead, fractional shares were rounded up to the nearest whole share number. The par value and authorized shares of Legacy Common Stock and preferred stock of the Company were not adjusted as a result of the Reverse Stock Splits.

Pursuant to the Amended Certificate of Incorporation, following the consummation of the Merger Transactions, the Company is authorized to issue 310,000,000 shares, consisting of (i) 300,000,000 shares of common stock, par value $0.0001 per share, divided into (A) 210,000,000 shares of Class A Common Stock and (B) 90,000,000 shares of Class B Common Stock and (ii) 10,000,000 shares of preferred stock, par value $0.0001 per share. Unless otherwise noted, all share and per share amounts in this Quarterly Report on Form 10-Q have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Splits.

Share information related to the Company's common stock as of September 30, 2023, is as follows:

Class A Common StockClass B Common StockTotal Common Stock
Authorized210,000,00090,000,000300,000,000
Issued17,656,8314,642,63622,299,467
Outstanding16,659,9964,642,63621,302,632


Class A Restricted Stock

In connection with the Merger Transactions, the Company issued restricted shares of Class A Common Stock (Class A Restricted Stock), which remain subject to vesting conditions, to Cibus Global Members that held unvested profits interest units at the time of the consummation of the Merger Transactions. Shares of Class A Restricted Stock are considered to be legally issued and outstanding as of the date of grant, notwithstanding that the shares remain subject to risk of forfeiture if the vesting conditions for such shares are not met. For financial statement presentation purposes, Class A Restricted Stock is treated as issued, but will only be treated as outstanding after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from items presenting Class A Common Stock, including the calculation of net loss per share of Class A Common Stock.

Going Concern

The Company has incurred losses since its inception. The Company’s net loss was $60.4 million and cash used for operating activities was $29.2 million for the nine months ended September 30, 2023. The Company’s primary source of liquidity is its cash and cash equivalents, with additional capital resources accessible, subject to market conditions and other factors, from the capital markets, including through offerings of common stock or other securities.

As of September 30, 2023, the Company had $31.9 million of cash and cash equivalents and $25.1 million of current liabilities.

The Company anticipates that it will continue to generate losses for the next several years. Over the longer term and until the Company can generate cash flows sufficient to support its operating capital requirements, it expects to finance a portion of future cash needs through (i) cash on hand, (ii) commercialization activities, which may result in various types of revenue streams from future product development agreements and technology licenses, including upfront and milestone payments, annual license fees, and royalties, (iii) government or other third-party funding, (iv) public or private equity or debt financings, or (v) a combination of the foregoing.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.

Management will need to raise additional capital to support its business plans to continue as a going concern within one year after the date that these financial statements are issued. Although the Company has implemented a strategic realignment, which has included headcount reductions, and has initiated cost reduction initiatives designed to preserve capital resources, if the Company is unable to raise additional capital in a sufficient amount or on acceptable terms, the Company may have to implement additional, more stringent cost reduction measures to manage liquidity, and the Company may have to significantly delay, scale back, or cease operations, in part or in full. If the Company raises additional funds through the issuance of additional debt or equity securities, including as part of a strategic alternative, it could result in substantial dilution to its existing stockholders and increased fixed payment obligations, and these securities may have rights senior to those of the Company’s shares of common stock. These factors raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date of issuance of these financial statements. Any of these events could significantly impact the Company’s business, financial condition, and prospects.
- 10 -
Use of Estimates

The preparation of the Company’s condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company’s historical experience, knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions. Key estimates made by the Company include revenue recognition, useful lives and impairment of long-lived assets, valuation of equity-based awards and related equity-based compensation expense, valuation of intangible assets, valuation allowances on deferred tax assets, and the valuation of the Royalty Liability (defined below under "Royalty liability - Related Parties").

Fair Value Measurements of Financial Instruments

The Company follows Accounting Standards Codification (ASC) Topic 820, Fair Value Measurements and Disclosures, for financial assets and liabilities that are recognized or disclosed at fair value in these condensed consolidated financial statements on a recurring basis. Under ASC 820, fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts its business. ASC 820 clarifies fair value should be based on assumptions market participants would use when pricing the asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to observable unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

The carrying amounts reflected in the accompanying condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate their fair value due to their short-term nature. Based on the borrowing rates currently available to the Company for notes payable with similar terms and consideration of default and credit risk, the carrying value of the notes payable approximates fair value, which is considered a Level 2 fair value measurement.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include cash in readily available checking and money market accounts. The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses with these financial institutions. As of September 30, 2023, the Company had cash balances deposited at major financial institutions.

Restricted Cash

The Company’s restricted cash balances are cash and cash equivalents deposited in an amount equal to the future rent payments as required under the Company’s equipment lease facility. The Company may request the return of excess restricted cash collateral annually in December. The amount of the restricted cash balance as of December 31, 2022, was returned in March of 2023.

Accounts Receivable

Accounts receivable are recorded at the amounts billed relating to contracted research and development (R&D) services provided. The Company makes judgments as to its ability to collect outstanding receivables and provides an allowance for receivables when collection is doubtful. Accounts receivable are written off when management believes that all efforts to collect the amounts outstanding have been exhausted. The allowance for credit losses is estimated by management based on evaluations of its historical bad debt, current collection experience, and estimate of remaining collectability. Bad debt expense is recorded as necessary to maintain an appropriate level of allowance for credit losses in selling, general, and administrative (SG&A) expense in the accompanying condensed consolidated statements of operations. Accounts receivable is presented net of allowance for credit losses which was $0 as of September 30, 2023, and December 31, 2022.

Property, Plant, and Equipment, net

Property, plant, and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation of buildings, lab equipment, furniture, and computer equipment and software is recorded using the straight-line method over the estimated useful lives of the respective assets, ranging from three to twenty years. Amortization of leasehold improvements are recorded using a straight-line method over the lesser of the estimated useful lives of the improvements or the remaining life of the lease. Expenditures which substantially increase the useful life of an asset, are capitalized. Expenditures for repairs and maintenance are expensed as incurred. Assets in progress include the construction of lab equipment and software to be used in the Company’s facility. The assets will be placed in service when the construction is completed and will be amortized over the useful life of the asset.

Goodwill and Acquired Intangible Assets

Goodwill is calculated as the excess of the purchase consideration paid in a business combination over the fair value of the assets acquired less liabilities assumed. Goodwill is not amortized and is tested for impairment at least annually or when events and circumstances indicate that fair value of a reporting unit may be below its carrying value. The Company has one reporting unit. The
- 11 -
Company first assesses qualitative factors to evaluate whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount or elects to bypass such assessment. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying value, or the Company elects to bypass the qualitative assessment, it performs a quantitative test by determining the fair value of the reporting unit. If the carrying value of the reporting unit exceeds the fair value, then an impairment loss is recognized for the difference.

Acquired in process R&D, developed technology, and trade names are related to the Merger Transactions. Acquired intangible assets are amortized on a straight-line basis over the estimated period over which the Company expects to realize economic value related to the intangible asset. In process R&D is not amortized until it is determined to be ready for its intended use. The acquired in process R&D will be tested for impairment annually, or more frequently, if an impairment indicator is identified. No impairment charges relating to acquired goodwill or indefinite lived intangible assets were recorded for the nine months ended September 30, 2023.

Leases

The Company determines if an arrangement is or contains a lease at inception. For leases with a term greater than one year, lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company excludes short-term leases, if any, having initial terms of 12 months or less at lease commencement as an accounting policy election. In determining the net present value of lease payments, the Company uses its incremental borrowing rate, which represents an estimated rate of interest that the Company would have to pay to borrow equivalent funds on a collateralized basis, at the lease commencement date. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statements of operations. Variable lease payments primarily include common area maintenance, utilities, real estate taxes, insurance, and other operating costs that are passed on from the lessor in proportion to the space leased by the Company. The Company has elected the practical expedient to not separate between lease and non-lease components.

Asset Retirement Obligation

The Company records an asset retirement obligation (ARO) for the estimated cost of removing constructed leasehold improvement assets and restoring the leased premises back to their original condition, at the time when the contractual obligations are incurred. The ARO represents the present value of the expected cost for the related restoration activities. The ARO assets and liabilities are recorded in property, plant, and equipment, net and other non-current liabilities, respectively, in the Company’s condensed consolidated balance sheets. The Company records accretion expense, which represents the increase in the ARO, over the remaining or operational life of the associated leasehold improvements. Accretion expense is recorded as R&D expense in the condensed consolidated statements of operations using an accretion rate based on the credit adjusted risk-free interest rate. Changes resulting from revisions to the timing or amount of the original estimate of cash flows are recognized as an increase or a decrease in the asset retirement cost, or income when the asset retirement cost is depleted.

Revenue Recognition

The Company’s revenues represent amounts earned from collaboration agreements related to contract research. The Company recognizes revenues under Topic 606 Revenue from Contracts with Customers (Topic 606) when control of services is transferred to the Company’s customers in an amount that reflects the consideration the Company expects to receive from the Company’s customers in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing the revenue when the performance obligations have been satisfied. The Company recognizes revenue for satisfied performance obligations only when the Company determines there are no uncertainties regarding payment terms or transfer of control. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract.

Collaboration Agreements Related to Contract Research

Performance obligations under collaboration arrangements include providing intellectual property licenses, performing R&D consulting services, and providing other materials. To date, the Company has concluded that the licenses of intellectual property in its collaboration arrangements have not been distinct, as intellectual property has not been licensed without related R&D support services. Under Topic 606, milestone fees are variable consideration that is initially constrained and included in the arrangement consideration only when it is probable that the milestones will be achieved. Arrangement consideration, including upfront fees, milestone fees, and fees for research services, is recognized over the period as services are provided using an input method to determine the amount to recognize each reporting period. The Company reviews the inputs each period, such as the Company’s level of effort expended, including the time the Company estimates it will take to complete the activities, or costs incurred relative to the total expected inputs to satisfy the performance obligation. Generally, input measures are labor hours expended or a time-based measure of progress towards the satisfaction of the performance obligation.

Contract Liabilities

The Company records contract liabilities when cash payments are received or due in advance of performance, primarily related to advances of upfront and milestone payments from contract research and collaboration agreements. Contract liabilities consist of deferred revenue on the accompanying condensed consolidated balance sheets. The Company expects to recognize the amounts included in deferred revenues within one year.
- 12 -

The following table represents the deferred revenue activity:

In ThousandsDeferred Revenue
Balance as of December 31, 2022$107 
Acquired from merger with Cibus Global, LLC1,186 
Consideration earned(714)
Consideration received1,058 
Balance as of September 30, 2023$1,637 

For the three months ended September 30, 2023, $0.5 million of deferred revenue was recognized as revenue in the accompanying condensed consolidated statements of operations. For the nine months ended September 30, 2023, $0.1 million of the deferred revenue balance as of December 31, 2022, had been recognized as revenue in the accompanying condensed consolidated statements of operations.

Selling, General, and Administrative Expenses

SG&A expense consists primarily of employee-related expenses, such as salaries for its executive, business development, legal, intellectual property, information technology, finance, human resources, and other administrative functions. These costs include legal, professional, and consulting fees for external firms and contractors. All selling and marketing expenses, including advertising expenses and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization, are included in SG&A expense in the accompanying condensed consolidated statements of operations.

Beginning in the second quarter of 2023, SG&A expense includes costs related to its intellectual property portfolio and costs to write and support the research for filing patents. Historically, the Company expensed patent application costs and related legal costs for maintenance of such patents as incurred and such costs were included in R&D expense in the accompanying condensed consolidated statements of operations.

In the nine months ended September 30, 2023, the Company recognized, during the second quarter of 2023, $0.4 million of deferred financing costs related to the liability classified common warrants (Common Warrants) in SG&A expense in the accompanying condensed consolidated statements of operations.

Research and Development Expenses

R&D costs are expensed as incurred in performing R&D activities and include salaries, lab supplies, consultant fees, and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization.

Historically, the Company recognized its intellectual property portfolio and costs to write and support the research for filing patents as R&D expense. Beginning in the second quarter of 2023, these expenses are included in SG&A expense in the accompanying condensed consolidated statements of operations. The amounts in the prior reporting periods are not material and as such no historical amounts have been reclassified.

Royalty Liability – Related Parties

In 2014, Cibus Global entered into the warrant exchange agreement (Warrant Exchange Agreement), which remains in place following the Company’s acquisition of Cibus Global in the Merger Transactions, Cibus Global is required to make ongoing quarterly payments equal to a portion of the aggregate amount of certain worldwide revenues received during the applicable quarter. The Company refers to such payment obligations as its Royalty Liability. Management estimates the total amount of royalty payments over the life of the Warrant Exchange Agreement that Cibus Global will be required to make to holders of certain warrants (Royalty Holders) that were exchanged for the rights to future royalty payments pursuant to the Warrant Exchange Agreement. The Royalty Liability is based on the Company’s current estimates of future royalties expected to be paid over the life of the arrangement. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. In order to determine the amortization of the Royalty Liability, the Company is required to estimate the total amount of future royalty payments to the Royalty Holders over the life of the Warrant Exchange Agreement. This estimate contains significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the royalty period. The Company will periodically assess the estimated royalty payments and to the extent the amount or timing of such payments is materially different than the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. See Note 11 for further details.

Non-Operating Income (Expenses)

Non-operating income (expenses) are income or expenses that are not directly related to ongoing operations and are primarily comprised of gains and losses from the mark-to-market of Common Warrants to purchase Class A Common Stock and foreign exchange transactions.

Net Loss Per Share of Class A Common Stock
- 13 -


Weighted average shares of Class A Common Stock outstanding excludes unvested Class A Common Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from the calculation of net loss per share of Class A Common Stock.

For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding as inclusion of the common stock equivalent securities would be anti-dilutive.

The Company’s potential dilutive securities, which include Common Warrants, unvested performance stock units, unvested restricted stock units, unvested restricted stock awards, and options to purchase Class A Common Stock, have been excluded from the computation of diluted net loss per share of Class A Common Stock as the effect would be antidilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share of Class A Common Stock is the same. The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their anti-dilutive effect:

As of September 30,
20232022
Stock options outstanding109,551116,936
Unvested restricted stock units198,19925,210
Unvested performance stock units—22,600
Unvested restricted stock awards945,780—
Common Warrants158,483158,483
Total1,412,013323,229


Warrants

The Company issued pre-funded warrants (Pre-Funded Warrants) to purchase Class A Common Stock in a follow-on offering on February 23, 2022 (the Follow-On Offering). The Pre-Funded Warrants, which were each exercisable for one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share, were exercised in full on May 4, 2022, and subsequently settled with the counterparty. While outstanding, the Pre-Funded Warrants were considered equity instruments and reported in stockholders’ equity in the Company’s condensed consolidated balance sheets, and the shares issuable upon exercise of the Pre-Funded Warrants were included in the determination of the Company’s net loss per share of Class A Common Stock.

The Company also issued Common Warrants in the Follow-On Offering. The Common Warrants expire on August 23, 2027, and are each exercisable for one share of the Company’s Class A Common Stock for $69.04 per share, after giving effect to the Reverse Stock Splits. The Common Warrants have been classified as a liability because they include a put option election available to their holder that is contingently exercisable if the Company enters into a fundamental transaction (Fundamental Transaction). Pursuant to the terms of the Common Warrants, a Fundamental Transaction occurs if (i) the Company, directly or indirectly, effects any merger or consolidation of the Company with or into another person in which the Company is not the surviving entity, (ii) the Company (and all of its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer is completed pursuant to which holders of the Company’s Class A Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50 percent or more of the outstanding Class A Common Stock of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization, or recapitalization of the Class A Common Stock or any compulsory share exchange pursuant to which the Class A Common Stock is effectively converted into or exchanged for other securities, cash, or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination with another person or group of persons whereby such other person or group acquires more than 50 percent of the voting power of the outstanding shares of Class A Common Stock (not including any shares of Class A Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business combination) (the Fundamental Change Put). If the Fundamental Change Put is exercised by the holder of a Common Warrant, holder may elect to receive either the consideration of the Fundamental Transaction or put the Common Warrants back to the Company in exchange for cash, based on terms and timing specified in the Common Warrant agreement. If the Fundamental Change Put option is exercised, the Company is required to pay cash to the holder in an amount as determined by the Black-Scholes pricing model, with assumptions determined in accordance with the terms of the Common Warrants. The Company believes that the Merger Transactions did not qualify as a Fundamental Transaction.

The Common Warrants are reported at fair value with changes in fair value reported in earnings. The Company reports the changes in fair value of the Common Warrants in non-operating income (expenses) in its condensed consolidated statements of operations.

Employee Retention Credit

Prior to the Merger Transactions, Cibus Global qualified for federal government assistance through the Employee Retention Credit
- 14 -
(ERC) provisions of the CARES Act passed in 2020, for the second, third, and fourth fiscal quarters of 2020, as well as the first and second fiscal quarters of 2021. The purpose of the ERC was to encourage employers to keep employees on the payroll, even if they were not working during the covered period because of the coronavirus outbreak. The Company recognizes amounts to be refundable as tax credits if there is a reasonable assurance of compliance with the grant conditions and receipt of credits. As of September 30, 2023, the Company recognized $0.2 million related to the employee retention credit, and it does not expect to receive any further credits.

Foreign Currency

The accompanying condensed consolidated financial statements are presented in United States dollars (USD) as the reporting currency. For those foreign subsidiaries where the Company has determined that the functional currency is the entity’s local currency, the assets and liabilities of such subsidiaries are translated into USD using exchange rates in effect at the balance sheet date. The revenue and expenses of such subsidiaries are translated into USD using average exchange rates in effect during the reporting period. Any translation adjustments are presented as accumulated other comprehensive income (loss), within stockholders' equity in the accompanying condensed consolidated statements of redeemable noncontrolling interest and stockholders' equity. Foreign currency transaction gains and losses are included in non-operating income (expenses) within the accompanying condensed consolidated statements of operations and were immaterial for all periods presented.

Segment Reporting

Management has determined that the Company has one operating segment, R&D of plant gene editing, which is consistent with the Company's structure and how it manages the business. Furthermore, the Company's Chief Operating Decision Maker, which is the Company's Chief Executive Officer, monitors and reviews financial information at a consolidated level for assessing operating results and the allocation of resources.
Recently Issued Accounting Pronouncements

From time-to-time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position, results of operations, or cash flows upon adoption.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU No. 2021-08 address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination. The amendments in ASU No. 2021-08 require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. Upon adoption, an acquirer should account for the related revenue contracts of the acquiree as if it has originated the contracts.

For public business entities, the amendments in ASU No. 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments in ASU No. 2021-08 should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company applied ASU No. 2021-08 to the Merger Transactions.

2. MERGER WITH CIBUS GLOBAL

As described in Note 1, on May 31, 2023, the Company completed the Merger Transactions.

Redeemable Noncontrolling Interest

All of the issued and outstanding Cibus Global membership units (Common Units) are held solely by the Company and certain members of Cibus Global who elected in connection with the Merger Transactions to receive units (Up-C Units), each consisting of one share of Class B Common Stock and one Common Unit at the closing of the Merger Transactions (Electing Members). The Up-C Units are generally exchangeable for shares of Class A Common Stock on a one-for-one basis, subject to certain restrictions. In accordance with ASC 810, Consolidation, Cibus Global is considered a Variable Interest Entity (VIE) with Cibus as its sole managing member and primary beneficiary. As such, Cibus consolidates Cibus Global, and the remaining Common Unit holders that hold economic interest directly in Cibus Global are presented as redeemable noncontrolling interest on the Company’s financial statements. There are no restrictions on the use of assets of Cibus Global.

Redeemable noncontrolling interest represents the portion of Cibus Global Common Units that are not owned directly by the Company. Redeemable noncontrolling interest is classified as temporary equity because the Common Units contained certain redemption features that were not solely within the control of the Company. As of both May 31, 2023, (the closing date of the Merger Transactions) and September 30, 2023, the Common Unit holders of the redeemable noncontrolling interest owned approximately 22 percent of Cibus Global.

Purchase Price

The purchase price for Cibus Global was determined as follows:
- 15 -

- 16 -
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (1)20,150,838 
Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (2)$31.50 
Purchase price$634,751,397 


(1) This share number represents the aggregate number of shares of Common Stock issued to Cibus Global members in the Merger Transactions and comprises: 15,508,202 shares of Class A Common Stock and 4,642,636 shares of Class B Common Stock. This share number excludes 1,019,282 shares of Class A Restricted Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture.
(2) Reflects the purchase price per share of the Company's Class A Common Stock, which was the closing price of the Class A Common Stock on May 31, 2023, the closing date of the Merger Transactions.

Purchase Price Allocation

The acquisition of Cibus Global was accounted for using the acquisition method, whereby all of the assets acquired and liabilities assumed were recognized at their fair value on the acquisition date, with any excess of the purchase price over the estimated fair value recorded as goodwill. The purchase price allocation is preliminary and subject to change, including completion of the Company's analysis on the deferred tax impact of the acquisition.

Identifiable assets acquired, liabilities assumed, and noncontrolling interest, if applicable, are recorded at their estimated fair values at the acquisition date. Significant judgment is required in determining the acquisition date fair value of the assets acquired and liabilities assumed, predominantly with respect to property, plant, and equipment and intangible assets. Evaluations included numerous inputs, including forecasted cash flows that incorporate the specific attributes of each asset. For property, plant, and equipment, the Company considered the remaining useful life of equipment, current replacement costs for similar assets, and comparable market transactions. The Company evaluated all available information, as well as all appropriate methodologies, when determining the fair value of assets acquired, liabilities assumed, and noncontrolling interest. In addition, the Company determined the remaining useful life for property, plant, and equipment and the amortization period and method of amortization for each finite-lived intangible asset.

- 17 -
The following table sets forth the preliminary allocation of the consideration:

In ThousandsMay 31, 2023
Cash and cash equivalents$59,381 
Accounts receivable2,216 
Due from related parties, net19 
Note receivable2,500 
Prepaid expenses and other current assets2,535 
Property, plant and equipment10,588 
Operating lease right-of-use-assets9,519 
Goodwill585,266 
Intangible assets135,429 
Other non-current assets457 
Accounts payable(5,582)
Accrued expenses(3,477)
Accrued compensation(2,859)
Due to related parties(8)
Deferred revenue(1,186)
Current portion of notes payable(517)
Current portion of operating lease obligations(4,687)
Current portion of financing lease obligations(165)
Other current liabilities(17)
Notes payable, net of current portion(749)
Operating lease obligations, net of current portion(6,006)
Financing lease obligations, net of current portion(10)
Royalty liability - related parties(146,360)
Other non-current liabilities(1,536)
Consideration transferred$634,751 


Receivables have been recognized at their fair value, and the Company has not recognized, and it does not expect, any credit losses and therefore expects cash flows to match the recognized receivables.
- 18 -
Intangible Assets Acquired

Intangible assets acquired, and their related estimated average useful lives, are as follows:

In Thousands, except useful lifeMay 31, 2023Estimated Average Useful Life (Years)
In-process research and development$99,051 Indefinite
Developed technology14,148 20
Trade name22,230 20
Total$135,429 


The weighted average amortization period for the Company's definite lived intangible assets, including developed technology and trade names, was 20 years.

The Company incurred expenses of approximately $8.2 million in connection with the completion of the Merger Transactions, of which approximately $0.4 million was recognized in 2022 in the condensed consolidated statements of operations. For the nine months ended September 30, 2023, approximately $3.5 million in legal and professional fees, $1.9 million in severance costs resulting from pre-existing employment agreements, and $1.1 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, were included in SG&A expense in the condensed consolidated statements of operations. Additionally, for the nine months ended September 30, 2023, approximately $1.3 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, was included in R&D expense in the condensed consolidated statements of operations.

The Company's condensed consolidated statements of operations are inclusive of activity relating to the acquired entity, Cibus Global, from the date of acquisition and include $0.7 million in revenue, $35.5 million in net loss attributable to controlling interest, and $9.9 million in net loss attributable to redeemable noncontrolling interest, for the nine months ended September 30, 2023.

These unaudited pro forma figures have been prepared as though the business combination had occurred on January 1, 2022. Pro forma adjustments have been made to reflect non-recurring stock compensation expense, legal and professional fees, severance costs, and amortization of acquired intangible assets, directly attributable to the business combination. The unaudited pro forma condensed financial information is not indicative of the results of operations that would have been achieved had the acquisitions reflected herein been consummated on the dates indicated or that will be achieved in the future.

Three Months Ended September 30,Nine Months Ended September 30,
Unaudited and in Thousands2023202220232022
Pro forma revenues$475 $307 $1,154 $992 
Pro forma net loss(34,528)(20,365)(88,474)(61,603)
Pro forma net loss attributable to controlling interest(24,575)(17,301)(70,855)(53,178)
Pro forma net loss attributable to redeemable noncontrolling interest$(9,953)$(3,064)$(17,619)$(8,425)


Tax Receivable Agreement

In conjunction with the Merger Transactions, the Company entered into a Tax Receivable Agreement (TRA) with the Electing Members. Pursuant to the TRA, the Company generally will be required to pay to the Electing Members, in the aggregate, 85 percent of the net income tax savings that the Company actually realizes (or in certain circumstances, is deemed to realize) as a result of (i) certain favorable tax attributes the Company acquired from the blocker entities party to the Merger Agreement in connection with the Merger Transactions (including net operating losses), (ii) increases to the Company's allocatable share of the tax basis of Cibus Global's assets resulting from future redemptions or exchanges of Common Units for shares of Class A Common Stock or cash, (iii) tax attributes resulting from certain payments made under the TRA and (iv) deductions in respect of interest under the TRA. The payment obligations under the TRA are the Company's obligations and not obligations of Cibus Global.

As of September 30, 2023, no Up-C Units have been exchanged by Electing Members for shares of Class A Common Stock. As of September 30, 2023, the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more-likely-than-not threshold. Since the benefit has not been recorded, the Company determined that the TRA liability is not probable and therefore no TRA liability existed as of September 30, 2023.


- 19 -
3. FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK
Financial Instruments Measured at Fair Value and Financial Statement Presentation
The accounting guidance establishes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as of the measurement date as follows:
Level 1: Fair values are based on unadjusted quoted prices in active trading markets for identical assets and liabilities.
Level 2: Fair values are based on observable quoted prices other than those in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
Level 3: Fair values are based on at least one significant unobservable input for the asset or liability.
Fair Value Measurements and Financial Statement Presentation
The Company’s financial instruments measured at fair value and their respective levels in the fair value hierarchy as of September 30, 2023, and December 31, 2022, were as follows:
 September 30, 2023December 31, 2022
 Fair Value of AssetsFair Value of Assets
In ThousandsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Money market funds (1)$7,389 $— $— $7,389 $— $— $— $— 
Total$7,389 $— $— $7,389 $— $— $— $— 


(1) Included in cash and cash equivalents on the accompanying condensed consolidated balance sheets


September 30, 2023December 31, 2022
Fair Value of LiabilitiesFair Value of Liabilities
In ThousandsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Common Warrants$— $— $1,512 $1,512 $— $— $291 $291 
Total$— $— $1,512 $1,512 $— $— $291 $291 


The following table summarizes the Common Warrants activity for the period ended September 30, 2023:

Level 3 Fair Value of Liabilities
Balance as of December 31, 2022291
Mark to market adjustment1,221
Balance as of September 30, 20231,512


The Company estimates the fair value of the Common Warrants as of the date of issuance and at the end of every fiscal period using a Black-Scholes option pricing model, which requires it to make assumptions regarding future stock price volatility and dividend yield. The Company estimates the risk-free interest rate based on the United States Treasury zero-coupon yield curve for the remaining life of the Common Warrants. The Company estimates its future stock price volatility using a weighted average historical volatility which takes into consideration the Company's historical volatility and historical volatility from a group of guideline companies, over the remaining life of the Common Warrants. The Company does not pay dividends and does not expect to pay dividends in the foreseeable future.
The estimated fair values of the Common Warrants, and the assumptions used for the Black-Scholes option pricing model were as follows:
 As of September 30, 2023As of December 31, 2022
Estimated fair value of Common Warrants$9.54 $1.87 
Assumptions: 
Risk-free interest rate4.7 %4.0 %
Expected volatility107.1 %85.0 %
Expected term to liquidation (in years)3.94.6
- 20 -
As of September 30, 2023, the Company had no other financial instruments measured at fair value.

Concentrations of Credit Risk
The Company invests its cash and cash equivalents in highly liquid securities and interest-bearing deposit accounts. The Company diversifies the risk associated with investing in securities by allocating its investments to a diverse portfolio of short-dated, high investment-grade securities, which it classifies as cash and cash equivalents that are recorded at fair value in its condensed consolidated financial statements. The Company maintains the credit risk in this portfolio in accordance with its internal policies and, if necessary, makes changes to investments to minimize credit risk. The Company has not experienced any counterparty credit losses. As of September 30, 2023, and December 31, 2022, the Company did not hold any short-term investments.

4. PROPERTY, PLANT, AND EQUIPMENT, NET

Property, plant, and equipment, net consists of the following:

In Thousands, except useful lifeUseful Life
(Years)		As of September 30, 2023As of December 31, 2022
Property, plant, and equipment, net:
Buildings
10 - 20
$900 $900 
Leasehold improvements
shorter of lease term or - 15
3,879 364 
Office furniture and equipment
5 - 10
13,570 7,803 
Office furniture and equipment under financing leases
4 - 20
373 414 
Computer equipment and software
3 - 5
3,264 912 
Assets in progressN/A3,272 — 
Total property, plant, and equipment25,258 10,393 
Less accumulated depreciation and amortization(8,061)(5,877)
Total$17,197 $4,516 



Depreciation and amortization expense is as follows:

Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Depreciation and amortization expense$1,225 $369 $2,208 $1,091 


Asset Retirement Obligation

Certain lease agreements require the Company to return designated areas of leased space to its original condition upon termination of the lease agreement. At the inception of such leases, the Company records an ARO and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. To determine the fair value of the ARO, the Company estimates the cost for a third-party to perform the restoration work. In subsequent periods, for each ARO, the Company records operating expense to accrete the ARO liability to full value and depreciation expense against the ARO, over the term of the associated lease agreement. The Company used a credit-adjusted risk free rate of 5.6 percent to discount the future obligation, and an inflation rate of 5.0 percent to determine the future value of the original estimate of restoration costs. The ARO is expected to be resolved in July 2025.

The following table presents the changes in the ARO during the nine months ended September 30, 2023.

In ThousandsAsset Retirement Obligations
Balance as of December 31, 2022$— 
Acquired from merger with Cibus Global, LLC264 
Obligations incurred— 
Accretion expense5 
Balance as of September 30, 2023$269 
- 21 -


5. GOODWILL AND INTANGIBLE ASSETS

Goodwill

In connection with the Merger Transactions with Cibus Global, the Company recognized goodwill totaling $585.3 million. The company had no goodwill prior to the Merger Transactions. Goodwill represents future economic benefits arising from acquiring Cibus Global, primarily due to its strong market position and its assembled workforce that are not individually identified and separately recognized as intangible assets. None of the goodwill recognized is expected to be deductible for income tax purposes.

Intangible Assets

Intangible assets as of September 30, 2023, were as follows:

In ThousandsGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
In-process research and development$99,051 $— $99,051 
Developed technology14,148 236 13,912 
Trade name22,230 370 21,860 
Other150 52 98 
Total$135,579 $658 $134,921 


Total amortization expense is as follows:

Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Amortization expense$459 $5 667 16 


Intangible assets as of December 31, 2022, were immaterial.
As of September 30, 2023, amortization expense for each of the next five years is estimated as follows:

In ThousandsAmortization Expense
Remainder of 2023$458 
20241,833 
20251,833 
20261,833 
20271,833 
20281,833 


6. NOTES PAYABLE

The Company has financed the costs associated with its enterprise science platform annual software license. The financing arrangement for the license has a term of one year and accrues interest at an annual rate of 10.9 percent. The Company makes monthly principal and interest payments. The note related to the annual license matures in July 2024.

Additionally, the Company has purchased various fixed assets using notes. The notes on financed equipment are subject to annual interest rates between 7.3 percent and 17.6 percent and have a weighted average remaining term of 2.8 years. Notes used to finance equipment mature between October 2023 and March 2028.

The Company has also financed certain annual insurance premiums using a note. The insurance note is subject to an annual interest rate of 7.5 percent, has a weighted average remaining term of 0.4 years, and matures in February 2024.
- 22 -

As of September 30, 2023, future minimum payments under notes payable were as follows:

In ThousandsAnnual LicensesFinanced EquipmentInsuranceTotal Notes Payable
Remainder of 2023$93 $137 $290 $520 
2024216 450 194 860 
2025— 351 — 351 
2026— 151 — 151 
2027— 89 — 89 
2028— 15 — 15 
309 1,193 484 1,986 
Less: interest(15)(168)(9)(192)
Total$294 $1,025 $475 $1,794 
Current portion294 396 475 1,165 
Noncurrent portion$— $629 $— $629 
7. STOCKHOLDERS’ EQUITY
Follow-On Public Offering
On February 23, 2022, the Company completed the Follow-On Offering, in which it issued 77,600 shares of Class A Common Stock, Pre-Funded Warrants to purchase up to 77,600 shares of Class A Common Stock, and Common Warrants to purchase up to 158,483 shares of Class A Common Stock, in each case giving effect to the Reverse Stock Splits. The aggregate offering price for each share of Class A Common Stock and accompanying Common Warrant was $70.50, as adjusted for the Reverse Stock Splits. The aggregate offering price for each Pre-Funded Warrant and accompanying Common Warrant was $70.4999, adjusted for the Reverse Stock Splits. In the aggregate, the Company received net proceeds of $10.0 million, after deducting approximately $0.9 million of underwriting discounts and estimated other offering expenses.

Pre-Funded Warrants
Each Pre-Funded Warrant entitled the holder to purchase one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share. While outstanding, the Pre-Funded Warrants were recorded as a component of stockholders’ equity within additional paid-in capital. The Pre-Funded Warrants were exercised in full on May 4, 2022, and subsequently settled with the counterparty.
Common Warrants
Each Common Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $69.04 per share. The Common Warrants became exercisable on August 23, 2022, and expire on August 23, 2027. The Common Warrants are recorded as a liability in the Company’s condensed consolidated balance sheets. Per the terms of the Common Warrants, holders of outstanding Common Warrants are not entitled to exercise any portion of such warrant if, upon exercise, the holder’s ownership of the Company’s Class A Common Stock (together with its affiliates) or the combined voting power of the Company’s securities beneficially owned by such holder (together with its affiliates) would exceed the 4.99 percent after giving effect to the exercise.
Common Warrant transactions for the nine months ended September 30, 2023, are as follows:
 Common Warrants
Weighted Average
Exercise
Price Per Share
Outstanding as of December 31, 2022158,483$69.04 
Issued—— 
Forfeited/canceled—— 
Exercised—— 
Outstanding as of September 30, 2023158,483$69.04 
Exercisable as of September 30, 2023158,483$69.04 
- 23 -

ATM Facility

On September 21, 2021, the Company entered into an Open Market Sale AgreementSM (the ATM Facility) with Jefferies LLC, as sole selling agent. The Company issued approximately 40,000 shares of Class A Common Stock under the ATM Facility in 2022 for net proceeds of $0.1 million. The Company has not issued any additional shares under the ATM Facility during the 2023 fiscal year.

Merger with Cibus Global

At the closing of the Merger Transactions, the Company contributed all of its assets and liabilities to Cibus Global, in exchange for Common Units. The Company issued an aggregate of 16,527,484 shares of Class A Common Stock (including 1,019,282 shares of restricted Class A Common Stock) and 4,642,636 shares of Class B Common Stock to Cibus Global equityholders, as consideration in the Merger Transactions, pursuant to the terms of the Merger Agreement.

Class A Common Stock

Shares of Class A Common Stock have full voting and economic rights. Unvested shares of Class A Restricted Common Stock, which were issued as equity compensation to certain of our employees and executive officers, carry all voting, dividend, distribution, and other rights as apply to shares of Class A Common Stock generally, except that (i) shares of Class A Restricted Common Stock are subject to transfer restrictions and (ii) dividends and distributions are held by the Company until vesting of the underlying shares of Class A Restricted Common Stock and remain subject to the same forfeiture provisions as such shares.

Class B Common Stock

Upon the Closing of the Merger Transactions, the Company issued shares of Class B Common Stock. The Class B Common Stock have full voting rights. The Class B Common Stock have no economic rights and do not participate in dividends or undistributed earnings. However, holders of Class B Common Stock hold a corresponding number of economic, non-voting Common Units through which they would receive pro rata distributions from Cibus Global.

Cibus Global Common Units

In connection with the Merger Transactions, the Company, Cibus Global, and the Electing Members entered into an Exchange Agreement (the Exchange Agreement). The Exchange Agreement sets forth the terms and conditions upon which holders of Up-C Units, comprising an equal number of shares of Class B Common Stock and Cibus Global Common Units, may exchange such Up-C Units for shares of Class A Common Stock. The Up-C Units are generally exchangeable for shares of Class A Common Stock on a one-for-one basis, subject to certain restrictions. The Electing Members’ ownership of Common Units represents the redeemable noncontrolling interest. As of September 30, 2023, there were 21,302,632 Cibus Common Units outstanding. Of the 21,302,632 Cibus Common Units outstanding, 16,659,996 are held by Cibus Inc. and 4,642,636 are held by the Electing Members.

Preferred Stock

Pursuant to the Amended Certificate of Incorporation, following the consummation of the Merger Transactions, the Company is authorized to issue 10,000,000 shares of preferred stock, par value $0.0001 per share. As of September 30, 2023, the Company has not issued any preferred stock.
8. STOCK-BASED COMPENSATION
The Company uses broad-based stock plans to attract and retain highly qualified officers and employees and to help ensure that management’s interests are aligned with those of its shareholders. The Company has also granted equity-based awards to directors, non-employees, and certain employees of Cellectis.
In December 2014, Legacy Calyxt adopted the Calyxt, Inc. Equity Incentive Plan (2014 Plan), which allowed for the grant of stock options, and in June 2017, it adopted the Calyxt, Inc. 2017 Omnibus Plan (2017 Plan), which allowed for the grant of stock options, RSUs, PSUs, and other types of equity awards. As part of the Merger Transactions, the name of the 2017 plan was amended to reflect the name change of the Company.

In July 2021, the Company also adopted the Calyxt, Inc. Employee Inducement Incentive Plan (the Inducement Plan), from which PSUs were granted to Michael A. Carr, the Company's former Chief Executive Officer.
As of September 30, 2023, 1,925,024 shares were available for grant in the form of stock options, restricted stock, RSUs, and PSUs under the 2017 Plan. Stock-based awards currently outstanding also include awards granted under the 2014 Plan. No further awards are available for grant or will be granted under either the 2014 Plan or the Inducement Plan.
Stock Options
The estimated fair values of stock options granted, and the assumptions used for the Black-Scholes option pricing model were as follows:
- 24 -
 Nine Months Ended September 30,
 20232022
Estimated fair values of stock options granted$— $42.83 
Assumptions:  
Risk-free interest rate
—%
1.9% - 3.5%
Expected volatility
—%
89.7% - 92.8%
Expected term (in years)
—
5.50 - 6.89
The Company estimates the fair value of each stock option on the grant date, or other measurement date if applicable, using a Black-Scholes option pricing model, which requires it to make predictive assumptions regarding employee exercise behavior, future stock price volatility, and dividend yield. The Company estimates the risk-free interest rate based on the United States Treasury zero-coupon yield curve at the date of grant for the expected term of the option. The Company estimates its future stock price volatility using a weighted average historical volatility which takes into consideration the Company's historical volatility and historical volatility from a group of guideline companies, over the expected term of the option. The expected term of stock options is estimated using the average of the vesting tranches and the contractual life of each grant for employee options, or the simplified method, as the Company has limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The use of the simplified method is dependent upon the type of equity award granted and the term of the award. The Company has not paid dividends and does not expect to pay dividends in the foreseeable future.
Option strike prices are set at 100 percent or more of the closing share price on the date of grant and generally vest over three to six years following the grant date. Options generally expire 10 years after the date of grant.

Modification of Stock Options

On March 1, 2023, the Company’s Board of Directors (Board) approved the modification of the award terms of all outstanding stock options with a 90-day post-separation exercise period from the current 90 days to five years from date of grant. The modification did not affect the vesting or service period of the stock options. These modifications were considered to be Type I and incremental stock compensation expense of $0.2 million was determined for all modified awards, of which $0.1 million was recognized associated with vested awards in the three months ended March 31, 2023. The remaining incremental expenses will be recognized over the remaining service period of the awards. The service period for these awards ended with the close of the Merger Transactions and the remaining expense was recognized in the three months ended June 30, 2023.
Information on stock option activity is as follows:
 
Options
Exercisable
Weighted Average
Exercise
Price Per
Share
Options
Outstanding
Weighted Average
Exercise
Price Per
Share
Balance as of December 31, 202267,978$496.83 116,860$367.58 
Granted—— —— 
Vested42,195154.28 —— 
Exercised—— —— 
Forfeited or expired(1,530)441.63 (7,309)369.43 
Balance as of September 30, 2023108,643$364.57 109,551$367.46 
Stock-based compensation expense related to stock option awards is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$40 $530 $1,835 $1,420 
As of September 30, 2023, both options outstanding and options exercisable had nominal aggregate intrinsic value and a weighted average remaining contractual term of 4.0 years.
As of September 30, 2023, unrecognized compensation expense related to non-vested stock options was $0.1 million which has a weighted average remaining recognition period of 1.0 year.
Restricted Stock Awards
- 25 -

The Company granted awards of Class A Restricted Stock (RSAs), in connection with the Merger Transactions, to Cibus Global members who held unvested restricted profits interest units. The Class A Restricted Stock will continue to vest following their original vesting schedules over the remaining life of the awards which is generally 2 months to four years after the date of grant. Information on Class A Restricted Stock award activity is as follows:
 
Restricted Stock
Awards
Weighted Average Grant
Date Fair Value
Unvested balance as of December 31, 2022—$— 
Granted1,019,28231.50 
Vested(71,969)31.50 
Forfeited(1,533)31.50 
Unvested balance as of September 30, 2023945,780$31.50 
The total grant-date fair value of RSAs that vested is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Grant-date fair value$1,725 $— $2,267 $— 
Stock-based compensation expense related to RSAs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$5,631 $— $7,555 $— 
As of September 30, 2023, unrecognized compensation expense related to RSAs was $24.5 million which has a weighted average remaining recognition period of 2.5 years.
Restricted Stock Units
The Company grants RSUs which generally vest over three to five years after the date of grant. Information on restricted stock unit activity is as follows:
 
Restricted Stock
Units
Weighted Average Grant
Date Fair Value
Unvested balance as of December 31, 202224,575$99.36 
Granted272,88519.02 
Vested(96,730)38.27 
Forfeited(2,531)127.84 
Unvested balance as of September 30, 2023198,199$18.19 
The total grant-date fair value of RSUs that vested is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Grant-date fair value$100 $530 $3,702 $1,686 
Stock-based compensation expense related to RSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$157 $334 $2,550 $992 
- 26 -
As of September 30, 2023, unrecognized compensation expense related to RSUs was $3.5 million which has a weighted average remaining recognition period of 3.4 years.
The Company accounted for stock-based compensation awards granted to employees of Cellectis as deemed dividends. These awards are fully vested as of December 31, 2022. The Company recorded deemed dividends as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Deemed dividends from grants to Cellectis employees$— $18 $— $82 
Performance Stock Units

From time-to-time, the Company issues PSUs to certain individuals in management in order to align their objectives with stockholders of the Company. Depending upon the type of PSU award, the Company uses a Monte Carlo simulation pricing model when estimating the fair value of these awards.

2023 Grant

On May 24, 2023, the Company granted 24,800 PSUs under the 2017 Plan to five employees including four executive officers. The PSUs included an annual performance period (2023) and target performance levels for the period linked to the achievement of Company objectives as determined annually for the respective period by the Compensation Committee of the Board (Compensation Committee). Once the annual objectives are approved, the associated expense will be recognized on a straight-line basis over the period through the determination date, which can be no later than March 15 of the following year. Earned awards are settled in shares of Class A Common Stock no later than the March 15 determination date in the following calendar year. In connection with the closing of the Merger Transactions, the Company’s Board determined the awards would vest at 100 percent.

2022 Grant

In March 2022, the Company granted 10,600 PSUs under the 2017 Plan to five employees including four executive officers. The PSUs included three annual performance periods (2022, 2023, and 2024) and target performance levels for each of those periods linked to the achievement of Company objectives as determined annually for the respective period by the Compensation Committee. Once the annual objectives are approved, the associated expense will be recognized on a straight-line basis over the period through the determination date, which can be no later than March 15 of the following year. Earned awards are settled in shares of Class A Common Stock no later than the March 15 determination date in the following calendar year. The grant date for the tranche of awards linked to 2022 performance was May 4, 2022, and on March 1, 2023, the Company’s Board determined the 2022 tranche of PSUs would vest at 100 percent. The grant date for the tranche of awards linked to 2023 performance was May 17, 2023, and on May 31, 2023, in connection with the closing of the Merger Transactions, the Company’s Board determined the 2023 tranche of PSUs would vest at 100 percent. Additionally on May 31, 2023, in connection with the closing of the Merger Transactions, the 2024 tranche of PSUs became fully vested.
2021 Grant
In July 2021, the Company granted 12,000 PSUs under the Inducement Plan to Mr. Carr. The PSUs will vest if the Company’s stock remains above three specified price levels for thirty calendar days over the three-year performance period. The PSUs will be settled in shares of Class A Common Stock on the vesting date. At the close of the Merger Transactions on May 31, 2023, 25 percent of these awards vested per the terms of the award agreement, and the remaining awards were forfeited due to the service period ending with Mr. Carr's termination upon the close of the Merger Transactions.
2019 Grant
In June 2022, PSUs granted to two executive officers in 2019 were forfeited because the underlying performance criteria were not met. These PSUs contained a market condition and had a five-year service period. At the close of the Merger Transactions, both of these executive officers were terminated. All expense for these awards was reversed in June 2023 due to the service period ending prior to vesting date.
PSU activity for the nine months ended September 30, 2023, is as follows:
 Performance Stock Units
Outstanding as of December 31, 202222,600
Issued24,800
Forfeited/canceled(9,333)
Exercised(38,067)
Outstanding as of September 30, 2023—
- 27 -
Stock-based compensation expense related to PSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation (benefit) expense$— $171 $(270)$478 
As of September 30, 2023, there is no unrecognized compensation expense related to PSUs.
9. INCOME TAXES

The Company provides for a valuation allowance when it is more likely than not that it will not realize a portion of the deferred tax assets. The Company has established a full valuation allowance for deferred tax assets due to the uncertainty that enough taxable income will be generated in the taxing jurisdiction to utilize the assets. Therefore, the Company has not reflected any benefit of such deferred tax assets in the accompanying condensed consolidated financial statements.

The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates, and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. The Company did not record any income tax provision for the three months ended September 30, 2023, due to its history of net operating losses, and the maintenance of a full valuation allowance against its net deferred tax assets.

As of September 30, 2023, there have been no Up-C Units exchanged by Electing Members for Class A Common Stock. As described in Note 2, the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more-likely-than-not threshold. Since the benefit has not been recorded, the Company determined that the TRA liability is not probable and therefore no TRA liability existed as of September 30, 2023.
As of September 30, 2023, there were no material changes to what the Company disclosed regarding tax uncertainties or penalties as of December 31, 2022.
10. LEASES, COMMITMENTS, AND CONTINGENCIES
Leases

The Company had an equipment financing arrangement at the Roseville, Minnesota location that was considered a financing-type lease. This equipment financing arrangement was repaid in full in the first quarter of 2023. The Company was required to deposit cash into a restricted account in an amount equal to the future rent payments required by the lease. As of March 31, 2023, the remaining restricted cash had been returned to the Company.

Upon the completion of the Merger Transactions, the Company assumed financing leases for certain equipment. In the third quarter of 2023, the Company added a financing lease for hardware and software. The ROU asset is included in other non-current assets in the condensed consolidated balance sheets.

The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:

 As of September 30, 2023As of December 31, 2022
In Thousands, except remaining termRemaining Term (years)Right-of-Use-AssetRemaining Term (years)Right-of-Use-Asset
Roseville, Minnesota lease14.6$13,244 15.3$13,613 
San Diego, California laboratory lease1.93,848 — — 
San Diego, California headquarters lease1.73,710 — — 
San Diego, California greenhouse lease4.91,541 — — 
Other leases
< 1.0 - 3.0
592 
< 1.0
2 
Total$22,935 $13,615 

The Roseville, Minnesota lease includes four options to extend the lease for five years. These options to extend the lease are not recognized as part of the ROU assets and operating lease liabilities as it is not reasonably certain that the Company will exercise those options. The Company’s lease agreement does not include options to terminate the lease.

Upon the completion of the Merger Transactions, the company assumed additional operating leases.

The lease for the Company's San Diego, California headquarters includes office and laboratory space with terms that expire in May 2025 and August 2025, respectively. The Company has one option to extend the laboratory space lease for one year. As the Company is not
- 28 -
reasonably certain to exercise this option at lease commencement, the option was not recognized as part of the associated operating lease ROU asset or liability.

Additionally, the Company has certain leases for greenhouse and warehouse facilities, with terms that expire in August 2028 and August 2026, respectively. The Company had one option to extend the term of the greenhouse lease, for five years, and executed this right with an amended lease agreement beginning in September 2023 and expiring at the end of August 2028. There are no other options to extend this lease. The Company has one option to extend the warehouse lease, for five years. However, as the Company is not reasonably certain to exercise either of those options at lease commencement, neither option was recognized as part of the associated operating lease ROU asset or liability.

Certain leases include rent abatement, rent escalations, tenant improvement allowances, and additional charges for common area maintenance and other costs. The Company is required to pay base rent expense as well as its proportionate share of the facilities operating expenses. The non-lease components, consisting primarily of common area maintenance, are paid separately based on actual costs incurred. Therefore, the variable non-lease components were not included in the ROU asset or lease liability and are reflected as expense in the period incurred.

The components of lease expense were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Finance lease costs$65 $57 $79 $73 
Operating lease costs1,635 381 2,830 1,174 
Total$1,700 $438 $2,909 $1,247 
Operating lease costs for short-term leases was not material for the three and nine months ended September 30, 2023, or 2022.
Supplemental cash flow information related to leases was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands, except for lease term and discount rate 2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows (operating leases)$1,297 $70 $1,848 $205 
Financing cash flows (finance leases)$132 $163 $242 $353 
- 29 -

Supplemental balance sheet information related to leases was as follows:
As of September 30, 2023As of December 31, 2022
OperatingFinancingOperatingFinancing
Weighted average remaining lease term (years) 10.51.415.30.4
Weighted average discount rate 7.5 %9.5 %7.9 %8.1 %
As of September 30, 2023, future minimum payments under operating and finance leases were as follows:
In Thousands
Operating
Financing
Total
Remainder of 2023$1,758 $40 $1,798 
20247,132 210 7,342 
20254,797 120 4,917 
20261,993 — 1,993 
20271,920 — 1,920 
20281,863 — 1,863 
Thereafter15,438 — 15,438 
 34,901 370 35,271 
Less: interest(10,621)(33)(10,654)
Total$24,280 $337 $24,617 
Current portion5,436 235 5,671 
Noncurrent portion$18,844 $102 $18,946 
Cibus Non-Profit Foundation

During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.

This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.

Litigation and Claims

In the fourth quarter of 2022, the Company reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, the Company received $0.75 million in the fourth quarter of 2022, and it received the final installment of $0.75 million in the first quarter of 2023.
The Company is not currently a party to any material pending legal proceeding.

11. ROYALTY LIABILITY - RELATED PARTIES

The Royalty Liability was assumed following the Company’s acquisition of Cibus Global in the Merger Transactions. In 2014, Cibus Global entered into the Warrant Exchange Agreement with certain members holding Series A Preferred Units, including members of the
- 30 -
board of directors and management of Cibus Global, who were also the holders of warrants to purchase Series A Preferred Units. Under the Warrant Exchange Agreement, the Royalty Holders are entitled to future royalty payments equal to 10 percent of the subject revenues (Subject Revenues), as defined, which includes all royalty revenues earned by Cibus Global, for licensing of plant traits to seed companies that use traits developed by the Company, but excludes specifically, (i) revenues attributable to the Nucelis product line, (ii) amounts received from the sale or disposition of the Company’s assets to the extent the purchaser agrees to be bound by the Warrant Exchange Agreement, (iii) payments for Cibus Global capital stock, and (iv) revenues attributable to collaboration and research projects. Royalty payments will not begin until the first fiscal quarter after which the aggregate Subject Revenues during any consecutive 12-month period equals or exceeds $50.0 million, at which point Cibus Global will be obligated to pay all aggregated but unpaid payments under the Warrant Exchange Agreement. This condition had not occurred as of September 30, 2023. Additionally, Cibus Global granted the Royalty Holders a continuing security interest in certain intellectual property of Cibus Global to secure the payment and performance of obligations of Cibus Global under the Warrant Exchange Agreement. The initial term of the Warrant Exchange Agreement is 30 years and may be extended for an additional 30-year term if the holders provide written notice and make a payment of $100.

For purposes of determining the Royalty Liability, the Company estimates the total amount of future revenues expected to be received from the Company's customers over the life of the agreement. The Company then calculates the amount of future royalty payments required to be paid based upon the estimated future revenues. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. Any change in expected future royalty payments is recognized prospectively as an adjustment to the effective yield as interest expense. As of September 30, 2023, the Royalty Liability reflected an effective yield of 23.7 percent.

As of September 30, 2023, the Royalty Liability activity is as follows:

In ThousandsRoyalty Liability - Related Parties
Balance as of December 31, 2022$— 
Acquired from merger with Cibus Global, LLC146,360 
Interest expense recognized10,753 
Balance as of September 30, 2023$157,113 

12. SUPPLEMENTAL INFORMATION
Certain balance sheet amounts are as follows:
In ThousandsAs of September 30, 2023As of December 31, 2022
Accrued Expenses:
Accrued consulting and professional fees$2,980 $119 
Accrued field trials1,716 — 
Other396 54 
Total$5,092 $173 
Certain statement of operations amounts are as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense:
Research and development$2,853 $210 $5,531 $620 
Selling, general, and administrative2,975 825 6,139 2,270 
Total$5,828 $1,035 $11,670 $2,890 
Supplemental statement of cash flows information is as follows:
 Nine Months Ended September 30,
In Thousands20232022
Interest paid$98 $67 
- 31 -
Non-cash transactions not reported in the condensed consolidated statement of cash flows is as follows:
 Nine Months Ended September 30,
In Thousands20232022
Receivable from Jefferies for shares issued under ATM facility$— $(260)
Property, plant, and equipment acquired through assuming liabilities419 (687)
Shares issued for consideration in the merger with Cibus Global634,751 — 
Forgiveness of interim funding resulting from merger with Cibus Global2,500 — 
Cumulative effect of adoption of lease accounting standard on stockholders’ equity— 832 
Establishment of financing lease right-of-use assets and associated operating lease liabilities307 — 
Establishment of operating lease right-of-use assets and associated operating lease liabilities$1,606 $14,090 



13. INTERIM FUNDING

Pursuant to the Merger Agreement, beginning at the earlier of March 15, 2023, and the date the Company's unrestricted cash balance first dropped below $1.5 million, the Company could request, and Cibus Global agreed to provide, an unsecured, interest-free revolving line of credit of up to $3.0 million in cash (Interim Funding). Funds could be drawn by the Company in $0.5 million increments and could only be used to fund operating expenses incurred in the ordinary course of business consistent with past practice and consistent with the negative covenants in the Merger Agreement. The Company received $2.5 million of Interim Funding in the aggregate from Cibus Global. The full balance of the Interim Funding was reduced to zero in connection with the closing of the Merger Transactions pursuant to the terms of the Merger Agreement.

14. COLLABORATION AGREEMENT

Prior to the Merger Transactions, Cibus Global and Procter & Gamble (P&G), a leading multi-national consumer product company, entered into a collaboration agreement under which P&G will fund a multi-year program to develop sustainable low carbon ingredients or materials that do not negatively impact the environment during production, use, or disposal to help P&G advance its sustainability objectives. As of September 30, 2023, the Company had $1.6 million of deferred revenue from R&D activities under the P&G agreement. The Company has determined the P&G agreement should be accounted for under Topic 606, and it will recognize revenue over time proportional to the R&D activities performed by the Company related to the collaboration agreement. During the nine months ended September 30, 2023, the Company recognized $0.4 million in revenue in the condensed consolidated statements of operations.
15. RELATED-PARTY TRANSACTIONS
Prior to the completion of the Merger Transactions, the Company was party to several agreements that governed its relationship with Cellectis, some of which required the Company to make payments to Cellectis. Pursuant to the Company’s management services agreement with Cellectis, it incurred no management fee expenses for the three and nine months ended September 30, 2023, and 2022. The management services agreement was terminated with respect to the Company upon the closing of the Merger Transactions.

Cellectis has guaranteed the lease agreement for the Company’s Roseville, Minnesota facility. Cellectis’ guarantee of the Company’s obligations under the lease will terminate at the end of the second consecutive calendar year in which the Company’s tangible net worth exceeds $300 million. The Company agreed to indemnify Cellectis for any obligations incurred by Cellectis under its guaranty of the obligations under the lease, effective upon Cellectis’ ownership falling to 50 percent or less of the Company’s outstanding common stock. This indemnification obligation was triggered in October 2022.
TALEN® is one of the Company's gene editing technologies. TALEN® technology was invented by researchers at the University of Minnesota and Iowa State University and exclusively licensed to Cellectis. The Company originally obtained an exclusive license for the TALEN® technology for commercial use in plants from Cellectis. Upon the closing of the Merger Transactions, the license agreement was amended (the Amended Cellectis License) to provide exclusive use to certain intellectual property in the field of developing and commercializing microorganism, agricultural, and food products, including, but not limited to traits, seeds, proteins, oils, carbohydrates, food, and food and animal feed ingredients, excluding (i) any application in connection with animals and animal cells and (ii) therapeutic applications (the Calyxt Field). This grant is non-exclusive solely in the non-exclusive fields as described in the Amended Cellectis License. Cellectis also grants to the Company a non-exclusive, worldwide, perpetual, irrevocable, royalty-free, and fully paid-up license (with certain rights to sublicense) under certain licensed plant patents in the Calyxt Field. Cellectis is entitled to royalties on any revenue the Company generates from sales of products less certain amounts as defined in the license agreement, royalties on certain cumulative revenue thresholds, and a percentage of any sublicense revenues. The Company has incurred nominal license and royalty fees for the three and nine months ended September 30, 2023, and 2022.

Prior to the Merger Transactions, amounts payable to Cellectis were reported in the Company's condensed consolidated balance sheets as Due to related parties. Beginning with the three months ended June 30, 2023, any amounts payable to Cellectis are included in accrued
- 32 -
expenses in the Company's condensed consolidated balance sheets.

16. SUBSEQUENT EVENTS

Strategic Realignment

On October 18, 2023, Cibus implemented a strategic realignment to align with its primary commercial objective of advancing its late-stage activities.

The strategic realignment resulted in a reduction in workforce in full time employees from 242 full-time employees as of October 17, 2023, to approximately 185 full-time employees. The Company estimates that it will incur approximately $0.5 million of one-time costs in connection with the reduction in workforce, primarily related to cash payments for accrued vacation and severance payments. The Company expects the majority of the associated costs to be incurred during the quarter ending December 31, 2023.

Loan Agreement

On October 20, 2023, Cibus entered into a binding term sheet (Binding Term Sheet) with Rory Riggs, the Company’s Chairman and Chief Executive Officer. Pursuant to the Binding Term Sheet, Mr. Riggs has agreed to make available to the Company a line of credit (the Loan) in the aggregate principal amount of $5.0 million (the Loan Amount). Cibus may make draws, in increments of $1.0 million, against the Loan Amount at any time during the period commencing January 1, 2024, and terminating on March 1, 2024. Amounts drawn under the Loan will bear simple interest at a rate of 12 percent per annum and are repayable at maturity on January 1, 2026. The Loan is unsecured and may be prepaid by the Company at any time without penalty. The Binding Term Sheet shall automatically terminate if the Company secures debt and/or equity financing in the aggregate amount of $20.0 million prior to January 1, 2024.
- 33 -
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of the Company’s financial condition and results of operations should be read together with its condensed consolidated financial statements and related notes, which are included elsewhere in this Quarterly Report on Form 10-Q and with its Annual Report, including the Consolidated Financial Statements and Notes incorporated therein.

OVERVIEW AND BUSINESS UPDATE

Cibus is a leading agricultural technology company that uses its proprietary gene editing technologies to develop and license traits to seed companies for royalties. The company is a technology leader in developing traits (or specific genetic characteristics) using gene editing. Its primary business is the development of productivity traits in major agricultural crops, such as canola, rice and soybean. Productivity traits help make farmers more productive, thereby driving greater farming profitability and efficiency. They do this in several ways such as making plants resistant to diseases or pests, thereby reducing the use of chemicals like fungicides and insecticides, enabling plants to process nutrients more efficiently, thereby reducing the use of fertilizers, and making crops more adaptable to their environment and to climate change.

In agriculture, gene editing is an advanced plant breeding technology. The promise of gene editing in agriculture is the ability to develop new plant traits that are indistinguishable from traits developed using conventional breeding but that can be developed at a fraction of the time and cost of conventional breeding or genetically-modified organism (GMO) breeding technologies. To many, gene editing represents agriculture’s “analog to digital” technology moment. It is a technology that promises to change the speed and scale of trait development.

The closing of the Merger Transactions in the second quarter of 2023 brought together two pioneers in the gene editing business combining their technology platforms and facilities to create a leader in precision gene editing focused on driving sustainable agriculture. This established one of the world’s most sophisticated facilities for trait development and next-generation plant breeding and consolidated important gene editing intellectual property and technologies of both companies.

In the second quarter of 2023, Cibus opened its Oberlin facility (Oberlin Facility), the first stand-alone high-throughput (gene editing) trait development facility for editing plants. The core of the Oberlin Facility is the Company's patented technology platform process called the Rapid Trait Development System™ or RTDS® (RTDS) which is covered by over 400 patents or patents pending. RTDS is the underlying technology platform for the Company's high-throughput semi-automated gene editing system that directly edits seed companies’ elite germplasm. The Company calls this semi-automated high-throughput system, the Trait Machine System (Trait Machine™). It is a time bound, reproducible, and predictable science-based breeding process. In addition, Legacy Calyxt has significant patented agricultural gene editing technologies including the exclusive rights to TALEN® for use in plants.
Importantly, in many countries, regulations have separated gene edited traits from traits developed using GMO technologies as long as the gene edited technologies, such as RTDS, do not contain transgenes in their final products. Over the past few years, many countries such as the US, Canada, large parts of South America, India, and Japan, have introduced regulations or guidelines for crop varieties that were developed using genome editing that enable the use of such edited lines in agriculture in a similar way as conventionally bred lines, provided, they do not contain a transgene or foreign genetic material. More recently in Europe, the UK approved a law to exempt genome-edited crops from GMO regulations. In parallel, the EU recently published proposed regulations that would also treat most gene edited lines in a similar way to conventional breeding. These regulatory distinctions are an important element of why gene edited traits are considered the beginning of the post GMO era in agriculture.

Because the Trait Machine is intended to be integrated into seed companies’ breeding operations, the customer relationship between Cibus and seed companies with which it engages is a progressive relationship. Typically, the customer relationship is initiated with Cibus through the entry into a material transfer agreement pursuant to which seed companies transfer elite germplasm lines to Cibus for gene-editing and delivery back to the seed company for pre-commercialization testing and validation. Accordingly, Cibus refers to seed company “customers” in its disclosure once such a customer relationship has been initiated. At present, all of the Company's customers discussed in this overview and business update are at this initial stage of a relationship. While this initial stage of such customer relationships is a necessary prerequisite to the entry into a revenue generating commercial contract with such seed companies, currently, Cibus has certain customer relationships which include commercial contract terms, however as the potential products are in various stages of development, including some in field testing, they have not yet generated revenue.

Cibus believes that RTDS and its Trait Machine, represent the technological breakthrough in plant breeding that is the ultimate promise of plant gene editing: the ability to materially accelerate the trait breeding process that currently averages more than a decade. The Trait Machine materially changes not only the scale and speed of the breeding process, but it also exponentially changes the range of possible genetic solutions from breeding and with it, the capability to develop desired characteristics or traits needed for greater farming sustainability and food security. The Oberlin Facility is operational and is currently serving canola (oil seed rape), and rice customers, and is expected to service soybean customers as the system comes fully online with respect to soybean in 2024. In the more distant future, gene editing technologies from Cibus and others has the potential to accelerate agriculture’s jump to a climate smart, more sustainable crop production system and industry’s move to sustainable low carbon ingredients.

2023 has been a major inflection point for Cibus. It transitioned from a primarily research-focused company to a primarily commercial-focused company based on its successful development of three important productivity traits for canola and rice and its development of its scalable editing platform in canola and rice. Based on the completion of successful validation field trials for these traits, the Company has witnessed increased demand for these traits based on customers observing trait performance in field trials. In addition, due to the speed with which the company is able to develop new traits, it has two advanced traits under development for Sclerotinia resistance and
- 34 -
a new broad leaf herbicide trait. What added to this major inflection point was the opening of the Oberlin Facility, a stand-alone gene editing facility, that is projected to enable Cibus to meet the editing demand from its new customer base to introduce its new traits to multiple lines on an accelerated basis. Lastly, the final highlight in this inflection year is the positive progress the Company has made in the development of an editing platform for soybean, including significant advances toward enabling a scalable editing system for soybean. The key system work is expected to be completed in the fourth quarter of 2023, with the soybean platform expected to be operational in 2024. Soybean is a 200+ million-acre crop for which our Sclerotinia and HT2 traits would have enormous potential to provide an important impact on productivity and value for soybean farmers. Once built, the editing platform for soybean could be a major platform for developing alternative oils that have the potential to replace traditional less sustainable sources of oils such as palm oil and palm kernel oil.

The Company's three initially developed traits are critical components of its commercial business. They address important needs for canola and rice crops. Together, they form a diverse product line of three key traits across multiple crops and geographies where these crops are grown. The Company's two additional advanced traits and its progress toward adding a third crop, soybean, to its Trait Machine fill out its pipeline with five traits and three crops creating an over 250 million-acre commercial opportunity. For each of these traits, Cibus would be paid trait royalties for each acre of seed a customer sells that incorporates a Cibus trait. This is identical to the trait royalty payments made to GMO trait providers for traits such as insect tolerance (using the BT trait) or glyphosate tolerance. These payments are typically made at the end of each season for each acre the seed is sold on.

•Its pod shatter reduction (PSR) trait in canola and winter oilseed rape (WOSR), strengthens the sheath around the canola seeds that is important to maintaining yields in high winds and extreme weather. Cibus has multiple years of successful field trials with this trait. Cibus currently has ten seed customers for PSR in canola and WOSR that have transferred to Cibus their elite germplasm for editing. These customers represent approximately 20 million acres of potential opportunity for the Company's traits to be deployed on. Cibus has edited each customer’s canola/WOSR breeding lines and has begun transferring back to them their elite germplasm with the PSR trait. The first was to Nuseed in the first quarter of 2023. Through the third quarter of 2023, Cibus has transferred three elite germplasm to different customers with the PSR trait. Taking advantage of the new rules in the UK for gene edited traits, a potential opportunity for expansion into WOSR crops in the UK with this trait was created when Cibus started field trials in the UK in the summer of 2023.

•The Company's herbicide tolerance (HT) traits HT1 and HT3 in rice fulfill an important need in rice farming because rice has not had the benefit of the widely used GMO traits for weed management that benefited, canola, corn, and soybean. These traits provide resistance to two different herbicides that could be used in rice farming. Cibus has multiple years of field trials in rice for both traits. Based on these trials, Cibus has developed strong customer potential in North and South America and has begun transferring their elite germplasm to Cibus. The Company made its first rice transfer back to Nutrien in the second quarter of 2023. Herbicide resistance will form an economic base for Cibus in parallel with the development of multiple traits in canola.

•The Company's two advanced traits for Sclerotinia resistance and for HT2 are both being developed for canola and WOSR. Sclerotinia is the costliest disease in canola and WOSR. In some seasons, farmers can lose a majority of their crop yield to Sclerotinia. It will be both an extremely important and valuable trait for canola/WOSR. HT2 is a new herbicide tolerance trait for broad leaf weeds. Because of the developing resistance of weeds due to overused herbicides, new herbicide traits are important and a key target for gene editing technologies. Together with PSR, these advanced traits will form an extremely important family of traits for Cibus.

•Soybean is expected to be the third leg of the Company's economic base and the key system work is expected to be completed in the fourth quarter of 2023, with the Trait Machine for soybean operational and initiating edits in 2024 with its lead customer GDM, the leading soybean seed company in South America. Both traits have strong demand in soybean which is a large 200+ million-acre crop. With canola and rice and the two advanced traits, soybean has the potential to provide a large third economic base for Cibus.

The three crops: canola, rice, and soybean; with the Company's five traits: PSR, HT1, HT2, HT3, and Sclerotinia resistance make up the core of its three crop-five trait business model which is the central focus of its business. The three crop-five trait core focus represents both an enormous business opportunity and an economic base from which to build Cibus upon. The three developed traits in canola and rice have strong customer demand already and initial transfers of customer elite germplasm have already started towards commercialization in the field.

Cibus sees its business as the start of the important gene editing industry in agriculture, an industry characterized by the ability to do high-throughput gene editing serving as extensions of seed company plant breeding operations. Further, there is great demand for the ability to develop complex traits such as disease resistance which historically has been very difficult to deliver. Cibus is a leader in this vision. Cibus and its Trait Machine do not compete with breeding operations, they augment them. Cibus provides traits that it edits in the elite germplasm of its customers for commercialization. Its role is to improve the efficiency and effectiveness of developing the complex traits needed to address agriculture’s, and farmers’, most pressing productivity issues. Importantly, Cibus and its Trait Machine provide the ability to efficiently gene edit these new traits directly into elite germplasm of major crops. Cibus sees itself as the leader in both gene editing process and trait development aspects of this new industry.

The Company has incurred net losses since its inception. As of September 30, 2023, the Company had an accumulated deficit of $262.7 million. The Company’s net losses were $60.4 million for the nine months ended September 30, 2023. As Cibus continues to develop its pipeline of productivity traits and as a result of its limited commercial activities, Cibus expects to continue to incur significant expenses and operating losses for the next several years. Those expenses and losses may fluctuate significantly from quarter-to-quarter and year-to-year.

Strategic Realignment
- 35 -


On October 18, 2023, Cibus implemented a strategic realignment to align with its primary commercial objective of advancing its late-stage activities. In particular, Cibus is focusing its operations on completing the launch of its first three traits—PSR, HT1, and HT3—in its crop programs in canola, WOSR, and rice, enabling its soybean platform, and advancing its Sclerotinia resistance trait and HT2 trait in canola, WOSR, and soybean.

The Company believes that this refocusing on its strengths and highest priorities best positions it to meet its strategic objectives.

The strategic realignment resulted in a reduction in workforce in full time employees from 242 full-time employees as of October 17, 2023, to approximately 185 full-time employees. This reduction was intended to align the Company’s human capital resources to meet its commercial and strategic goals. The Company communicated the workforce reduction to affected employees on October 18, 2023, and expects the majority of the associated costs to be incurred during the quarter ending December 31, 2023.

As part of the strategic realignment, the Company has also initiated cost reduction initiatives designed to preserve capital resources for the advancement of its priority objectives, which initiatives include reductions in capital expenditures, streamlining of independent contractor utilization, and prioritization of near-term payment obligations.
RELATIONSHIP WITH CELLECTIS AND COMPARABILITY OF RESULTS
Prior to the completion of the Merger Transactions, the Company's largest shareholder was Cellectis, which owned approximately 48.0 percent of the Company’s issued and outstanding common stock. Immediately following the completion of the Merger Transactions, Cellectis reported in a Schedule 13D filing that it held 2.9 percent of the Company's outstanding Class A Common Stock and did not hold any of the Company's Class B Common Stock. Upon the completion of the Merger Transactions, Cellectis no longer possesses any contractual governance rights under the Company's Amended Certificate of Incorporation or bylaws.

Cellectis has guaranteed the lease agreement for the Company’s Roseville, Minnesota facility. However, the Company previously agreed to indemnify Cellectis for any obligations under this guaranty, effective upon Cellectis’ ownership falling to 50 percent or less of the Company’s outstanding common stock. Accordingly, the Company’s indemnification obligation was triggered in October 2022.
The Company holds a license from Cellectis that broadly covers the use of engineered nucleases for plant gene editing. Information about the license can be found in Note 15 to the unaudited condensed consolidated financial statements.
FINANCIAL OPERATIONS OVERVIEW
Revenue
Revenue is recognized from research collaboration agreements, sales of products, from licenses of technology, and from product development activities for customers.

Collaboration and research revenues are primarily related to revenues earned from performance obligations under collaboration arrangements. Pursuant to the terms of the collaboration agreements, the Company receives non-refundable payments for ongoing R&D activities, reimbursements of R&D costs, and milestone payments upon the achievement of certain scientific, regulatory, or commercial milestones. Pursuant to the collaboration agreements, the Company also will receive royalty payments in connection with the sale of commercialized products containing the traits that are subject to those agreements.
In the future, the Company may continue to generate revenue from collaboration and research agreements, but it expects an increasing amount of its revenue to come from royalty payments relating to its trait development activities. The Company is using advanced technologies, including RTDS, to develop desirable plant traits for the global seed industry. The Company plans to sell or license its developed traits with royalty revenue from these licensing agreements increasingly becoming its main source of future revenues.
The Company's ability to generate substantial revenue from plant traits depends upon the ability to further expand its Trait Machine/RTDS platforms, which are fundamental for multiple different plant traits. The Company is advancing the licensing for commercialization by seed companies of traits developed using RTDS and currently has three “developed” traits for two global crops.

Research and Development Expenses
The company's R&D expenses primarily consist of expenses incurred while performing activities to discover and develop potential product candidates and to establish Trait Machine/RTDS platforms such as:
•personnel costs, including salaries and related benefits, for employees engaged in scientific R&D functions;
•cost of third-party contractors and consultants who support its product candidate and Trait Machine/RTDS platform development;
•development costs associated with seed increases (small-scale and large-scale testing) for trait validation;
•purchases of laboratory supplies and non-capital equipment used for its R&D activities;
•facilities costs, including rent, utilities, and maintenance expenses, allocated to R&D activities; and
•costs of in-licensing or acquiring technology from third parties.

The Company's R&D efforts are focused on advancing its existing product candidates, enhancing its product candidate pipeline through the development of additional traits within its Trait Machine/RTDS platforms, and establishing additional Trait Machine/RTDS
- 36 -
platforms for the development and advancement of additional traits. The Company's infrastructure resources are utilized across multiple R&D programs. In addition, employees typically work across multiple R&D programs. The Company manages certain activities, such as field trials and seed production, through third-party vendors. Due to the number of ongoing projects and its ability to use resources across several projects, it does not record or maintain information regarding the costs incurred for its R&D programs on a program-specific basis.

The Company's R&D efforts are central to its business and account for a significant portion of its operating expenses. R&D expenses are expected to increase for the foreseeable future as the product candidate pipeline is expanded, additional Trait Machine/RTDS platforms are established, additional technologies are developed or acquired and additional personnel are hired to support product development. Additionally, product candidates in later stages of development generally have higher development costs than those in earlier stages of development, primarily due to the increased expense associated with large-scale field testing and seed increases (small scale and large-scale) for trait validation.

The Company recognizes R&D expenses as they are incurred, primarily due to the uncertainty of future commercial value. At this time, it cannot reasonably estimate or know the nature, timing, and estimated costs of the efforts that will be necessary to complete the development of its current product candidates or any new product candidates that may be identified and developed. The duration, costs, and timing of development of its product candidates are subject to numerous uncertainties and will depend on a variety of factors, including:
•levels of hiring and retaining R&D personnel;
•the extent to which any serious adverse events in its field trials are encountered;
•the impact of any business interruptions to operations or to those of the third parties with whom the Company works with; and
•the impact of any new or changing government regulations related to its product candidates.
Any of these factors could significantly impact the costs, timing, and viability associated with the development of its product candidates.

Prior to the second quarter of 2023, the Company recognized its intellectual property portfolio and costs to write and support the research for filing patents as R&D expense. It made the decision to classify these expenses as part of selling, general, and administrative (SG&A) expense going forward. The amounts in the prior reporting periods are not material and as such no historical amounts have been reclassified.

Selling, General, and Administrative Expenses
SG&A expense consists primarily of employee-related expenses, such as salaries for its executive, business development, legal, intellectual property, information technology, finance, human resources, and other administrative functions. These costs include legal, professional, and consulting fees for external firms and contractors. All selling and marketing expenses, including advertising expenses and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization, are included in SG&A expense in the accompanying condensed consolidated statements of operations.

Beginning in the second quarter of 2023, SG&A expense includes costs related to its intellectual property portfolio and costs to write and support the research for filing patents. Historically, the Company expensed patent application costs and related legal costs for maintenance of such patents as incurred and such costs were included in R&D expense in the accompanying condensed consolidated statements of operations.

Royalty Liability Interest Expense - Related Parties

Royalty liability interest expense – related parties (Royalty Liability Interest) is based on the warrant exchange agreement (Warrant Exchange Agreement) Cibus Global entered into in 2014, which remains in place following the Company's acquisition of Cibus Global in the Merger Transactions, Cibus Global is required to make ongoing quarterly payments equal to a portion of the aggregate amount of certain worldwide revenues received during the applicable quarter. The Company refers to such payment obligations as its Royalty Liability. Management estimates the total amount of royalty payments over the life of the Warrant Exchange Agreement that Cibus Global will be required to make to holders of certain warrants (Royalty Holders) that were exchanged for the rights to future royalty payments pursuant to the Warrant Exchange Agreement. See Note 11 to the accompanying unaudited condensed consolidated financial statements for information related to the calculation and valuation of the Royalty Liability.

The Company expects the Royalty Liability balance to continue to increase each year until the accretion of Royalty Liability Interest, which increases the Royalty Liability, outpaces the cash payments for royalties due, which decreases the Royalty Liability. Similarly, the Company also expects the related non-cash Royalty Liability Interest it records to increase in conjunction with the underlying Royalty Liability balance. There are risks associated with the Royalty Liability. See “Risk Factors—Risks Related to Cibus’ Organization and Operation—Cibus’ Royalty Liability may contribute to net losses for Cibus and cause the value for securities of Cibus to fluctuate,” included in the Closing 8-K.

Other Interest Income (Expense), net
Other interest income (expense), net is comprised of interest income resulting from investments of cash and cash equivalents and interest expense incurred related to financing lease obligations and notes payable. It is also driven by balances, yields, and timing of financing and other capital raising activities.

Non-Operating Income (Expenses)
- 37 -


Non-operating income (expenses) are income or expenses that are not directly related to ongoing operations and are primarily comprised of gains and losses from the mark-to-market of Common Warrants, gain from a legal settlement, and foreign exchange-related transactions.

Revenues and Costs

Prior to the Merger Transactions, Legacy Calyxt reduced employee headcount and streamlined and focused business activities on a limited scope of core projects. Subsequent to the completion of the Merger Transactions, the Company’s employee headcount increased as a result of the acquisition of Cibus Global. As of September 30, 2023, the Company had 236 employees.
RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023, COMPARED TO THE THREE MONTHS ENDED SEPTEMBER 30, 2022
A summary of the Company’s results of operations for the three months ended September 30, 2023, and 2022 follows:
 
Three Months Ended September 30,
In Thousands, except per share and percentage values
2023
2022
$ Change
% Change
Revenue$475 $42 $433 1,031 %
Research and development17,521 3,016 14,505 481 %
Selling, general, and administrative8,751 3,229 5,522 171 %
Loss from operations(25,797)(6,203)(19,594)(316)%
Royalty liability interest expense - related parties(8,136)— (8,136)NM
Other interest income (expense), net281 (47)328 698 %
Non-operating income (expenses)(876)300 (1,176)(392)%
Net loss$(34,528)$(5,950)$(28,578)(480)%
Net loss attributable to redeemable noncontrolling interest(8,099)— (8,099)NM
Net loss attributable to Cibus, Inc.$(26,429)$(5,950)$(20,479)(344)%
Basic and diluted net loss per share of Class A common stock$(1.59)$(6.36)$4.77 75 %

NM – not meaningful

Revenue

Revenue was $0.5 million in the third quarter of 2023, an increase of $0.4 million, or 1,031 percent, from the third quarter of 2022. The increase was driven by the addition of Cibus Global revenue which included amounts earned from collaboration agreements related to contract research for rice and soybean. Revenue in the third quarter of 2023 and 2022 from Legacy Calyxt's operations was primarily associated with the Company’s agreement with a large food ingredient manufacturer to develop a palm oil alternative.

Research and Development Expense

R&D expense was $17.5 million in the third quarter of 2023, an increase of $14.5 million, or 481 percent, from the third quarter of 2022. The increase was primarily driven by expenses of $12.7 million incurred due to the acquisition of Cibus Global which primarily included increases in headcount, laboratory supplies, and facility costs and $2.8 million of stock compensation expense related to RSAs granted as part of the completion of the Merger Transactions. These expenses were partially offset by a $1.0 million decrease in Legacy Calyxt expenses due to lower headcount and cost reduction efforts in preparation for the Merger Transactions.

Selling, General, and Administrative Expense

SG&A expense was $8.8 million in the third quarter of 2023, an increase of $5.5 million, or 171 percent, from the third quarter of 2022. The increase was primarily driven by expenses of $5.1 million incurred due to the acquisition of Cibus Global which primarily included increases in headcount and professional fees and $2.9 million of stock compensation expense related to RSAs granted as part of the completion of the Merger Transactions contributed to the increase. These expenses were partially offset by a $2.6 million decrease in Legacy Calyxt expenses due to lower headcount and cost reduction efforts in preparation of the Merger Transactions.

Royalty Liability Interest Expense - Related Parties

Royalty Liability Interest was $8.1 million in the third quarter of 2023, an increase of $8.1 million from the third quarter of 2022. The increase was due to the assumption of the Royalty Liability as part of the Merger Transactions.

Other Interest Income (Expense), net

Other interest income (expense), net was income of $0.3 million in the third quarter of 2023, an increase in income of $0.3 million, or
- 38 -
698 percent, from the third quarter of 2022. The increase in income was driven by interest earned on the $59.4 million cash received in connection with the closing of the Merger Transactions.

Non-Operating Income (Expenses)

Non-operating income (expenses) was expense of $0.9 million in the third quarter of 2023, a decrease in income of $1.2 million, or 392 percent, from the third quarter of 2022. The decrease in income was driven by an increase in expense related to the mark-to-market of the Common Warrants due to a $0.9 million loss in the current period in addition to a $0.3 million gain in the prior year period.

Net Loss Attributable to Redeemable Noncontrolling Interest

Net loss attributable to redeemable noncontrolling interest was $8.1 million in third quarter of 2023, an increase in net loss attributable to redeemable noncontrolling interest of $8.1 million, from the third quarter of 2022. The increase in net loss attributable to redeemable noncontrolling interest is a result of the Up-C Units created as part of the closing of the Merger Transactions, and the amount for the period is based on the percentage of Cibus Global that is not owned by Cibus Inc.
RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023, COMPARED TO THE NINE MONTHS ENDED SEPTEMBER 30, 2022
A summary of the Company’s results of operations for the nine months ended September 30, 2023, and 2022 follows:
 
Nine Months Ended September 30,
In Thousands, except per share and percentage values
2023
2022
$ Change
% Change
Revenue$714 $115 $599 521 %
Research and development28,159 9,207 18,952 206 %
Selling, general, and administrative22,126 9,965 12,161 122 %
Loss from operations(49,571)(19,057)(30,514)(160)%
Royalty liability interest expense - related parties(10,753)— (10,753)NM
Other interest income (expense), net359 (80)439 549 %
Non-operating income (expenses)(466)5,083 (5,549)(109)%
Net loss$(60,431)$(14,054)$(46,377)(330)%
Net loss attributable to redeemable noncontrolling interest(9,918)— (9,918)NM
Net loss attributable to Cibus, Inc.$(50,513)$(14,054)$(36,459)(259)%
Basic and diluted net loss per share of Class A common stock$(6.33)$(15.56)$9.23 59 %
NM – not meaningful

Revenue

Revenue was $0.7 million in the first nine months of 2023, an increase of $0.6 million, or 521 percent, from the first nine months of 2022. The increase was driven by the addition of Cibus Global revenue which included amounts earned from collaboration agreements related to contract research for rice and soybean. Revenue from Legacy Calyxt's operations in the first nine months of 2023 and 2022 was primarily associated with the Company’s agreement with a large food ingredient manufacturer to develop a palm oil alternative.

Research and Development Expense

R&D expense was $28.2 million in the first nine months of 2023, an increase of $19.0 million, or 206 percent, from the first nine months of 2022. The increase was primarily driven by expenses of $16.9 million incurred due to the acquisition of Cibus Global which primarily included increases in headcount, laboratory supplies, and facility costs, $3.8 million of stock compensation expense related to RSAs granted as part of the completion of the Merger Transactions, and $1.3 million of one-time stock compensation expense from accelerated share vesting per the individual stock award agreements due to the completion of the Merger Transactions. These expenses were partially offset by a $3.1 million decrease in Legacy Calyxt expenses due to lower headcount and cost reduction efforts in preparation for the Merger Transactions.

Selling, General, and Administrative Expense

SG&A expense was $22.1 million in the first nine months of 2023, an increase of $12.2 million, or 122 percent, from the first nine months of 2022. The increase was primarily driven by an increase of $6.8 million due to the addition of Cibus Global which primarily included increases in headcount and professional fees and $3.9 million of stock compensation expense related to RSAs granted as part of the completion of the Merger Transactions, In addition, $6.5 million in one-time expenses due to the closing of the Merger Transactions which included $3.5 million of legal and professional fees, $1.9 million of severance resulting from pre-existing employment
- 39 -
agreements, and $1.1 million related to stock compensation expense from accelerated share vesting per the individual stock award agreements contributed to this increase. These expenses were partially offset by a $5.5 million decrease in Legacy Calyxt expenses due to lower headcount and cost reduction efforts in preparation of the Merger Transactions.

Royalty Liability Interest Expense - Related Parties

Royalty Liability Interest was $10.8 million in the first nine months of 2023, an increase of $10.8 million from the first nine months of 2022. The increase was due to the assumption of the Royalty Liability as part of the Merger Transactions.

Other Interest Income (Expense), net

Other interest income (expense), net was $0.4 million in the first nine months of 2023, an increase in income of $0.4 million, or 549 percent, from the first nine months of 2022. The increase in income was driven by interest earned on the $59.4 million cash received in connection with the closing of the Merger Transactions.

Non-Operating Income (Expenses)

Non-operating income (expenses) was expense of $0.5 million in the first nine months of 2023, a decrease in income of $5.5 million, or 109 percent, from the first nine months of 2022. The decrease in income was driven by an increase in expense of $6.2 million related to the mark-to-market of the Common Warrants due to a $5.0 million gain in the prior year period in addition to a $1.2 million loss in the current period. This expense was partially offset by a $0.8 million of gain contingency associated with the final payment to the Company for settlement of a legal matter with one of the Company's technology vendors regarding alleged intellectual property infringement.

Net Loss Attributable to Redeemable Noncontrolling Interest
Net loss attributable to redeemable noncontrolling interest was $9.9 million in first nine months of 2023, an increase in net loss attributable to redeemable noncontrolling interest of $9.9 million, from the first nine months of 2022. The increase in net loss attributable to redeemable noncontrolling interest is a result of the Up-C Units created as part of the closing of the Merger Transactions, and the amount for the period is based on the percentage of Cibus Global that is not owned by Cibus Inc.
LIQUIDITY AND CAPITAL RESOURCES

Liquidity

The Company’s primary source of liquidity is its cash and cash equivalents, with additional capital resources accessible from the capital markets, subject to market conditions and other factors, including limitations that may apply to the Company under applicable SEC and Nasdaq regulations. In addition, on October 20, 2023, Cibus entered into a binding term sheet with Rory Riggs, the Company’s Chairman and Chief Executive Officer, which makes available to the Company, beginning January 1, 2024, a line of credit (the Loan) in the aggregate principal amount of $5.0 million. The Loan, which automatically terminates if the Company secures additional financing in the aggregate amount of $20.0 million prior to January 1, 2024, is intended to provide additional certainty with respect to the Company’s capital resources as it pursues additional debt and/or equity financing.

As of September 30, 2023, the Company had $31.9 million of cash and cash equivalents. Current liabilities were $25.1 million as of September 30, 2023.

The Company’s liquidity funds its non-discretionary cash requirements and its discretionary spending. The Company has contractual obligations related to recurring business operations, primarily related to lease payments for its corporate and laboratory facilities. The Company’s principal discretionary cash spending is for salaries, capital expenditures, short-term working capital payments, and professional and other transaction-related expenses incurred as the Company pursues additional financing.

The Company incurred net losses of $60.4 million for the nine months ended September 30, 2023. As of September 30, 2023, the Company had an accumulated deficit of $262.7 million and expects to continue to incur losses in the future.
- 40 -
Cash Flows from Operating Activities
 Nine Months Ended September 30,
In Thousands, except percentage values20232022$ Change% Change
Net loss$(60,431)$(14,054)$(46,377)(330)%
Royalty liability interest expense - related parties10,753 — 10,753 NM
Depreciation and amortization2,875 1,158 1,717 148 %
Stock-based compensation11,670 2,890 8,780 304 %
Change in fair value of liability classified Class A common stock warrants1,221 (5,009)6,230 124 %
Other17 — 17 NM
Changes in operating assets and liabilities4,702 (586)5,288 902 %
Net cash used by operating activities$(29,193)$(15,601)$(13,592)(87)%
NM – not meaningful

Net cash used by operating activities was $29.2 million in the first nine months of 2023, an increase in cash used of $13.6 million, or 87 percent, from the first nine months of 2022. The increase in cash used was primarily driven by an increase in net loss related to the operations acquired in the Merger Transactions offset by an increase of $5.3 million from the changes in operating assets and liabilities related to assets and liabilities assumed from the closing of the Merger Transactions with Cibus Global, LLC.
The Company expects cash used by operating activities in 2023 to be higher than 2022 driven by consummation of the Merger Transactions and the resulting operating activities conducted by Cibus Global, as a subsidiary of the Company.

Cash Flows from Investing Activities
 Nine Months Ended September 30,
In Thousands, except percentage values20232022$ Change% Change
Cash acquired from merger with Cibus Global, LLC$59,381 $— $59,381 NM
Purchases of property, plant, and equipment(3,872)(1,509)(2,363)(157)%
Net cash provided by (used) by investing activities$55,509 $(1,509)$57,018 3,779 %

NM – not meaningful

Net cash provided by investing activities was $55.5 million in the first nine months of 2023, an increase of $57.0 million, or 3,779 percent, from the first nine months of 2022. The increase was driven by the cash acquired resulting from the merger with Cibus Global partially offset by an increase in capital expenditures.
The Company expects cash provided by investing activities in 2023 to be higher than 2022 driven by the cash acquired as a result of the Merger Transactions.

Cash Flows from Financing Activities
 Nine Months Ended September 30,
In Thousands, except percentage values20232022$ Change% Change
Proceeds from Class A common stock issuance$— $11,209 $(11,209)(100)%
Costs incurred related to the issuance of Class A common stock— (962)962 100 %
Proceeds from draws on revolving line of credit from Cibus Global, LLC2,500 — 2,500 NM
Payment of taxes related to vested restricted stock units(742)— (742)NM
Proceeds from issuance of notes payable1,287 — 1,287 NM
Repayments of financing lease obligations(242)(353)111 31 %
Repayments of notes payable(760)— (760)NM
Net cash provided by financing activities$2,043 $9,894 $(7,851)(79)%

NM – not meaningful

Net cash provided by financing activities was $2.0 million in the first nine months of 2023, a decrease of $7.9 million, or 79 percent, from the first nine months of 2022. The decrease was primarily due to the receipt of $10.0 million of net proceeds from the Follow-On Offering in the first quarter of 2022, $0.8 million from repayments of notes payable, and $0.7 million from payments of taxes related to
- 41 -
vested restricted stock units. These decreases were partially offset by the $2.5 million receipt of the Interim Funding and $1.3 million issuance of notes payable related to equipment and insurance policy purchases.

The Company expects cash provided by financing activities in 2023 to be similar to 2022 driven by potential financing activity as the Company evaluates capital markets conditions during the fourth quarter of 2023.

Capital Resources

Operating Capital Requirements

The Company has incurred losses since its inception and its net loss was $60.4 million for the nine months ended September 30, 2023, and it used $29.2 million of cash for operating activities for the nine months ended September 30, 2023. The Company’s primary source of liquidity is its cash and cash equivalents, with additional capital resources accessible, subject to market conditions and other factors, including limitations that may apply to the Company under applicable SEC and Nasdaq regulations, from the capital markets, including through stock offerings of common stock or other securities, which may be implemented pursuant to the Company’s effective registration statement on Form S-3. In addition, the Loan, which automatically terminates if the Company secures additional financing in the aggregate amount of $20.0 million prior to January 1, 2024, is intended to provide additional certainty with respect to the Company’s capital resources as it pursues additional debt and/or equity financing.

As of September 30, 2023, the Company had $31.9 million of cash and cash equivalents. Current liabilities were $25.1 million as of September 30, 2023.

As part of the Company’s strategic realignment discussed above, the Company has initiated cost reduction initiatives designed to preserve capital resources for the advancement of its priority objectives, which initiatives include reductions in capital expenditures, streamlining of independent contractor utilization, and prioritization of near-term payment obligations.

The Company has incurred losses since its inception and anticipates that it will continue to generate losses for the next several years. Over the longer term and until the Company can generate cash flows sufficient to support its operating capital requirements, it expects to finance a portion of future cash needs through (i) cash on hand, (ii) commercialization activities, which may result in various types of revenue streams from future trait R&D collaboration agreements and technology licenses, including upfront and milestone payments, annual license fees, and royalties; (iii) government or other third-party funding (iv) public or private equity or debt financings, or (v) a combination of the foregoing. However, capital generated by commercialization activities, if any, is expected to be received over a period of time and near-term additional capital may not be available on reasonable terms, if at all.

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.

The Company’s ability to continue as a going concern will depend on its ability to obtain additional public or private equity or debt financing, obtain government or private grants and other similar types of funding, attain further operating efficiencies, reduce or contain expenditures, and, ultimately, to generate revenue. The Company believes that its cash and cash equivalents as of September 30, 2023 is not sufficient to fund its operations for a period of 12 months or more from the date of this filing. Taking into account anticipated cost savings and without giving effect to potential financing transactions that Cibus is pursuing, Cibus expects that existing cash and cash equivalents will fund planned operating expenses and capital expenditure requirements into early in the first quarter of 2024.

Management will need to raise additional capital to support its business plans to continue as a going concern within one year after the date that these financial statements are issued. Although the Company has implemented a strategic realignment, which has included headcount reductions, and has initiated cost reduction initiatives designed to preserve capital resources, if the Company is unable to raise additional capital in a sufficient amount or on acceptable terms, the Company may have to implement additional, more stringent cost reduction measures to manage liquidity, and the Company may have to significantly delay, scale back, or cease operations, in part or in full. If the Company raises additional funds through the issuance of additional debt or equity securities, including as part of a strategic alternative, it could result in substantial dilution to its existing stockholders and increased fixed payment obligations, and these securities may have rights senior to those of the Company’s shares of common stock. These factors raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date of issuance of these financial statements. Any of these events could impact the Company’s business, financial condition, and prospects.

The Company’s financing needs are subject to change depending on, among other things, the success of its trait and product development efforts, the effective execution of its business model, its revenue, and its efforts to effectively manage expenses. The effects of macroeconomic events and potential geopolitical developments on the financial markets and broader economic uncertainties may make obtaining capital through equity or debt financings more challenging and may exacerbate the risk that such capital, if available, may not be available on terms acceptable to the Company.

CONTRACTUAL OBLIGATIONS, COMMITMENTS, AND CONTINGENCIES
The following table summarizes the Company's contractual obligations and commitments as of September 30, 2023:
- 42 -

- 43 -
In ThousandsOperating Lease ObligationsFinancing Lease ObligationsNotes PayableTotal
Remainder of 2023$1,758 $40 $520 $2,318 
20247,132 210 860 8,202 
20254,797 120 351 5,268 
20261,993 — 151 2,144 
20271,920 — 89 2,009 
20281,863 — 15 1,878 
Thereafter15,438 — — 15,438 
34,901 370 1,986 37,257 
Less: interest(10,621)(33)(192)(10,846)
Total$24,280 $337 $1,794 $26,411 
Current portion5,436 235 1,165 6,836 
Noncurrent portion$18,844 $102 $629 $19,575 


Royalty Liability - Related Parties

The company assumed the Royalty Liability as part of the Merger Transactions. In 2014, Cibus Global entered into the Warrant Exchange Agreement. Under the Warrant Exchange Agreement, the Royalty Holders are entitled to future royalty payments equal to 10 percent of the subject revenues (Subject Revenues), which includes all revenues earned by Cibus Global, including consideration attributable to crop traits developed using the Company’s gene editing technology, but excludes specifically, (i) revenues attributable to the Nucelis product line, (ii) amounts received from the sale or disposition of the Company’s assets to the extent the purchaser agrees to be bound by the Warrant Exchange Agreement, (iii) payments for the Cibus Global capital stock, and (iv) revenues attributable to collaboration and research projects. Royalty payments will begin in the first fiscal quarter after which the aggregate Subject Revenues during any consecutive 12-month period equals or exceeds $50.0 million, at which point Cibus Global will be obligated to pay all aggregated but unpaid payments under the Warrant Exchange Agreement. This condition had not occurred as of September 30, 2023. Additionally, Cibus Global granted the Royalty Holders a continuing security interest in certain intellectual property of Cibus Global to secure the payment and performance of obligations of Cibus Global under the Warrant Exchange Agreement. The initial term of the Warrant Exchange Agreement is 30 years and may be extended for an additional 30-year term if the holders provide written notice and make a payment of $100. The Company's payments under, and performance of, the Royalty Liability are secured by a security interest in substantially all of its intellectual property.

Cibus Non-Profit Foundation

During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.

This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.

As of September 30, 2023, there were no other material changes in the Company’s commitments under contractual obligations as disclosed in its Annual Report.
- 44 -
CRITICAL ACCOUNTING ESTIMATES
The preceding discussion and analysis of the Company’s financial condition and results of operations are based upon its condensed consolidated financial statements and the related disclosures, which have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires the Company to make estimates, assumptions, and judgments that affect the reported amounts in its condensed consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company believes the policies discussed in Note 1, Basis of Presentation & Summary of Significant Accounting Policies, are the most critical to an understanding of its financial condition and results of operations because they require it to make estimates, assumptions, and judgments about matters that are inherently uncertain.

Valuation of Common Warrants
The Common Warrants have been classified as a liability in the Company’s condensed consolidated balance sheets because the warrants include a put option election available to the holder of a Common Warrant that is contingently exercisable if the Company enters into a Fundamental Transaction through a Change of Control Put. If the Change of Control Put is exercised by the holder of a Common Warrant, they may elect to receive either the consideration of the Fundamental Transaction or put the Common Warrant back to the Company in exchange for cash, based on terms and timing specified in the Common Warrant. If the put option is exercised, the Company is required to pay cash to the holder in an amount as determined by the Black-Scholes pricing model, with assumptions determined in accordance with the terms of the Common Warrants.
The estimated fair values of the Common Warrants, and the assumptions used for the Black-Scholes option pricing model were as follows:
 As of September 30, 2023As of December 31, 2022
Estimated fair value of Common Warrants$9.54 $1.87 
Assumptions: 
Risk-free interest rate4.7 %4.0 %
Expected volatility107.1 %85.0 %
Expected term to liquidation (in years)3.94.6

A ten percent change in any of the assumptions would not have had a material effect on the Company’s results of financial condition or results of operations.

Royalty Liability - Related Parties

Changes in expected royalty payments, as a result of changes to estimates of the underlying revenues, are recognized prospectively as an adjustment to the effective yield as interest expense. For purposes of determining the Royalty Liability, the Company estimates the total amount of future revenues expected to be received from the Company's customers over the life of the agreement. The Company then calculates the amount of future royalty payments required to be paid based upon the estimated future revenues. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. If global net sales of the company's products developed using RTDS technologies are greater than or less than expected, the interest expense recorded with respect to the Royalty Liability would be greater or less, respectively, over the term of the arrangement. As of September 30, 2023, the Royalty Liability reflected an effective yield of 23.7 percent.

Accounting for Business Combinations

The Company applies Accounting Standards Codification (ASC) 805, Business Combinations, when accounting for acquisitions of a business under GAAP. Identifiable assets acquired, liabilities assumed, and noncontrolling interest, if applicable, are recorded at their estimated fair values at the acquisition date. Significant judgment is required in determining the acquisition date fair value of the assets acquired and liabilities assumed, predominantly with respect to property, plant, and equipment and intangible assets. Evaluations include numerous inputs, including forecasted cash flows that incorporate the specific attributes of each asset. For property, plant, and equipment, the Company considers the remaining useful life of equipment, current replacement costs for similar assets, and comparable market transactions. The Company evaluates all available information, as well as all appropriate methodologies, when determining the fair value of assets acquired, liabilities assumed, and noncontrolling interest, if applicable, in a business combination. In addition, once the appropriate fair values are determined, the Company must determine the remaining useful life for property, plant, and equipment and the amortization period and method of amortization for each finite-lived intangible asset. The estimates of fair values of assets impact future depreciation and amortization and the initial amount of goodwill recorded.

Impairment Testing of Goodwill and Indefinite-Lived Intangible Assets

As of September 30, 2023, the Company performed a qualitative impairment assessment of goodwill and indefinite-lived intangible assets which included an evaluation of changes in industry, market, and macroeconomic conditions as well as consideration of its
- 45 -
financial performance and any significant trends. The qualitative assessment indicated that it was not more likely than not that goodwill and indefinite-lived intangible assets are impaired as of September 30, 2023. If the Company experiences a sustained decline in its stock price or other material changes in the significant assumptions that affect the determination of the fair value of the Company’s single reporting unit, it may result in a goodwill and/or intangible asset impairment charge in future periods, and such charge may be material. On an annual basis, the Company performs an impairment test which is planned for the fourth quarter of 2023.
As of September 30, 2023, there were no other significant changes to the Company’s critical accounting policies disclosure reported in “Critical Accounting Estimates” in its Annual Report.
Item 4. Controls and Procedures
Management’s Evaluation of Disclosure Controls and Procedures
Based on an evaluation under the supervision and with the participation of the Company’s management, its principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, were effective as of September 30, 2023.
Changes in Internal Control over Financial Reporting
No changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the three months ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
- 46 -
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The Company is not a party to any material pending legal proceedings as of September 30, 2023. From time to time, the Company may be involved in legal proceedings arising in the ordinary course of business.

Item 1A. Risk Factors

There have been no material changes in risk factors in the period covered by this report, except for the supplemental risk factors reported by the Company in its Current Report on Form 8-K filed on October 18, 2023, which are incorporated by reference herein. See the discussion of risk factors described in Exhibit 99.3 to the Company's Current Report on Form 8-K filed on June 1, 2023, and under the heading “Item 8.01 – Other Events—Supplemental Risk Factors” in the Company's Current Report on Form 8-K filed on October 18, 2023.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.

During the period covered by this Quarterly Report on Form 10-Q, the Company did not issue any unregistered equity securities, other than pursuant to transactions previously disclosed in the Company’s Current Reports on Form 8-K.

The Company did not repurchase any shares of Class A Common Stock or Class B Common Stock during the period covered by this Quarterly Report on Form 10-Q. During the period covered by this Quarterly Report on Form 10-Q, 30,653 shares of Class A Common Stock were withheld for net share settlement resulting from restricted stock unit award vesting.

Item 5. Other Information

During the Company’s fiscal quarter ended September 30, 2023, none of the Company’s directors or officers adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Regulation 408(a) of Regulation S-K).
- 47 -
Item 6. Exhibits
(a)Index of Exhibits
Exhibit
Number
Description
2.1
2.2
3.1
3.2
10.1
31.1*
31.2*
32*
101.INS*Inline XBRL Instance Document
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*
The cover page for the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, has been formatted in Inline XBRL
*Filed herewith
SIGNATURE
Pursuant to the requirements of the Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 9, 2023.
CIBUS, INC.
By:/s/ Rory Riggs
Name:Rory Riggs
Title:
Chief Executive Officer and Chairman
(Principal Executive Officer)
By:/s/ Wade King
Name:Wade King
Title:
Chief Financial Officer
(Principal Financial and Accounting Officer)
 EX-31.1 2 cbus-20230930xexx311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION PURSUANT TO RULES 13a-l4(a) AND l5d-l4(a)
UNDER THE SECURITIES EXCHANGE ACT, AS AMENDED
I, Rory Riggs, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Cibus, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and I 5d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 9, 2023
/s/ Rory Riggs
Rory Riggs
Chief Executive Officer and Chairman

 EX-31.2 3 cbus-20230930xexx312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT, AS AMENDED
I, Wade King, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Cibus, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and I 5d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 9, 2023
/s/ Wade King
Wade King
Chief Financial Officer

 EX-32.1 4 cbus-20230930xexx32.htm EX-32.1 Document

Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Cibus, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 9, 2023
/s/ Rory Riggs
Rory Riggs
Chief Executive Officer and Chairman
/s/ Wade King
Wade King
Chief Financial Officer

 EX-101.SCH 5 cbus-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - COVER PAGE link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - MERGER WITH CIBUS GLOBAL link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - SUPPLEMENTAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - INTERIM FUNDING link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - COLLABORATION AGREEMENT link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - RELATED-PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - MERGER WITH CIBUS GLOBAL (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - SUPPLEMENTAL INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock by Class (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Deferred Revenue Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - MERGER WITH CIBUS GLOBAL - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Purchase Price for Merger Transaction (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Recognized the Preliminary Allocation of the Consideration (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Intangible Assets Acquired in Merger Transaction (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - MERGER WITH CIBUS GLOBAL - Business Acquisition, Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value Measurements and Financial Statement Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Common Warrants Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value of the Common Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Property, Plant, and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Change in Asset Retirement Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - NOTES PAYABLE - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - NOTES PAYABLE - Schedule of Future Minimum Payments Under Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - NOTES PAYABLE - Schedule of Future Minimum Payments Under Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - STOCKHOLDERS' EQUITY - Follow-On Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - STOCKHOLDERS' EQUITY - Disclosure of Warrants Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - STOCKHOLDERS' EQUITY - ATM Facility (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - STOCKHOLDERS' EQUITY - Merger with Cibus Global (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - STOCKHOLDERS' EQUITY - Cibus Common Units (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - STOCKHOLDERS' EQUITY - Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - STOCK-BASED COMPENSATION - Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Nonvested Shares Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - STOCK-BASED COMPENSATION - Summary of Grant Date Fair Value of Awards Vested (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Granted as Deemed Dividends (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - STOCK-BASED COMPENSATION - Share-Based Payment Arrangement, Performance Shares, Outstanding Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Schedule of Non-Cancellable Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Other Information Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Supplemental Balance Sheet Information Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES - Schedule of Royalty Liability (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - SUPPLEMENTAL INFORMATION - Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - SUPPLEMENTAL INFORMATION - Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954529 - Disclosure - SUPPLEMENTAL INFORMATION - Supplemental Cash Flows Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954530 - Disclosure - INTERIM FUNDING (Details) link:presentationLink link:calculationLink link:definitionLink 9954531 - Disclosure - COLLABORATION AGREEMENT (Details) link:presentationLink link:calculationLink link:definitionLink 9954532 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 9954533 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 cbus-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 cbus-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 cbus-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Inflation Rate Measurement Input, Inflation Rate [Member] Measurement Input, Inflation Rate Financed Equipment Financed Equipment [Member] Financed Equipment Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Deemed Dividends Deemed Dividends [Member] Non employee restricted stock units. Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Accrued expenses Total Accrued Liabilities, Current Current portion of operating lease obligations Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Operating Lease, Liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Operating Lease, Liability Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Research and development Research and Development Expense Accrued expenses Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Expenses Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Expenses Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Stock option expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Deferred financing costs related to common warrants Warrant Liability, Current, Deferred Financing Costs Warrant Liability, Current, Deferred Financing Costs Award Type Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Schedule of Recognized the Preliminary Allocation of the Consideration Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Insider Trading Policies and Procedures [Line Items] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Offering price (in dollars per share) Shares Issued, Price Per Share Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five Term of agreement Related Party Transaction, Term Related Party Transaction, Term Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] STOCKHOLDERS' EQUITY Equity [Text Block] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Accrued Expenses: Accrued Liabilities, Current [Abstract] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Required payment to extend agreement Related Party Transaction, Required Payment To Extend Agreement Related Party Transaction, Required Payment To Extend Agreement Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Current portion Operating And Finance Lease, Liability, Current Operating And Finance Lease, Liability, Current Current liabilities: Liabilities, Current [Abstract] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Forfeited or expired (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Diluted net loss per share of Class A common stock (in dollars per share) Earnings Per Share, Diluted Threshold amount in which the lease will terminate at the end of the second consecutive calendar year in which the Company’s tangible net worth exceeds Related Party Transaction, Tangible Net Worth Threshold For Two Consecutive Years Which Terminates Agreement Related Party Transaction, Tangible Net Worth Threshold For Two Consecutive Years Which Terminates Agreement Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Accounting Standards Update [Extensible Enumeration] Accounting Standards Update [Extensible Enumeration] Line of Credit Line of Credit [Member] 2025 Operating And Finance Lease, Liability, To Be Paid, Year Two Operating and finance lease liabilities payments next two years. Redeemable noncontrolling interest Beginning balance Ending balance Redeemable Noncontrolling Interest, Equity, Carrying Amount Trading Symbol Trading Symbol Mark to market adjustment Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Cash acquired from merger with Cibus Global, LLC Cash Acquired from Acquisition Fair Value Disclosures [Abstract] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Gross Carrying Amount Intangible Assets, Gross (Excluding Goodwill) Other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Stockholders’ equity: Equity, Attributable to Parent [Abstract] 2026 Operating And Finance Lease, Liability, To Be Paid, Year Three Operating and finance lease liabilities payments next three years. Other Other Intangible Assets [Member] Executive Category: Executive Category [Axis] Restricted Stock Awards/Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Financial Instruments [Domain] Financial Instruments [Domain] Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Accrued expenses Increase (Decrease) in Accrued Liabilities Share-based compensation arrangement by share-based payment award, number of shares registered and available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 2025 Long-Term Debt, Maturity, Year Two Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Entity Small Business Entity Small Business 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Follow-on Public Offering Follow On Public Offering [Member] Follow on public offering. Local Phone Number Local Phone Number Pro forma net loss attributable to redeemable noncontrolling interest Business Acquisition, Pro Forma Net Income (Loss), Attributable To Redeemable Noncontrolling Interest Business Acquisition, Pro Forma Net Income (Loss), Attributable To Redeemable Noncontrolling Interest Recovery of Erroneously Awarded Compensation Disclosure [Line Items] 2028 Finance Lease, Liability, to be Paid, Year Five Warehouse Lease Warehouse Lease [Member] Warehouse Lease Other leases Other Leases [Member] Other Leases BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Unvested restricted stock units Restricted Stock Units Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Operating Leases, Operating [Abstract] Depreciation and amortization expense Depreciation Line of Credit Facility [Table] Line of Credit Facility [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Cellectis Cellectis [Member] Cellectis. Shares withheld for net share settlement Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Schedule of Purchase Price for Merger Transaction Schedule of Business Acquisitions, by Acquisition [Table Text Block] Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Research and development Research and Development Expense [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Expenses incurred in connection with Merger Business Combination, Acquisition Related Costs Acquired from merger with Cibus Global, LLC Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination Award Type Award Type [Axis] Total (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Non-cash transactions not reported in the consolidated statement of cash flows Noncash Investing and Financing Items [Abstract] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Goodwill [Line Items] Goodwill [Line Items] Land, buildings, and equipment, gross Property, Plant and Equipment, Gross Establishment of operating lease right-of-use assets and associated operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability RELATED-PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Less: interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount LEASES, COMMITMENTS, AND CONTINGENCIES Lessee, Finance Leases [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Current portion of operating lease obligations Current portion Operating Lease, Liability, Current Roseville, Minnesota lease Roseville, MN Lease [Member] Roseville, MN lease. 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Number of employees Share Based Compensation Arrangement, Granted Shares, Number Of Employees Share Based Compensation Arrangement, Granted Shares, Number Of Employees Intangible Assets, Net Finite-Lived Intangible Assets, Net Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Interim Funding Agreement Interim Funding Agreement [Member] Interim Funding Agreement Purchase price Shares issued for consideration in the merger with Cibus Global Business Combination, Consideration Transferred Deferred revenue Beginning balance Ending balance Deferred revenue for upfront payments Contract with Customer, Liability, Current Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Selling, general, and administrative Selling, General and Administrative Expense Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Award vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage COLLABORATION AGREEMENT Collaborative Arrangement Disclosure [Text Block] Stock options outstanding Stock Options Employee Stock Option [Member] Options priced at fair market value, percent Share-Based Compensation Arrangement By Share-Based Payment Award, Strike Price Percentage Of Closing Share Price On The Date Of Grant Option price at percentage of fair market value. Maximum Maximum [Member] Document Type Document Type Schedule of Royalty Liability Schedule of Related Party Transactions [Table Text Block] Goodwill, acquired during period Goodwill, Acquired During Period Tabular List, Table Tabular List [Table Text Block] Foreign currency translation adjustments Temporary Equity, Foreign Currency Translation Adjustments Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Royalty Liability - Related Parties Related Parties, Policy [Policy Text Block] Related Parties, Policy 2026 Finance Lease, Liability, to be Paid, Year Three Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Operating expenses: Costs and Expenses [Abstract] Title of 12(b) Security Title of 12(b) Security Other non-current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Related Party, Type [Domain] Related Party, Type [Domain] Number of securities called by each warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Share-based payment arrangement, plan modification, incremental cost Share-Based Payment Arrangement, Plan Modification, Incremental Cost In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Unvested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Estimated fair values of stock options granted (USD per share) Share Based Compensation Arrangement By Share Based Payment Award Estimated Fair Value Of Awards Granted Share Based Compensation Arrangement By Share Based Payment Award Estimated Fair Value Of Awards Granted Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Disclosure of Warrants Transactions [Table] Disclosure of Warrants Transactions [Table] disclosure of warrants transactions. Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Total Lease, Cost Statistical Measurement Statistical Measurement [Axis] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Entity Interactive Data Current Entity Interactive Data Current Beginning balance Ending balance Asset Retirement Obligation Adjustments to reconcile net loss to net cash used by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Goodwill and Acquired Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Revenue Recognition and Contract Liabilities Revenue from Contract with Customer [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current portion of financing lease obligations Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Finance Lease, Liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Finance Lease, Liability Counterparty Name [Axis] Counterparty Name [Axis] Warrants Derivatives, Policy [Policy Text Block] Vested (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule Of Related Party Transactions By Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Maximum borrowing increments Line Of Credit Facility, Maximum Borrowing Increments Line Of Credit Facility, Maximum Borrowing Increments 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Operating cash flows (operating leases) Operating Lease, Payments Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Outstanding (in shares) Common Stock, Shares, Outstanding PEO PEO [Member] Notes payable, net of current portion Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt Other Other Operating Activities, Cash Flow Statement Management Management [Member] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Up-C Units to Class A Common Stock exchange ratio Business Combination, Share Conversion Ratio Business Combination, Share Conversion Ratio Sale of Stock Sale of Stock [Axis] Financing Finance Lease, Liability [Abstract] San Diego, California headquarters lease San Diego, California Headquarters Lease [Member] San Diego, California Headquarters Lease Net cash provided by (used) by investing activities Net Cash Provided by (Used in) Investing Activities Legal and professional fees Professional Fees Debt Instrument [Axis] Debt Instrument [Axis] Revenue of acquiree since acquisition date Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Remainder of 2023 Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Measurement Input Type [Domain] Measurement Input Type [Domain] Credit Facility [Axis] Credit Facility [Axis] Forfeited or expired (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period, Weighted Average Exercise Price Schedule of Future Minimum Payments Under Notes Payable Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Exercisable (in dollars per share) Class Of Warrant Or Right, Exercisable, Weighted Average Exercise Price Of Warrants Or Rights Class Of Warrant Or Right, Exercisable, Weighted Average Exercise Price Of Warrants Or Rights PROPERTY, PLANT, AND EQUIPMENT, NET Property, Plant and Equipment Disclosure [Text Block] Title of Individual Title of Individual [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Related Party Transaction [Domain] Related Party Transaction [Domain] Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Subsequent Event [Line Items] Subsequent Event [Line Items] Affiliated Entity Affiliated Entity [Member] Expected volatility Measurement Input, Option Volatility [Member] Accrued consulting and professional fees Accrued Professional Fees, Current Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Class A common stock warrants Common Warrants Warrant Liability, Current Warrant Liability, Current Segment Reporting Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Number of Common Stock shares included in Up-C Units (in shares) Business Combination, Number Of Shares Issued To Elective Members, Common Stock Business Combination, Number Of Shares Issued To Elective Members, Common Stock Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table] Restructuring Type [Axis] Restructuring Type [Axis] Net Loss Per Share of Class A Common Stock Earnings Per Share, Policy [Policy Text Block] GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Balance as of December 31, 2022 Balance as of September 30, 2023 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Schedule of Indefinite-Lived Intangible Assets Acquired in Merger Transaction Schedule of Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Outstanding (in shares) Class of Warrant or Right, Outstanding Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Five 2027 Finance Lease, Liability, to be Paid, Year Four Accounts Receivable Accounts Receivable [Policy Text Block] Net cash used by operating activities Net cash used by operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Calyxt, Inc. Calyxt, Inc. [Member] Calyxt, Inc. Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Depreciation and amortization Depreciation, Depletion and Amortization Due from related parties, net Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Other Receivables Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Other Receivables Common units outstanding (in shares) Common Unit, Outstanding Office furniture and equipment Furniture and Fixtures [Member] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Business Combination and Asset Acquisition [Abstract] Pro forma revenues Business Acquisition, Pro Forma Revenue Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Financing Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Revenue recognized from deferred revenue balance Contract with Customer, Liability, Revenue Recognized Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Fair Value Concentration Of Risk [Table] Fair Value, Concentration of Risk [Table] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Assumptions: Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Forfeited or expired (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period Entity Emerging Growth Company Entity Emerging Growth Company Asset retirement obligation, measurement input Asset Retirement Obligation, Measurement Input Asset Retirement Obligation, Measurement Input Intangible assets, net Intangible Assets, Net Intangible Assets, Net (Excluding Goodwill) Debt instrument, weighted average remaining term Debt Instrument, Weighted Average Remaining Term Debt Instrument, Weighted Average Remaining Term Schedule of Non-Cancellable Operating Leases Assets, Lessee [Table Text Block] Assets, Lessee Acquired finite-lived intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title At-The-Market Offering At-The-Market Offering [Member] At-The-Market Offering Common Stock Common Stock [Member] Individual: Individual [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code 2028 Operating And Finance Lease, Liability, To Be Paid, Year Five Operating and finance lease liabilities payments next five years. Income Statement Location Income Statement Location [Domain] Proceeds from issuance of notes payable Proceeds from Notes Payable Restricted Common Class A Restricted Common Class A [Member] Restricted Common Class A Redeemable noncontrolling interest resulting from merger with Cibus Global, LLC Adjustments To Additional Paid In Capital, Redeemable Noncontrolling Interests Resulting From Merger Adjustments To Additional Paid In Capital, Redeemable Noncontrolling Interests Resulting From Merger Summary of Common Warrants Activity Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Less: interest Operating And Finance Lease, Liability, Undiscounted Excess Amount Operating and finance lease liability undiscounted excess amount. Minimum Minimum [Member] Proceeds from legal settlements Proceeds from Legal Settlements Disclosure of Warrants Transactions Disclosure Of Warrants Transactions [Table Text Block] Disclosure of warrants transactions. Estimated fair value of Common Warrants Estimated Fair Value of Common Warrants, Measurement Input Estimated fair value of common warrants, measurement input. Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Aggregate funds received Proceeds from Issuance of Long-Term Debt Employee Retention Credit refund received Employee Retention Credit, CARES Act, Refund Received Employee Retention Credit, CARES Act, Refund Received Payment of taxes related to vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities LEASES, COMMITMENTS, AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Accumulated Deficit Retained Earnings [Member] Goodwill, expected tax deductible amount Business Acquisition, Goodwill, Expected Tax Deductible Amount Current portion of notes payable Current portion Long-Term Debt, Current Maturities Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Basic net loss per share of Class A common stock (in dollars per share) Earnings Per Share, Basic Unrecognized stock-based compensation expense related to non-vested stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Sale of Stock Sale of Stock [Domain] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Acquired from merger with Cibus Global, LLC Accrued Royalties, Acquired During Period Accrued Royalties, Acquired During Period Warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Finance lease costs Finance Lease, Cost Finance lease cost. Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Unsecured Debt Unsecured Debt [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Percentage of income tax savings required to be paid under the TRA Tax Receivable Agreement, Percentage Of Income Tax Savings Required To Be Paid Tax Receivable Agreement, Percentage Of Income Tax Savings Required To Be Paid Accounts payable Increase (Decrease) in Accounts Payable Number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options 2027 Operating And Finance Lease, Liability, To Be Paid, Year Four Operating and finance lease liabilities payments next four years. Property, Plant and Equipment [Abstract] Notes Payable, Gross Long-Term Debt, Gross All Trading Arrangements All Trading Arrangements [Member] Less accumulated depreciation and amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Reverse stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Compensation Amount Outstanding Recovery Compensation Amount Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Subsequent Event Type [Axis] Subsequent Event Type [Axis] Lease Guarantee Lease Guarantee [Member] Lease Guarantee Statement of Comprehensive Income [Abstract] Thereafter Operating And Finance Lease, Liability, To Be Paid, After Year Five Operating and finance lease liabilities payments after five years. Collaborative Agreements Related to Contract Research Collaborative Arrangement, Accounting Policy [Policy Text Block] Total Finance Lease, Liability Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares 2024 Long-Term Debt, Maturity, Year One Cibus Global Cibus Global [Member] Cibus Global Schedule of Change in Asset Retirement Obligation Schedule of Change in Asset Retirement Obligation [Table Text Block] Condensed Cash Flow Statements, Captions [Line Items] Condensed Cash Flow Statements, Captions [Line Items] Issuance of common stock resulting from merger with Cibus Global, LLC (in shares) Stock issued during period for acquisitions (in shares) Stock Issued During Period, Shares, Acquisitions Receivable from Jefferies for shares issued under ATM facility Receivable Related To Shares Issued Via Debt Related Arrangement Receivable from Jefferies for shares issued under ATM Facility. Document Period End Date Document Period End Date Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Adoption Date Trading Arrangement Adoption Date Forgiveness of interim funding resulting from merger with Cibus Global Forgiveness Of Long-Term Debt Forgiveness Of Long-Term Debt Subject revenue threshold, minimum Related Party Transaction, Twelve Month Revenue Threshold Related Party Transaction, Twelve Month Revenue Threshold Weighted average discount rate Finance Lease, Weighted Average Discount Rate, Percent Financing lease obligations, net of current portion Noncurrent portion Finance Lease, Liability, Noncurrent Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Shares in Treasury Treasury Stock, Common [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Income taxes Income tax provision Income Tax Expense (Benefit) Vesting Vesting [Axis] FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK Fair Value Disclosures [Text Block] Number of operating segments Number of Operating Segments Total Operating And Finance Lease, Liability Lessee operating and finance lease liability. Equity [Abstract] Equity [Abstract] Weighted average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Consideration transferred Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Money Market Funds Money Market Funds [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Repayments of notes payable Repayments of Notes Payable Shares withheld for net share settlement (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Credit Facility [Domain] Credit Facility [Domain] Line of credit, incremental draw amount Line Of Credit, Incremental Draw Amount Line Of Credit, Incremental Draw Amount Property, plant, and equipment acquired through assuming liabilities Noncash Or Part Noncash Acquisition Fixed Assets Acquired Noncash Or Part Noncash Acquisition Fixed Assets Acquired Land, buildings, and equipment useful Life Useful Life (Years) Property, Plant and Equipment, Useful Life Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Royalty liability - related parties Beginning balance Ending balance Accrued Royalties, Noncurrent Accrued Royalties, Noncurrent Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Intangible assets Total Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Schedule of Deferred Revenue Activity Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Establishment of financing lease right-of-use assets and associated operating lease liabilities Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Less: interest Finance Lease, Liability, Undiscounted Excess Amount Consideration earned Contract With Customer, Liability, Consideration Earned Contract With Customer, Liability, Consideration Earned Insurance Insurance Notes [Member] Insurance Notes Additional Paid-In Capital Additional Paid-in Capital [Member] Cover [Abstract] Cover [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Accrued Royalties [Roll Forward] Accrued Royalties [Roll Forward] Accrued Royalties Fundamental Transaction voting threshold, percent Class Of Warrant Or Right, Fundamental Transaction Voting Threshold, Percent Class Of Warrant Or Right, Fundamental Transaction Voting Threshold, Percent Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Options Exercisable Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable [Roll Forward] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable Other non-current liabilities Other Liabilities, Noncurrent Operating lease, liability, to be paid Lessee, Operating Lease, Liability, to be Paid Forfeited or expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Schedule of Statements of Certain Statements of Cash Flows Amounts Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Total operating expenses Operating Expenses Common Warrants Common Warrants Common Warrants [Member] Common warrants. Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Renewal term Lessee, Operating Lease, Renewal Term Equity Component Equity Component [Domain] Current portion of financing lease obligations Current portion Finance Lease, Liability, Current Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Current Reporting Status Entity Current Reporting Status Loss from operations Operating Income (Loss) 2017 Omnibus Plan Two Thousand Seventeen Omnibus Plan [Member] Two thousand seventeen omnibus plan. Number of reporting units Number of Reporting Units Charitable contribution obligation, percentage of net royalty revenue Charitable Contribution Obligation, Percentage Of Net Royalty Revenue If Threshold Is Exceeded Charitable Contribution Obligation, Percentage Of Net Royalty Revenue If Threshold Is Exceeded Consolidated Entities [Domain] Consolidated Entities [Domain] Stock-based compensation expense: Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract] Obligations incurred Asset Retirement Obligation, Liabilities Incurred Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Accrued compensation Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Employee-Related Liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Employee-Related Liabilities Property, Plant, and Equipment, net Property, Plant and Equipment, Policy [Policy Text Block] Scenario [Domain] Scenario [Domain] Weighted Average Exercise Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Type of Restructuring [Domain] Type of Restructuring [Domain] Share-Based Payment Arrangement, Tranche One Share-Based Payment Arrangement, Tranche One [Member] Consolidated Entities [Axis] Consolidated Entities [Axis] Pay vs Performance Disclosure [Line Items] Statistical Measurement Statistical Measurement [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Remaining Term (years) Lessee, Operating Lease, Remaining Lease Term Unvested beginning balance (in shares) Unvested ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number NOTES PAYABLE INTERIM FUNDING Debt Disclosure [Text Block] Redeemable noncontrolling interest resulting from merger with Cibus Global, LLC Temporary Equity, Stock Issued During Period, Value, New Issues Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Revolving Credit Facility Revolving Credit Facility [Member] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Unvested performance stock units Performance Stock Units Performance Shares [Member] Accounts payable Accounts Payable, Current Loss of acquiree since acquisition date, attributable to controlling interest Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Restatement Determination Date: Restatement Determination Date [Axis] Non-Operating Income (Expenses) Nonoperating Income (Expense), Policy [Policy Text Block] Nonoperating Income (Expense), Policy Commitments and contingencies (See Note 10) Commitments and Contingencies Operating Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Proceeds from Class A common stock issuance Proceeds from Issuance of Common Stock Schedule of Goodwill [Table] Schedule of Goodwill [Table] Variable interest entity, ownership percentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Award requisite service period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] INCOME TAXES Income Tax Disclosure [Text Block] Deferred revenues Increase (Decrease) in Contract with Customer, Liability Total property, plant, and equipment Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Leases Lessee, Leases [Policy Text Block] Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Binding Term Sheet Binding Term Sheet [Member] Binding Term Sheet Schedule of Finite-Lived Intangible Assets Acquired in Merger Transaction Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Business Acquisition [Line Items] Business Acquisition [Line Items] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] PEO Total Compensation Amount PEO Total Compensation Amount Acquired Indefinite-Lived Intangible Assets [Line Items] Acquired Indefinite-Lived Intangible Assets [Line Items] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (in dollars per share) Business Acquisition, Share Price Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Treasury stock, shares (in shares) Treasury Stock, Common, Shares Condensed Cash Flow Statement [Table] Condensed Cash Flow Statement [Table] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accelerated stock compensation expense Share-Based Payment Arrangement, Accelerated Cost Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net loss attributable to Cibus, Inc. Net loss Net Income (Loss) Total current liabilities Total current liabilities Liabilities, Current 2025 Finance Lease, Liability, to be Paid, Year Two Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name LEASES, COMMITMENTS, AND CONTINGENCIES Lessee, Operating Leases [Text Block] Property, plant, and equipment, net Total Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Liabilities, redeemable noncontrolling interest, and stockholders’ equity Liabilities and Equity [Abstract] 2024 Operating And Finance Lease, Liability, To Be Paid, Year One Operating and finance lease liabilities payments next twelve months. Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Common and preferred stock, shares authorized (in shares) Common And Preferred Stock, Shares Authorized Common And Preferred Stock, Shares Authorized Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Operating and finance lease, liability, to be paid Operating And Finance Lease, Liability, To Be Paid Operating and finance lease liability payment due. Accrued field trials Accrued Field Trials, Current Accrued Field Trials, Current Stock option, vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Weighted average amortization period for definite lived intangible assets Estimated Average Useful Life (Years) Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Class B Common Stock Common Class B [Member] Other Commitments [Table] Other Commitments [Table] Name Measure Name Name Forgone Recovery, Individual Name Goodwill Goodwill Electing Members Electing Members [Member] Electing Members Underlying Securities Award Underlying Securities Amount Computer equipment and software Computer Equipment And Software [Member] Computer Equipment And Software Accounts receivable Increase (Decrease) in Accounts Receivable Forecast Forecast [Member] Remainder of 2023 Long-Term Debt, Maturity, Remainder of Fiscal Year Selling, general, and administrative Selling, General and Administrative Expenses [Member] Common Warrants Warrant [Member] Operating lease obligations, net of current portion Noncurrent portion Operating Lease, Liability, Noncurrent Debt instrument, term Debt Instrument, Term Class of Warrant or Right [Table] Class of Warrant or Right [Table] Costs incurred related to the issuance of Class A common stock Underwriting discounts and estimated other offering expenses Payments of Stock Issuance Costs Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Maximum voting percentage, before warrants cannot be exercised Class Of Warrant Or Right, Voting Power Threshold Maximum Before Warrants Cannot Be Exercised Class Of Warrant Or Right, Voting Power Threshold Maximum Before Warrants Cannot Be Exercised Right-of-use assets and lease liabilities, net Increase (Decrease) In Operating Lease Right-Of-Use Asset And Operating Lease Liability Increase (Decrease) In Operating Lease Right-Of-Use Asset And Operating Lease Liability Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Warrant activity, Fair Value [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Income Statement Location Income Statement Location [Axis] Less: interest Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Royalty liability, measurement input Accrued Royalties, Measurement Input Accrued Royalties, Measurement Input Lessee, Operating Lease, Liability, to be Paid, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Total Operating Lease And Finance Lease, Liability, To Be Paid, Fiscal Year Maturity [Abstract] Operating Lease And Finance Lease, Liability, To Be Paid, Fiscal Year Maturity Offering costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Risk-free interest rate Risk Free Interest Rate Measurement Input, Risk Free Interest Rate [Member] Summary of Fair Value Measurements and Financial Statement Presentation Fair Value, by Balance Sheet Grouping [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Summary of Lease Expense, Supplemental Cash Flow Information Related to Leases, and Supplemental Balance Sheet Information Related to Leases Lease, Cost [Table Text Block] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Plan Name Plan Name [Domain] Unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrestricted cash balance threshold Debt Instrument, Covenant, Unrestricted Cash Balance Threshold Debt Instrument, Covenant, Unrestricted Cash Balance Threshold Notes Payable Notes Payable, Other Payables [Member] Remainder of 2023 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Trading Arrangement: Trading Arrangement [Axis] Share-based Payment Arrangement, Performance Shares, Outstanding Activity Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five 2026 Long-Term Debt, Maturity, Year Three Amortization expense Amortization of Intangible Assets Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Entity Shell Company Entity Shell Company Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Restatement Determination Date Restatement Determination Date Inducement Plan [Member] Inducement Plan [Member] Inducement plan. Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Stock by Class Schedule of Stock by Class [Table Text Block] Cash, cash equivalents, and restricted cash – beginning of period Cash, cash equivalents, and restricted cash – end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Grant-date fair value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value Expected term to liquidation (in years) Measurement Input, Expected Term [Member] Operating lease costs Operating Lease, Cost Common stock, shares issued (in shares) Issued (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Severance costs Severance Costs Class A common stock in treasury, at cost; 32,660 shares as of September 30, 2023, and 2,007 shares as of December 31, 2022 Treasury Stock, Common, Value Total Outstanding debt balance Long-Term Debt Total Assets, Fair Value Disclosure Net proceeds on issuance of common stock Sale of Stock, Consideration Received on Transaction 2027 Long-Term Debt, Maturity, Year Four Forfeited/canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Finite-Lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Class A Common Stock Common Class A [Member] Unrecognized stock-based compensation expense, expected recognition weighted-average period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Comprehensive loss attributable to Cibus, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Common stock issued and outstanding, ownership percentage Common Stock Issued And Outstanding, Ownership Percentage Common Stock Issued And Outstanding, Ownership Percentage Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Remainder of 2023 Operating And Finance Lease, Liability, To Be Paid, Remainder Of Fiscal Year Operating and finance lease liabilities payments remainder of fiscal year. Issuance of common stock resulting from merger with Cibus Global, LLC Stock Issued During Period, Value, Acquisitions Entity Address, Address Line One Entity Address, Address Line One Subsequent Event [Table] Subsequent Event [Table] 2024 Finance Lease, Liability, to be Paid, Year One Weighted Average Exercise Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Subsequent Event Subsequent Event [Member] Royalty payment, percentage of subject revenues Related Party Transaction, Rate Note receivable Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Notes Receivable Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Notes Receivable Net loss attributable to redeemable noncontrolling interest Net loss Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other current liabilities Other Liabilities, Current Income Statement [Abstract] Income Statement [Abstract] Employee Retention Credit Employee Retention Credit, CARES Act, Policy [Policy Text Block] Employee Retention Credit, CARES Act, Policy Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Weighted Average Exercise Price Per Share Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights [Abstract] Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Pro forma net loss Business Acquisition, Pro Forma Net Income (Loss) Useful Life (Years) Lessee, Finance Lease, Term of Contract Class of Stock [Line Items] Class of Stock [Line Items] Exercisable (in shares) Class Of Warrant Or Right, Exercisable Class Of Warrant Or Right, Exercisable Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items] Financial Instrument [Axis] Financial Instrument [Axis] Other non-current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] MERGER WITH CIBUS GLOBAL Mergers, Acquisitions and Dispositions Disclosures [Text Block] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Issuance of class A common stock upon exercise of per-funded warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Accumulated deficit Retained Earnings (Accumulated Deficit) Annual Licenses Annual Licenses [Member] Annual Licenses Current assets: Assets, Current [Abstract] Other Commitments [Line Items] Other Commitments [Line Items] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Finance lease, liability, to be paid Finance Lease, Liability, to be Paid Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Royalty liability - related parties Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Royalty Liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Royalty Liability Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Outstanding (in dollars per share) Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights Threshold percentage of minimum ownership in outstanding common stock to enact indemnification agreement Minimum Threshold Percentage Of Ownership In Outstanding Common Stock To Enact Indemnification Agreement Threshold percentage of ownership in outstanding common stock to enact indemnification agreement. Class of Stock [Domain] Class of Stock [Domain] Options Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Total Operating Lease, Liability Charitable contribution obligation, net royalty revenue threshold Charitable Contribution Obligation, Net Royalty Revenue Threshold Charitable Contribution Obligation, Net Royalty Revenue Threshold Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Vesting Vesting [Domain] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Plan Name Plan Name [Axis] Pre-Funded Warrants Pre-Funded Warrants [Member] Pre funded warrants. Debt Disclosure [Abstract] Renewal term Related Party Transaction, Renewal Term Related Party Transaction, Renewal Term Performance Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Common stock Common Stock, Value, Issued Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Trade name Trade Names [Member] Pro forma net loss attributable to controlling interest Business Acquisition, Pro Forma Net Income (Loss), Attributable To Parent Business Acquisition, Pro Forma Net Income (Loss), Attributable To Parent Number of full time employees Restructuring And Related Cost, Number Of Full Time Employees Restructuring And Related Cost, Number Of Full Time Employees Repayments of financing lease obligations Financing cash flows (finance leases) Finance Lease, Principal Payments Finance Lease, Liability, to be Paid, Maturity Finance Lease, Liability, to be Paid, Maturity [Table Text Block] Revenue: Revenue from Contract with Customer [Abstract] All Individuals All Individuals [Member] Non-operating income (expenses) Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date San Diego, California greenhouse lease San Diego, California Greenhouse Lease [Member] San Diego, California Greenhouse Lease PEO Name PEO Name Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Line of credit, financing threshold for termination Line Of Credit, Financing Threshold For Termination Line Of Credit, Financing Threshold For Termination Disclosure of Warrants Transactions [Line Items] Disclosure of Warrants Transactions [Line Items] disclosure of warrants transactions. Restricted cash Restricted Cash, Current Buildings Building [Member] Other Other Accrued Liabilities, Current Change in fair value of liability classified Class A common stock warrants Fair Value Adjustment of Warrants Noncurrent portion Operating And Finance Lease, Liability, Noncurrent Operating And Finance Lease, Liability, Noncurrent Other assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Share-based compensation arrangement by share-based payment award, threshold consecutive trading days Share-Based Compensation Arrangement by Share-Based Payment Award, Threshold Consecutive Trading Days Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Threshold, Consecutive Trading Days Debt instrument, interest rate Debt Instrument, Interest Rate, Stated Percentage Intangible Assets Acquired As Part Of Business Combination [Line Items] Intangible Assets Acquired As Part Of Business Combination [Line Items] Intangible Assets Acquired As Part Of Business Combination Accrued compensation Increase (Decrease) in Employee Related Liabilities Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders’ equity Beginning balance Ending balance Cumulative effect of adoption of lease accounting standard on stockholders’ equity Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Loss of acquiree since acquisition date, attributable to noncontrolling interest Business Combination, Pro Forma Information, Earnings Or Loss Of Acquiree Since Acquisition Date, Attributable To Redeemable Noncontrolling Interest, Actual Business Combination, Pro Forma Information, Earnings Or Loss Of Acquiree Since Acquisition Date, Attributable To Redeemable Noncontrolling Interest, Actual Common unit conversion ratio Common Unit, Convertible, Conversion Ratio Common Unit, Convertible, Conversion Ratio Unvested restricted stock awards Restricted Stock Restricted Stock [Member] Summary of Fair Value of the Common Warrants Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Events [Abstract] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Assumptions: Warrants and Rights Outstanding, Measurement Input Level 2 Fair Value, Inputs, Level 2 [Member] Royalty liability interest expense - related parties Royalty liability interest expense - related parties Interest expense recognized Interest Expense, Royalty Liability Interest Expense, Royalty Liability Number of classes of stock Number Of Classes Of Stock Number Of Classes Of Stock Financing lease obligations, net of current portion Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Finance Lease, Liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Finance Lease, Liability Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Outstanding (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Finance lease, right-of-use asset, before accumulated amortization Finance Lease, Right-of-Use Asset, before Accumulated Amortization City Area Code City Area Code Cibus, Inc. Cibus, Inc. [Member] Cibus, Inc. Schedule of Nonvested Share Activity Schedule of Nonvested Share Activity [Table Text Block] Asset Retirement Obligation Asset Retirement Obligation [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Stock option post-separation exercise period Share-Based Compensation Arrangement By Share-Based Payment Award, Option, Award Post Separation Exercise Period Share-Based Compensation Arrangement By Share-Based Payment Award, Option, Award Post Separation Exercise Period Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Goodwill and Intangible Assets Disclosure [Abstract] Total Liabilities, Fair Value Disclosure Nonrelated Party Nonrelated Party [Member] Net loss Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Developed technology Developed Technology Rights [Member] Summary of Stock-based Compensation Expense Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Total liabilities, redeemable noncontrolling interest, and stockholders' equity Liabilities and Equity Other non-current assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Operating lease right-of-use assets Right-of-Use-Asset Operating Lease, Right-of-Use Asset Vested (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period, Weighted Average Exercise Price Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Indefinite-Lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Operating lease right-of-use-assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset Remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Restructuring cost, expected amount Restructuring and Related Cost, Expected Cost Arrangement Duration Trading Arrangement Duration In-process research and development In Process Research and Development [Member] Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Related Party Related Party [Member] Number of Common Units included in Up-C Units (in shares) Business Combination, Number Of Shares Issued To Elective Members, Common Unit Business Combination, Number Of Shares Issued To Elective Members, Common Unit SUPPLEMENTAL INFORMATION Supplemental Balance Sheet Disclosures [Text Block] Fair Value Measurements of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Authorized (in shares) Common Stock, Shares Authorized Document Information [Table] Document Information [Table] Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Stockholders Equity [Line Items] Stockholders Equity [Line Items] Stockholders Equity [Line Items] Indefinite-Lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Award Timing Disclosures [Line Items] Title of Individual Title of Individual [Domain] Comprehensive loss attributable to redeemable noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Additional paid-in capital Additional Paid in Capital Executive Officer Executive Officer [Member] Document Information [Line Items] Document Information [Line Items] Change in value of redeemable noncontrolling interest Temporary Equity, Change In Value Of Redeemable Noncontrolling Interest Temporary Equity, Change In Value Of Redeemable Noncontrolling Interest Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Insider Trading Arrangements [Line Items] Summary of Stock-Based Compensation Granted As Deemed Dividends Disclosure Of Share Based Compensation Awards Restricted Stock Units Deemed Dividends Table [Table Text Block] Disclosure of share-based compensation awards restricted stock units deemed dividends. Fair Value Concentration Of Risk Financial Statement Captions [Line Items] Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] Related Party, Type [Axis] Related Party, Type [Axis] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Stockholders Equity [Table] Stockholders Equity [Table] Stockholders Equity [Table] Adjustment to Compensation, Amount Adjustment to Compensation Amount Share-Based Payment Arrangement, Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Due to/from related parties Increase (Decrease) in Other Current Liabilities Employee Severance Employee Severance [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Entity Central Index Key Entity Central Index Key Fair Value of Liabilities Liabilities, Fair Value Disclosure [Abstract] Stock-based compensation (benefit) expense Total Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accrued compensation Employee-related Liabilities, Current Name Trading Arrangement, Individual Name Accretion expense Asset Retirement Obligation, Accretion Expense Issuance of common stock Stock Issued During Period, Value, New Issues Accounts receivable Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Accounts Receivable Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Accounts Receivable Total revenue Revenue from collaboration agreement Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Acquired indefinite-lived intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Legal Entity [Axis] Legal Entity [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Fair Value of Assets Assets, Fair Value Disclosure [Abstract] Notes payable, net of current portion Noncurrent portion Long-Term Debt, Excluding Current Maturities Weighted average remaining lease term (years) Finance Lease, Weighted Average Remaining Lease Term Deemed dividends from grants to Cellectis employees Deemed Dividend (Deficit) Deemed Dividend (Deficit). Leasehold improvements Leasehold Improvements [Member] Selling, General and Administrative Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] Weighted average shares of Class A common stock outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Contract with Customer, Liability [Roll Forward] Contract with Customer, Liability [Roll Forward] Contract with Customer, Liability Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Common Warrants Class Of Warrant Or Right, Outstanding [Abstract] Class Of Warrant Or Right, Outstanding Award performance period Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period Summary of Grant Date Fair Value of Awards Vested Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block] Other interest income (expense), net Interest Income (Expense), Nonoperating, Net Purchases of property, plant, and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Thereafter Finance Lease, Liability, to be Paid, after Year Five Proctor & Gamble Proctor & Gamble [Member] Proctor & Gamble Weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 2028 Long-Term Debt, Maturity, Year Five Intangible Assets Acquired As Part Of Business Combination [Table] Intangible Assets Acquired As Part Of Business Combination [Table] Intangible Assets Acquired As Part Of Business Combination Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Change in value of redeemable noncontrolling interest Adjustments To Additional Paid In Capital, Change In Value Of Redeemable Noncontrolling Interest Adjustments To Additional Paid In Capital, Change In Value Of Redeemable Noncontrolling Interest Assets in progress Construction in Progress [Member] Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Current portion of notes payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt Greenhouse Lease Greenhouse Lease [Member] Greenhouse Lease Non-PEO NEO Non-PEO NEO [Member] Goodwill and intangible asset impairment Goodwill and Intangible Asset Impairment Warrant Exchange Agreement Warrant Exchange Agreement [Member] Warrant Exchange Agreement Adjustment to Compensation: Adjustment to Compensation [Axis] Consideration received Contract With Customer, Liability, Consideration Received Contract With Customer, Liability, Consideration Received Scenario [Axis] Scenario [Axis] Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted average shares of Class A common stock outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Operating lease obligations, net of current portion Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability Acquired from merger with Cibus Global, LLC Asset Retirement Obligation, Acquired Asset Retirement Obligation, Acquired San Diego, California laboratory lease San Diego, California Laboratory Lease [Member] San Diego, California Laboratory Lease Related Party Transaction [Axis] Related Party Transaction [Axis] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Proceeds from draws on revolving line of credit from Cibus Global, LLC Proceeds from Long-Term Lines of Credit Accounting Standards Update 2016-02 [Member] EX-101.PRE 9 cbus-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 10 cbus-20230930_g1.jpg GRAPHIC begin 644 cbus-20230930_g1.jpg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end XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
COVER PAGE - shares
 9 Months Ended
Sep. 30, 2023
Nov. 08, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-38161  
Entity Registrant Name Cibus, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 27-1967997  
Entity Address, Address Line One 6455 Nancy Ridge Drive  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92121  
City Area Code (858)  
Local Phone Number 450-0008  
Title of 12(b) Security Class A Common Stock, $0.0001 par value per share  
Trading Symbol CBUS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0001705843  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Class A Common Stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   16,699,948
Class B Common Stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   4,642,636
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 31,883,000 $ 3,427,000
Restricted cash 0 99,000
Accounts receivable 560,000 0
Prepaid expenses and other current assets 2,029,000 606,000
Total current assets 34,472,000 4,132,000
Property, plant, and equipment, net 17,197,000 4,516,000
Operating lease right-of-use assets 22,935,000 13,615,000
Intangible assets, net 134,921,000 158,000
Goodwill 585,266,000 0
Other non-current assets 1,444,000 0
Total assets 796,235,000 22,421,000
Current liabilities:    
Accounts payable 6,281,000 340,000
Accrued expenses 5,092,000 173,000
Accrued compensation 3,704,000 107,000
Deferred revenue 1,637,000 107,000
Current portion of notes payable 1,165,000 0
Current portion of financing lease obligations 235,000 97,000
Current portion of operating lease obligations 5,436,000 367,000
Class A common stock warrants 1,512,000 291,000
Total current liabilities 25,079,000 1,662,000
Notes payable, net of current portion 629,000 0
Financing lease obligations, net of current portion 102,000 0
Operating lease obligations, net of current portion 18,844,000 13,447,000
Royalty liability - related parties 157,113,000 0
Other non-current liabilities 1,974,000 79,000
Total liabilities 203,741,000 15,188,000
Commitments and contingencies (See Note 10)
Redeemable noncontrolling interest 129,104,000 0
Stockholders’ equity:    
Additional paid-in capital 727,821,000 220,422,000
Class A common stock in treasury, at cost; 32,660 shares as of September 30, 2023, and 2,007 shares as of December 31, 2022 (1,785,000) (1,043,000)
Accumulated deficit (262,664,000) (212,151,000)
Accumulated other comprehensive income 10,000 0
Total stockholders’ equity 463,390,000 7,233,000
Total liabilities, redeemable noncontrolling interest, and stockholders' equity 796,235,000 22,421,000
Class A Common Stock    
Stockholders’ equity:    
Common stock 8,000 5,000
Class B Common Stock    
Stockholders’ equity:    
Common stock 0 0
Related Party    
Current liabilities:    
Other current liabilities 0 175,000
Nonrelated Party    
Current liabilities:    
Other current liabilities $ 17,000 $ 5,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Common stock, shares authorized (in shares) 300,000,000  
Common stock, shares issued (in shares) 22,299,467  
Common stock, shares outstanding (in shares) 21,302,632  
Treasury stock, shares (in shares) 32,660 2,007
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 210,000,000 275,000,000
Common stock, shares issued (in shares) 17,656,831 978,915
Common stock, shares outstanding (in shares) 16,659,996 976,908
Class B Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 90,000,000 0
Common stock, shares issued (in shares) 4,642,636 0
Common stock, shares outstanding (in shares) 4,642,636 0
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue:        
Total revenue $ 475,000 $ 42,000 $ 714,000 $ 115,000
Operating expenses:        
Research and development 17,521,000 3,016,000 28,159,000 9,207,000
Selling, general, and administrative 8,751,000 3,229,000 22,126,000 9,965,000
Total operating expenses 26,272,000 6,245,000 50,285,000 19,172,000
Loss from operations (25,797,000) (6,203,000) (49,571,000) (19,057,000)
Royalty liability interest expense - related parties (8,136,000) 0 (10,753,000) 0
Other interest income (expense), net 281,000 (47,000) 359,000 (80,000)
Non-operating income (expenses) (876,000) 300,000 (466,000) 5,083,000
Loss before income taxes (34,528,000) (5,950,000) (60,431,000) (14,054,000)
Income taxes 0 0 0 0
Net loss (34,528,000) (5,950,000) (60,431,000) (14,054,000)
Net loss attributable to redeemable noncontrolling interest (8,099,000) 0 (9,918,000) 0
Net loss attributable to Cibus, Inc. $ (26,429,000) $ (5,950,000) $ (50,513,000) $ (14,054,000)
Basic net loss per share of Class A common stock (in dollars per share) $ (1.59) $ (6.36) $ (6.33) $ (15.56)
Diluted net loss per share of Class A common stock (in dollars per share) $ (1.59) $ (6.36) $ (6.33) $ (15.56)
Weighted average shares of Class A common stock outstanding - basic (in shares) 16,641,127 935,702 7,979,132 903,476
Weighted average shares of Class A common stock outstanding - diluted (in shares) 16,641,127 935,702 7,979,132 903,476
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net loss $ (34,528) $ (5,950) $ (60,431) $ (14,054)
Foreign currency translation adjustments 15 0 13 0
Comprehensive loss (34,513) (5,950) (60,418) (14,054)
Comprehensive loss attributable to redeemable noncontrolling interest (8,096) 0 (9,915) 0
Comprehensive loss attributable to Cibus, Inc. $ (26,417) $ (5,950) $ (50,503) $ (14,054)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
At-The-Market Offering
Follow-on Public Offering
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Common Stock
Follow-on Public Offering
Class A Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
At-The-Market Offering
Additional Paid-In Capital
Follow-on Public Offering
Shares in Treasury
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Net loss $ 0                              
Beginning balance (in shares) at Dec. 31, 2021             775,480                  
Beginning balance at Dec. 31, 2021 14,132         $ 832 $ 4     $ 211,263     $ (1,043) $ (196,092) $ 832  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (14,054)                         (14,054)    
Stock-based compensation 2,890                 2,890            
Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares)             5,518                  
Issuance of common stock (in shares)                 77,600              
Issuance of common stock       $ (7) $ 5,051       $ 1   $ (7) $ 5,050        
Issuance of class A common stock upon exercise of per-funded warrants (in shares)             77,600                  
Ending balance (in shares) at Sep. 30, 2022             936,198                  
Ending balance at Sep. 30, 2022 8,844         832 $ 5     219,196     (1,043) (209,314)    
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Net loss 0                              
Beginning balance (in shares) at Jun. 30, 2022             934,327                  
Beginning balance at Jun. 30, 2022 13,759           $ 5     218,161     (1,043) (203,364)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (5,950)                         (5,950)    
Stock-based compensation 1,035                 1,035            
Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares)             1,871                  
Ending balance (in shares) at Sep. 30, 2022             936,198                  
Ending balance at Sep. 30, 2022 8,844         $ 832 $ 5     219,196     (1,043) (209,314)    
Beginning balance at Dec. 31, 2022 0                              
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Net loss (9,918)                              
Redeemable noncontrolling interest resulting from merger with Cibus Global, LLC 138,685                              
Change in value of redeemable noncontrolling interest 334                              
Foreign currency translation adjustments 3                              
Ending balance at Sep. 30, 2023 129,104                              
Beginning balance (in shares) at Dec. 31, 2022   976,908 0       976,908 0                
Beginning balance at Dec. 31, 2022 7,233           $ 5 $ 0   220,422     (1,043) (212,151)   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (50,513)                         (50,513)    
Stock-based compensation 11,670                 11,670            
Issuance of common stock resulting from merger with Cibus Global, LLC (in shares)             15,508,202 4,642,636                
Issuance of common stock resulting from merger with Cibus Global, LLC 634,751           $ 3     634,748            
Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares)             207,546                  
Shares withheld for net share settlement (in shares)             (32,660)                  
Shares withheld for net share settlement (742)                       (742)      
Redeemable noncontrolling interest resulting from merger with Cibus Global, LLC (138,685)                 (138,685)            
Change in value of redeemable noncontrolling interest (334)                 (334)            
Foreign currency translation adjustments $ 10                             10
Ending balance (in shares) at Sep. 30, 2023 21,302,632 16,659,996 4,642,636       16,659,996 4,642,636                
Ending balance at Sep. 30, 2023 $ 463,390           $ 8 $ 0   727,821     (1,785) (262,664)   10
Beginning balance at Jun. 30, 2023 136,866                              
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Net loss (8,099)                              
Change in value of redeemable noncontrolling interest 334                              
Foreign currency translation adjustments 3                              
Ending balance at Sep. 30, 2023 129,104                              
Beginning balance (in shares) at Jun. 30, 2023             16,606,401 4,642,636                
Beginning balance at Jun. 30, 2023 484,313           $ 8 $ 0   722,327     (1,785) (236,235)   (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Net loss (26,429)                         (26,429)    
Stock-based compensation 5,828                 5,828            
Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares)             53,608                  
Shares withheld for net share settlement (in shares)             (13)                  
Change in value of redeemable noncontrolling interest (334)                 (334)            
Foreign currency translation adjustments $ 12                             12
Ending balance (in shares) at Sep. 30, 2023 21,302,632 16,659,996 4,642,636       16,659,996 4,642,636                
Ending balance at Sep. 30, 2023 $ 463,390           $ 8 $ 0   $ 727,821     $ (1,785) $ (262,664)   $ 10
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY (Parenthetical)
$ in Millions
 9 Months Ended
Sep. 30, 2022
USD ($)
Statement of Stockholders' Equity [Abstract]  
Offering costs $ 0.5
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities    
Net loss $ (60,431) $ (14,054)
Adjustments to reconcile net loss to net cash used by operating activities:    
Royalty liability interest expense - related parties 10,753 0
Depreciation and amortization 2,875 1,158
Stock-based compensation 11,670 2,890
Change in fair value of liability classified Class A common stock warrants 1,221 (5,009)
Other 17 0
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 1,674 0
Due to/from related parties (95) (34)
Prepaid expenses and other current assets 1,111 297
Accounts payable (61) (188)
Accrued expenses 1,357 41
Accrued compensation 738 (166)
Deferred revenues 340 (115)
Right-of-use assets and lease liabilities, net (28) 154
Other assets and liabilities, net (334) (575)
Net cash used by operating activities (29,193) (15,601)
Investing activities    
Cash acquired from merger with Cibus Global, LLC 59,381 0
Purchases of property, plant, and equipment (3,872) (1,509)
Net cash provided by (used) by investing activities 55,509 (1,509)
Financing activities    
Proceeds from Class A common stock issuance 0 11,209
Costs incurred related to the issuance of Class A common stock 0 (962)
Proceeds from draws on revolving line of credit from Cibus Global, LLC 2,500 0
Payment of taxes related to vested restricted stock units (742) 0
Proceeds from issuance of notes payable 1,287 0
Repayments of financing lease obligations (242) (353)
Repayments of notes payable (760) 0
Net cash provided by financing activities 2,043 9,894
Effect of exchange rate changes on cash and cash equivalents (2) 0
Net increase (decrease) in cash, cash equivalents, and restricted cash 28,357 (7,216)
Cash, cash equivalents, and restricted cash – beginning of period 3,526 14,421
Cash, cash equivalents, and restricted cash – end of period $ 31,883 $ 7,205
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESThe unaudited condensed consolidated financial statements of Cibus, Inc. (Cibus or the Company) have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP or GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC) applicable to interim financial statements. In the Company’s opinion, the accompanying condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of its statements of financial position, results of operations, and cash flows for the periods presented but they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Except as otherwise disclosed herein, these adjustments consist of normal recurring items. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole or any other interim period.

For further information, refer to the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, as amended by the Company’s Form 10-K/A for the year ended December 31, 2022, filed with the SEC on March 2, 2023, and March 3, 2023, respectively (collectively, the Annual Report). The accompanying condensed consolidated balance sheets as of December 31, 2022, was derived from the audited consolidated financial statements. This Quarterly Report on Form 10-Q should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Annual Report.

Description of Business

Cibus, Inc. (formerly Calyxt, Inc.) completed the Merger Transactions (as defined below under “—Merger Transactions”) on May 31, 2023, with Cibus Global, LLC (Cibus Global), and the Company carries on its business through Cibus Global and its subsidiaries. Cibus is the sole managing member of Cibus Global and, as sole managing member, the Company operates and controls all of the business and affairs of Cibus Global. As a result, the Company consolidates the financial results of Cibus Global and its subsidiaries and reports redeemable noncontrolling interest representing the economic interest in Cibus Global held by the other members of Cibus Global.

Cibus Global, a Delaware limited liability company, was formed on May 10, 2019. Immediately prior to the effective date of this formation, Cibus Global was organized as a British Virgin Islands company (Cibus Global, Ltd.), which was formed on November 5, 2001. On May 10, 2019, Cibus Global was converted to be a Delaware limited liability company.

Cibus Global is a plant trait company using gene editing technologies to develop and license gene edited plant traits that improve farming productivity or produce renewable low carbon plant products.

Completion of Merger Transactions

On May 31, 2023, the Company completed the business combination transactions contemplated by the Agreement and Plan of Merger, dated as of January 13, 2023, as amended by the First Amendment thereto dated as of April 14, 2023 (as amended, the Merger Agreement, and the transactions contemplated thereby, the Merger Transactions), by and among Legacy Calyxt; Calypso Merger Subsidiary, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company; Cibus Global, LLC (Cibus Global); and certain blocker entities party thereto. Among other things, as part of the Merger Transactions, the Company’s amended and restated certificate of incorporation was further amended and restated (the Amended Certificate of Incorporation). The Company is organized in an “Up-C” structure, and the Company’s only material asset consists of membership units of Cibus Global. The Amended Certificate of Incorporation designated two classes of the Company’s common stock: (i) Class A Common Stock, par value $0.0001 per share (the Class A Common Stock), which shares have full voting and economic rights, and (ii) Class B Common Stock, par value $0.0001 per share (the Class B Common Stock), which shares have full voting, but no economic rights. Each share of Legacy Calyxt’s common stock, par value $0.0001 per share (Legacy Common Stock) existing and outstanding immediately prior to the Merger Transactions remained outstanding as a share of Class A Common Stock without any conversion or exchange thereof.

At the closing of the Merger Transactions, the Company contributed all of its assets and liabilities to Cibus Global, in exchange for Common Units. The Company issued an aggregate of 16,527,484 shares of Class A Common Stock (including 1,019,282 shares of restricted Class A Common Stock) and 4,642,636 shares of Class B Common Stock to Cibus Global equityholders, as consideration in the Merger Transactions, pursuant to the terms of the Merger Agreement. Upon closing, Legacy Calyxt stockholders held approximately 4.8 percent of the issued and outstanding common stock of the Company and legacy holders of membership units of Cibus Global (including profits interest units and warrants) held approximately 95.2 percent of the issued and outstanding common stock of the Company.

The primary purpose of the merger was to bring together the technology platforms and facilities of two pioneering companies to create a leading agricultural technology company for the development of productivity traits and to consolidated significant patented agricultural gene editing technology.

Reverse Stock Splits

Prior to the Merger Transactions, Legacy Calyxt effected a one-for-ten reverse stock split (the First Reverse Stock Split) of the Legacy Common Stock, which became effective on April 24, 2023. The First Reverse Stock Split was reflected on the Nasdaq Capital Market
beginning with the opening of trading on April 25, 2023.

Immediately prior to the Merger Transactions, the Company effected a one-for-five reverse stock split (the Second Reverse Stock Split and, together with the First Reverse Stock Split, the Reverse Stock Splits) of the Legacy Common Stock, which became effective on May 31, 2023. The Second Reverse Stock Split was reflected on the Nasdaq Capital Market beginning with the opening of trading of the Class A Common Stock on June 1, 2023.

No fractional shares were issued in connection with the Reverse Stock Splits and instead, fractional shares were rounded up to the nearest whole share number. The par value and authorized shares of Legacy Common Stock and preferred stock of the Company were not adjusted as a result of the Reverse Stock Splits.

Pursuant to the Amended Certificate of Incorporation, following the consummation of the Merger Transactions, the Company is authorized to issue 310,000,000 shares, consisting of (i) 300,000,000 shares of common stock, par value $0.0001 per share, divided into (A) 210,000,000 shares of Class A Common Stock and (B) 90,000,000 shares of Class B Common Stock and (ii) 10,000,000 shares of preferred stock, par value $0.0001 per share. Unless otherwise noted, all share and per share amounts in this Quarterly Report on Form 10-Q have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Splits.

Share information related to the Company's common stock as of September 30, 2023, is as follows:

Class A Common StockClass B Common StockTotal Common Stock
Authorized210,000,00090,000,000300,000,000
Issued17,656,8314,642,63622,299,467
Outstanding16,659,9964,642,63621,302,632


Class A Restricted Stock

In connection with the Merger Transactions, the Company issued restricted shares of Class A Common Stock (Class A Restricted Stock), which remain subject to vesting conditions, to Cibus Global Members that held unvested profits interest units at the time of the consummation of the Merger Transactions. Shares of Class A Restricted Stock are considered to be legally issued and outstanding as of the date of grant, notwithstanding that the shares remain subject to risk of forfeiture if the vesting conditions for such shares are not met. For financial statement presentation purposes, Class A Restricted Stock is treated as issued, but will only be treated as outstanding after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from items presenting Class A Common Stock, including the calculation of net loss per share of Class A Common Stock.

Going Concern

The Company has incurred losses since its inception. The Company’s net loss was $60.4 million and cash used for operating activities was $29.2 million for the nine months ended September 30, 2023. The Company’s primary source of liquidity is its cash and cash equivalents, with additional capital resources accessible, subject to market conditions and other factors, from the capital markets, including through offerings of common stock or other securities.

As of September 30, 2023, the Company had $31.9 million of cash and cash equivalents and $25.1 million of current liabilities.

The Company anticipates that it will continue to generate losses for the next several years. Over the longer term and until the Company can generate cash flows sufficient to support its operating capital requirements, it expects to finance a portion of future cash needs through (i) cash on hand, (ii) commercialization activities, which may result in various types of revenue streams from future product development agreements and technology licenses, including upfront and milestone payments, annual license fees, and royalties, (iii) government or other third-party funding, (iv) public or private equity or debt financings, or (v) a combination of the foregoing.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.

Management will need to raise additional capital to support its business plans to continue as a going concern within one year after the date that these financial statements are issued. Although the Company has implemented a strategic realignment, which has included headcount reductions, and has initiated cost reduction initiatives designed to preserve capital resources, if the Company is unable to raise additional capital in a sufficient amount or on acceptable terms, the Company may have to implement additional, more stringent cost reduction measures to manage liquidity, and the Company may have to significantly delay, scale back, or cease operations, in part or in full. If the Company raises additional funds through the issuance of additional debt or equity securities, including as part of a strategic alternative, it could result in substantial dilution to its existing stockholders and increased fixed payment obligations, and these securities may have rights senior to those of the Company’s shares of common stock. These factors raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date of issuance of these financial statements. Any of these events could significantly impact the Company’s business, financial condition, and prospects.
Use of Estimates

The preparation of the Company’s condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company’s historical experience, knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions. Key estimates made by the Company include revenue recognition, useful lives and impairment of long-lived assets, valuation of equity-based awards and related equity-based compensation expense, valuation of intangible assets, valuation allowances on deferred tax assets, and the valuation of the Royalty Liability (defined below under "Royalty liability - Related Parties").

Fair Value Measurements of Financial Instruments

The Company follows Accounting Standards Codification (ASC) Topic 820, Fair Value Measurements and Disclosures, for financial assets and liabilities that are recognized or disclosed at fair value in these condensed consolidated financial statements on a recurring basis. Under ASC 820, fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts its business. ASC 820 clarifies fair value should be based on assumptions market participants would use when pricing the asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to observable unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

The carrying amounts reflected in the accompanying condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate their fair value due to their short-term nature. Based on the borrowing rates currently available to the Company for notes payable with similar terms and consideration of default and credit risk, the carrying value of the notes payable approximates fair value, which is considered a Level 2 fair value measurement.

Cash and Cash Equivalents

The Company considers all liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include cash in readily available checking and money market accounts. The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses with these financial institutions. As of September 30, 2023, the Company had cash balances deposited at major financial institutions.

Restricted Cash

The Company’s restricted cash balances are cash and cash equivalents deposited in an amount equal to the future rent payments as required under the Company’s equipment lease facility. The Company may request the return of excess restricted cash collateral annually in December. The amount of the restricted cash balance as of December 31, 2022, was returned in March of 2023.

Accounts Receivable

Accounts receivable are recorded at the amounts billed relating to contracted research and development (R&D) services provided. The Company makes judgments as to its ability to collect outstanding receivables and provides an allowance for receivables when collection is doubtful. Accounts receivable are written off when management believes that all efforts to collect the amounts outstanding have been exhausted. The allowance for credit losses is estimated by management based on evaluations of its historical bad debt, current collection experience, and estimate of remaining collectability. Bad debt expense is recorded as necessary to maintain an appropriate level of allowance for credit losses in selling, general, and administrative (SG&A) expense in the accompanying condensed consolidated statements of operations. Accounts receivable is presented net of allowance for credit losses which was $0 as of September 30, 2023, and December 31, 2022.

Property, Plant, and Equipment, net

Property, plant, and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation of buildings, lab equipment, furniture, and computer equipment and software is recorded using the straight-line method over the estimated useful lives of the respective assets, ranging from three to twenty years. Amortization of leasehold improvements are recorded using a straight-line method over the lesser of the estimated useful lives of the improvements or the remaining life of the lease. Expenditures which substantially increase the useful life of an asset, are capitalized. Expenditures for repairs and maintenance are expensed as incurred. Assets in progress include the construction of lab equipment and software to be used in the Company’s facility. The assets will be placed in service when the construction is completed and will be amortized over the useful life of the asset.

Goodwill and Acquired Intangible Assets

Goodwill is calculated as the excess of the purchase consideration paid in a business combination over the fair value of the assets acquired less liabilities assumed. Goodwill is not amortized and is tested for impairment at least annually or when events and circumstances indicate that fair value of a reporting unit may be below its carrying value. The Company has one reporting unit. The
Company first assesses qualitative factors to evaluate whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount or elects to bypass such assessment. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying value, or the Company elects to bypass the qualitative assessment, it performs a quantitative test by determining the fair value of the reporting unit. If the carrying value of the reporting unit exceeds the fair value, then an impairment loss is recognized for the difference.

Acquired in process R&D, developed technology, and trade names are related to the Merger Transactions. Acquired intangible assets are amortized on a straight-line basis over the estimated period over which the Company expects to realize economic value related to the intangible asset. In process R&D is not amortized until it is determined to be ready for its intended use. The acquired in process R&D will be tested for impairment annually, or more frequently, if an impairment indicator is identified. No impairment charges relating to acquired goodwill or indefinite lived intangible assets were recorded for the nine months ended September 30, 2023.

Leases

The Company determines if an arrangement is or contains a lease at inception. For leases with a term greater than one year, lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company excludes short-term leases, if any, having initial terms of 12 months or less at lease commencement as an accounting policy election. In determining the net present value of lease payments, the Company uses its incremental borrowing rate, which represents an estimated rate of interest that the Company would have to pay to borrow equivalent funds on a collateralized basis, at the lease commencement date. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statements of operations. Variable lease payments primarily include common area maintenance, utilities, real estate taxes, insurance, and other operating costs that are passed on from the lessor in proportion to the space leased by the Company. The Company has elected the practical expedient to not separate between lease and non-lease components.

Asset Retirement Obligation

The Company records an asset retirement obligation (ARO) for the estimated cost of removing constructed leasehold improvement assets and restoring the leased premises back to their original condition, at the time when the contractual obligations are incurred. The ARO represents the present value of the expected cost for the related restoration activities. The ARO assets and liabilities are recorded in property, plant, and equipment, net and other non-current liabilities, respectively, in the Company’s condensed consolidated balance sheets. The Company records accretion expense, which represents the increase in the ARO, over the remaining or operational life of the associated leasehold improvements. Accretion expense is recorded as R&D expense in the condensed consolidated statements of operations using an accretion rate based on the credit adjusted risk-free interest rate. Changes resulting from revisions to the timing or amount of the original estimate of cash flows are recognized as an increase or a decrease in the asset retirement cost, or income when the asset retirement cost is depleted.

Revenue Recognition

The Company’s revenues represent amounts earned from collaboration agreements related to contract research. The Company recognizes revenues under Topic 606 Revenue from Contracts with Customers (Topic 606) when control of services is transferred to the Company’s customers in an amount that reflects the consideration the Company expects to receive from the Company’s customers in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing the revenue when the performance obligations have been satisfied. The Company recognizes revenue for satisfied performance obligations only when the Company determines there are no uncertainties regarding payment terms or transfer of control. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract.

Collaboration Agreements Related to Contract Research

Performance obligations under collaboration arrangements include providing intellectual property licenses, performing R&D consulting services, and providing other materials. To date, the Company has concluded that the licenses of intellectual property in its collaboration arrangements have not been distinct, as intellectual property has not been licensed without related R&D support services. Under Topic 606, milestone fees are variable consideration that is initially constrained and included in the arrangement consideration only when it is probable that the milestones will be achieved. Arrangement consideration, including upfront fees, milestone fees, and fees for research services, is recognized over the period as services are provided using an input method to determine the amount to recognize each reporting period. The Company reviews the inputs each period, such as the Company’s level of effort expended, including the time the Company estimates it will take to complete the activities, or costs incurred relative to the total expected inputs to satisfy the performance obligation. Generally, input measures are labor hours expended or a time-based measure of progress towards the satisfaction of the performance obligation.

Contract Liabilities

The Company records contract liabilities when cash payments are received or due in advance of performance, primarily related to advances of upfront and milestone payments from contract research and collaboration agreements. Contract liabilities consist of deferred revenue on the accompanying condensed consolidated balance sheets. The Company expects to recognize the amounts included in deferred revenues within one year.

The following table represents the deferred revenue activity:

In ThousandsDeferred Revenue
Balance as of December 31, 2022$107 
Acquired from merger with Cibus Global, LLC1,186 
Consideration earned(714)
Consideration received1,058 
Balance as of September 30, 2023$1,637 

For the three months ended September 30, 2023, $0.5 million of deferred revenue was recognized as revenue in the accompanying condensed consolidated statements of operations. For the nine months ended September 30, 2023, $0.1 million of the deferred revenue balance as of December 31, 2022, had been recognized as revenue in the accompanying condensed consolidated statements of operations.

Selling, General, and Administrative Expenses

SG&A expense consists primarily of employee-related expenses, such as salaries for its executive, business development, legal, intellectual property, information technology, finance, human resources, and other administrative functions. These costs include legal, professional, and consulting fees for external firms and contractors. All selling and marketing expenses, including advertising expenses and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization, are included in SG&A expense in the accompanying condensed consolidated statements of operations.

Beginning in the second quarter of 2023, SG&A expense includes costs related to its intellectual property portfolio and costs to write and support the research for filing patents. Historically, the Company expensed patent application costs and related legal costs for maintenance of such patents as incurred and such costs were included in R&D expense in the accompanying condensed consolidated statements of operations.

In the nine months ended September 30, 2023, the Company recognized, during the second quarter of 2023, $0.4 million of deferred financing costs related to the liability classified common warrants (Common Warrants) in SG&A expense in the accompanying condensed consolidated statements of operations.

Research and Development Expenses

R&D costs are expensed as incurred in performing R&D activities and include salaries, lab supplies, consultant fees, and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization.

Historically, the Company recognized its intellectual property portfolio and costs to write and support the research for filing patents as R&D expense. Beginning in the second quarter of 2023, these expenses are included in SG&A expense in the accompanying condensed consolidated statements of operations. The amounts in the prior reporting periods are not material and as such no historical amounts have been reclassified.

Royalty Liability – Related Parties

In 2014, Cibus Global entered into the warrant exchange agreement (Warrant Exchange Agreement), which remains in place following the Company’s acquisition of Cibus Global in the Merger Transactions, Cibus Global is required to make ongoing quarterly payments equal to a portion of the aggregate amount of certain worldwide revenues received during the applicable quarter. The Company refers to such payment obligations as its Royalty Liability. Management estimates the total amount of royalty payments over the life of the Warrant Exchange Agreement that Cibus Global will be required to make to holders of certain warrants (Royalty Holders) that were exchanged for the rights to future royalty payments pursuant to the Warrant Exchange Agreement. The Royalty Liability is based on the Company’s current estimates of future royalties expected to be paid over the life of the arrangement. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. In order to determine the amortization of the Royalty Liability, the Company is required to estimate the total amount of future royalty payments to the Royalty Holders over the life of the Warrant Exchange Agreement. This estimate contains significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the royalty period. The Company will periodically assess the estimated royalty payments and to the extent the amount or timing of such payments is materially different than the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. See Note 11 for further details.

Non-Operating Income (Expenses)

Non-operating income (expenses) are income or expenses that are not directly related to ongoing operations and are primarily comprised of gains and losses from the mark-to-market of Common Warrants to purchase Class A Common Stock and foreign exchange transactions.

Net Loss Per Share of Class A Common Stock


Weighted average shares of Class A Common Stock outstanding excludes unvested Class A Common Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from the calculation of net loss per share of Class A Common Stock.

For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding as inclusion of the common stock equivalent securities would be anti-dilutive.

The Company’s potential dilutive securities, which include Common Warrants, unvested performance stock units, unvested restricted stock units, unvested restricted stock awards, and options to purchase Class A Common Stock, have been excluded from the computation of diluted net loss per share of Class A Common Stock as the effect would be antidilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share of Class A Common Stock is the same. The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their anti-dilutive effect:

As of September 30,
20232022
Stock options outstanding109,551116,936
Unvested restricted stock units198,19925,210
Unvested performance stock units—22,600
Unvested restricted stock awards945,780—
Common Warrants158,483158,483
Total1,412,013323,229


Warrants

The Company issued pre-funded warrants (Pre-Funded Warrants) to purchase Class A Common Stock in a follow-on offering on February 23, 2022 (the Follow-On Offering). The Pre-Funded Warrants, which were each exercisable for one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share, were exercised in full on May 4, 2022, and subsequently settled with the counterparty. While outstanding, the Pre-Funded Warrants were considered equity instruments and reported in stockholders’ equity in the Company’s condensed consolidated balance sheets, and the shares issuable upon exercise of the Pre-Funded Warrants were included in the determination of the Company’s net loss per share of Class A Common Stock.

The Company also issued Common Warrants in the Follow-On Offering. The Common Warrants expire on August 23, 2027, and are each exercisable for one share of the Company’s Class A Common Stock for $69.04 per share, after giving effect to the Reverse Stock Splits. The Common Warrants have been classified as a liability because they include a put option election available to their holder that is contingently exercisable if the Company enters into a fundamental transaction (Fundamental Transaction). Pursuant to the terms of the Common Warrants, a Fundamental Transaction occurs if (i) the Company, directly or indirectly, effects any merger or consolidation of the Company with or into another person in which the Company is not the surviving entity, (ii) the Company (and all of its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer is completed pursuant to which holders of the Company’s Class A Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50 percent or more of the outstanding Class A Common Stock of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization, or recapitalization of the Class A Common Stock or any compulsory share exchange pursuant to which the Class A Common Stock is effectively converted into or exchanged for other securities, cash, or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination with another person or group of persons whereby such other person or group acquires more than 50 percent of the voting power of the outstanding shares of Class A Common Stock (not including any shares of Class A Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business combination) (the Fundamental Change Put). If the Fundamental Change Put is exercised by the holder of a Common Warrant, holder may elect to receive either the consideration of the Fundamental Transaction or put the Common Warrants back to the Company in exchange for cash, based on terms and timing specified in the Common Warrant agreement. If the Fundamental Change Put option is exercised, the Company is required to pay cash to the holder in an amount as determined by the Black-Scholes pricing model, with assumptions determined in accordance with the terms of the Common Warrants. The Company believes that the Merger Transactions did not qualify as a Fundamental Transaction.

The Common Warrants are reported at fair value with changes in fair value reported in earnings. The Company reports the changes in fair value of the Common Warrants in non-operating income (expenses) in its condensed consolidated statements of operations.

Employee Retention Credit

Prior to the Merger Transactions, Cibus Global qualified for federal government assistance through the Employee Retention Credit
(ERC) provisions of the CARES Act passed in 2020, for the second, third, and fourth fiscal quarters of 2020, as well as the first and second fiscal quarters of 2021. The purpose of the ERC was to encourage employers to keep employees on the payroll, even if they were not working during the covered period because of the coronavirus outbreak. The Company recognizes amounts to be refundable as tax credits if there is a reasonable assurance of compliance with the grant conditions and receipt of credits. As of September 30, 2023, the Company recognized $0.2 million related to the employee retention credit, and it does not expect to receive any further credits.

Foreign Currency

The accompanying condensed consolidated financial statements are presented in United States dollars (USD) as the reporting currency. For those foreign subsidiaries where the Company has determined that the functional currency is the entity’s local currency, the assets and liabilities of such subsidiaries are translated into USD using exchange rates in effect at the balance sheet date. The revenue and expenses of such subsidiaries are translated into USD using average exchange rates in effect during the reporting period. Any translation adjustments are presented as accumulated other comprehensive income (loss), within stockholders' equity in the accompanying condensed consolidated statements of redeemable noncontrolling interest and stockholders' equity. Foreign currency transaction gains and losses are included in non-operating income (expenses) within the accompanying condensed consolidated statements of operations and were immaterial for all periods presented.

Segment Reporting

Management has determined that the Company has one operating segment, R&D of plant gene editing, which is consistent with the Company's structure and how it manages the business. Furthermore, the Company's Chief Operating Decision Maker, which is the Company's Chief Executive Officer, monitors and reviews financial information at a consolidated level for assessing operating results and the allocation of resources.
Recently Issued Accounting Pronouncements

From time-to-time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position, results of operations, or cash flows upon adoption.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU No. 2021-08 address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination. The amendments in ASU No. 2021-08 require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. Upon adoption, an acquirer should account for the related revenue contracts of the acquiree as if it has originated the contracts.

For public business entities, the amendments in ASU No. 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments in ASU No. 2021-08 should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company applied ASU No. 2021-08 to the Merger Transactions.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
MERGER WITH CIBUS GLOBAL
 9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
MERGER WITH CIBUS GLOBAL MERGER WITH CIBUS GLOBALAs described in Note 1, on May 31, 2023, the Company completed the Merger Transactions.Redeemable Noncontrolling Interest

All of the issued and outstanding Cibus Global membership units (Common Units) are held solely by the Company and certain members of Cibus Global who elected in connection with the Merger Transactions to receive units (Up-C Units), each consisting of one share of Class B Common Stock and one Common Unit at the closing of the Merger Transactions (Electing Members). The Up-C Units are generally exchangeable for shares of Class A Common Stock on a one-for-one basis, subject to certain restrictions. In accordance with ASC 810, Consolidation, Cibus Global is considered a Variable Interest Entity (VIE) with Cibus as its sole managing member and primary beneficiary. As such, Cibus consolidates Cibus Global, and the remaining Common Unit holders that hold economic interest directly in Cibus Global are presented as redeemable noncontrolling interest on the Company’s financial statements. There are no restrictions on the use of assets of Cibus Global.

Redeemable noncontrolling interest represents the portion of Cibus Global Common Units that are not owned directly by the Company. Redeemable noncontrolling interest is classified as temporary equity because the Common Units contained certain redemption features that were not solely within the control of the Company. As of both May 31, 2023, (the closing date of the Merger Transactions) and September 30, 2023, the Common Unit holders of the redeemable noncontrolling interest owned approximately 22 percent of Cibus Global.

Purchase Price

The purchase price for Cibus Global was determined as follows:
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (1)20,150,838 
Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (2)$31.50 
Purchase price$634,751,397 


(1) This share number represents the aggregate number of shares of Common Stock issued to Cibus Global members in the Merger Transactions and comprises: 15,508,202 shares of Class A Common Stock and 4,642,636 shares of Class B Common Stock. This share number excludes 1,019,282 shares of Class A Restricted Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture.
(2) Reflects the purchase price per share of the Company's Class A Common Stock, which was the closing price of the Class A Common Stock on May 31, 2023, the closing date of the Merger Transactions.

Purchase Price Allocation

The acquisition of Cibus Global was accounted for using the acquisition method, whereby all of the assets acquired and liabilities assumed were recognized at their fair value on the acquisition date, with any excess of the purchase price over the estimated fair value recorded as goodwill. The purchase price allocation is preliminary and subject to change, including completion of the Company's analysis on the deferred tax impact of the acquisition.

Identifiable assets acquired, liabilities assumed, and noncontrolling interest, if applicable, are recorded at their estimated fair values at the acquisition date. Significant judgment is required in determining the acquisition date fair value of the assets acquired and liabilities assumed, predominantly with respect to property, plant, and equipment and intangible assets. Evaluations included numerous inputs, including forecasted cash flows that incorporate the specific attributes of each asset. For property, plant, and equipment, the Company considered the remaining useful life of equipment, current replacement costs for similar assets, and comparable market transactions. The Company evaluated all available information, as well as all appropriate methodologies, when determining the fair value of assets acquired, liabilities assumed, and noncontrolling interest. In addition, the Company determined the remaining useful life for property, plant, and equipment and the amortization period and method of amortization for each finite-lived intangible asset.
The following table sets forth the preliminary allocation of the consideration:

In ThousandsMay 31, 2023
Cash and cash equivalents$59,381 
Accounts receivable2,216 
Due from related parties, net19 
Note receivable2,500 
Prepaid expenses and other current assets2,535 
Property, plant and equipment10,588 
Operating lease right-of-use-assets9,519 
Goodwill585,266 
Intangible assets135,429 
Other non-current assets457 
Accounts payable(5,582)
Accrued expenses(3,477)
Accrued compensation(2,859)
Due to related parties(8)
Deferred revenue(1,186)
Current portion of notes payable(517)
Current portion of operating lease obligations(4,687)
Current portion of financing lease obligations(165)
Other current liabilities(17)
Notes payable, net of current portion(749)
Operating lease obligations, net of current portion(6,006)
Financing lease obligations, net of current portion(10)
Royalty liability - related parties(146,360)
Other non-current liabilities(1,536)
Consideration transferred$634,751 


Receivables have been recognized at their fair value, and the Company has not recognized, and it does not expect, any credit losses and therefore expects cash flows to match the recognized receivables.
Intangible Assets Acquired

Intangible assets acquired, and their related estimated average useful lives, are as follows:

In Thousands, except useful lifeMay 31, 2023Estimated Average Useful Life (Years)
In-process research and development$99,051 Indefinite
Developed technology14,148 20
Trade name22,230 20
Total$135,429 


The weighted average amortization period for the Company's definite lived intangible assets, including developed technology and trade names, was 20 years.

The Company incurred expenses of approximately $8.2 million in connection with the completion of the Merger Transactions, of which approximately $0.4 million was recognized in 2022 in the condensed consolidated statements of operations. For the nine months ended September 30, 2023, approximately $3.5 million in legal and professional fees, $1.9 million in severance costs resulting from pre-existing employment agreements, and $1.1 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, were included in SG&A expense in the condensed consolidated statements of operations. Additionally, for the nine months ended September 30, 2023, approximately $1.3 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, was included in R&D expense in the condensed consolidated statements of operations.

The Company's condensed consolidated statements of operations are inclusive of activity relating to the acquired entity, Cibus Global, from the date of acquisition and include $0.7 million in revenue, $35.5 million in net loss attributable to controlling interest, and $9.9 million in net loss attributable to redeemable noncontrolling interest, for the nine months ended September 30, 2023.

These unaudited pro forma figures have been prepared as though the business combination had occurred on January 1, 2022. Pro forma adjustments have been made to reflect non-recurring stock compensation expense, legal and professional fees, severance costs, and amortization of acquired intangible assets, directly attributable to the business combination. The unaudited pro forma condensed financial information is not indicative of the results of operations that would have been achieved had the acquisitions reflected herein been consummated on the dates indicated or that will be achieved in the future.

Three Months Ended September 30,Nine Months Ended September 30,
Unaudited and in Thousands2023202220232022
Pro forma revenues$475 $307 $1,154 $992 
Pro forma net loss(34,528)(20,365)(88,474)(61,603)
Pro forma net loss attributable to controlling interest(24,575)(17,301)(70,855)(53,178)
Pro forma net loss attributable to redeemable noncontrolling interest$(9,953)$(3,064)$(17,619)$(8,425)


Tax Receivable Agreement

In conjunction with the Merger Transactions, the Company entered into a Tax Receivable Agreement (TRA) with the Electing Members. Pursuant to the TRA, the Company generally will be required to pay to the Electing Members, in the aggregate, 85 percent of the net income tax savings that the Company actually realizes (or in certain circumstances, is deemed to realize) as a result of (i) certain favorable tax attributes the Company acquired from the blocker entities party to the Merger Agreement in connection with the Merger Transactions (including net operating losses), (ii) increases to the Company's allocatable share of the tax basis of Cibus Global's assets resulting from future redemptions or exchanges of Common Units for shares of Class A Common Stock or cash, (iii) tax attributes resulting from certain payments made under the TRA and (iv) deductions in respect of interest under the TRA. The payment obligations under the TRA are the Company's obligations and not obligations of Cibus Global.

As of September 30, 2023, no Up-C Units have been exchanged by Electing Members for shares of Class A Common Stock. As of September 30, 2023, the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more-likely-than-not threshold. Since the benefit has not been recorded, the Company determined that the TRA liability is not probable and therefore no TRA liability existed as of September 30, 2023.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK
Financial Instruments Measured at Fair Value and Financial Statement Presentation
The accounting guidance establishes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as of the measurement date as follows:
Level 1: Fair values are based on unadjusted quoted prices in active trading markets for identical assets and liabilities.
Level 2: Fair values are based on observable quoted prices other than those in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
Level 3: Fair values are based on at least one significant unobservable input for the asset or liability.
Fair Value Measurements and Financial Statement Presentation
The Company’s financial instruments measured at fair value and their respective levels in the fair value hierarchy as of September 30, 2023, and December 31, 2022, were as follows:
 September 30, 2023December 31, 2022
 Fair Value of AssetsFair Value of Assets
In ThousandsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Money market funds (1)$7,389 $— $— $7,389 $— $— $— $— 
Total$7,389 $— $— $7,389 $— $— $— $— 


(1) Included in cash and cash equivalents on the accompanying condensed consolidated balance sheets


September 30, 2023December 31, 2022
Fair Value of LiabilitiesFair Value of Liabilities
In ThousandsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Common Warrants$— $— $1,512 $1,512 $— $— $291 $291 
Total$— $— $1,512 $1,512 $— $— $291 $291 


The following table summarizes the Common Warrants activity for the period ended September 30, 2023:

Level 3 Fair Value of Liabilities
Balance as of December 31, 2022291
Mark to market adjustment1,221
Balance as of September 30, 20231,512


The Company estimates the fair value of the Common Warrants as of the date of issuance and at the end of every fiscal period using a Black-Scholes option pricing model, which requires it to make assumptions regarding future stock price volatility and dividend yield. The Company estimates the risk-free interest rate based on the United States Treasury zero-coupon yield curve for the remaining life of the Common Warrants. The Company estimates its future stock price volatility using a weighted average historical volatility which takes into consideration the Company's historical volatility and historical volatility from a group of guideline companies, over the remaining life of the Common Warrants. The Company does not pay dividends and does not expect to pay dividends in the foreseeable future.
The estimated fair values of the Common Warrants, and the assumptions used for the Black-Scholes option pricing model were as follows:
 As of September 30, 2023As of December 31, 2022
Estimated fair value of Common Warrants$9.54 $1.87 
Assumptions: 
Risk-free interest rate4.7 %4.0 %
Expected volatility107.1 %85.0 %
Expected term to liquidation (in years)3.94.6
As of September 30, 2023, the Company had no other financial instruments measured at fair value.

Concentrations of Credit Risk The Company invests its cash and cash equivalents in highly liquid securities and interest-bearing deposit accounts. The Company diversifies the risk associated with investing in securities by allocating its investments to a diverse portfolio of short-dated, high investment-grade securities, which it classifies as cash and cash equivalents that are recorded at fair value in its condensed consolidated financial statements. The Company maintains the credit risk in this portfolio in accordance with its internal policies and, if necessary, makes changes to investments to minimize credit risk. The Company has not experienced any counterparty credit losses. As of September 30, 2023, and December 31, 2022, the Company did not hold any short-term investments.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
PROPERTY, PLANT, AND EQUIPMENT, NET
 9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT, AND EQUIPMENT, NET PROPERTY, PLANT, AND EQUIPMENT, NET

Property, plant, and equipment, net consists of the following:

In Thousands, except useful lifeUseful Life
(Years)		As of September 30, 2023As of December 31, 2022
Property, plant, and equipment, net:
Buildings
10 - 20
$900 $900 
Leasehold improvements
shorter of lease term or - 15
3,879 364 
Office furniture and equipment
5 - 10
13,570 7,803 
Office furniture and equipment under financing leases
4 - 20
373 414 
Computer equipment and software
3 - 5
3,264 912 
Assets in progressN/A3,272 — 
Total property, plant, and equipment25,258 10,393 
Less accumulated depreciation and amortization(8,061)(5,877)
Total$17,197 $4,516 



Depreciation and amortization expense is as follows:

Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Depreciation and amortization expense$1,225 $369 $2,208 $1,091 


Asset Retirement Obligation

Certain lease agreements require the Company to return designated areas of leased space to its original condition upon termination of the lease agreement. At the inception of such leases, the Company records an ARO and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. To determine the fair value of the ARO, the Company estimates the cost for a third-party to perform the restoration work. In subsequent periods, for each ARO, the Company records operating expense to accrete the ARO liability to full value and depreciation expense against the ARO, over the term of the associated lease agreement. The Company used a credit-adjusted risk free rate of 5.6 percent to discount the future obligation, and an inflation rate of 5.0 percent to determine the future value of the original estimate of restoration costs. The ARO is expected to be resolved in July 2025.

The following table presents the changes in the ARO during the nine months ended September 30, 2023.

In ThousandsAsset Retirement Obligations
Balance as of December 31, 2022$— 
Acquired from merger with Cibus Global, LLC264 
Obligations incurred— 
Accretion expense5 
Balance as of September 30, 2023$269 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETSGoodwill

In connection with the Merger Transactions with Cibus Global, the Company recognized goodwill totaling $585.3 million. The company had no goodwill prior to the Merger Transactions. Goodwill represents future economic benefits arising from acquiring Cibus Global, primarily due to its strong market position and its assembled workforce that are not individually identified and separately recognized as intangible assets. None of the goodwill recognized is expected to be deductible for income tax purposes.

Intangible Assets

Intangible assets as of September 30, 2023, were as follows:

In ThousandsGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
In-process research and development$99,051 $— $99,051 
Developed technology14,148 236 13,912 
Trade name22,230 370 21,860 
Other150 52 98 
Total$135,579 $658 $134,921 


Total amortization expense is as follows:

Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Amortization expense$459 $5 667 16 


Intangible assets as of December 31, 2022, were immaterial.
As of September 30, 2023, amortization expense for each of the next five years is estimated as follows:

In ThousandsAmortization Expense
Remainder of 2023$458 
20241,833 
20251,833 
20261,833 
20271,833 
20281,833 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
NOTES PAYABLE
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
NOTES PAYABLE NOTES PAYABLEThe Company has financed the costs associated with its enterprise science platform annual software license. The financing arrangement for the license has a term of one year and accrues interest at an annual rate of 10.9 percent. The Company makes monthly principal and interest payments. The note related to the annual license matures in July 2024.Additionally, the Company has purchased various fixed assets using notes. The notes on financed equipment are subject to annual interest rates between 7.3 percent and 17.6 percent and have a weighted average remaining term of 2.8 years. Notes used to finance equipment mature between October 2023 and March 2028.

The Company has also financed certain annual insurance premiums using a note. The insurance note is subject to an annual interest rate of 7.5 percent, has a weighted average remaining term of 0.4 years, and matures in February 2024.
As of September 30, 2023, future minimum payments under notes payable were as follows:

In ThousandsAnnual LicensesFinanced EquipmentInsuranceTotal Notes Payable
Remainder of 2023$93 $137 $290 $520 
2024216 450 194 860 
2025— 351 — 351 
2026— 151 — 151 
2027— 89 — 89 
2028— 15 — 15 
309 1,193 484 1,986 
Less: interest(15)(168)(9)(192)
Total$294 $1,025 $475 $1,794 
Current portion294 396 475 1,165 
Noncurrent portion$— $629 $— $629 
INTERIM FUNDINGPursuant to the Merger Agreement, beginning at the earlier of March 15, 2023, and the date the Company's unrestricted cash balance first dropped below $1.5 million, the Company could request, and Cibus Global agreed to provide, an unsecured, interest-free revolving line of credit of up to $3.0 million in cash (Interim Funding). Funds could be drawn by the Company in $0.5 million increments and could only be used to fund operating expenses incurred in the ordinary course of business consistent with past practice and consistent with the negative covenants in the Merger Agreement. The Company received $2.5 million of Interim Funding in the aggregate from Cibus Global. The full balance of the Interim Funding was reduced to zero in connection with the closing of the Merger Transactions pursuant to the terms of the Merger Agreement.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Follow-On Public Offering
On February 23, 2022, the Company completed the Follow-On Offering, in which it issued 77,600 shares of Class A Common Stock, Pre-Funded Warrants to purchase up to 77,600 shares of Class A Common Stock, and Common Warrants to purchase up to 158,483 shares of Class A Common Stock, in each case giving effect to the Reverse Stock Splits. The aggregate offering price for each share of Class A Common Stock and accompanying Common Warrant was $70.50, as adjusted for the Reverse Stock Splits. The aggregate offering price for each Pre-Funded Warrant and accompanying Common Warrant was $70.4999, adjusted for the Reverse Stock Splits. In the aggregate, the Company received net proceeds of $10.0 million, after deducting approximately $0.9 million of underwriting discounts and estimated other offering expenses.

Pre-Funded Warrants
Each Pre-Funded Warrant entitled the holder to purchase one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share. While outstanding, the Pre-Funded Warrants were recorded as a component of stockholders’ equity within additional paid-in capital. The Pre-Funded Warrants were exercised in full on May 4, 2022, and subsequently settled with the counterparty.
Common Warrants
Each Common Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $69.04 per share. The Common Warrants became exercisable on August 23, 2022, and expire on August 23, 2027. The Common Warrants are recorded as a liability in the Company’s condensed consolidated balance sheets. Per the terms of the Common Warrants, holders of outstanding Common Warrants are not entitled to exercise any portion of such warrant if, upon exercise, the holder’s ownership of the Company’s Class A Common Stock (together with its affiliates) or the combined voting power of the Company’s securities beneficially owned by such holder (together with its affiliates) would exceed the 4.99 percent after giving effect to the exercise.
Common Warrant transactions for the nine months ended September 30, 2023, are as follows:
 Common Warrants
Weighted Average
Exercise
Price Per Share
Outstanding as of December 31, 2022158,483$69.04 
Issued—— 
Forfeited/canceled—— 
Exercised—— 
Outstanding as of September 30, 2023158,483$69.04 
Exercisable as of September 30, 2023158,483$69.04 

ATM Facility

On September 21, 2021, the Company entered into an Open Market Sale AgreementSM (the ATM Facility) with Jefferies LLC, as sole selling agent. The Company issued approximately 40,000 shares of Class A Common Stock under the ATM Facility in 2022 for net proceeds of $0.1 million. The Company has not issued any additional shares under the ATM Facility during the 2023 fiscal year.

Merger with Cibus Global

At the closing of the Merger Transactions, the Company contributed all of its assets and liabilities to Cibus Global, in exchange for Common Units. The Company issued an aggregate of 16,527,484 shares of Class A Common Stock (including 1,019,282 shares of restricted Class A Common Stock) and 4,642,636 shares of Class B Common Stock to Cibus Global equityholders, as consideration in the Merger Transactions, pursuant to the terms of the Merger Agreement.

Class A Common Stock

Shares of Class A Common Stock have full voting and economic rights. Unvested shares of Class A Restricted Common Stock, which were issued as equity compensation to certain of our employees and executive officers, carry all voting, dividend, distribution, and other rights as apply to shares of Class A Common Stock generally, except that (i) shares of Class A Restricted Common Stock are subject to transfer restrictions and (ii) dividends and distributions are held by the Company until vesting of the underlying shares of Class A Restricted Common Stock and remain subject to the same forfeiture provisions as such shares.

Class B Common Stock

Upon the Closing of the Merger Transactions, the Company issued shares of Class B Common Stock. The Class B Common Stock have full voting rights. The Class B Common Stock have no economic rights and do not participate in dividends or undistributed earnings. However, holders of Class B Common Stock hold a corresponding number of economic, non-voting Common Units through which they would receive pro rata distributions from Cibus Global.

Cibus Global Common Units

In connection with the Merger Transactions, the Company, Cibus Global, and the Electing Members entered into an Exchange Agreement (the Exchange Agreement). The Exchange Agreement sets forth the terms and conditions upon which holders of Up-C Units, comprising an equal number of shares of Class B Common Stock and Cibus Global Common Units, may exchange such Up-C Units for shares of Class A Common Stock. The Up-C Units are generally exchangeable for shares of Class A Common Stock on a one-for-one basis, subject to certain restrictions. The Electing Members’ ownership of Common Units represents the redeemable noncontrolling interest. As of September 30, 2023, there were 21,302,632 Cibus Common Units outstanding. Of the 21,302,632 Cibus Common Units outstanding, 16,659,996 are held by Cibus Inc. and 4,642,636 are held by the Electing Members.

Preferred Stock

Pursuant to the Amended Certificate of Incorporation, following the consummation of the Merger Transactions, the Company is authorized to issue 10,000,000 shares of preferred stock, par value $0.0001 per share. As of September 30, 2023, the Company has not issued any preferred stock.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
The Company uses broad-based stock plans to attract and retain highly qualified officers and employees and to help ensure that management’s interests are aligned with those of its shareholders. The Company has also granted equity-based awards to directors, non-employees, and certain employees of Cellectis.
In December 2014, Legacy Calyxt adopted the Calyxt, Inc. Equity Incentive Plan (2014 Plan), which allowed for the grant of stock options, and in June 2017, it adopted the Calyxt, Inc. 2017 Omnibus Plan (2017 Plan), which allowed for the grant of stock options, RSUs, PSUs, and other types of equity awards. As part of the Merger Transactions, the name of the 2017 plan was amended to reflect the name change of the Company.

In July 2021, the Company also adopted the Calyxt, Inc. Employee Inducement Incentive Plan (the Inducement Plan), from which PSUs were granted to Michael A. Carr, the Company's former Chief Executive Officer.
As of September 30, 2023, 1,925,024 shares were available for grant in the form of stock options, restricted stock, RSUs, and PSUs under the 2017 Plan. Stock-based awards currently outstanding also include awards granted under the 2014 Plan. No further awards are available for grant or will be granted under either the 2014 Plan or the Inducement Plan.
Stock Options
The estimated fair values of stock options granted, and the assumptions used for the Black-Scholes option pricing model were as follows:
 Nine Months Ended September 30,
 20232022
Estimated fair values of stock options granted$— $42.83 
Assumptions:  
Risk-free interest rate
—%
1.9% - 3.5%
Expected volatility
—%
89.7% - 92.8%
Expected term (in years)
—
5.50 - 6.89
The Company estimates the fair value of each stock option on the grant date, or other measurement date if applicable, using a Black-Scholes option pricing model, which requires it to make predictive assumptions regarding employee exercise behavior, future stock price volatility, and dividend yield. The Company estimates the risk-free interest rate based on the United States Treasury zero-coupon yield curve at the date of grant for the expected term of the option. The Company estimates its future stock price volatility using a weighted average historical volatility which takes into consideration the Company's historical volatility and historical volatility from a group of guideline companies, over the expected term of the option. The expected term of stock options is estimated using the average of the vesting tranches and the contractual life of each grant for employee options, or the simplified method, as the Company has limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The use of the simplified method is dependent upon the type of equity award granted and the term of the award. The Company has not paid dividends and does not expect to pay dividends in the foreseeable future.
Option strike prices are set at 100 percent or more of the closing share price on the date of grant and generally vest over three to six years following the grant date. Options generally expire 10 years after the date of grant.

Modification of Stock Options

On March 1, 2023, the Company’s Board of Directors (Board) approved the modification of the award terms of all outstanding stock options with a 90-day post-separation exercise period from the current 90 days to five years from date of grant. The modification did not affect the vesting or service period of the stock options. These modifications were considered to be Type I and incremental stock compensation expense of $0.2 million was determined for all modified awards, of which $0.1 million was recognized associated with vested awards in the three months ended March 31, 2023. The remaining incremental expenses will be recognized over the remaining service period of the awards. The service period for these awards ended with the close of the Merger Transactions and the remaining expense was recognized in the three months ended June 30, 2023.
Information on stock option activity is as follows:
 
Options
Exercisable
Weighted Average
Exercise
Price Per
Share
Options
Outstanding
Weighted Average
Exercise
Price Per
Share
Balance as of December 31, 202267,978$496.83 116,860$367.58 
Granted—— —— 
Vested42,195154.28 —— 
Exercised—— —— 
Forfeited or expired(1,530)441.63 (7,309)369.43 
Balance as of September 30, 2023108,643$364.57 109,551$367.46 
Stock-based compensation expense related to stock option awards is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$40 $530 $1,835 $1,420 
As of September 30, 2023, both options outstanding and options exercisable had nominal aggregate intrinsic value and a weighted average remaining contractual term of 4.0 years.
As of September 30, 2023, unrecognized compensation expense related to non-vested stock options was $0.1 million which has a weighted average remaining recognition period of 1.0 year.
Restricted Stock Awards

The Company granted awards of Class A Restricted Stock (RSAs), in connection with the Merger Transactions, to Cibus Global members who held unvested restricted profits interest units. The Class A Restricted Stock will continue to vest following their original vesting schedules over the remaining life of the awards which is generally 2 months to four years after the date of grant. Information on Class A Restricted Stock award activity is as follows:
 
Restricted Stock
Awards
Weighted Average Grant
Date Fair Value
Unvested balance as of December 31, 2022—$— 
Granted1,019,28231.50 
Vested(71,969)31.50 
Forfeited(1,533)31.50 
Unvested balance as of September 30, 2023945,780$31.50 
The total grant-date fair value of RSAs that vested is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Grant-date fair value$1,725 $— $2,267 $— 
Stock-based compensation expense related to RSAs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$5,631 $— $7,555 $— 
As of September 30, 2023, unrecognized compensation expense related to RSAs was $24.5 million which has a weighted average remaining recognition period of 2.5 years.
Restricted Stock Units
The Company grants RSUs which generally vest over three to five years after the date of grant. Information on restricted stock unit activity is as follows:
 
Restricted Stock
Units
Weighted Average Grant
Date Fair Value
Unvested balance as of December 31, 202224,575$99.36 
Granted272,88519.02 
Vested(96,730)38.27 
Forfeited(2,531)127.84 
Unvested balance as of September 30, 2023198,199$18.19 
The total grant-date fair value of RSUs that vested is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Grant-date fair value$100 $530 $3,702 $1,686 
Stock-based compensation expense related to RSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$157 $334 $2,550 $992 
As of September 30, 2023, unrecognized compensation expense related to RSUs was $3.5 million which has a weighted average remaining recognition period of 3.4 years.
The Company accounted for stock-based compensation awards granted to employees of Cellectis as deemed dividends. These awards are fully vested as of December 31, 2022. The Company recorded deemed dividends as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Deemed dividends from grants to Cellectis employees$— $18 $— $82 
Performance Stock Units

From time-to-time, the Company issues PSUs to certain individuals in management in order to align their objectives with stockholders of the Company. Depending upon the type of PSU award, the Company uses a Monte Carlo simulation pricing model when estimating the fair value of these awards.

2023 Grant

On May 24, 2023, the Company granted 24,800 PSUs under the 2017 Plan to five employees including four executive officers. The PSUs included an annual performance period (2023) and target performance levels for the period linked to the achievement of Company objectives as determined annually for the respective period by the Compensation Committee of the Board (Compensation Committee). Once the annual objectives are approved, the associated expense will be recognized on a straight-line basis over the period through the determination date, which can be no later than March 15 of the following year. Earned awards are settled in shares of Class A Common Stock no later than the March 15 determination date in the following calendar year. In connection with the closing of the Merger Transactions, the Company’s Board determined the awards would vest at 100 percent.

2022 Grant

In March 2022, the Company granted 10,600 PSUs under the 2017 Plan to five employees including four executive officers. The PSUs included three annual performance periods (2022, 2023, and 2024) and target performance levels for each of those periods linked to the achievement of Company objectives as determined annually for the respective period by the Compensation Committee. Once the annual objectives are approved, the associated expense will be recognized on a straight-line basis over the period through the determination date, which can be no later than March 15 of the following year. Earned awards are settled in shares of Class A Common Stock no later than the March 15 determination date in the following calendar year. The grant date for the tranche of awards linked to 2022 performance was May 4, 2022, and on March 1, 2023, the Company’s Board determined the 2022 tranche of PSUs would vest at 100 percent. The grant date for the tranche of awards linked to 2023 performance was May 17, 2023, and on May 31, 2023, in connection with the closing of the Merger Transactions, the Company’s Board determined the 2023 tranche of PSUs would vest at 100 percent. Additionally on May 31, 2023, in connection with the closing of the Merger Transactions, the 2024 tranche of PSUs became fully vested.
2021 Grant
In July 2021, the Company granted 12,000 PSUs under the Inducement Plan to Mr. Carr. The PSUs will vest if the Company’s stock remains above three specified price levels for thirty calendar days over the three-year performance period. The PSUs will be settled in shares of Class A Common Stock on the vesting date. At the close of the Merger Transactions on May 31, 2023, 25 percent of these awards vested per the terms of the award agreement, and the remaining awards were forfeited due to the service period ending with Mr. Carr's termination upon the close of the Merger Transactions.
2019 Grant
In June 2022, PSUs granted to two executive officers in 2019 were forfeited because the underlying performance criteria were not met. These PSUs contained a market condition and had a five-year service period. At the close of the Merger Transactions, both of these executive officers were terminated. All expense for these awards was reversed in June 2023 due to the service period ending prior to vesting date.
PSU activity for the nine months ended September 30, 2023, is as follows:
 Performance Stock Units
Outstanding as of December 31, 202222,600
Issued24,800
Forfeited/canceled(9,333)
Exercised(38,067)
Outstanding as of September 30, 2023—
Stock-based compensation expense related to PSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation (benefit) expense$— $171 $(270)$478 
As of September 30, 2023, there is no unrecognized compensation expense related to PSUs.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES
 9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXESThe Company provides for a valuation allowance when it is more likely than not that it will not realize a portion of the deferred tax assets. The Company has established a full valuation allowance for deferred tax assets due to the uncertainty that enough taxable income will be generated in the taxing jurisdiction to utilize the assets. Therefore, the Company has not reflected any benefit of such deferred tax assets in the accompanying condensed consolidated financial statements.

The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates, and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. The Company did not record any income tax provision for the three months ended September 30, 2023, due to its history of net operating losses, and the maintenance of a full valuation allowance against its net deferred tax assets.

As of September 30, 2023, there have been no Up-C Units exchanged by Electing Members for Class A Common Stock. As described in Note 2, the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more-likely-than-not threshold. Since the benefit has not been recorded, the Company determined that the TRA liability is not probable and therefore no TRA liability existed as of September 30, 2023.As of September 30, 2023, there were no material changes to what the Company disclosed regarding tax uncertainties or penalties as of December 31, 2022.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
LEASES, COMMITMENTS, AND CONTINGENCIES LEASES, COMMITMENTS, AND CONTINGENCIES
Leases

The Company had an equipment financing arrangement at the Roseville, Minnesota location that was considered a financing-type lease. This equipment financing arrangement was repaid in full in the first quarter of 2023. The Company was required to deposit cash into a restricted account in an amount equal to the future rent payments required by the lease. As of March 31, 2023, the remaining restricted cash had been returned to the Company.

Upon the completion of the Merger Transactions, the Company assumed financing leases for certain equipment. In the third quarter of 2023, the Company added a financing lease for hardware and software. The ROU asset is included in other non-current assets in the condensed consolidated balance sheets.

The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:

 As of September 30, 2023As of December 31, 2022
In Thousands, except remaining termRemaining Term (years)Right-of-Use-AssetRemaining Term (years)Right-of-Use-Asset
Roseville, Minnesota lease14.6$13,244 15.3$13,613 
San Diego, California laboratory lease1.93,848 — — 
San Diego, California headquarters lease1.73,710 — — 
San Diego, California greenhouse lease4.91,541 — — 
Other leases
< 1.0 - 3.0
592 
< 1.0
2 
Total$22,935 $13,615 

The Roseville, Minnesota lease includes four options to extend the lease for five years. These options to extend the lease are not recognized as part of the ROU assets and operating lease liabilities as it is not reasonably certain that the Company will exercise those options. The Company’s lease agreement does not include options to terminate the lease.

Upon the completion of the Merger Transactions, the company assumed additional operating leases.

The lease for the Company's San Diego, California headquarters includes office and laboratory space with terms that expire in May 2025 and August 2025, respectively. The Company has one option to extend the laboratory space lease for one year. As the Company is not
reasonably certain to exercise this option at lease commencement, the option was not recognized as part of the associated operating lease ROU asset or liability.

Additionally, the Company has certain leases for greenhouse and warehouse facilities, with terms that expire in August 2028 and August 2026, respectively. The Company had one option to extend the term of the greenhouse lease, for five years, and executed this right with an amended lease agreement beginning in September 2023 and expiring at the end of August 2028. There are no other options to extend this lease. The Company has one option to extend the warehouse lease, for five years. However, as the Company is not reasonably certain to exercise either of those options at lease commencement, neither option was recognized as part of the associated operating lease ROU asset or liability.

Certain leases include rent abatement, rent escalations, tenant improvement allowances, and additional charges for common area maintenance and other costs. The Company is required to pay base rent expense as well as its proportionate share of the facilities operating expenses. The non-lease components, consisting primarily of common area maintenance, are paid separately based on actual costs incurred. Therefore, the variable non-lease components were not included in the ROU asset or lease liability and are reflected as expense in the period incurred.

The components of lease expense were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Finance lease costs$65 $57 $79 $73 
Operating lease costs1,635 381 2,830 1,174 
Total$1,700 $438 $2,909 $1,247 
Operating lease costs for short-term leases was not material for the three and nine months ended September 30, 2023, or 2022.
Supplemental cash flow information related to leases was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands, except for lease term and discount rate 2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows (operating leases)$1,297 $70 $1,848 $205 
Financing cash flows (finance leases)$132 $163 $242 $353 
Supplemental balance sheet information related to leases was as follows:
As of September 30, 2023As of December 31, 2022
OperatingFinancingOperatingFinancing
Weighted average remaining lease term (years) 10.51.415.30.4
Weighted average discount rate 7.5 %9.5 %7.9 %8.1 %
As of September 30, 2023, future minimum payments under operating and finance leases were as follows:
In Thousands
Operating
Financing
Total
Remainder of 2023$1,758 $40 $1,798 
20247,132 210 7,342 
20254,797 120 4,917 
20261,993 — 1,993 
20271,920 — 1,920 
20281,863 — 1,863 
Thereafter15,438 — 15,438 
 34,901 370 35,271 
Less: interest(10,621)(33)(10,654)
Total$24,280 $337 $24,617 
Current portion5,436 235 5,671 
Noncurrent portion$18,844 $102 $18,946 
Cibus Non-Profit Foundation

During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.

This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.

Litigation and Claims

In the fourth quarter of 2022, the Company reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, the Company received $0.75 million in the fourth quarter of 2022, and it received the final installment of $0.75 million in the first quarter of 2023.
The Company is not currently a party to any material pending legal proceeding.
LEASES, COMMITMENTS, AND CONTINGENCIES LEASES, COMMITMENTS, AND CONTINGENCIES
Leases

The Company had an equipment financing arrangement at the Roseville, Minnesota location that was considered a financing-type lease. This equipment financing arrangement was repaid in full in the first quarter of 2023. The Company was required to deposit cash into a restricted account in an amount equal to the future rent payments required by the lease. As of March 31, 2023, the remaining restricted cash had been returned to the Company.

Upon the completion of the Merger Transactions, the Company assumed financing leases for certain equipment. In the third quarter of 2023, the Company added a financing lease for hardware and software. The ROU asset is included in other non-current assets in the condensed consolidated balance sheets.

The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:

 As of September 30, 2023As of December 31, 2022
In Thousands, except remaining termRemaining Term (years)Right-of-Use-AssetRemaining Term (years)Right-of-Use-Asset
Roseville, Minnesota lease14.6$13,244 15.3$13,613 
San Diego, California laboratory lease1.93,848 — — 
San Diego, California headquarters lease1.73,710 — — 
San Diego, California greenhouse lease4.91,541 — — 
Other leases
< 1.0 - 3.0
592 
< 1.0
2 
Total$22,935 $13,615 

The Roseville, Minnesota lease includes four options to extend the lease for five years. These options to extend the lease are not recognized as part of the ROU assets and operating lease liabilities as it is not reasonably certain that the Company will exercise those options. The Company’s lease agreement does not include options to terminate the lease.

Upon the completion of the Merger Transactions, the company assumed additional operating leases.

The lease for the Company's San Diego, California headquarters includes office and laboratory space with terms that expire in May 2025 and August 2025, respectively. The Company has one option to extend the laboratory space lease for one year. As the Company is not
reasonably certain to exercise this option at lease commencement, the option was not recognized as part of the associated operating lease ROU asset or liability.

Additionally, the Company has certain leases for greenhouse and warehouse facilities, with terms that expire in August 2028 and August 2026, respectively. The Company had one option to extend the term of the greenhouse lease, for five years, and executed this right with an amended lease agreement beginning in September 2023 and expiring at the end of August 2028. There are no other options to extend this lease. The Company has one option to extend the warehouse lease, for five years. However, as the Company is not reasonably certain to exercise either of those options at lease commencement, neither option was recognized as part of the associated operating lease ROU asset or liability.

Certain leases include rent abatement, rent escalations, tenant improvement allowances, and additional charges for common area maintenance and other costs. The Company is required to pay base rent expense as well as its proportionate share of the facilities operating expenses. The non-lease components, consisting primarily of common area maintenance, are paid separately based on actual costs incurred. Therefore, the variable non-lease components were not included in the ROU asset or lease liability and are reflected as expense in the period incurred.

The components of lease expense were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Finance lease costs$65 $57 $79 $73 
Operating lease costs1,635 381 2,830 1,174 
Total$1,700 $438 $2,909 $1,247 
Operating lease costs for short-term leases was not material for the three and nine months ended September 30, 2023, or 2022.
Supplemental cash flow information related to leases was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands, except for lease term and discount rate 2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows (operating leases)$1,297 $70 $1,848 $205 
Financing cash flows (finance leases)$132 $163 $242 $353 
Supplemental balance sheet information related to leases was as follows:
As of September 30, 2023As of December 31, 2022
OperatingFinancingOperatingFinancing
Weighted average remaining lease term (years) 10.51.415.30.4
Weighted average discount rate 7.5 %9.5 %7.9 %8.1 %
As of September 30, 2023, future minimum payments under operating and finance leases were as follows:
In Thousands
Operating
Financing
Total
Remainder of 2023$1,758 $40 $1,798 
20247,132 210 7,342 
20254,797 120 4,917 
20261,993 — 1,993 
20271,920 — 1,920 
20281,863 — 1,863 
Thereafter15,438 — 15,438 
 34,901 370 35,271 
Less: interest(10,621)(33)(10,654)
Total$24,280 $337 $24,617 
Current portion5,436 235 5,671 
Noncurrent portion$18,844 $102 $18,946 
Cibus Non-Profit Foundation

During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.

This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.

Litigation and Claims

In the fourth quarter of 2022, the Company reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, the Company received $0.75 million in the fourth quarter of 2022, and it received the final installment of $0.75 million in the first quarter of 2023.
The Company is not currently a party to any material pending legal proceeding.
LEASES, COMMITMENTS, AND CONTINGENCIES LEASES, COMMITMENTS, AND CONTINGENCIES
Leases

The Company had an equipment financing arrangement at the Roseville, Minnesota location that was considered a financing-type lease. This equipment financing arrangement was repaid in full in the first quarter of 2023. The Company was required to deposit cash into a restricted account in an amount equal to the future rent payments required by the lease. As of March 31, 2023, the remaining restricted cash had been returned to the Company.

Upon the completion of the Merger Transactions, the Company assumed financing leases for certain equipment. In the third quarter of 2023, the Company added a financing lease for hardware and software. The ROU asset is included in other non-current assets in the condensed consolidated balance sheets.

The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:

 As of September 30, 2023As of December 31, 2022
In Thousands, except remaining termRemaining Term (years)Right-of-Use-AssetRemaining Term (years)Right-of-Use-Asset
Roseville, Minnesota lease14.6$13,244 15.3$13,613 
San Diego, California laboratory lease1.93,848 — — 
San Diego, California headquarters lease1.73,710 — — 
San Diego, California greenhouse lease4.91,541 — — 
Other leases
< 1.0 - 3.0
592 
< 1.0
2 
Total$22,935 $13,615 

The Roseville, Minnesota lease includes four options to extend the lease for five years. These options to extend the lease are not recognized as part of the ROU assets and operating lease liabilities as it is not reasonably certain that the Company will exercise those options. The Company’s lease agreement does not include options to terminate the lease.

Upon the completion of the Merger Transactions, the company assumed additional operating leases.

The lease for the Company's San Diego, California headquarters includes office and laboratory space with terms that expire in May 2025 and August 2025, respectively. The Company has one option to extend the laboratory space lease for one year. As the Company is not
reasonably certain to exercise this option at lease commencement, the option was not recognized as part of the associated operating lease ROU asset or liability.

Additionally, the Company has certain leases for greenhouse and warehouse facilities, with terms that expire in August 2028 and August 2026, respectively. The Company had one option to extend the term of the greenhouse lease, for five years, and executed this right with an amended lease agreement beginning in September 2023 and expiring at the end of August 2028. There are no other options to extend this lease. The Company has one option to extend the warehouse lease, for five years. However, as the Company is not reasonably certain to exercise either of those options at lease commencement, neither option was recognized as part of the associated operating lease ROU asset or liability.

Certain leases include rent abatement, rent escalations, tenant improvement allowances, and additional charges for common area maintenance and other costs. The Company is required to pay base rent expense as well as its proportionate share of the facilities operating expenses. The non-lease components, consisting primarily of common area maintenance, are paid separately based on actual costs incurred. Therefore, the variable non-lease components were not included in the ROU asset or lease liability and are reflected as expense in the period incurred.

The components of lease expense were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Finance lease costs$65 $57 $79 $73 
Operating lease costs1,635 381 2,830 1,174 
Total$1,700 $438 $2,909 $1,247 
Operating lease costs for short-term leases was not material for the three and nine months ended September 30, 2023, or 2022.
Supplemental cash flow information related to leases was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands, except for lease term and discount rate 2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows (operating leases)$1,297 $70 $1,848 $205 
Financing cash flows (finance leases)$132 $163 $242 $353 
Supplemental balance sheet information related to leases was as follows:
As of September 30, 2023As of December 31, 2022
OperatingFinancingOperatingFinancing
Weighted average remaining lease term (years) 10.51.415.30.4
Weighted average discount rate 7.5 %9.5 %7.9 %8.1 %
As of September 30, 2023, future minimum payments under operating and finance leases were as follows:
In Thousands
Operating
Financing
Total
Remainder of 2023$1,758 $40 $1,798 
20247,132 210 7,342 
20254,797 120 4,917 
20261,993 — 1,993 
20271,920 — 1,920 
20281,863 — 1,863 
Thereafter15,438 — 15,438 
 34,901 370 35,271 
Less: interest(10,621)(33)(10,654)
Total$24,280 $337 $24,617 
Current portion5,436 235 5,671 
Noncurrent portion$18,844 $102 $18,946 
Cibus Non-Profit Foundation

During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.

This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.

Litigation and Claims

In the fourth quarter of 2022, the Company reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, the Company received $0.75 million in the fourth quarter of 2022, and it received the final installment of $0.75 million in the first quarter of 2023.
The Company is not currently a party to any material pending legal proceeding.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
ROYALTY LIABILITY - RELATED PARTIES
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED-PARTY TRANSACTIONS ROYALTY LIABILITY - RELATED PARTIESThe Royalty Liability was assumed following the Company’s acquisition of Cibus Global in the Merger Transactions. In 2014, Cibus Global entered into the Warrant Exchange Agreement with certain members holding Series A Preferred Units, including members of the
board of directors and management of Cibus Global, who were also the holders of warrants to purchase Series A Preferred Units. Under the Warrant Exchange Agreement, the Royalty Holders are entitled to future royalty payments equal to 10 percent of the subject revenues (Subject Revenues), as defined, which includes all royalty revenues earned by Cibus Global, for licensing of plant traits to seed companies that use traits developed by the Company, but excludes specifically, (i) revenues attributable to the Nucelis product line, (ii) amounts received from the sale or disposition of the Company’s assets to the extent the purchaser agrees to be bound by the Warrant Exchange Agreement, (iii) payments for Cibus Global capital stock, and (iv) revenues attributable to collaboration and research projects. Royalty payments will not begin until the first fiscal quarter after which the aggregate Subject Revenues during any consecutive 12-month period equals or exceeds $50.0 million, at which point Cibus Global will be obligated to pay all aggregated but unpaid payments under the Warrant Exchange Agreement. This condition had not occurred as of September 30, 2023. Additionally, Cibus Global granted the Royalty Holders a continuing security interest in certain intellectual property of Cibus Global to secure the payment and performance of obligations of Cibus Global under the Warrant Exchange Agreement. The initial term of the Warrant Exchange Agreement is 30 years and may be extended for an additional 30-year term if the holders provide written notice and make a payment of $100.

For purposes of determining the Royalty Liability, the Company estimates the total amount of future revenues expected to be received from the Company's customers over the life of the agreement. The Company then calculates the amount of future royalty payments required to be paid based upon the estimated future revenues. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. Any change in expected future royalty payments is recognized prospectively as an adjustment to the effective yield as interest expense. As of September 30, 2023, the Royalty Liability reflected an effective yield of 23.7 percent.

As of September 30, 2023, the Royalty Liability activity is as follows:

In ThousandsRoyalty Liability - Related Parties
Balance as of December 31, 2022$— 
Acquired from merger with Cibus Global, LLC146,360 
Interest expense recognized10,753 
Balance as of September 30, 2023$157,113 
RELATED-PARTY TRANSACTIONS
Prior to the completion of the Merger Transactions, the Company was party to several agreements that governed its relationship with Cellectis, some of which required the Company to make payments to Cellectis. Pursuant to the Company’s management services agreement with Cellectis, it incurred no management fee expenses for the three and nine months ended September 30, 2023, and 2022. The management services agreement was terminated with respect to the Company upon the closing of the Merger Transactions.

Cellectis has guaranteed the lease agreement for the Company’s Roseville, Minnesota facility. Cellectis’ guarantee of the Company’s obligations under the lease will terminate at the end of the second consecutive calendar year in which the Company’s tangible net worth exceeds $300 million. The Company agreed to indemnify Cellectis for any obligations incurred by Cellectis under its guaranty of the obligations under the lease, effective upon Cellectis’ ownership falling to 50 percent or less of the Company’s outstanding common stock. This indemnification obligation was triggered in October 2022.
TALEN® is one of the Company's gene editing technologies. TALEN® technology was invented by researchers at the University of Minnesota and Iowa State University and exclusively licensed to Cellectis. The Company originally obtained an exclusive license for the TALEN® technology for commercial use in plants from Cellectis. Upon the closing of the Merger Transactions, the license agreement was amended (the Amended Cellectis License) to provide exclusive use to certain intellectual property in the field of developing and commercializing microorganism, agricultural, and food products, including, but not limited to traits, seeds, proteins, oils, carbohydrates, food, and food and animal feed ingredients, excluding (i) any application in connection with animals and animal cells and (ii) therapeutic applications (the Calyxt Field). This grant is non-exclusive solely in the non-exclusive fields as described in the Amended Cellectis License. Cellectis also grants to the Company a non-exclusive, worldwide, perpetual, irrevocable, royalty-free, and fully paid-up license (with certain rights to sublicense) under certain licensed plant patents in the Calyxt Field. Cellectis is entitled to royalties on any revenue the Company generates from sales of products less certain amounts as defined in the license agreement, royalties on certain cumulative revenue thresholds, and a percentage of any sublicense revenues. The Company has incurred nominal license and royalty fees for the three and nine months ended September 30, 2023, and 2022.

Prior to the Merger Transactions, amounts payable to Cellectis were reported in the Company's condensed consolidated balance sheets as Due to related parties. Beginning with the three months ended June 30, 2023, any amounts payable to Cellectis are included in accrued
expenses in the Company's condensed consolidated balance sheets.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL INFORMATION
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUPPLEMENTAL INFORMATION SUPPLEMENTAL INFORMATION
Certain balance sheet amounts are as follows:
In ThousandsAs of September 30, 2023As of December 31, 2022
Accrued Expenses:
Accrued consulting and professional fees$2,980 $119 
Accrued field trials1,716 — 
Other396 54 
Total$5,092 $173 
Certain statement of operations amounts are as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense:
Research and development$2,853 $210 $5,531 $620 
Selling, general, and administrative2,975 825 6,139 2,270 
Total$5,828 $1,035 $11,670 $2,890 
Supplemental statement of cash flows information is as follows:
 Nine Months Ended September 30,
In Thousands20232022
Interest paid$98 $67 
Non-cash transactions not reported in the condensed consolidated statement of cash flows is as follows:
 Nine Months Ended September 30,
In Thousands20232022
Receivable from Jefferies for shares issued under ATM facility$— $(260)
Property, plant, and equipment acquired through assuming liabilities419 (687)
Shares issued for consideration in the merger with Cibus Global634,751 — 
Forgiveness of interim funding resulting from merger with Cibus Global2,500 — 
Cumulative effect of adoption of lease accounting standard on stockholders’ equity— 832 
Establishment of financing lease right-of-use assets and associated operating lease liabilities307 — 
Establishment of operating lease right-of-use assets and associated operating lease liabilities$1,606 $14,090 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
INTERIM FUNDING
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
INTERIM FUNDING NOTES PAYABLEThe Company has financed the costs associated with its enterprise science platform annual software license. The financing arrangement for the license has a term of one year and accrues interest at an annual rate of 10.9 percent. The Company makes monthly principal and interest payments. The note related to the annual license matures in July 2024.Additionally, the Company has purchased various fixed assets using notes. The notes on financed equipment are subject to annual interest rates between 7.3 percent and 17.6 percent and have a weighted average remaining term of 2.8 years. Notes used to finance equipment mature between October 2023 and March 2028.

The Company has also financed certain annual insurance premiums using a note. The insurance note is subject to an annual interest rate of 7.5 percent, has a weighted average remaining term of 0.4 years, and matures in February 2024.
As of September 30, 2023, future minimum payments under notes payable were as follows:

In ThousandsAnnual LicensesFinanced EquipmentInsuranceTotal Notes Payable
Remainder of 2023$93 $137 $290 $520 
2024216 450 194 860 
2025— 351 — 351 
2026— 151 — 151 
2027— 89 — 89 
2028— 15 — 15 
309 1,193 484 1,986 
Less: interest(15)(168)(9)(192)
Total$294 $1,025 $475 $1,794 
Current portion294 396 475 1,165 
Noncurrent portion$— $629 $— $629 
INTERIM FUNDINGPursuant to the Merger Agreement, beginning at the earlier of March 15, 2023, and the date the Company's unrestricted cash balance first dropped below $1.5 million, the Company could request, and Cibus Global agreed to provide, an unsecured, interest-free revolving line of credit of up to $3.0 million in cash (Interim Funding). Funds could be drawn by the Company in $0.5 million increments and could only be used to fund operating expenses incurred in the ordinary course of business consistent with past practice and consistent with the negative covenants in the Merger Agreement. The Company received $2.5 million of Interim Funding in the aggregate from Cibus Global. The full balance of the Interim Funding was reduced to zero in connection with the closing of the Merger Transactions pursuant to the terms of the Merger Agreement.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
COLLABORATION AGREEMENT
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
COLLABORATION AGREEMENT COLLABORATION AGREEMENTPrior to the Merger Transactions, Cibus Global and Procter & Gamble (P&G), a leading multi-national consumer product company, entered into a collaboration agreement under which P&G will fund a multi-year program to develop sustainable low carbon ingredients or materials that do not negatively impact the environment during production, use, or disposal to help P&G advance its sustainability objectives. As of September 30, 2023, the Company had $1.6 million of deferred revenue from R&D activities under the P&G agreement. The Company has determined the P&G agreement should be accounted for under Topic 606, and it will recognize revenue over time proportional to the R&D activities performed by the Company related to the collaboration agreement. During the nine months ended September 30, 2023, the Company recognized $0.4 million in revenue in the condensed consolidated statements of operations.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
RELATED-PARTY TRANSACTIONS
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED-PARTY TRANSACTIONS ROYALTY LIABILITY - RELATED PARTIESThe Royalty Liability was assumed following the Company’s acquisition of Cibus Global in the Merger Transactions. In 2014, Cibus Global entered into the Warrant Exchange Agreement with certain members holding Series A Preferred Units, including members of the
board of directors and management of Cibus Global, who were also the holders of warrants to purchase Series A Preferred Units. Under the Warrant Exchange Agreement, the Royalty Holders are entitled to future royalty payments equal to 10 percent of the subject revenues (Subject Revenues), as defined, which includes all royalty revenues earned by Cibus Global, for licensing of plant traits to seed companies that use traits developed by the Company, but excludes specifically, (i) revenues attributable to the Nucelis product line, (ii) amounts received from the sale or disposition of the Company’s assets to the extent the purchaser agrees to be bound by the Warrant Exchange Agreement, (iii) payments for Cibus Global capital stock, and (iv) revenues attributable to collaboration and research projects. Royalty payments will not begin until the first fiscal quarter after which the aggregate Subject Revenues during any consecutive 12-month period equals or exceeds $50.0 million, at which point Cibus Global will be obligated to pay all aggregated but unpaid payments under the Warrant Exchange Agreement. This condition had not occurred as of September 30, 2023. Additionally, Cibus Global granted the Royalty Holders a continuing security interest in certain intellectual property of Cibus Global to secure the payment and performance of obligations of Cibus Global under the Warrant Exchange Agreement. The initial term of the Warrant Exchange Agreement is 30 years and may be extended for an additional 30-year term if the holders provide written notice and make a payment of $100.

For purposes of determining the Royalty Liability, the Company estimates the total amount of future revenues expected to be received from the Company's customers over the life of the agreement. The Company then calculates the amount of future royalty payments required to be paid based upon the estimated future revenues. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. Any change in expected future royalty payments is recognized prospectively as an adjustment to the effective yield as interest expense. As of September 30, 2023, the Royalty Liability reflected an effective yield of 23.7 percent.

As of September 30, 2023, the Royalty Liability activity is as follows:

In ThousandsRoyalty Liability - Related Parties
Balance as of December 31, 2022$— 
Acquired from merger with Cibus Global, LLC146,360 
Interest expense recognized10,753 
Balance as of September 30, 2023$157,113 
RELATED-PARTY TRANSACTIONS
Prior to the completion of the Merger Transactions, the Company was party to several agreements that governed its relationship with Cellectis, some of which required the Company to make payments to Cellectis. Pursuant to the Company’s management services agreement with Cellectis, it incurred no management fee expenses for the three and nine months ended September 30, 2023, and 2022. The management services agreement was terminated with respect to the Company upon the closing of the Merger Transactions.

Cellectis has guaranteed the lease agreement for the Company’s Roseville, Minnesota facility. Cellectis’ guarantee of the Company’s obligations under the lease will terminate at the end of the second consecutive calendar year in which the Company’s tangible net worth exceeds $300 million. The Company agreed to indemnify Cellectis for any obligations incurred by Cellectis under its guaranty of the obligations under the lease, effective upon Cellectis’ ownership falling to 50 percent or less of the Company’s outstanding common stock. This indemnification obligation was triggered in October 2022.
TALEN® is one of the Company's gene editing technologies. TALEN® technology was invented by researchers at the University of Minnesota and Iowa State University and exclusively licensed to Cellectis. The Company originally obtained an exclusive license for the TALEN® technology for commercial use in plants from Cellectis. Upon the closing of the Merger Transactions, the license agreement was amended (the Amended Cellectis License) to provide exclusive use to certain intellectual property in the field of developing and commercializing microorganism, agricultural, and food products, including, but not limited to traits, seeds, proteins, oils, carbohydrates, food, and food and animal feed ingredients, excluding (i) any application in connection with animals and animal cells and (ii) therapeutic applications (the Calyxt Field). This grant is non-exclusive solely in the non-exclusive fields as described in the Amended Cellectis License. Cellectis also grants to the Company a non-exclusive, worldwide, perpetual, irrevocable, royalty-free, and fully paid-up license (with certain rights to sublicense) under certain licensed plant patents in the Calyxt Field. Cellectis is entitled to royalties on any revenue the Company generates from sales of products less certain amounts as defined in the license agreement, royalties on certain cumulative revenue thresholds, and a percentage of any sublicense revenues. The Company has incurred nominal license and royalty fees for the three and nine months ended September 30, 2023, and 2022.

Prior to the Merger Transactions, amounts payable to Cellectis were reported in the Company's condensed consolidated balance sheets as Due to related parties. Beginning with the three months ended June 30, 2023, any amounts payable to Cellectis are included in accrued
expenses in the Company's condensed consolidated balance sheets.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
SUBSEQUENT EVENTS
 9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTSStrategic Realignment

On October 18, 2023, Cibus implemented a strategic realignment to align with its primary commercial objective of advancing its late-stage activities.

The strategic realignment resulted in a reduction in workforce in full time employees from 242 full-time employees as of October 17, 2023, to approximately 185 full-time employees. The Company estimates that it will incur approximately $0.5 million of one-time costs in connection with the reduction in workforce, primarily related to cash payments for accrued vacation and severance payments. The Company expects the majority of the associated costs to be incurred during the quarter ending December 31, 2023.

Loan Agreement

On October 20, 2023, Cibus entered into a binding term sheet (Binding Term Sheet) with Rory Riggs, the Company’s Chairman and Chief Executive Officer. Pursuant to the Binding Term Sheet, Mr. Riggs has agreed to make available to the Company a line of credit (the Loan) in the aggregate principal amount of $5.0 million (the Loan Amount). Cibus may make draws, in increments of $1.0 million, against the Loan Amount at any time during the period commencing January 1, 2024, and terminating on March 1, 2024. Amounts drawn under the Loan will bear simple interest at a rate of 12 percent per annum and are repayable at maturity on January 1, 2026. The Loan is unsecured and may be prepaid by the Company at any time without penalty. The Binding Term Sheet shall automatically terminate if the Company secures debt and/or equity financing in the aggregate amount of $20.0 million prior to January 1, 2024.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure        
Net loss $ (26,429) $ (5,950) $ (50,513) $ (14,054)
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation The unaudited condensed consolidated financial statements of Cibus, Inc. (Cibus or the Company) have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP or GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC) applicable to interim financial statements. In the Company’s opinion, the accompanying condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of its statements of financial position, results of operations, and cash flows for the periods presented but they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Except as otherwise disclosed herein, these adjustments consist of normal recurring items. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole or any other interim period.

For further information, refer to the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, as amended by the Company’s Form 10-K/A for the year ended December 31, 2022, filed with the SEC on March 2, 2023, and March 3, 2023, respectively (collectively, the Annual Report). The accompanying condensed consolidated balance sheets as of December 31, 2022, was derived from the audited consolidated financial statements. This Quarterly Report on Form 10-Q should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Annual Report.
Use of Estimates Use of Estimates

The preparation of the Company’s condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company’s historical experience, knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions. Key estimates made by the Company include revenue recognition, useful lives and impairment of long-lived assets, valuation of equity-based awards and related equity-based compensation expense, valuation of intangible assets, valuation allowances on deferred tax assets, and the valuation of the Royalty Liability (defined below under "Royalty liability - Related Parties").
Fair Value Measurements of Financial Instruments Fair Value Measurements of Financial Instruments

The Company follows Accounting Standards Codification (ASC) Topic 820, Fair Value Measurements and Disclosures, for financial assets and liabilities that are recognized or disclosed at fair value in these condensed consolidated financial statements on a recurring basis. Under ASC 820, fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts its business. ASC 820 clarifies fair value should be based on assumptions market participants would use when pricing the asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to observable unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

The carrying amounts reflected in the accompanying condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate their fair value due to their short-term nature. Based on the borrowing rates currently available to the Company for notes payable with similar terms and consideration of default and credit risk, the carrying value of the notes payable approximates fair value, which is considered a Level 2 fair value measurement.
Cash and Cash Equivalents Cash and Cash EquivalentsThe Company considers all liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include cash in readily available checking and money market accounts. The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses with these financial institutions.
Restricted Cash Restricted CashThe Company’s restricted cash balances are cash and cash equivalents deposited in an amount equal to the future rent payments as required under the Company’s equipment lease facility. The Company may request the return of excess restricted cash collateral annually in December.
Accounts Receivable Accounts ReceivableAccounts receivable are recorded at the amounts billed relating to contracted research and development (R&D) services provided. The Company makes judgments as to its ability to collect outstanding receivables and provides an allowance for receivables when collection is doubtful. Accounts receivable are written off when management believes that all efforts to collect the amounts outstanding have been exhausted. The allowance for credit losses is estimated by management based on evaluations of its historical bad debt, current collection experience, and estimate of remaining collectability. Bad debt expense is recorded as necessary to maintain an appropriate level of allowance for credit losses in selling, general, and administrative (SG&A) expense in the accompanying condensed consolidated statements of operations. Accounts receivable is presented net of allowance for credit losses
Property, Plant, and Equipment, net Property, Plant, and Equipment, net

Property, plant, and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation of buildings, lab equipment, furniture, and computer equipment and software is recorded using the straight-line method over the estimated useful lives of the respective assets, ranging from three to twenty years. Amortization of leasehold improvements are recorded using a straight-line method over the lesser of the estimated useful lives of the improvements or the remaining life of the lease. Expenditures which substantially increase the useful life of an asset, are capitalized. Expenditures for repairs and maintenance are expensed as incurred. Assets in progress include the construction of lab equipment and software to be used in the Company’s facility. The assets will be placed in service when the construction is completed and will be amortized over the useful life of the asset.
Goodwill and Acquired Intangible Assets Goodwill and Acquired Intangible AssetsGoodwill is calculated as the excess of the purchase consideration paid in a business combination over the fair value of the assets acquired less liabilities assumed. Goodwill is not amortized and is tested for impairment at least annually or when events and circumstances indicate that fair value of a reporting unit may be below its carrying value. The Company has one reporting unit. The Company first assesses qualitative factors to evaluate whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount or elects to bypass such assessment. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying value, or the Company elects to bypass the qualitative assessment, it performs a quantitative test by determining the fair value of the reporting unit. If the carrying value of the reporting unit exceeds the fair value, then an impairment loss is recognized for the difference.Acquired in process R&D, developed technology, and trade names are related to the Merger Transactions. Acquired intangible assets are amortized on a straight-line basis over the estimated period over which the Company expects to realize economic value related to the intangible asset. In process R&D is not amortized until it is determined to be ready for its intended use. The acquired in process R&D will be tested for impairment annually, or more frequently, if an impairment indicator is identified.
Leases Leases

The Company determines if an arrangement is or contains a lease at inception. For leases with a term greater than one year, lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company excludes short-term leases, if any, having initial terms of 12 months or less at lease commencement as an accounting policy election. In determining the net present value of lease payments, the Company uses its incremental borrowing rate, which represents an estimated rate of interest that the Company would have to pay to borrow equivalent funds on a collateralized basis, at the lease commencement date. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statements of operations. Variable lease payments primarily include common area maintenance, utilities, real estate taxes, insurance, and other operating costs that are passed on from the lessor in proportion to the space leased by the Company. The Company has elected the practical expedient to not separate between lease and non-lease components.
Asset Retirement Obligation Asset Retirement Obligation

The Company records an asset retirement obligation (ARO) for the estimated cost of removing constructed leasehold improvement assets and restoring the leased premises back to their original condition, at the time when the contractual obligations are incurred. The ARO represents the present value of the expected cost for the related restoration activities. The ARO assets and liabilities are recorded in property, plant, and equipment, net and other non-current liabilities, respectively, in the Company’s condensed consolidated balance sheets. The Company records accretion expense, which represents the increase in the ARO, over the remaining or operational life of the associated leasehold improvements. Accretion expense is recorded as R&D expense in the condensed consolidated statements of operations using an accretion rate based on the credit adjusted risk-free interest rate. Changes resulting from revisions to the timing or amount of the original estimate of cash flows are recognized as an increase or a decrease in the asset retirement cost, or income when the asset retirement cost is depleted.
Revenue Recognition and Contract Liabilities Revenue Recognition

The Company’s revenues represent amounts earned from collaboration agreements related to contract research. The Company recognizes revenues under Topic 606 Revenue from Contracts with Customers (Topic 606) when control of services is transferred to the Company’s customers in an amount that reflects the consideration the Company expects to receive from the Company’s customers in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing the revenue when the performance obligations have been satisfied. The Company recognizes revenue for satisfied performance obligations only when the Company determines there are no uncertainties regarding payment terms or transfer of control. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract.

Contract Liabilities

The Company records contract liabilities when cash payments are received or due in advance of performance, primarily related to advances of upfront and milestone payments from contract research and collaboration agreements. Contract liabilities consist of deferred revenue on the accompanying condensed consolidated balance sheets. The Company expects to recognize the amounts included in deferred revenues within one year.
Collaborative Agreements Related to Contract Research Collaboration Agreements Related to Contract Research

Performance obligations under collaboration arrangements include providing intellectual property licenses, performing R&D consulting services, and providing other materials. To date, the Company has concluded that the licenses of intellectual property in its collaboration arrangements have not been distinct, as intellectual property has not been licensed without related R&D support services. Under Topic 606, milestone fees are variable consideration that is initially constrained and included in the arrangement consideration only when it is probable that the milestones will be achieved. Arrangement consideration, including upfront fees, milestone fees, and fees for research services, is recognized over the period as services are provided using an input method to determine the amount to recognize each reporting period. The Company reviews the inputs each period, such as the Company’s level of effort expended, including the time the Company estimates it will take to complete the activities, or costs incurred relative to the total expected inputs to satisfy the performance obligation. Generally, input measures are labor hours expended or a time-based measure of progress towards the satisfaction of the performance obligation.
Selling, General and Administrative Expenses Selling, General, and Administrative ExpensesSG&A expense consists primarily of employee-related expenses, such as salaries for its executive, business development, legal, intellectual property, information technology, finance, human resources, and other administrative functions. These costs include legal, professional, and consulting fees for external firms and contractors. All selling and marketing expenses, including advertising expenses and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization, are included in SG&A expense in the accompanying condensed consolidated statements of operations.Beginning in the second quarter of 2023, SG&A expense includes costs related to its intellectual property portfolio and costs to write and support the research for filing patents. Historically, the Company expensed patent application costs and related legal costs for maintenance of such patents as incurred and such costs were included in R&D expense in the accompanying condensed consolidated statements of operations.
Research and Development Expenses

Research and Development Expenses

R&D costs are expensed as incurred in performing R&D activities and include salaries, lab supplies, consultant fees, and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization.

Historically, the Company recognized its intellectual property portfolio and costs to write and support the research for filing patents as R&D expense. Beginning in the second quarter of 2023, these expenses are included in SG&A expense in the accompanying condensed consolidated statements of operations. The amounts in the prior reporting periods are not material and as such no historical amounts have been reclassified.
Royalty Liability - Related Parties Royalty Liability – Related PartiesIn 2014, Cibus Global entered into the warrant exchange agreement (Warrant Exchange Agreement), which remains in place following the Company’s acquisition of Cibus Global in the Merger Transactions, Cibus Global is required to make ongoing quarterly payments equal to a portion of the aggregate amount of certain worldwide revenues received during the applicable quarter. The Company refers to such payment obligations as its Royalty Liability. Management estimates the total amount of royalty payments over the life of the Warrant Exchange Agreement that Cibus Global will be required to make to holders of certain warrants (Royalty Holders) that were exchanged for the rights to future royalty payments pursuant to the Warrant Exchange Agreement. The Royalty Liability is based on the Company’s current estimates of future royalties expected to be paid over the life of the arrangement. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. In order to determine the amortization of the Royalty Liability, the Company is required to estimate the total amount of future royalty payments to the Royalty Holders over the life of the Warrant Exchange Agreement. This estimate contains significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the royalty period. The Company will periodically assess the estimated royalty payments and to the extent the amount or timing of such payments is materially different than the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense.
Non-Operating Income (Expenses) Non-Operating Income (Expenses)

Non-operating income (expenses) are income or expenses that are not directly related to ongoing operations and are primarily comprised of gains and losses from the mark-to-market of Common Warrants to purchase Class A Common Stock and foreign exchange transactions.
Net Loss Per Share of Class A Common Stock Net Loss Per Share of Class A Common Stock Weighted average shares of Class A Common Stock outstanding excludes unvested Class A Common Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from the calculation of net loss per share of Class A Common Stock.

For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding as inclusion of the common stock equivalent securities would be anti-dilutive.

The Company’s potential dilutive securities, which include Common Warrants, unvested performance stock units, unvested restricted stock units, unvested restricted stock awards, and options to purchase Class A Common Stock, have been excluded from the computation of diluted net loss per share of Class A Common Stock as the effect would be antidilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share of Class A Common Stock is the same.
Warrants Warrants

The Company issued pre-funded warrants (Pre-Funded Warrants) to purchase Class A Common Stock in a follow-on offering on February 23, 2022 (the Follow-On Offering). The Pre-Funded Warrants, which were each exercisable for one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share, were exercised in full on May 4, 2022, and subsequently settled with the counterparty. While outstanding, the Pre-Funded Warrants were considered equity instruments and reported in stockholders’ equity in the Company’s condensed consolidated balance sheets, and the shares issuable upon exercise of the Pre-Funded Warrants were included in the determination of the Company’s net loss per share of Class A Common Stock. The Company also issued Common Warrants in the Follow-On Offering. The Common Warrants expire on August 23, 2027, and are each exercisable for one share of the Company’s Class A Common Stock for $69.04 per share, after giving effect to the Reverse Stock Splits. The Common Warrants have been classified as a liability because they include a put option election available to their holder that is contingently exercisable if the Company enters into a fundamental transaction (Fundamental Transaction). Pursuant to the terms of the Common Warrants, a Fundamental Transaction occurs if (i) the Company, directly or indirectly, effects any merger or consolidation of the Company with or into another person in which the Company is not the surviving entity, (ii) the Company (and all of its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer is completed pursuant to which holders of the Company’s Class A Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50 percent or more of the outstanding Class A Common Stock of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization, or recapitalization of the Class A Common Stock or any compulsory share exchange pursuant to which the Class A Common Stock is effectively converted into or exchanged for other securities, cash, or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination with another person or group of persons whereby such other person or group acquires more than 50 percent of the voting power of the outstanding shares of Class A Common Stock (not including any shares of Class A Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business combination) (the Fundamental Change Put). If the Fundamental Change Put is exercised by the holder of a Common Warrant, holder may elect to receive either the consideration of the Fundamental Transaction or put the Common Warrants back to the Company in exchange for cash, based on terms and timing specified in the Common Warrant agreement. If the Fundamental Change Put option is exercised, the Company is required to pay cash to the holder in an amount as determined by the Black-Scholes pricing model, with assumptions determined in accordance with the terms of the Common Warrants. The Company believes that the Merger Transactions did not qualify as a Fundamental Transaction.

The Common Warrants are reported at fair value with changes in fair value reported in earnings. The Company reports the changes in fair value of the Common Warrants in non-operating income (expenses) in its condensed consolidated statements of operations.
Employee Retention Credit Employee Retention Credit

Prior to the Merger Transactions, Cibus Global qualified for federal government assistance through the Employee Retention Credit (ERC) provisions of the CARES Act passed in 2020, for the second, third, and fourth fiscal quarters of 2020, as well as the first and second fiscal quarters of 2021. The purpose of the ERC was to encourage employers to keep employees on the payroll, even if they were not working during the covered period because of the coronavirus outbreak. The Company recognizes amounts to be refundable as tax credits if there is a reasonable assurance of compliance with the grant conditions and receipt of credits.
Foreign Currency Foreign Currency

The accompanying condensed consolidated financial statements are presented in United States dollars (USD) as the reporting currency. For those foreign subsidiaries where the Company has determined that the functional currency is the entity’s local currency, the assets and liabilities of such subsidiaries are translated into USD using exchange rates in effect at the balance sheet date. The revenue and expenses of such subsidiaries are translated into USD using average exchange rates in effect during the reporting period. Any translation adjustments are presented as accumulated other comprehensive income (loss), within stockholders' equity in the accompanying condensed consolidated statements of redeemable noncontrolling interest and stockholders' equity. Foreign currency transaction gains and losses are included in non-operating income (expenses) within the accompanying condensed consolidated statements of operations and were immaterial for all periods presented.
Segment Reporting Segment Reporting

Management has determined that the Company has one operating segment, R&D of plant gene editing, which is consistent with the Company's structure and how it manages the business. Furthermore, the Company's Chief Operating Decision Maker, which is the Company's Chief Executive Officer, monitors and reviews financial information at a consolidated level for assessing operating results and the allocation of resources.
Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements

From time-to-time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position, results of operations, or cash flows upon adoption.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU No. 2021-08 address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination. The amendments in ASU No. 2021-08 require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. Upon adoption, an acquirer should account for the related revenue contracts of the acquiree as if it has originated the contracts.

For public business entities, the amendments in ASU No. 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments in ASU No. 2021-08 should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company applied ASU No. 2021-08 to the Merger Transactions.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Stock by Class Share information related to the Company's common stock as of September 30, 2023, is as follows:
Class A Common StockClass B Common StockTotal Common Stock
Authorized210,000,00090,000,000300,000,000
Issued17,656,8314,642,63622,299,467
Outstanding16,659,9964,642,63621,302,632
Schedule of Deferred Revenue Activity
The following table represents the deferred revenue activity:

In ThousandsDeferred Revenue
Balance as of December 31, 2022$107 
Acquired from merger with Cibus Global, LLC1,186 
Consideration earned(714)
Consideration received1,058 
Balance as of September 30, 2023$1,637 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their anti-dilutive effect:
As of September 30,
20232022
Stock options outstanding109,551116,936
Unvested restricted stock units198,19925,210
Unvested performance stock units—22,600
Unvested restricted stock awards945,780—
Common Warrants158,483158,483
Total1,412,013323,229
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
MERGER WITH CIBUS GLOBAL (Tables)
 9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Purchase Price for Merger Transaction The purchase price for Cibus Global was determined as follows:
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (1)20,150,838 
Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (2)$31.50 
Purchase price$634,751,397 


(1) This share number represents the aggregate number of shares of Common Stock issued to Cibus Global members in the Merger Transactions and comprises: 15,508,202 shares of Class A Common Stock and 4,642,636 shares of Class B Common Stock. This share number excludes 1,019,282 shares of Class A Restricted Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture.(2) Reflects the purchase price per share of the Company's Class A Common Stock, which was the closing price of the Class A Common Stock on May 31, 2023, the closing date of the Merger Transactions.
Schedule of Recognized the Preliminary Allocation of the Consideration The following table sets forth the preliminary allocation of the consideration:

In ThousandsMay 31, 2023
Cash and cash equivalents$59,381 
Accounts receivable2,216 
Due from related parties, net19 
Note receivable2,500 
Prepaid expenses and other current assets2,535 
Property, plant and equipment10,588 
Operating lease right-of-use-assets9,519 
Goodwill585,266 
Intangible assets135,429 
Other non-current assets457 
Accounts payable(5,582)
Accrued expenses(3,477)
Accrued compensation(2,859)
Due to related parties(8)
Deferred revenue(1,186)
Current portion of notes payable(517)
Current portion of operating lease obligations(4,687)
Current portion of financing lease obligations(165)
Other current liabilities(17)
Notes payable, net of current portion(749)
Operating lease obligations, net of current portion(6,006)
Financing lease obligations, net of current portion(10)
Royalty liability - related parties(146,360)
Other non-current liabilities(1,536)
Consideration transferred$634,751 
Schedule of Finite-Lived Intangible Assets Acquired in Merger Transaction Intangible assets acquired, and their related estimated average useful lives, are as follows:

In Thousands, except useful lifeMay 31, 2023Estimated Average Useful Life (Years)
In-process research and development$99,051 Indefinite
Developed technology14,148 20
Trade name22,230 20
Total$135,429 
Schedule of Indefinite-Lived Intangible Assets Acquired in Merger Transaction Intangible assets acquired, and their related estimated average useful lives, are as follows:

In Thousands, except useful lifeMay 31, 2023Estimated Average Useful Life (Years)
In-process research and development$99,051 Indefinite
Developed technology14,148 20
Trade name22,230 20
Total$135,429 
Business Acquisition, Pro Forma Information These unaudited pro forma figures have been prepared as though the business combination had occurred on January 1, 2022. Pro forma adjustments have been made to reflect non-recurring stock compensation expense, legal and professional fees, severance costs, and amortization of acquired intangible assets, directly attributable to the business combination. The unaudited pro forma condensed financial information is not indicative of the results of operations that would have been achieved had the acquisitions reflected herein been consummated on the dates indicated or that will be achieved in the future.

Three Months Ended September 30,Nine Months Ended September 30,
Unaudited and in Thousands2023202220232022
Pro forma revenues$475 $307 $1,154 $992 
Pro forma net loss(34,528)(20,365)(88,474)(61,603)
Pro forma net loss attributable to controlling interest(24,575)(17,301)(70,855)(53,178)
Pro forma net loss attributable to redeemable noncontrolling interest$(9,953)$(3,064)$(17,619)$(8,425)
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK (Tables)
 9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Fair Value Measurements and Financial Statement Presentation The Company’s financial instruments measured at fair value and their respective levels in the fair value hierarchy as of September 30, 2023, and December 31, 2022, were as follows:
 September 30, 2023December 31, 2022
 Fair Value of AssetsFair Value of Assets
In ThousandsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Money market funds (1)$7,389 $— $— $7,389 $— $— $— $— 
Total$7,389 $— $— $7,389 $— $— $— $— 


(1) Included in cash and cash equivalents on the accompanying condensed consolidated balance sheets


September 30, 2023December 31, 2022
Fair Value of LiabilitiesFair Value of Liabilities
In ThousandsLevel 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Common Warrants$— $— $1,512 $1,512 $— $— $291 $291 
Total$— $— $1,512 $1,512 $— $— $291 $291 
Summary of Common Warrants Activity

The following table summarizes the Common Warrants activity for the period ended September 30, 2023:

Level 3 Fair Value of Liabilities
Balance as of December 31, 2022291
Mark to market adjustment1,221
Balance as of September 30, 20231,512
Summary of Fair Value of the Common Warrants
The estimated fair values of the Common Warrants, and the assumptions used for the Black-Scholes option pricing model were as follows:
 As of September 30, 2023As of December 31, 2022
Estimated fair value of Common Warrants$9.54 $1.87 
Assumptions: 
Risk-free interest rate4.7 %4.0 %
Expected volatility107.1 %85.0 %
Expected term to liquidation (in years)3.94.6
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
PROPERTY, PLANT, AND EQUIPMENT, NET (Tables)
 9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
Property, plant, and equipment, net consists of the following:

In Thousands, except useful lifeUseful Life
(Years)		As of September 30, 2023As of December 31, 2022
Property, plant, and equipment, net:
Buildings
10 - 20
$900 $900 
Leasehold improvements
shorter of lease term or - 15
3,879 364 
Office furniture and equipment
5 - 10
13,570 7,803 
Office furniture and equipment under financing leases
4 - 20
373 414 
Computer equipment and software
3 - 5
3,264 912 
Assets in progressN/A3,272 — 
Total property, plant, and equipment25,258 10,393 
Less accumulated depreciation and amortization(8,061)(5,877)
Total$17,197 $4,516 
Depreciation and amortization expense is as follows:

Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Depreciation and amortization expense$1,225 $369 $2,208 $1,091 
Schedule of Change in Asset Retirement Obligation
The following table presents the changes in the ARO during the nine months ended September 30, 2023.

In ThousandsAsset Retirement Obligations
Balance as of December 31, 2022$— 
Acquired from merger with Cibus Global, LLC264 
Obligations incurred— 
Accretion expense5 
Balance as of September 30, 2023$269 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS (Tables)
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets Intangible assets as of September 30, 2023, were as follows:

In ThousandsGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
In-process research and development$99,051 $— $99,051 
Developed technology14,148 236 13,912 
Trade name22,230 370 21,860 
Other150 52 98 
Total$135,579 $658 $134,921 
Schedule of Indefinite-Lived Intangible Assets Intangible assets as of September 30, 2023, were as follows:

In ThousandsGross Carrying AmountAccumulated AmortizationIntangible Assets, Net
In-process research and development$99,051 $— $99,051 
Developed technology14,148 236 13,912 
Trade name22,230 370 21,860 
Other150 52 98 
Total$135,579 $658 $134,921 
Finite-Lived Intangible Assets Amortization Expense
Total amortization expense is as follows:

Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Amortization expense$459 $5 667 16 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense As of September 30, 2023, amortization expense for each of the next five years is estimated as follows:

In ThousandsAmortization Expense
Remainder of 2023$458 
20241,833 
20251,833 
20261,833 
20271,833 
20281,833 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
NOTES PAYABLE (Tables)
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Future Minimum Payments Under Notes Payable
As of September 30, 2023, future minimum payments under notes payable were as follows:

In ThousandsAnnual LicensesFinanced EquipmentInsuranceTotal Notes Payable
Remainder of 2023$93 $137 $290 $520 
2024216 450 194 860 
2025— 351 — 351 
2026— 151 — 151 
2027— 89 — 89 
2028— 15 — 15 
309 1,193 484 1,986 
Less: interest(15)(168)(9)(192)
Total$294 $1,025 $475 $1,794 
Current portion294 396 475 1,165 
Noncurrent portion$— $629 $— $629 
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Disclosure of Warrants Transactions
Common Warrant transactions for the nine months ended September 30, 2023, are as follows:
 Common Warrants
Weighted Average
Exercise
Price Per Share
Outstanding as of December 31, 2022158,483$69.04 
Issued—— 
Forfeited/canceled—— 
Exercised—— 
Outstanding as of September 30, 2023158,483$69.04 
Exercisable as of September 30, 2023158,483$69.04 
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model The estimated fair values of stock options granted, and the assumptions used for the Black-Scholes option pricing model were as follows:
 Nine Months Ended September 30,
 20232022
Estimated fair values of stock options granted$— $42.83 
Assumptions:  
Risk-free interest rate
—%
1.9% - 3.5%
Expected volatility
—%
89.7% - 92.8%
Expected term (in years)
—
5.50 - 6.89
Summary of Stock Option Activity
Information on stock option activity is as follows:
 
Options
Exercisable
Weighted Average
Exercise
Price Per
Share
Options
Outstanding
Weighted Average
Exercise
Price Per
Share
Balance as of December 31, 202267,978$496.83 116,860$367.58 
Granted—— —— 
Vested42,195154.28 —— 
Exercised—— —— 
Forfeited or expired(1,530)441.63 (7,309)369.43 
Balance as of September 30, 2023108,643$364.57 109,551$367.46 
Summary of Stock-based Compensation Expense
Stock-based compensation expense related to stock option awards is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$40 $530 $1,835 $1,420 
Stock-based compensation expense related to RSAs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$5,631 $— $7,555 $— 
Stock-based compensation expense related to RSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$157 $334 $2,550 $992 
Stock-based compensation expense related to PSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation (benefit) expense$— $171 $(270)$478 
Certain statement of operations amounts are as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense:
Research and development$2,853 $210 $5,531 $620 
Selling, general, and administrative2,975 825 6,139 2,270 
Total$5,828 $1,035 $11,670 $2,890 
Schedule of Nonvested Share Activity Information on Class A Restricted Stock award activity is as follows:
 
Restricted Stock
Awards
Weighted Average Grant
Date Fair Value
Unvested balance as of December 31, 2022—$— 
Granted1,019,28231.50 
Vested(71,969)31.50 
Forfeited(1,533)31.50 
Unvested balance as of September 30, 2023945,780$31.50 
Information on restricted stock unit activity is as follows:
 
Restricted Stock
Units
Weighted Average Grant
Date Fair Value
Unvested balance as of December 31, 202224,575$99.36 
Granted272,88519.02 
Vested(96,730)38.27 
Forfeited(2,531)127.84 
Unvested balance as of September 30, 2023198,199$18.19 
Summary of Grant Date Fair Value of Awards Vested
The total grant-date fair value of RSAs that vested is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Grant-date fair value$1,725 $— $2,267 $— 
The total grant-date fair value of RSUs that vested is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Grant-date fair value$100 $530 $3,702 $1,686 
Summary of Stock-Based Compensation Granted As Deemed Dividends The Company recorded deemed dividends as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Deemed dividends from grants to Cellectis employees$— $18 $— $82 
Share-based Payment Arrangement, Performance Shares, Outstanding Activity
PSU activity for the nine months ended September 30, 2023, is as follows:
 Performance Stock Units
Outstanding as of December 31, 202222,600
Issued24,800
Forfeited/canceled(9,333)
Exercised(38,067)
Outstanding as of September 30, 2023—
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES (Tables)
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Non-Cancellable Operating Leases The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:
 As of September 30, 2023As of December 31, 2022
In Thousands, except remaining termRemaining Term (years)Right-of-Use-AssetRemaining Term (years)Right-of-Use-Asset
Roseville, Minnesota lease14.6$13,244 15.3$13,613 
San Diego, California laboratory lease1.93,848 — — 
San Diego, California headquarters lease1.73,710 — — 
San Diego, California greenhouse lease4.91,541 — — 
Other leases
< 1.0 - 3.0
592 
< 1.0
2 
Total$22,935 $13,615 
Summary of Lease Expense, Supplemental Cash Flow Information Related to Leases, and Supplemental Balance Sheet Information Related to Leases
The components of lease expense were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Finance lease costs$65 $57 $79 $73 
Operating lease costs1,635 381 2,830 1,174 
Total$1,700 $438 $2,909 $1,247 
Supplemental cash flow information related to leases was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
In Thousands, except for lease term and discount rate 2023202220232022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows (operating leases)$1,297 $70 $1,848 $205 
Financing cash flows (finance leases)$132 $163 $242 $353 
Supplemental balance sheet information related to leases was as follows:
As of September 30, 2023As of December 31, 2022
OperatingFinancingOperatingFinancing
Weighted average remaining lease term (years) 10.51.415.30.4
Weighted average discount rate 7.5 %9.5 %7.9 %8.1 %
Lessee, Operating Lease, Liability, to be Paid, Maturity
As of September 30, 2023, future minimum payments under operating and finance leases were as follows:
In Thousands
Operating
Financing
Total
Remainder of 2023$1,758 $40 $1,798 
20247,132 210 7,342 
20254,797 120 4,917 
20261,993 — 1,993 
20271,920 — 1,920 
20281,863 — 1,863 
Thereafter15,438 — 15,438 
 34,901 370 35,271 
Less: interest(10,621)(33)(10,654)
Total$24,280 $337 $24,617 
Current portion5,436 235 5,671 
Noncurrent portion$18,844 $102 $18,946 
Finance Lease, Liability, to be Paid, Maturity
As of September 30, 2023, future minimum payments under operating and finance leases were as follows:
In Thousands
Operating
Financing
Total
Remainder of 2023$1,758 $40 $1,798 
20247,132 210 7,342 
20254,797 120 4,917 
20261,993 — 1,993 
20271,920 — 1,920 
20281,863 — 1,863 
Thereafter15,438 — 15,438 
 34,901 370 35,271 
Less: interest(10,621)(33)(10,654)
Total$24,280 $337 $24,617 
Current portion5,436 235 5,671 
Noncurrent portion$18,844 $102 $18,946 
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
ROYALTY LIABILITY - RELATED PARTIES (Tables)
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Schedule of Royalty Liability
As of September 30, 2023, the Royalty Liability activity is as follows:

In ThousandsRoyalty Liability - Related Parties
Balance as of December 31, 2022$— 
Acquired from merger with Cibus Global, LLC146,360 
Interest expense recognized10,753 
Balance as of September 30, 2023$157,113 
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accrued Expenses
Certain balance sheet amounts are as follows:
In ThousandsAs of September 30, 2023As of December 31, 2022
Accrued Expenses:
Accrued consulting and professional fees$2,980 $119 
Accrued field trials1,716 — 
Other396 54 
Total$5,092 $173 
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense related to stock option awards is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$40 $530 $1,835 $1,420 
Stock-based compensation expense related to RSAs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$5,631 $— $7,555 $— 
Stock-based compensation expense related to RSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense$157 $334 $2,550 $992 
Stock-based compensation expense related to PSUs is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation (benefit) expense$— $171 $(270)$478 
Certain statement of operations amounts are as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
In Thousands2023202220232022
Stock-based compensation expense:
Research and development$2,853 $210 $5,531 $620 
Selling, general, and administrative2,975 825 6,139 2,270 
Total$5,828 $1,035 $11,670 $2,890 
Schedule of Statements of Certain Statements of Cash Flows Amounts
Supplemental statement of cash flows information is as follows:
 Nine Months Ended September 30,
In Thousands20232022
Interest paid$98 $67 
Non-cash transactions not reported in the condensed consolidated statement of cash flows is as follows:
 Nine Months Ended September 30,
In Thousands20232022
Receivable from Jefferies for shares issued under ATM facility$— $(260)
Property, plant, and equipment acquired through assuming liabilities419 (687)
Shares issued for consideration in the merger with Cibus Global634,751 — 
Forgiveness of interim funding resulting from merger with Cibus Global2,500 — 
Cumulative effect of adoption of lease accounting standard on stockholders’ equity— 832 
Establishment of financing lease right-of-use assets and associated operating lease liabilities307 — 
Establishment of operating lease right-of-use assets and associated operating lease liabilities$1,606 $14,090 
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
May 31, 2023
class_of_stock
$ / shares
shares
Apr. 24, 2023
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
reporting_unit
segment
$ / shares
shares
Sep. 30, 2022
USD ($)
May 30, 2023
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Feb. 23, 2022
$ / shares
shares
Class of Warrant or Right [Line Items]                    
Number of classes of stock | class_of_stock   2                
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001                
Reverse stock split conversion ratio   0.2                
Common and preferred stock, shares authorized (in shares)   310,000,000                
Common stock, shares authorized (in shares) 300,000,000 300,000,000   300,000,000   300,000,000        
Preferred stock, shares authorized (in shares)   10,000,000                
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001                
Net loss | $       $ 34,528,000 $ 5,950,000 $ 60,431,000 $ 14,054,000      
Net cash used by operating activities | $           29,193,000 $ 15,601,000      
Cash and cash equivalents | $ $ 31,883,000     31,883,000   31,883,000     $ 3,427,000  
Total current liabilities | $ 25,079,000     25,079,000   25,079,000     1,662,000  
Allowance for doubtful accounts | $ $ 0     0   $ 0     $ 0  
Number of reporting units | reporting_unit           1        
Goodwill and intangible asset impairment | $           $ 0        
Revenue recognized from deferred revenue balance | $       $ 500,000   $ 100,000        
Fundamental Transaction voting threshold, percent 50.00%     50.00%   50.00%        
Employee Retention Credit refund received | $ $ 200,000                  
Number of operating segments | segment           1        
Cibus Global                    
Class of Warrant or Right [Line Items]                    
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares)   20,150,838                
Common Warrants                    
Class of Warrant or Right [Line Items]                    
Deferred financing costs related to common warrants | $           $ 400,000        
Exercise price of warrants (in dollars per share) | $ / shares                   $ 69.04
Number of securities called by each warrant (in shares)                   1
Pre-Funded Warrants                    
Class of Warrant or Right [Line Items]                    
Exercise price of warrants (in dollars per share) | $ / shares                   $ 0.0001
Number of securities called by each warrant (in shares)                   1
Minimum                    
Class of Warrant or Right [Line Items]                    
Land, buildings, and equipment useful Life 3 years     3 years   3 years        
Maximum                    
Class of Warrant or Right [Line Items]                    
Land, buildings, and equipment useful Life 20 years     20 years   20 years        
Calyxt, Inc.                    
Class of Warrant or Right [Line Items]                    
Common stock, par value (in dollars per share) | $ / shares               $ 0.0001    
Common stock issued and outstanding, ownership percentage   4.80%                
Reverse stock split conversion ratio     0.1              
Cibus Global                    
Class of Warrant or Right [Line Items]                    
Common stock issued and outstanding, ownership percentage   95.20%                
Class A Common Stock                    
Class of Warrant or Right [Line Items]                    
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001   $ 0.0001   $ 0.0001     $ 0.0001  
Stock issued during period for acquisitions (in shares)   16,527,484                
Common stock, shares authorized (in shares) 210,000,000 210,000,000   210,000,000   210,000,000     275,000,000  
Class A Common Stock | Cibus Global                    
Class of Warrant or Right [Line Items]                    
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares)   15,508,202                
Class B Common Stock                    
Class of Warrant or Right [Line Items]                    
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001   $ 0.0001   $ 0.0001     $ 0.0001  
Common stock, shares authorized (in shares) 90,000,000 90,000,000   90,000,000   90,000,000     0  
Class B Common Stock | Cibus Global                    
Class of Warrant or Right [Line Items]                    
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares)   4,642,636                
Restricted Common Class A                    
Class of Warrant or Right [Line Items]                    
Stock issued during period for acquisitions (in shares)   1,019,282                
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock by Class (Details) - shares
Sep. 30, 2023
May 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]      
Authorized (in shares) 300,000,000 300,000,000  
Issued (in shares) 22,299,467    
Outstanding (in shares) 21,302,632    
Class A Common Stock      
Class of Stock [Line Items]      
Authorized (in shares) 210,000,000 210,000,000 275,000,000
Issued (in shares) 17,656,831   978,915
Outstanding (in shares) 16,659,996   976,908
Class B Common Stock      
Class of Stock [Line Items]      
Authorized (in shares) 90,000,000 90,000,000 0
Issued (in shares) 4,642,636   0
Outstanding (in shares) 4,642,636   0
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Deferred Revenue Activity (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
USD ($)
Contract with Customer, Liability [Roll Forward]  
Beginning balance $ 107
Acquired from merger with Cibus Global, LLC 1,186
Consideration earned (714)
Consideration received 1,058
Ending balance $ 1,637
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 1,412,013 323,229
Stock options outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 109,551 116,936
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 198,199 25,210
Unvested performance stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 0 22,600
Unvested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 945,780 0
Common Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total (in shares) 158,483 158,483
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
MERGER WITH CIBUS GLOBAL - Narrative (Details)
$ in Millions
 9 Months Ended 12 Months Ended 21 Months Ended
Sep. 30, 2023
May 31, 2023
shares
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
Business Acquisition [Line Items]          
Weighted average amortization period for definite lived intangible assets   20 years      
Percentage of income tax savings required to be paid under the TRA   85.00%      
Variable Interest Entity, Primary Beneficiary          
Business Acquisition [Line Items]          
Variable interest entity, ownership percentage 22.00% 22.00%      
Cibus Global          
Business Acquisition [Line Items]          
Number of Common Units included in Up-C Units (in shares) | shares   1      
Up-C Units to Class A Common Stock exchange ratio   1      
Expenses incurred in connection with Merger       $ 0.4 $ 8.2
Legal and professional fees     $ 3.5    
Severance costs     1.9    
Revenue of acquiree since acquisition date     0.7    
Loss of acquiree since acquisition date, attributable to controlling interest     (35.5)    
Loss of acquiree since acquisition date, attributable to noncontrolling interest     (9.9)    
Cibus Global | Selling, general, and administrative          
Business Acquisition [Line Items]          
Accelerated stock compensation expense     1.1    
Cibus Global | Research and development          
Business Acquisition [Line Items]          
Accelerated stock compensation expense     $ 1.3    
Cibus Global | Class B Common Stock          
Business Acquisition [Line Items]          
Number of Common Stock shares included in Up-C Units (in shares) | shares   1      
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
MERGER WITH CIBUS GLOBAL - Schedule of Purchase Price for Merger Transaction (Details) - USD ($)
 9 Months Ended
May 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Business Acquisition [Line Items]      
Purchase price   $ 634,751,000 $ 0
Cibus Global      
Business Acquisition [Line Items]      
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) 20,150,838    
Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (in dollars per share) $ 31.50    
Purchase price $ 634,751,397    
Cibus Global | Restricted Stock      
Business Acquisition [Line Items]      
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) 1,019,282    
Cibus Global | Class A Common Stock      
Business Acquisition [Line Items]      
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) 15,508,202    
Cibus Global | Class B Common Stock      
Business Acquisition [Line Items]      
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) 4,642,636    
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
MERGER WITH CIBUS GLOBAL - Schedule of Recognized the Preliminary Allocation of the Consideration (Details) - USD ($)
Sep. 30, 2023
May 31, 2023
May 30, 2023
Dec. 31, 2022
Business Acquisition [Line Items]        
Goodwill $ 585,266,000   $ 0 $ 0
Cibus Global        
Business Acquisition [Line Items]        
Cash and cash equivalents   $ 59,381,000    
Accounts receivable   2,216,000    
Note receivable   2,500,000    
Prepaid expenses and other current assets   2,535,000    
Property, plant and equipment   10,588,000    
Operating lease right-of-use-assets   9,519,000    
Goodwill   585,266,000    
Intangible assets   135,429,000    
Other non-current assets   457,000    
Accounts payable   (5,582,000)    
Accrued expenses   (3,477,000)    
Accrued compensation   (2,859,000)    
Deferred revenue   (1,186,000)    
Current portion of notes payable   (517,000)    
Current portion of operating lease obligations   (4,687,000)    
Current portion of financing lease obligations   (165,000)    
Notes payable, net of current portion   (749,000)    
Operating lease obligations, net of current portion   (6,006,000)    
Financing lease obligations, net of current portion   (10,000)    
Other non-current liabilities   (1,536,000)    
Consideration transferred   634,751,000    
Cibus Global | Related Party        
Business Acquisition [Line Items]        
Due from related parties, net   19,000    
Other current liabilities   (8,000)    
Royalty liability - related parties   (146,360,000)    
Cibus Global | Nonrelated Party        
Business Acquisition [Line Items]        
Other current liabilities   $ (17,000)    
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
MERGER WITH CIBUS GLOBAL - Schedule of Intangible Assets Acquired in Merger Transaction (Details)
$ in Thousands
May 31, 2023
USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated Average Useful Life (Years) 20 years
Cibus Global  
Intangible Assets Acquired As Part Of Business Combination [Line Items]  
Total $ 135,429
Cibus Global | In-process research and development  
Acquired Indefinite-Lived Intangible Assets [Line Items]  
Acquired indefinite-lived intangible assets 99,051
Cibus Global | Developed technology  
Acquired Finite-Lived Intangible Assets [Line Items]  
Acquired finite-lived intangibles $ 14,148
Estimated Average Useful Life (Years) 20 years
Cibus Global | Trade name  
Acquired Finite-Lived Intangible Assets [Line Items]  
Acquired finite-lived intangibles $ 22,230
Estimated Average Useful Life (Years) 20 years
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
MERGER WITH CIBUS GLOBAL - Business Acquisition, Pro Forma Information (Details) - Cibus Global - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]        
Pro forma revenues $ 475 $ 307 $ 1,154 $ 992
Pro forma net loss (34,528) (20,365) (88,474) (61,603)
Pro forma net loss attributable to controlling interest (24,575) (17,301) (70,855) (53,178)
Pro forma net loss attributable to redeemable noncontrolling interest $ (9,953) $ (3,064) $ (17,619) $ (8,425)
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value Measurements and Financial Statement Presentation (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Fair Value of Assets    
Total $ 7,389 $ 0
Fair Value of Liabilities    
Common Warrants 1,512 291
Total 1,512 291
Common Warrants    
Fair Value of Liabilities    
Common Warrants 1,512 291
Level 1    
Fair Value of Assets    
Total 7,389 0
Fair Value of Liabilities    
Total 0 0
Level 1 | Common Warrants    
Fair Value of Liabilities    
Common Warrants 0 0
Level 2    
Fair Value of Assets    
Total 0 0
Fair Value of Liabilities    
Total 0 0
Level 2 | Common Warrants    
Fair Value of Liabilities    
Common Warrants 0 0
Level 3    
Fair Value of Assets    
Total 0 0
Fair Value of Liabilities    
Total 1,512 291
Level 3 | Common Warrants    
Fair Value of Liabilities    
Common Warrants 1,512 291
Money Market Funds    
Fair Value of Assets    
Money market funds 7,389 0
Money Market Funds | Level 1    
Fair Value of Assets    
Money market funds 7,389 0
Money Market Funds | Level 2    
Fair Value of Assets    
Money market funds 0 0
Money Market Funds | Level 3    
Fair Value of Assets    
Money market funds $ 0 $ 0
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Common Warrants Activity (Details) - Common Warrants
$ in Thousands
 9 Months Ended
Sep. 30, 2023
USD ($)
Warrant activity, Fair Value [Roll Forward]  
Balance as of December 31, 2022 $ 291
Mark to market adjustment 1,221
Balance as of September 30, 2023 $ 1,512
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.3
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value of the Common Warrants (Details)
Sep. 30, 2023
yr
Dec. 31, 2022
yr
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Estimated fair value of Common Warrants 9.54 1.87
Risk-free interest rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assumptions: 0.047 0.040
Expected volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assumptions: 1.071 0.850
Expected term to liquidation (in years)    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assumptions: 3.9 4.6
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.3
PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Property, Plant, and Equipment (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Property, Plant and Equipment [Line Items]          
Total property, plant, and equipment $ 25,258   $ 25,258   $ 10,393
Less accumulated depreciation and amortization (8,061)   (8,061)   (5,877)
Total 17,197   17,197   4,516
Depreciation and amortization expense $ 1,225 $ 369 $ 2,208 $ 1,091  
Minimum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 3 years   3 years    
Maximum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 20 years   20 years    
Buildings          
Property, Plant and Equipment [Line Items]          
Land, buildings, and equipment, gross $ 900   $ 900   900
Buildings | Minimum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 10 years   10 years    
Buildings | Maximum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 20 years   20 years    
Leasehold improvements          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 15 years   15 years    
Land, buildings, and equipment, gross $ 3,879   $ 3,879   364
Office furniture and equipment          
Property, Plant and Equipment [Line Items]          
Land, buildings, and equipment, gross 13,570   13,570   7,803
Finance lease, right-of-use asset, before accumulated amortization $ 373   $ 373   414
Office furniture and equipment | Minimum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 5 years   5 years    
Useful Life (Years) 4 years   4 years    
Office furniture and equipment | Maximum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 10 years   10 years    
Useful Life (Years) 20 years   20 years    
Computer equipment and software          
Property, Plant and Equipment [Line Items]          
Land, buildings, and equipment, gross $ 3,264   $ 3,264   912
Computer equipment and software | Minimum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 3 years   3 years    
Computer equipment and software | Maximum          
Property, Plant and Equipment [Line Items]          
Useful Life (Years) 5 years   5 years    
Assets in progress          
Property, Plant and Equipment [Line Items]          
Land, buildings, and equipment, gross $ 3,272   $ 3,272   $ 0
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.3
PROPERTY, PLANT, AND EQUIPMENT, NET - Narrative (Details)
Sep. 30, 2023
Risk Free Interest Rate  
Property, Plant and Equipment [Line Items]  
Asset retirement obligation, measurement input 0.056
Inflation Rate  
Property, Plant and Equipment [Line Items]  
Asset retirement obligation, measurement input 0.05
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.3
PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Change in Asset Retirement Obligation (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
USD ($)
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]  
Beginning balance $ 0
Acquired from merger with Cibus Global, LLC 264
Obligations incurred 0
Accretion expense 5
Ending balance $ 269
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)
May 31, 2023
Sep. 30, 2023
May 30, 2023
Dec. 31, 2022
Goodwill [Line Items]        
Goodwill, acquired during period $ 585,300,000      
Goodwill   $ 585,266,000 $ 0 $ 0
Cibus Global        
Goodwill [Line Items]        
Goodwill 585,266,000      
Goodwill, expected tax deductible amount $ 0      
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Accumulated Amortization $ 658  
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Gross Carrying Amount 135,579  
Accumulated Amortization 658  
Intangible Assets, Net 134,921 $ 158
In-process research and development    
Indefinite-Lived Intangible Assets [Line Items]    
In-process research and development 99,051  
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 14,148  
Accumulated Amortization 236  
Intangible Assets, Net 13,912  
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization 236  
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 22,230  
Accumulated Amortization 370  
Intangible Assets, Net 21,860  
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization 370  
Other    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 150  
Accumulated Amortization 52  
Intangible Assets, Net 98  
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ 52  
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS - Schedule Of Amortization (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization expense $ 459 $ 5 $ 667 $ 16
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Remainder of 2023 $ 458
2024 1,833
2025 1,833
2026 1,833
2027 1,833
2028 $ 1,833
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.3
NOTES PAYABLE - Narrative (Details) - Notes Payable
 9 Months Ended
Sep. 30, 2023
Annual Licenses  
Debt Instrument [Line Items]  
Debt instrument, term 1 year
Debt instrument, interest rate 10.90%
Financed Equipment  
Debt Instrument [Line Items]  
Debt instrument, weighted average remaining term 2 years 9 months 18 days
Financed Equipment | Minimum  
Debt Instrument [Line Items]  
Debt instrument, interest rate 7.30%
Financed Equipment | Maximum  
Debt Instrument [Line Items]  
Debt instrument, interest rate 17.60%
Insurance  
Debt Instrument [Line Items]  
Debt instrument, interest rate 7.50%
Debt instrument, weighted average remaining term 4 months 24 days
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.3
NOTES PAYABLE - Schedule of Future Minimum Payments Under Notes Payable (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Remainder of 2023 $ 520  
2024 860  
2025 351  
2026 151  
2027 89  
2028 15  
Notes Payable, Gross 1,986  
Less: interest (192)  
Total 1,794  
Current portion 1,165 $ 0
Noncurrent portion 629 $ 0
Annual Licenses    
Debt Instrument [Line Items]    
Remainder of 2023 93  
2024 216  
2025 0  
2026 0  
2027 0  
2028 0  
Notes Payable, Gross 309  
Less: interest (15)  
Total 294  
Current portion 294  
Noncurrent portion 0  
Financed Equipment    
Debt Instrument [Line Items]    
Remainder of 2023 137  
2024 450  
2025 351  
2026 151  
2027 89  
2028 15  
Notes Payable, Gross 1,193  
Less: interest (168)  
Total 1,025  
Current portion 396  
Noncurrent portion 629  
Insurance    
Debt Instrument [Line Items]    
Remainder of 2023 290  
2024 194  
2025 0  
2026 0  
2027 0  
2028 0  
Notes Payable, Gross 484  
Less: interest (9)  
Total 475  
Current portion 475  
Noncurrent portion $ 0  
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY - Follow-On Public Offering (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended
Feb. 23, 2022
Sep. 30, 2023
Sep. 30, 2022
Stockholders Equity [Line Items]      
Underwriting discounts and estimated other offering expenses   $ 0 $ 962
Pre-Funded Warrants      
Stockholders Equity [Line Items]      
Number of securities called by each warrant (in shares) 1    
Exercise price of warrants (in dollars per share) $ 0.0001    
Common Warrants      
Stockholders Equity [Line Items]      
Number of securities called by each warrant (in shares) 1    
Exercise price of warrants (in dollars per share) $ 69.04    
Follow-on Public Offering      
Stockholders Equity [Line Items]      
Offering price (in dollars per share) $ 70.50    
Net proceeds on issuance of common stock $ 10,000    
Underwriting discounts and estimated other offering expenses $ 900    
Follow-on Public Offering | Pre-Funded Warrants      
Stockholders Equity [Line Items]      
Warrants issued (in shares) 77,600    
Offering price (in dollars per share) $ 70.4999    
Exercise price of warrants (in dollars per share) $ 0.0001    
Follow-on Public Offering | Common Warrants      
Stockholders Equity [Line Items]      
Warrants issued (in shares) 158,483    
Exercise price of warrants (in dollars per share) $ 69.04    
Maximum voting percentage, before warrants cannot be exercised 4.99%    
Class A Common Stock | Follow-on Public Offering      
Stockholders Equity [Line Items]      
Issuance of common stock (in shares) 77,600    
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY - Disclosure of Warrants Transactions (Details) - Common Warrants - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Common Warrants    
Outstanding (in shares) 158,483 158,483
Exercisable (in shares) 158,483  
Weighted Average Exercise Price Per Share    
Outstanding (in dollars per share) $ 69.04 $ 69.04
Exercisable (in dollars per share) $ 69.04  
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY - ATM Facility (Details) - At-The-Market Offering - USD ($)
$ in Millions
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]    
Number of shares issued in transaction (in shares) 0 40,000
Net proceeds on issuance of common stock   $ 0.1
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY - Merger with Cibus Global (Details)
May 31, 2023
shares
Cibus Global  
Stockholders Equity [Line Items]  
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) 20,150,838
Class A Common Stock  
Stockholders Equity [Line Items]  
Stock issued during period for acquisitions (in shares) 16,527,484
Class A Common Stock | Cibus Global  
Stockholders Equity [Line Items]  
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) 15,508,202
Restricted Common Class A  
Stockholders Equity [Line Items]  
Stock issued during period for acquisitions (in shares) 1,019,282
Class B Common Stock | Cibus Global  
Stockholders Equity [Line Items]  
Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares) 4,642,636
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY - Cibus Common Units (Details)
Sep. 30, 2023
shares
May 31, 2023
Stockholders Equity [Line Items]    
Common unit conversion ratio   1
Common units outstanding (in shares) 21,302,632  
Cibus, Inc.    
Stockholders Equity [Line Items]    
Common units outstanding (in shares) 16,659,996  
Electing Members    
Stockholders Equity [Line Items]    
Common units outstanding (in shares) 4,642,636  
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY - Preferred Stock (Details) - $ / shares
Sep. 30, 2023
May 31, 2023
Equity [Abstract]    
Preferred stock, shares authorized (in shares)   10,000,000
Preferred stock, par value (in dollars per share)   $ 0.0001
Preferred stock, shares issued (in shares) 0  
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Narrative (Details)
 1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2023
May 24, 2023
employee
shares
Mar. 01, 2023
Feb. 28, 2023
Mar. 01, 2022
Jun. 30, 2022
Mar. 31, 2022
employee
shares
Jul. 31, 2021
shares
Mar. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option post-separation exercise period     5 years 90 days            
Weighted average remaining contractual term                   4 years
Unrecognized stock-based compensation expense related to non-vested stock options | $                   $ 100,000
Stock Options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Options priced at fair market value, percent                   100.00%
Stock option expiration period                   10 years
Share-based payment arrangement, plan modification, incremental cost | $                 $ 100,000 $ 200,000
Unrecognized stock-based compensation expense, expected recognition weighted-average period                   1 year
Stock Options | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option, vesting period                   3 years
Stock Options | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option, vesting period                   6 years
Restricted Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Unrecognized stock-based compensation expense, expected recognition weighted-average period                   2 years 6 months
Unrecognized stock-based compensation expense | $                   $ 24,500,000
Granted (in shares) | shares                   1,019,282
Restricted Stock | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option, vesting period                   2 months
Restricted Stock | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option, vesting period                   4 years
Restricted Stock Units                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Unrecognized stock-based compensation expense, expected recognition weighted-average period                   3 years 4 months 24 days
Unrecognized stock-based compensation expense | $                   $ 3,500,000
Granted (in shares) | shares                   272,885
Restricted Stock Units | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option, vesting period                   3 years
Restricted Stock Units | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option, vesting period                   5 years
Performance Stock Units                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Unrecognized stock-based compensation expense | $                   $ 0
Award requisite service period           5 years        
2017 Omnibus Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share-based compensation arrangement by share-based payment award, number of shares registered and available for grant (in shares) | shares                   1,925,024
2017 Omnibus Plan | Performance Stock Units                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares) | shares   24,800         10,600      
Number of employees | employee   5         5      
Award vesting rights, percentage   100.00%                
Award performance period             3 years      
2017 Omnibus Plan | Performance Stock Units | Share-Based Payment Arrangement, Tranche One                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting rights, percentage         100.00%          
2017 Omnibus Plan | Performance Stock Units | Share-Based Payment Arrangement, Tranche Two                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting rights, percentage 100.00%                  
2017 Omnibus Plan | Performance Stock Units | Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of employees | employee   4         4      
Inducement Plan [Member] | Performance Stock Units                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares) | shares               12,000    
Award vesting rights, percentage 25.00%                  
Award performance period               3 years    
Share-based compensation arrangement by share-based payment award, threshold consecutive trading days               30 days    
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model (Details) - Stock Options - $ / shares
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Estimated fair values of stock options granted (USD per share) $ 0 $ 42.83
Assumptions:    
Risk-free interest rate 0.00%  
Risk-free interest rate, minimum   1.90%
Risk-free interest rate, maximum   3.50%
Expected volatility 0.00%  
Expected volatility, minimum   89.70%
Expected volatility, maximum   92.80%
Minimum    
Assumptions:    
Expected term (in years)   5 years 6 months
Maximum    
Assumptions:    
Expected term (in years)   6 years 10 months 20 days
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details) - $ / shares
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Options Exercisable    
Beginning balance (in shares) 67,978  
Vested (in shares) 42,195  
Forfeited or expired (in shares) (1,530)  
Ending balance (in shares) 108,643  
Weighted Average Exercise Price Per Share    
Exercisable (in dollars per share) $ 364.57 $ 496.83
Vested (in dollars per share) 154.28  
Forfeited or expired (in dollars per share) $ 441.63  
Options Outstanding    
Beginning balance (in shares) 116,860  
Granted (in shares) 0  
Exercised (in shares) 0  
Forfeited or expired (in shares) (7,309)  
Ending balance (in shares) 109,551  
Weighted Average Exercise Price Per Share    
Outstanding (in dollars per share) $ 367.46 $ 367.58
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0  
Forfeited or expired (in dollars per share) $ 369.43  
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation (benefit) expense $ 5,828 $ 1,035 $ 11,670 $ 2,890
Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation (benefit) expense 40 530 1,835 1,420
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation (benefit) expense 5,631 0 7,555 0
Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation (benefit) expense 157 334 2,550 992
Performance Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation (benefit) expense $ 0 $ 171 $ (270) $ 478
XML 80 R70.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Schedule of Nonvested Shares Activity (Details) - $ / shares
 9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Restricted Stock    
Restricted Stock Awards/Units    
Unvested beginning balance (in shares) 0  
Granted (in shares) 1,019,282  
Vested (in shares) (71,969)  
Forfeited (in shares) (1,533)  
Unvested ending balance (in shares) 945,780  
Weighted Average Grant Date Fair Value    
Unvested (in dollars per share) $ 31.50 $ 0
Granted (in dollars per share) 31.50  
Vested (in dollars per share) 31.50  
Forfeited (in dollars per share) $ 31.50  
Restricted Stock Units    
Restricted Stock Awards/Units    
Unvested beginning balance (in shares) 24,575  
Granted (in shares) 272,885  
Vested (in shares) (96,730)  
Forfeited (in shares) (2,531)  
Unvested ending balance (in shares) 198,199  
Weighted Average Grant Date Fair Value    
Unvested (in dollars per share) $ 18.19 $ 99.36
Granted (in dollars per share) 19.02  
Vested (in dollars per share) 38.27  
Forfeited (in dollars per share) $ 127.84  
XML 81 R71.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Summary of Grant Date Fair Value of Awards Vested (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grant-date fair value $ 1,725 $ 0 $ 2,267 $ 0
Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grant-date fair value $ 100 $ 530 $ 3,702 $ 1,686
XML 82 R72.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Granted as Deemed Dividends (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Deemed Dividends | Related Party        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Deemed dividends from grants to Cellectis employees $ 0 $ 18 $ 0 $ 82
XML 83 R73.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION - Share-Based Payment Arrangement, Performance Shares, Outstanding Activity (Details) - Performance Stock Units
 9 Months Ended
Sep. 30, 2023
shares
Performance Stock Units  
Beginning balance (in shares) 22,600
Issued (in shares) 24,800
Forfeited/canceled (in shares) (9,333)
Exercised (in shares) (38,067)
Ending balance (in shares) 0
XML 84 R74.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]        
Income tax provision $ 0 $ 0 $ 0 $ 0
XML 85 R75.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES - Schedule of Non-Cancellable Operating Leases (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Operating Leased Assets [Line Items]    
Right-of-Use-Asset $ 22,935 $ 13,615
Roseville, Minnesota lease    
Operating Leased Assets [Line Items]    
Remaining Term (years) 14 years 7 months 6 days 15 years 3 months 18 days
Right-of-Use-Asset $ 13,244 $ 13,613
San Diego, California laboratory lease    
Operating Leased Assets [Line Items]    
Remaining Term (years) 1 year 10 months 24 days  
Right-of-Use-Asset $ 3,848 0
San Diego, California headquarters lease    
Operating Leased Assets [Line Items]    
Remaining Term (years) 1 year 8 months 12 days  
Right-of-Use-Asset $ 3,710 0
San Diego, California greenhouse lease    
Operating Leased Assets [Line Items]    
Remaining Term (years) 4 years 10 months 24 days  
Right-of-Use-Asset $ 1,541 $ 0
Other leases    
Operating Leased Assets [Line Items]    
Remaining Term (years)   1 year
Right-of-Use-Asset $ 592 $ 2
Other leases | Minimum    
Operating Leased Assets [Line Items]    
Remaining Term (years) 1 year  
Other leases | Maximum    
Operating Leased Assets [Line Items]    
Remaining Term (years) 3 years  
XML 86 R76.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES - Narrative (Details)
 3 Months Ended
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
option
Other Commitments [Line Items]      
Proceeds from legal settlements | $ $ 750,000 $ 750,000  
Minimum      
Other Commitments [Line Items]      
Charitable contribution obligation, percentage of net royalty revenue     0.01
Charitable contribution obligation, net royalty revenue threshold | $     $ 100,000,000
Maximum      
Other Commitments [Line Items]      
Charitable contribution obligation, percentage of net royalty revenue     0.02
Charitable contribution obligation, net royalty revenue threshold | $     $ 1,000,000,000
Roseville, Minnesota lease      
Other Commitments [Line Items]      
Number of renewal options     4
Renewal term     5 years
San Diego, California laboratory lease      
Other Commitments [Line Items]      
Number of renewal options     1
Renewal term     1 year
Greenhouse Lease      
Other Commitments [Line Items]      
Number of renewal options     1
Renewal term     5 years
Warehouse Lease      
Other Commitments [Line Items]      
Number of renewal options     1
Renewal term     5 years
XML 87 R77.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Lease Cost (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]        
Finance lease costs $ 65 $ 57 $ 79 $ 73
Operating lease costs 1,635 381 2,830 1,174
Total $ 1,700 $ 438 $ 2,909 $ 1,247
XML 88 R78.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Other Information Related to Leases (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]        
Operating cash flows (operating leases) $ 1,297 $ 70 $ 1,848 $ 205
Financing cash flows (finance leases) $ 132 $ 163 $ 242 $ 353
XML 89 R79.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES - Supplemental Balance Sheet Information Related to Leases (Details)
Sep. 30, 2023
Dec. 31, 2022
Operating    
Weighted average remaining lease term (years) 10 years 6 months 15 years 3 months 18 days
Weighted average discount rate 7.50% 7.90%
Financing    
Weighted average remaining lease term (years) 1 year 4 months 24 days 4 months 24 days
Weighted average discount rate 9.50% 8.10%
XML 90 R80.htm IDEA: XBRL DOCUMENT v3.23.3
LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Operating    
Remainder of 2023 $ 1,758  
2024 7,132  
2025 4,797  
2026 1,993  
2027 1,920  
2028 1,863  
Thereafter 15,438  
Operating lease, liability, to be paid 34,901  
Less: interest (10,621)  
Total 24,280  
Current portion 5,436 $ 367
Noncurrent portion 18,844 13,447
Financing    
Remainder of 2023 40  
2024 210  
2025 120  
2026 0  
2027 0  
2028 0  
Thereafter 0  
Finance lease, liability, to be paid 370  
Less: interest (33)  
Total 337  
Current portion 235 97
Noncurrent portion 102 $ 0
Total    
Remainder of 2023 1,798  
2024 7,342  
2025 4,917  
2026 1,993  
2027 1,920  
2028 1,863  
Thereafter 15,438  
Operating and finance lease, liability, to be paid 35,271  
Less: interest (10,654)  
Total 24,617  
Current portion 5,671  
Noncurrent portion $ 18,946  
XML 91 R81.htm IDEA: XBRL DOCUMENT v3.23.3
ROYALTY LIABILITY - RELATED PARTIES - Narrative (Details) - Management
 9 Months Ended
Sep. 30, 2023
USD ($)
Warrant Exchange Agreement  
Related Party Transaction [Line Items]  
Royalty payment, percentage of subject revenues 10.00%
Subject revenue threshold, minimum $ 50,000,000
Term of agreement 30 years
Renewal term 30 years
Required payment to extend agreement $ 100
Measurement Input, Discount Rate  
Related Party Transaction [Line Items]  
Royalty liability, measurement input 0.237
XML 92 R82.htm IDEA: XBRL DOCUMENT v3.23.3
ROYALTY LIABILITY - RELATED PARTIES - Schedule of Royalty Liability (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Accrued Royalties [Roll Forward]        
Beginning balance     $ 0  
Interest expense recognized $ 8,136 $ 0 10,753 $ 0
Ending balance 157,113   157,113  
Management        
Accrued Royalties [Roll Forward]        
Beginning balance     0  
Acquired from merger with Cibus Global, LLC     146,360  
Interest expense recognized     10,753  
Ending balance $ 157,113   $ 157,113  
XML 93 R83.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL INFORMATION - Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Accrued Expenses:    
Accrued consulting and professional fees $ 2,980 $ 119
Accrued field trials 1,716 0
Other 396 54
Total $ 5,092 $ 173
XML 94 R84.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL INFORMATION - Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Stock-based compensation expense:        
Total $ 5,828 $ 1,035 $ 11,670 $ 2,890
Research and development        
Stock-based compensation expense:        
Total 2,853 210 5,531 620
Selling, general, and administrative        
Stock-based compensation expense:        
Total $ 2,975 $ 825 $ 6,139 $ 2,270
XML 95 R85.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL INFORMATION - Supplemental Cash Flows Information (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Condensed Cash Flow Statements, Captions [Line Items]            
Interest paid $ 98 $ 67        
Non-cash transactions not reported in the consolidated statement of cash flows            
Receivable from Jefferies for shares issued under ATM facility 0 (260)        
Property, plant, and equipment acquired through assuming liabilities 419 (687)        
Shares issued for consideration in the merger with Cibus Global 634,751 0        
Forgiveness of interim funding resulting from merger with Cibus Global 2,500 0        
Cumulative effect of adoption of lease accounting standard on stockholders’ equity 463,390 8,844 $ 484,313 $ 7,233 $ 13,759 $ 14,132
Establishment of financing lease right-of-use assets and associated operating lease liabilities 307 0        
Establishment of operating lease right-of-use assets and associated operating lease liabilities $ 1,606 14,090        
Cumulative Effect, Period of Adoption, Adjustment            
Non-cash transactions not reported in the consolidated statement of cash flows            
Cumulative effect of adoption of lease accounting standard on stockholders’ equity   $ 832       $ 832
XML 96 R86.htm IDEA: XBRL DOCUMENT v3.23.3
INTERIM FUNDING (Details) - USD ($)
 3 Months Ended
May 30, 2023
Sep. 30, 2023
May 31, 2023
Mar. 15, 2023
Line of Credit Facility [Line Items]        
Outstanding debt balance   $ 1,794,000    
Cibus Global | Revolving Credit Facility | Interim Funding Agreement | Unsecured Debt | Affiliated Entity        
Line of Credit Facility [Line Items]        
Unrestricted cash balance threshold       $ 1,500,000
Maximum borrowing capacity       3,000,000
Maximum borrowing increments       $ 500,000
Aggregate funds received $ 2,500,000      
Outstanding debt balance     $ 0  
XML 97 R87.htm IDEA: XBRL DOCUMENT v3.23.3
COLLABORATION AGREEMENT (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Deferred revenue for upfront payments $ 1,637   $ 1,637   $ 107
Revenue from collaboration agreement $ 475 $ 42 714 $ 115  
Proctor & Gamble          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue from collaboration agreement     $ 400    
XML 98 R88.htm IDEA: XBRL DOCUMENT v3.23.3
RELATED-PARTY TRANSACTIONS (Details) - Cellectis - Related Party - Lease Guarantee - USD ($)
 1 Months Ended
Oct. 31, 2022
Sep. 30, 2023
Related Party Transaction [Line Items]    
Threshold amount in which the lease will terminate at the end of the second consecutive calendar year in which the Company’s tangible net worth exceeds   $ 300,000,000
Threshold percentage of minimum ownership in outstanding common stock to enact indemnification agreement 50.00%  
XML 99 R89.htm IDEA: XBRL DOCUMENT v3.23.3
SUBSEQUENT EVENTS (Details)
 2 Months Ended
Mar. 01, 2024
USD ($)
Dec. 31, 2023
USD ($)
Oct. 20, 2023
USD ($)
Oct. 18, 2023
USD ($)
employee
Oct. 17, 2023
employee
Line of Credit | Binding Term Sheet | Forecast          
Subsequent Event [Line Items]          
Line of credit, incremental draw amount $ 1,000,000.0        
Line of credit, financing threshold for termination   $ 20,000,000.0      
Subsequent Event | Employee Severance          
Subsequent Event [Line Items]          
Number of full time employees | employee       185 242
Restructuring cost, expected amount       $ 500,000  
Subsequent Event | Line of Credit | Binding Term Sheet          
Subsequent Event [Line Items]          
Maximum borrowing capacity     $ 5,000,000.0    
Debt instrument, interest rate     12.00%    
XML 100 R9999.htm IDEA: XBRL DOCUMENT v3.23.3
Label Element Value
Accounting Standards Update [Extensible Enumeration] us-gaap_AccountingStandardsUpdateExtensibleList Accounting Standards Update 2016-02 [Member]
XML 101 cbus-20230930_htm.xml IDEA: XBRL DOCUMENT 0001705843 2023-01-01 2023-09-30 0001705843 us-gaap:CommonClassAMember 2023-11-08 0001705843 us-gaap:CommonClassBMember 2023-11-08 0001705843 2023-09-30 0001705843 2022-12-31 0001705843 us-gaap:RelatedPartyMember 2023-09-30 0001705843 us-gaap:RelatedPartyMember 2022-12-31 0001705843 us-gaap:NonrelatedPartyMember 2023-09-30 0001705843 us-gaap:NonrelatedPartyMember 2022-12-31 0001705843 us-gaap:CommonClassAMember 2022-12-31 0001705843 us-gaap:CommonClassAMember 2023-09-30 0001705843 us-gaap:CommonClassBMember 2023-09-30 0001705843 us-gaap:CommonClassBMember 2022-12-31 0001705843 2023-07-01 2023-09-30 0001705843 2022-07-01 2022-09-30 0001705843 2022-01-01 2022-09-30 0001705843 2023-06-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-06-30 0001705843 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001705843 us-gaap:TreasuryStockCommonMember 2023-06-30 0001705843 us-gaap:RetainedEarningsMember 2023-06-30 0001705843 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001705843 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001705843 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-09-30 0001705843 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001705843 us-gaap:TreasuryStockCommonMember 2023-09-30 0001705843 us-gaap:RetainedEarningsMember 2023-09-30 0001705843 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001705843 us-gaap:TreasuryStockCommonMember 2022-06-30 0001705843 us-gaap:RetainedEarningsMember 2022-06-30 0001705843 2022-06-30 0001705843 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001705843 us-gaap:TreasuryStockCommonMember 2022-09-30 0001705843 us-gaap:RetainedEarningsMember 2022-09-30 0001705843 2022-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001705843 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001705843 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001705843 us-gaap:TreasuryStockCommonMember 2022-12-31 0001705843 us-gaap:RetainedEarningsMember 2022-12-31 0001705843 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001705843 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001705843 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001705843 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0001705843 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001705843 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001705843 us-gaap:TreasuryStockCommonMember 2021-12-31 0001705843 us-gaap:RetainedEarningsMember 2021-12-31 0001705843 2021-12-31 0001705843 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember cbus:AtTheMarketOfferingMember 2022-01-01 2022-09-30 0001705843 cbus:AtTheMarketOfferingMember 2022-01-01 2022-09-30 0001705843 us-gaap:CommonClassAMember us-gaap:CommonStockMember cbus:FollowOnPublicOfferingMember 2022-01-01 2022-09-30 0001705843 us-gaap:AdditionalPaidInCapitalMember cbus:FollowOnPublicOfferingMember 2022-01-01 2022-09-30 0001705843 cbus:FollowOnPublicOfferingMember 2022-01-01 2022-09-30 0001705843 2021-01-01 2021-12-31 0001705843 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2021-12-31 0001705843 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001705843 2023-05-31 0001705843 us-gaap:CommonClassAMember 2023-05-31 0001705843 us-gaap:CommonClassBMember 2023-05-31 0001705843 cbus:CalyxtIncMember 2023-05-30 0001705843 us-gaap:CommonClassAMember 2023-05-31 2023-05-31 0001705843 cbus:RestrictedCommonClassAMember 2023-05-31 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:CommonClassBMember 2023-05-31 2023-05-31 0001705843 cbus:CalyxtIncMember 2023-05-31 0001705843 cbus:CibusGlobalMember 2023-05-31 0001705843 srt:MinimumMember 2023-09-30 0001705843 srt:MaximumMember 2023-09-30 0001705843 cbus:CommonWarrantsMember 2023-01-01 2023-09-30 0001705843 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001705843 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001705843 us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0001705843 us-gaap:PerformanceSharesMember 2022-01-01 2022-09-30 0001705843 us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0001705843 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001705843 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001705843 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001705843 cbus:PreFundedWarrantsMember 2022-02-23 0001705843 cbus:CommonWarrantsMember 2022-02-23 0001705843 2023-09-30 2023-09-30 0001705843 cbus:CalyxtIncMember 2023-04-24 2023-04-24 0001705843 2023-05-31 2023-05-31 0001705843 cbus:CibusGlobalMember 2023-05-31 2023-05-31 0001705843 cbus:CibusGlobalMember 2023-05-31 0001705843 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-09-30 2023-09-30 0001705843 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-05-31 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:CommonClassAMember 2023-05-31 2023-05-31 0001705843 us-gaap:RestrictedStockMember cbus:CibusGlobalMember 2023-05-31 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:RelatedPartyMember 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:NonrelatedPartyMember 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:InProcessResearchAndDevelopmentMember 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:DevelopedTechnologyRightsMember 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:DevelopedTechnologyRightsMember 2023-05-31 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:TradeNamesMember 2023-05-31 0001705843 cbus:CibusGlobalMember us-gaap:TradeNamesMember 2023-05-31 2023-05-31 0001705843 cbus:CibusGlobalMember 2022-01-01 2023-09-30 0001705843 cbus:CibusGlobalMember 2022-01-01 2022-12-31 0001705843 cbus:CibusGlobalMember 2023-01-01 2023-09-30 0001705843 cbus:CibusGlobalMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001705843 cbus:CibusGlobalMember us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-09-30 0001705843 cbus:CibusGlobalMember 2023-07-01 2023-09-30 0001705843 cbus:CibusGlobalMember 2022-07-01 2022-09-30 0001705843 cbus:CibusGlobalMember 2022-01-01 2022-09-30 0001705843 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001705843 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2023-09-30 0001705843 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0001705843 us-gaap:MoneyMarketFundsMember 2023-09-30 0001705843 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001705843 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001705843 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001705843 us-gaap:MoneyMarketFundsMember 2022-12-31 0001705843 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001705843 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001705843 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001705843 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001705843 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001705843 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001705843 us-gaap:FairValueInputsLevel1Member cbus:CommonWarrantsMember 2023-09-30 0001705843 us-gaap:FairValueInputsLevel2Member cbus:CommonWarrantsMember 2023-09-30 0001705843 us-gaap:FairValueInputsLevel3Member cbus:CommonWarrantsMember 2023-09-30 0001705843 cbus:CommonWarrantsMember 2023-09-30 0001705843 us-gaap:FairValueInputsLevel1Member cbus:CommonWarrantsMember 2022-12-31 0001705843 us-gaap:FairValueInputsLevel2Member cbus:CommonWarrantsMember 2022-12-31 0001705843 us-gaap:FairValueInputsLevel3Member cbus:CommonWarrantsMember 2022-12-31 0001705843 cbus:CommonWarrantsMember 2022-12-31 0001705843 cbus:CommonWarrantsMember 2023-01-01 2023-09-30 0001705843 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001705843 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001705843 us-gaap:MeasurementInputOptionVolatilityMember 2023-09-30 0001705843 us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001705843 us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001705843 us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001705843 srt:MinimumMember us-gaap:BuildingMember 2023-09-30 0001705843 srt:MaximumMember us-gaap:BuildingMember 2023-09-30 0001705843 us-gaap:BuildingMember 2023-09-30 0001705843 us-gaap:BuildingMember 2022-12-31 0001705843 us-gaap:LeaseholdImprovementsMember 2023-09-30 0001705843 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001705843 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-09-30 0001705843 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-09-30 0001705843 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001705843 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001705843 srt:MinimumMember cbus:ComputerEquipmentAndSoftwareMember 2023-09-30 0001705843 srt:MaximumMember cbus:ComputerEquipmentAndSoftwareMember 2023-09-30 0001705843 cbus:ComputerEquipmentAndSoftwareMember 2023-09-30 0001705843 cbus:ComputerEquipmentAndSoftwareMember 2022-12-31 0001705843 us-gaap:ConstructionInProgressMember 2023-09-30 0001705843 us-gaap:ConstructionInProgressMember 2022-12-31 0001705843 cbus:MeasurementInputInflationRateMember 2023-09-30 0001705843 2023-05-30 0001705843 us-gaap:InProcessResearchAndDevelopmentMember 2023-09-30 0001705843 us-gaap:DevelopedTechnologyRightsMember 2023-09-30 0001705843 us-gaap:TradeNamesMember 2023-09-30 0001705843 us-gaap:OtherIntangibleAssetsMember 2023-09-30 0001705843 cbus:AnnualLicensesMember us-gaap:NotesPayableOtherPayablesMember 2023-01-01 2023-09-30 0001705843 cbus:AnnualLicensesMember us-gaap:NotesPayableOtherPayablesMember 2023-09-30 0001705843 srt:MinimumMember cbus:FinancedEquipmentMember us-gaap:NotesPayableOtherPayablesMember 2023-09-30 0001705843 srt:MaximumMember cbus:FinancedEquipmentMember us-gaap:NotesPayableOtherPayablesMember 2023-09-30 0001705843 cbus:FinancedEquipmentMember us-gaap:NotesPayableOtherPayablesMember 2023-01-01 2023-09-30 0001705843 cbus:InsuranceNotesMember us-gaap:NotesPayableOtherPayablesMember 2023-09-30 0001705843 cbus:InsuranceNotesMember us-gaap:NotesPayableOtherPayablesMember 2023-01-01 2023-09-30 0001705843 cbus:AnnualLicensesMember 2023-09-30 0001705843 cbus:FinancedEquipmentMember 2023-09-30 0001705843 cbus:InsuranceNotesMember 2023-09-30 0001705843 us-gaap:CommonClassAMember cbus:FollowOnPublicOfferingMember 2022-02-23 2022-02-23 0001705843 cbus:PreFundedWarrantsMember cbus:FollowOnPublicOfferingMember 2022-02-23 0001705843 cbus:CommonWarrantsMember cbus:FollowOnPublicOfferingMember 2022-02-23 0001705843 cbus:FollowOnPublicOfferingMember 2022-02-23 0001705843 cbus:FollowOnPublicOfferingMember 2022-02-23 2022-02-23 0001705843 cbus:CommonWarrantsMember 2022-12-31 0001705843 cbus:CommonWarrantsMember 2023-09-30 0001705843 cbus:AtTheMarketOfferingMember 2022-01-01 2022-12-31 0001705843 cbus:AtTheMarketOfferingMember 2023-01-01 2023-09-30 0001705843 cbus:CibusIncMember 2023-09-30 0001705843 cbus:ElectingMembersMember 2023-09-30 0001705843 cbus:TwoThousandSeventeenOmnibusPlanMember 2023-09-30 0001705843 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001705843 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001705843 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001705843 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001705843 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001705843 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001705843 2023-02-28 2023-02-28 0001705843 2023-03-01 2023-03-01 0001705843 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001705843 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001705843 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0001705843 srt:MinimumMember us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0001705843 srt:MaximumMember us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0001705843 us-gaap:RestrictedStockMember 2022-12-31 0001705843 us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0001705843 us-gaap:RestrictedStockMember 2023-09-30 0001705843 us-gaap:RestrictedStockMember 2023-07-01 2023-09-30 0001705843 us-gaap:RestrictedStockMember 2022-07-01 2022-09-30 0001705843 us-gaap:RestrictedStockMember 2022-01-01 2022-09-30 0001705843 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001705843 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001705843 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001705843 cbus:DeemedDividendsMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001705843 cbus:DeemedDividendsMember us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001705843 cbus:DeemedDividendsMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001705843 cbus:DeemedDividendsMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001705843 us-gaap:PerformanceSharesMember cbus:TwoThousandSeventeenOmnibusPlanMember 2023-05-24 2023-05-24 0001705843 srt:ExecutiveOfficerMember us-gaap:PerformanceSharesMember cbus:TwoThousandSeventeenOmnibusPlanMember 2023-05-24 2023-05-24 0001705843 us-gaap:PerformanceSharesMember cbus:TwoThousandSeventeenOmnibusPlanMember 2022-03-01 2022-03-31 0001705843 srt:ExecutiveOfficerMember us-gaap:PerformanceSharesMember cbus:TwoThousandSeventeenOmnibusPlanMember 2022-03-01 2022-03-31 0001705843 us-gaap:PerformanceSharesMember cbus:TwoThousandSeventeenOmnibusPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-03-01 2022-03-01 0001705843 us-gaap:PerformanceSharesMember cbus:TwoThousandSeventeenOmnibusPlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-05-31 2023-05-31 0001705843 us-gaap:PerformanceSharesMember cbus:InducementPlanMember 2021-07-01 2021-07-31 0001705843 us-gaap:PerformanceSharesMember cbus:InducementPlanMember 2023-05-31 2023-05-31 0001705843 us-gaap:PerformanceSharesMember 2022-06-01 2022-06-30 0001705843 us-gaap:PerformanceSharesMember 2022-12-31 0001705843 us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0001705843 us-gaap:PerformanceSharesMember 2023-09-30 0001705843 us-gaap:PerformanceSharesMember 2023-07-01 2023-09-30 0001705843 us-gaap:PerformanceSharesMember 2022-07-01 2022-09-30 0001705843 us-gaap:PerformanceSharesMember 2022-01-01 2022-09-30 0001705843 cbus:RosevilleMnLeaseMember 2023-09-30 0001705843 cbus:RosevilleMnLeaseMember 2022-12-31 0001705843 cbus:SanDiegoCaliforniaLaboratoryLeaseMember 2023-09-30 0001705843 cbus:SanDiegoCaliforniaLaboratoryLeaseMember 2022-12-31 0001705843 cbus:SanDiegoCaliforniaHeadquartersLeaseMember 2023-09-30 0001705843 cbus:SanDiegoCaliforniaHeadquartersLeaseMember 2022-12-31 0001705843 cbus:SanDiegoCaliforniaGreenhouseLeaseMember 2023-09-30 0001705843 cbus:SanDiegoCaliforniaGreenhouseLeaseMember 2022-12-31 0001705843 cbus:OtherLeasesMember 2022-12-31 0001705843 srt:MinimumMember cbus:OtherLeasesMember 2023-09-30 0001705843 srt:MaximumMember cbus:OtherLeasesMember 2023-09-30 0001705843 cbus:OtherLeasesMember 2023-09-30 0001705843 cbus:GreenhouseLeaseMember 2023-09-30 0001705843 cbus:WarehouseLeaseMember 2023-09-30 0001705843 2022-10-01 2022-12-31 0001705843 2023-01-01 2023-03-31 0001705843 cbus:WarrantExchangeAgreementMember srt:ManagementMember 2023-01-01 2023-09-30 0001705843 cbus:WarrantExchangeAgreementMember srt:ManagementMember 2023-09-30 0001705843 us-gaap:MeasurementInputDiscountRateMember srt:ManagementMember 2023-09-30 0001705843 srt:ManagementMember 2022-12-31 0001705843 srt:ManagementMember 2023-01-01 2023-09-30 0001705843 srt:ManagementMember 2023-09-30 0001705843 us-gaap:ResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0001705843 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0001705843 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-09-30 0001705843 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-09-30 0001705843 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001705843 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0001705843 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001705843 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0001705843 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2022-09-30 0001705843 cbus:CibusGlobalMember us-gaap:RevolvingCreditFacilityMember cbus:InterimFundingAgreementMember us-gaap:UnsecuredDebtMember srt:AffiliatedEntityMember 2023-03-15 0001705843 cbus:CibusGlobalMember us-gaap:RevolvingCreditFacilityMember cbus:InterimFundingAgreementMember us-gaap:UnsecuredDebtMember srt:AffiliatedEntityMember 2023-03-15 2023-05-30 0001705843 cbus:CibusGlobalMember us-gaap:RevolvingCreditFacilityMember cbus:InterimFundingAgreementMember us-gaap:UnsecuredDebtMember srt:AffiliatedEntityMember 2023-05-31 0001705843 cbus:ProctorGambleMember 2023-01-01 2023-09-30 0001705843 cbus:CellectisMember cbus:LeaseGuaranteeMember us-gaap:RelatedPartyMember 2023-09-30 0001705843 cbus:CellectisMember cbus:LeaseGuaranteeMember us-gaap:RelatedPartyMember 2022-10-01 2022-10-31 0001705843 us-gaap:EmployeeSeveranceMember us-gaap:SubsequentEventMember 2023-10-17 0001705843 us-gaap:EmployeeSeveranceMember us-gaap:SubsequentEventMember 2023-10-18 0001705843 us-gaap:LineOfCreditMember cbus:BindingTermSheetMember us-gaap:SubsequentEventMember 2023-10-20 0001705843 srt:ScenarioForecastMember us-gaap:LineOfCreditMember cbus:BindingTermSheetMember 2024-01-01 2024-03-01 0001705843 srt:ScenarioForecastMember us-gaap:LineOfCreditMember cbus:BindingTermSheetMember 2023-10-21 2023-12-31 shares iso4217:USD iso4217:USD shares cbus:class_of_stock pure cbus:reporting_unit cbus:segment utr:Y cbus:employee cbus:option 0001705843 --12-31 2023 Q3 false http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member P3Y 0.1 0.2 P3Y P3Y P3Y P30D 10-Q true 2023-09-30 false 001-38161 Cibus, Inc. DE 27-1967997 6455 Nancy Ridge Drive San Diego CA 92121 (858) 450-0008 Class A Common Stock, $0.0001 par value per share CBUS NASDAQ Yes Yes Non-accelerated Filer true false false 16699948 4642636 31883000 3427000 0 99000 560000 0 2029000 606000 34472000 4132000 17197000 4516000 22935000 13615000 134921000 158000 585266000 0 1444000 0 796235000 22421000 6281000 340000 5092000 173000 3704000 107000 0 175000 1637000 107000 1165000 0 235000 97000 5436000 367000 1512000 291000 17000 5000 25079000 1662000 629000 0 102000 0 18844000 13447000 157113000 0 1974000 79000 203741000 15188000 129104000 0 0.0001 0.0001 210000000 17656831 16659996 275000000 978915 976908 8000 5000 0.0001 0.0001 90000000 4642636 4642636 0 0 0 0 0 727821000 220422000 32660 2007 1785000 1043000 -262664000 -212151000 10000 0 463390000 7233000 796235000 22421000 475000 42000 714000 115000 475000 42000 714000 115000 17521000 3016000 28159000 9207000 8751000 3229000 22126000 9965000 26272000 6245000 50285000 19172000 -25797000 -6203000 -49571000 -19057000 8136000 0 10753000 0 281000 -47000 359000 -80000 -876000 300000 -466000 5083000 -34528000 -5950000 -60431000 -14054000 0 0 0 0 -34528000 -5950000 -60431000 -14054000 -8099000 0 -9918000 0 -26429000 -5950000 -50513000 -14054000 -1.59 -1.59 -6.36 -6.36 -6.33 -6.33 -15.56 -15.56 16641127 16641127 935702 935702 7979132 7979132 903476 903476 -34528000 -5950000 -60431000 -14054000 15000 0 13000 0 -34513000 -5950000 -60418000 -14054000 -8096000 0 -9915000 0 -26417000 -5950000 -50503000 -14054000 136866000 16606401 8000 4642636 0 722327000 -1785000 -236235000 -2000 484313000 -8099000 -26429000 -26429000 5828000 5828000 53608 13 334000 -334000 -334000 3000 12000 12000 129104000 16659996 8000 4642636 0 727821000 -1785000 -262664000 10000 463390000 934327 5000 218161000 -1043000 -203364000 13759000 -5950000 -5950000 1035000 1035000 1871 936198 5000 219196000 -1043000 -209314000 8844000 0 976908 5000 0 0 220422000 -1043000 -212151000 0 7233000 -9918000 -50513000 -50513000 11670000 11670000 15508202 3000 4642636 634748000 634751000 207546 32660 742000 742000 138685000 138685000 138685000 334000 -334000 -334000 3000 10000 10000 129104000 16659996 8000 4642636 0 727821000 -1785000 -262664000 10000 463390000 775480 4000 211263000 -1043000 -196092000 14132000 -14054000 -14054000 2890000 2890000 5518 -7000 -7000 500000 77600 1000 5050000 5051000 77600 832000 832000 936198 5000 219196000 -1043000 -209314000 8844000 -60431000 -14054000 10753000 0 2875000 1158000 11670000 2890000 1221000 -5009000 17000 0 -1674000 0 -95000 -34000 -1111000 -297000 -61000 -188000 1357000 41000 738000 -166000 340000 -115000 -28000 154000 334000 575000 -29193000 -15601000 59381000 0 3872000 1509000 55509000 -1509000 0 11209000 0 962000 2500000 0 742000 0 1287000 0 242000 353000 760000 0 2043000 9894000 -2000 0 28357000 -7216000 3526000 14421000 31883000 7205000 BASIS OF PRESENTATION &amp; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements of Cibus, Inc. (Cibus or the Company) have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP or GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC) applicable to interim financial statements. In the Company’s opinion, the accompanying condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of its statements of financial position, results of operations, and cash flows for the periods presented but they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Except as otherwise disclosed herein, these adjustments consist of normal recurring items. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole or any other interim period.<br/><br/>For further information, refer to the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, as amended by the Company’s Form 10-K/A for the year ended December 31, 2022, filed with the SEC on March 2, 2023, and March</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3, 2023, respectively (collectively, the Annual Report). The accompanying condensed consolidated balance sheets as of December 31, 2022, was derived from the audited consolidated financial statements. This Quarterly Report on Form 10-Q should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Annual Report.<br/><br/></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Description of Business<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cibus, Inc. (formerly Calyxt, Inc.) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">completed the Merger Transactions (as defined below under “—Merger Transactions”) on May 31, 2023, with Cibus Global, LLC (Cibus Global), and the Company carries on its business through Cibus Global and its subsidiaries. Cibus is the sole managing member of Cibus Global and, as sole managing member, the Company operates and controls all of the business and affairs of Cibus Global. As a result, the Company consolidates the financial results of Cibus Global and its subsidiaries and reports redeemable noncontrolling interest representing the economic interest in Cibus Global held by the other members of Cibus Global.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cibus Global, a Delaware limited liability company, was formed on May 10, 2019. Immediately prior to the effective date of this formation, Cibus Global was organized as a British Virgin Islands company (Cibus Global, Ltd.), which was formed on November 5, 2001. On May 10, 2019, Cibus Global was converted to be a Delaware limited liability company.</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Cibus Global is a plant trait company using gene editing technologies to develop and license gene edited plant traits that improve farming productivity or produce renewable low carbon plant products.<br/><br/></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Completion of Merger Transactions</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/>On May 31, 2023, the Company completed the business combination transactions contemplated by the Agreement and Plan of Merger, dated as of January 13, 2023, as amended by the First Amendment thereto dated as of April 14, 2023 (as amended, the Merger Agreement, and the transactions contemplated thereby, the Merger Transactions), by and among Legacy Calyxt; Calypso Merger Subsidiary, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company; Cibus Global, LLC (Cibus Global); and certain blocker entities party thereto. Among other things, as part of the Merger Transactions, the Company’s amended and restated certificate of incorporation was further amended and restated (the Amended Certificate of Incorporation). The Company is organized in an “Up-C” structure, and the Company’s only material asset consists of membership units of Cibus Global.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Amended Certificate of Incorporation designated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">two</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> classes of the Company’s common stock: (i) Class A Common Stock, par value $0.0001 per share (the Class A Common Stock), which shares have full voting and economic rights, and (ii) Class B Common Stock, par value $0.0001 per share (the Class B Common Stock), which shares have full voting, but no economic rights. Each share of Legacy Calyxt’s common stock, par value $0.0001 per share (Legacy Common Stock) existing and outstanding immediately prior to the Merger Transactions remained outstanding as a share of Class A Common Stock without any conversion or exchange thereof.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At the closing of the Merger Transactions, the Company contributed all of its assets and liabilities to Cibus Global, in exchange for Common Units. The Company issued an aggregate of 16,527,484 shares of Class A Common Stock (including 1,019,282 shares of restricted Class A Common Stock) and 4,642,636 shares of Class B Common Stock to Cibus Global equityholders, as consideration in the Merger Transactions, pursuant to the terms of the Merger Agreement. Upon closing, Legacy Calyxt stockholders held approximately 4.8 percent of the issued and outstanding common stock of the Company and legacy holders of membership units of Cibus Global (including profits interest units and warrants) held approximately 95.2 percent of the issued and outstanding common stock of the Company.<br/><br/>The primary purpose of the merger was to bring together the technology platforms and facilities of two pioneering companies to create a leading agricultural technology company for the development of productivity traits and to consolidated significant patented agricultural gene editing technology.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Reverse Stock Splits<br/><br/></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prior to the Merger Transactions, Legacy Calyxt effected a one-for-ten reverse stock split (the First Reverse Stock Split) of the Legacy Common Stock, which became effective on April 24, 2023. The First Reverse Stock Split was reflected on the Nasdaq Capital Market </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">beginning with the opening of trading on April 25, 2023.<br/><br/>Immediately prior to the Merger Transactions, the Company effected a one-for-five reverse stock split (the Second Reverse Stock Split and, together with the First Reverse Stock Split, the Reverse Stock Splits) of the Legacy Common Stock, which became effective on May 31, 2023. The Second Reverse Stock Split was reflected on the Nasdaq Capital Market beginning with the opening of trading of the Class A Common Stock on June 1, 2023. <br/><br/>No fractional shares were issued in connection with the Reverse Stock Splits and instead, fractional shares were rounded up to the nearest whole share number. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The par value and authorized shares of Legacy Common Stock and preferred stock of the Company were not adjusted as a result of the Reverse Stock Splits.<br/><br/></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Pursuant to the Amended Certificate of Incorporation, following the consummation of the Merger Transactions, the Company is authorized to issue 310,000,000 shares, consisting of (i) 300,000,000 shares of common stock, par value $0.0001 per share, divided into (A) 210,000,000 shares of Class A Common Stock and (B) 90,000,000 shares of Class B Common Stock and (ii) 10,000,000 shares of preferred stock, par value $0.0001 per share. Unless otherwise noted, all share and per share amounts in this Quarterly Report on Form 10-Q have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Splits.<br/><br/>Share information related to the Company's common stock as of September 30, 2023, is as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Class A Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Class B Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Common Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Authorized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210,000,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">90,000,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">300,000,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,656,831</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,642,636</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,299,467</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,659,996</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,642,636</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,302,632</span></td></tr></table><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Class A Restricted Stock<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the Merger Transactions, the Company issued restricted shares of Class A Common Stock (Class A Restricted Stock), which remain subject to vesting conditions, to Cibus Global Members that held unvested profits interest units at the time of the consummation of the Merger Transactions. Shares of Class A Restricted Stock are considered to be legally issued and outstanding as of the date of grant, notwithstanding that the shares remain subject to risk of forfeiture if the vesting conditions for such shares are not met. For financial statement presentation purposes, Class A Restricted Stock is treated as issued, but will only be treated as outstanding after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from items presenting Class A Common Stock, including the calculation of net loss per share of Class A Common Stock.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Going Concern</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/>The Company has incurred losses since its inception. The Company’s net loss was $60.4 million and cash used for operating activities was $29.2 million for the nine months ended September 30, 2023. The Company’s primary source of liquidity is its cash and cash equivalents, with additional capital resources accessible, subject to market conditions and other factors, from the capital markets, including through offerings of common stock or other securities.<br/><br/>As of September 30, 2023, the Company had $31.9 million of cash and cash equivalents and $25.1 million of current liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">The Company anticipates that it will continue to generate losses for the next several years. Over the longer term and until the Company can generate cash flows sufficient to support its operating capital requirements, it expects to finance a portion of future cash needs through (i) cash on hand, (ii) commercialization activities, which may result in various types of revenue streams from future product development agreements and technology licenses, including upfront and milestone payments, annual license fees, and royalties, (iii) government or other third-party funding, (iv) public or private equity or debt financings, or (v) a combination of the foregoing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Management will need to raise additional capital to support its business plans to continue as a going concern within one year after the date that these financial statements are issued. Although the Company has implemented a strategic realignment, which has included headcount reductions, and has initiated cost reduction initiatives designed to preserve capital resources, if the Company is unable to raise additional capital in a sufficient amount or on acceptable terms, the Company may have to implement additional, more stringent cost reduction measures to manage liquidity, and the Company may have to significantly delay, scale back, or cease operations, in part or in full. If the Company raises additional funds through the issuance of additional debt or equity securities, including as part of a strategic alternative, it could result in substantial dilution to its existing stockholders and increased fixed payment obligations, and these securities may have rights senior to those of the Company’s shares of common stock. These factors raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date of issuance of these financial statements. Any of these events could significantly impact the Company’s business, financial condition, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The preparation of the Company’s condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company’s historical experience, knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions. Key estimates made by the Company include revenue recognition, useful lives and impairment of long-lived assets, valuation of equity-based awards and related equity-based compensation expense, valuation of intangible assets, valuation allowances on deferred tax assets, and the valuation of the Royalty Liability (defined below under "Royalty liability - Related Parties").</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Fair Value Measurements of Financial Instruments<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company follows Accounting Standards Codification (ASC) Topic 820, Fair Value Measurements and Disclosures, for financial assets and liabilities that are recognized or disclosed at fair value in these condensed consolidated financial statements on a recurring basis. Under ASC 820, fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts its business. ASC 820 clarifies fair value should be based on assumptions market participants would use when pricing the asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to observable unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). <br/><br/>The carrying amounts reflected in the accompanying condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate their fair value due to their short-term nature. Based on the borrowing rates currently available to the Company for notes payable with similar terms and consideration of default and credit risk, the carrying value of the notes payable approximates fair value, which is considered a Level 2 fair value measurement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>The Company considers all liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include cash in readily available checking and money market accounts. The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses with these financial institutions. As of September 30, 2023, the Company had cash balances deposited at major financial institutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>The Company’s restricted cash balances are cash and cash equivalents deposited in an amount equal to the future rent payments as required under the Company’s equipment lease facility. The Company may request the return of excess restricted cash collateral annually in December. The amount of the restricted cash balance as of December 31, 2022, was returned in March of 2023.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>Accounts receivable are recorded at the amounts billed relating to contracted research and development (R&amp;D) services provided. The Company makes judgments as to its ability to collect outstanding receivables and provides an allowance for receivables when collection is doubtful. Accounts receivable are written off when management believes that all efforts to collect the amounts outstanding have been exhausted. The allowance for credit losses is estimated by management based on evaluations of its historical bad debt, current collection experience, and estimate of remaining collectability. Bad debt expense is recorded as necessary to maintain an appropriate level of allowance for credit losses in selling, general, and administrative (SG&amp;A) expense in the accompanying condensed consolidated statements of operations. Accounts receivable is presented net of allowance for credit losses which was $0 as of September 30, 2023, and December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Property, Plant, and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>Property, plant, and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation of buildings, lab equipment, furniture, and computer equipment and software is recorded using the straight-line method over the estimated useful lives of the respective assets, ranging from <span style="-sec-ix-hidden:f-440">three</span> to twenty years. Amortization of leasehold improvements are recorded using a straight-line method over the lesser of the estimated useful lives of the improvements or the remaining life of the lease. Expenditures which substantially increase the useful life of an asset, are capitalized. Expenditures for repairs and maintenance are expensed as incurred. Assets in progress include the construction of lab equipment and software to be used in the Company’s facility. The assets will be placed in service when the construction is completed and will be amortized over the useful life of the asset.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Goodwill and Acquired Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Goodwill is calculated as the excess of the purchase consideration paid in a business combination over the fair value of the assets acquired less liabilities assumed. Goodwill is not amortized and is tested for impairment at least annually or when events and circumstances indicate that fair value of a reporting unit may be below its carrying value. The Company has one reporting unit. The </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Company first assesses qualitative factors to evaluate whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount or elects to bypass such assessment. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying value, or the Company elects to bypass the qualitative assessment, it performs a quantitative test by determining the fair value of the reporting unit. If the carrying value of the reporting unit exceeds the fair value, then an impairment loss is recognized for the difference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Acquired in process R&amp;D, developed technology, and trade names are related to the Merger Transactions. Acquired intangible assets are amortized on a straight-line basis over the estimated period over which the Company expects to realize economic value related to the intangible asset. In process R&amp;D is not amortized until it is determined to be ready for its intended use. The acquired in process R&amp;D will be tested for impairment annually, or more frequently, if an impairment indicator is identified. No impairment charges relating to acquired goodwill or indefinite lived intangible assets were recorded for the nine months ended September 30, 2023.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Leases<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company determines if an arrangement is or contains a lease at inception. For leases with a term greater than one year, lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company excludes short-term leases, if any, having initial terms of 12 months or less at lease commencement as an accounting policy election. In determining the net present value of lease payments, the Company uses its incremental borrowing rate, which represents an estimated rate of interest that the Company would have to pay to borrow equivalent funds on a collateralized basis, at the lease commencement date. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statements of operations. Variable lease payments primarily include common area maintenance, utilities, real estate taxes, insurance, and other operating costs that are passed on from the lessor in proportion to the space leased by the Company. The Company has elected the practical expedient to not separate between lease and non-lease components.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Asset Retirement Obligation<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company records an asset retirement obligation (ARO) for the estimated cost of removing constructed leasehold improvement assets and restoring the leased premises back to their original condition, at the time when the contractual obligations are incurred. The ARO represents the present value of the expected cost for the related restoration activities. The ARO assets and liabilities are recorded in property, plant, and equipment, net and other non-current liabilities, respectively, in the Company’s condensed consolidated balance sheets. The Company records accretion expense, which represents the increase in the ARO, over the remaining or operational life of the associated leasehold improvements. Accretion expense is recorded as R&amp;D expense in the condensed consolidated statements of operations using an accretion rate based on the credit adjusted risk-free interest rate. Changes resulting from revisions to the timing or amount of the original estimate of cash flows are recognized as an increase or a decrease in the asset retirement cost, or income when the asset retirement cost is depleted.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>The Company’s revenues represent amounts earned from collaboration agreements related to contract research. The Company recognizes revenues under Topic 606 Revenue from Contracts with Customers (Topic 606) when control of services is transferred to the Company’s customers in an amount that reflects the consideration the Company expects to receive from the Company’s customers in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing the revenue when the performance obligations have been satisfied. The Company recognizes revenue for satisfied performance obligations only when the Company determines there are no uncertainties regarding payment terms or transfer of control. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Collaboration Agreements Related to Contract Research</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>Performance obligations under collaboration arrangements include providing intellectual property licenses, performing R&amp;D consulting services, and providing other materials. To date, the Company has concluded that the licenses of intellectual property in its collaboration arrangements have not been distinct, as intellectual property has not been licensed without related R&amp;D support services. Under Topic 606, milestone fees are variable consideration that is initially constrained and included in the arrangement consideration only when it is probable that the milestones will be achieved. Arrangement consideration, including upfront fees, milestone fees, and fees for research services, is recognized over the period as services are provided using an input method to determine the amount to recognize each reporting period. The Company reviews the inputs each period, such as the Company’s level of effort expended, including the time the Company estimates it will take to complete the activities, or costs incurred relative to the total expected inputs to satisfy the performance obligation. Generally, input measures are labor hours expended or a time-based measure of progress towards the satisfaction of the performance obligation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Contract Liabilities<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company records contract liabilities when cash payments are received or due in advance of performance, primarily related to advances of upfront and milestone payments from contract research and collaboration agreements. Contract liabilities consist of deferred revenue on the accompanying condensed consolidated balance sheets. The Company expects to recognize the amounts included in deferred revenues within one year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>The following table represents the deferred revenue activity:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deferred Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">107 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquired from merger with Cibus Global, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consideration earned</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consideration received</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,637</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">For the three months ended September 30, 2023, $0.5 million of deferred revenue was recognized as revenue in the accompanying condensed consolidated statements of operations. For the nine months ended September 30, 2023, $0.1 million of the deferred revenue balance as of December 31, 2022, had been recognized as revenue in the accompanying condensed consolidated statements of operations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Selling, General, and Administrative Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>SG&amp;A expense consists primarily of employee-related expenses, such as salaries for its executive, business development, legal, intellectual property, information technology, finance, human resources, and other administrative functions. These costs include legal, professional, and consulting fees for external firms and contractors. All selling and marketing expenses, including advertising expenses and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization, are included in SG&amp;A expense in the accompanying condensed consolidated statements of operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/>Beginning in the second quarter of 2023, SG&amp;A expense includes costs related to its intellectual property portfolio and costs to write and support the research for filing patents. Historically, the Company expensed patent application costs and related legal costs for maintenance of such patents as incurred and such costs were included in R&amp;D expense in the accompanying condensed consolidated statements of operations.<br/><br/>In the nine months ended September 30, 2023, the Company recognized, during the second quarter of 2023, $0.4 million of deferred financing costs related to the liability classified common warrants (Common Warrants) in SG&amp;A expense in the accompanying condensed consolidated statements of operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Research and Development Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>R&amp;D costs are expensed as incurred in performing R&amp;D activities and include salaries, lab supplies, consultant fees, and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization.<br/><br/>Historically, the Company recognized its intellectual property portfolio and costs to write and support the research for filing patents as R&amp;D expense. Beginning in the second quarter of 2023, these expenses are included in SG&amp;A expense in the accompanying condensed consolidated statements of operations. The amounts in the prior reporting periods are not material and as such no historical amounts have been reclassified.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Royalty Liability – Related Parties<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In 2014, Cibus Global entered into the warrant exchange agreement (Warrant Exchange Agreement), which remains in place following the Company’s acquisition of Cibus Global in the Merger Transactions, Cibus Global is required to make ongoing quarterly payments equal to a portion of the aggregate amount of certain worldwide revenues received during the applicable quarter. The Company refers to such payment obligations as its Royalty Liability. Management estimates the total amount of royalty payments over the life of the Warrant Exchange Agreement that Cibus Global will be required to make to holders of certain warrants (Royalty Holders) that were exchanged for the rights to future royalty payments pursuant to the Warrant Exchange Agreement. The Royalty Liability is based on the Company’s current estimates of future royalties expected to be paid over the life of the arrangement. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. In order to determine the amortization of the Royalty Liability, the Company is required to estimate the total amount of future royalty payments to the Royalty Holders over the life of the Warrant Exchange Agreement. This estimate contains significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the royalty period. The Company will periodically assess the estimated royalty payments and to the extent the amount or timing of such payments is materially different than the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. See Note 11 for further details.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Non-Operating Income (Expenses)<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Non-operating income (expenses) are income or expenses that are not directly related to ongoing operations and are primarily comprised of gains and losses from the mark-to-market of Common Warrants to purchase Class A Common Stock and foreign exchange transactions.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net Loss Per Share of Class A Common Stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Weighted average shares of Class A Common Stock outstanding excludes unvested Class A Common Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from the calculation of net loss per share of Class A Common Stock.<br/><br/>For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding as inclusion of the common stock equivalent securities would be anti-dilutive.<br/><br/>The Company’s potential dilutive securities, which include Common Warrants, unvested performance stock units, unvested restricted stock units, unvested restricted stock awards, and options to purchase Class A Common Stock, have been excluded from the computation of diluted net loss per share of Class A Common Stock as the effect would be antidilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share of Class A Common Stock is the same. The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their anti-dilutive effect:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">109,551</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,936</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">198,199</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,210</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested performance stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,600</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">945,780</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,483</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,412,013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">323,229</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Warrants<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company issued pre-funded warrants (Pre-Funded Warrants) to purchase Class A Common Stock in a follow-on offering on February 23, 2022 (the Follow-On Offering). The Pre-Funded Warrants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">, which were each exercisable for one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">were exercised in full on May 4, 2022, and subsequently settled with the counterparty. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">While outstanding, the Pre-Funded Warrants were considered equity instruments and reported in stockholders’ equity in the Company’s condensed consolidated balance sheets, and the shares issuable upon exercise of the Pre-Funded Warrants were included in the determination of the Company’s net loss per share of Class A Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company also issued Common Warrants in the Follow-On Offering. The Common Warrants expire on August 23, 2027, and are each exercisable for one share of the Company’s Class A Common Stock for $69.04 per share</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">, after giving effect to the Reverse Stock Splits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. The Common Warrants have been classified as a liability because they include a put option election available to their holder that is contingently exercisable if the Company enters into a fundamental transaction (Fundamental Transaction). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Pursuant to the terms of the Common Warrants, a Fundamental Transaction occurs if (i) the Company, directly or indirectly, effects any merger or consolidation of the Company with or into another person in which the Company is not the surviving entity, (ii) the Company (and all of its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer is completed pursuant to which holders of the Company’s Class A Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50 percent or more of the outstanding Class A Common Stock of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization, or recapitalization of the Class A Common Stock or any compulsory share exchange pursuant to which the Class A Common Stock is effectively converted into or exchanged for other securities, cash, or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination with another person or group of persons whereby such other person or group acquires more than 50 percent of the voting power of the outstanding shares of Class A Common Stock (not including any shares of Class A Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business combination) (the Fundamental Change Put). If the Fundamental Change Put is exercised by the holder of a Common Warrant, holder may elect to receive either the consideration of the Fundamental Transaction or put the Common Warrants back to the Company in exchange for cash, based on terms and timing specified in the Common Warrant agreement. If the Fundamental Change Put option is exercised, the Company is required to pay cash to the holder in an amount as determined by the Black-Scholes pricing model, with assumptions determined in accordance with the terms of the Common Warrants. The Company believes that the Merger Transactions did not qualify as a Fundamental Transaction.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Common Warrants are reported at fair value with changes in fair value reported in earnings. The Company reports the changes in fair value of the Common Warrants in non-operating income (expenses) in its condensed consolidated statements of operations.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Employee Retention Credit<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prior to the Merger Transactions, Cibus Global qualified for federal government assistance through the Employee Retention Credit </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(ERC) provisions of the CARES Act passed in 2020, for the second, third, and fourth fiscal quarters of 2020, as well as the first and second fiscal quarters of 2021. The purpose of the ERC was to encourage employers to keep employees on the payroll, even if they were not working during the covered period because of the coronavirus outbreak. The Company recognizes amounts to be refundable as tax credits if there is a reasonable assurance of compliance with the grant conditions and receipt of credits. As of September 30, 2023, the Company recognized $0.2 million related to the employee retention credit, and it does not expect to receive any further credits.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Foreign Currency<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements are presented in United States dollars (USD) as the reporting currency. For those foreign subsidiaries where the Company has determined that the functional currency is the entity’s local currency, the assets and liabilities of such subsidiaries are translated into USD using exchange rates in effect at the balance sheet date. The revenue and expenses of such subsidiaries are translated into USD using average exchange rates in effect during the reporting period. Any translation adjustments are presented as accumulated other comprehensive income (loss), within stockholders' equity in the accompanying condensed consolidated statements of redeemable noncontrolling interest and stockholders' equity. Foreign currency transaction gains and losses are included in non-operating income (expenses) within the accompanying condensed consolidated statements of operations and were immaterial for all periods presented.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Segment Reporting<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Management has determined that the Company has one operating segment, R&amp;D of plant gene editing, which is consistent with the Company's structure and how it manages the business. Furthermore, the Company's Chief Operating Decision Maker, which is the Company's Chief Executive Officer, monitors and reviews financial information at a consolidated level for assessing operating results and the allocation of resources.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time-to-time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position, results of operations, or cash flows upon adoption.<br/><br/>In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU No. 2021-08 address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination. The amendments in ASU No. 2021-08 require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. Upon adoption, an acquirer should account for the related revenue contracts of the acquiree as if it has originated the contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">For public business entities, the amendments in ASU No. 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments in ASU No. 2021-08 should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company applied ASU No. 2021-08 to the Merger Transactions.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/><br/></span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements of Cibus, Inc. (Cibus or the Company) have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP or GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC) applicable to interim financial statements. In the Company’s opinion, the accompanying condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of its statements of financial position, results of operations, and cash flows for the periods presented but they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Except as otherwise disclosed herein, these adjustments consist of normal recurring items. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole or any other interim period.<br/><br/>For further information, refer to the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K, as amended by the Company’s Form 10-K/A for the year ended December 31, 2022, filed with the SEC on March 2, 2023, and March</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3, 2023, respectively (collectively, the Annual Report). The accompanying condensed consolidated balance sheets as of December 31, 2022, was derived from the audited consolidated financial statements. This Quarterly Report on Form 10-Q should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Annual Report.<br/><br/></span> 2 0.0001 0.0001 0.0001 16527484 1019282 4642636 0.048 0.952 310000000 300000000 0.0001 210000000 90000000 10000000 0.0001 Share information related to the Company's common stock as of September 30, 2023, is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Class A Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Class B Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Common Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Authorized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210,000,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">90,000,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">300,000,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,656,831</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,642,636</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,299,467</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,659,996</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,642,636</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,302,632</span></td></tr></table> 210000000 90000000 300000000 17656831 4642636 22299467 16659996 4642636 21302632 -60400000 -29200000 31900000 25100000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The preparation of the Company’s condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company’s historical experience, knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions. Key estimates made by the Company include revenue recognition, useful lives and impairment of long-lived assets, valuation of equity-based awards and related equity-based compensation expense, valuation of intangible assets, valuation allowances on deferred tax assets, and the valuation of the Royalty Liability (defined below under "Royalty liability - Related Parties").</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Fair Value Measurements of Financial Instruments<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company follows Accounting Standards Codification (ASC) Topic 820, Fair Value Measurements and Disclosures, for financial assets and liabilities that are recognized or disclosed at fair value in these condensed consolidated financial statements on a recurring basis. Under ASC 820, fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts its business. ASC 820 clarifies fair value should be based on assumptions market participants would use when pricing the asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to observable unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). <br/><br/>The carrying amounts reflected in the accompanying condensed consolidated balance sheets for cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate their fair value due to their short-term nature. Based on the borrowing rates currently available to the Company for notes payable with similar terms and consideration of default and credit risk, the carrying value of the notes payable approximates fair value, which is considered a Level 2 fair value measurement.</span> Cash and Cash EquivalentsThe Company considers all liquid investments purchased with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include cash in readily available checking and money market accounts. The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses with these financial institutions. Restricted CashThe Company’s restricted cash balances are cash and cash equivalents deposited in an amount equal to the future rent payments as required under the Company’s equipment lease facility. The Company may request the return of excess restricted cash collateral annually in December. Accounts ReceivableAccounts receivable are recorded at the amounts billed relating to contracted research and development (R&amp;D) services provided. The Company makes judgments as to its ability to collect outstanding receivables and provides an allowance for receivables when collection is doubtful. Accounts receivable are written off when management believes that all efforts to collect the amounts outstanding have been exhausted. The allowance for credit losses is estimated by management based on evaluations of its historical bad debt, current collection experience, and estimate of remaining collectability. Bad debt expense is recorded as necessary to maintain an appropriate level of allowance for credit losses in selling, general, and administrative (SG&amp;A) expense in the accompanying condensed consolidated statements of operations. Accounts receivable is presented net of allowance for credit losses 0 0 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Property, Plant, and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>Property, plant, and equipment are recorded at cost, less accumulated depreciation and amortization. Depreciation of buildings, lab equipment, furniture, and computer equipment and software is recorded using the straight-line method over the estimated useful lives of the respective assets, ranging from <span style="-sec-ix-hidden:f-440">three</span> to twenty years. Amortization of leasehold improvements are recorded using a straight-line method over the lesser of the estimated useful lives of the improvements or the remaining life of the lease. Expenditures which substantially increase the useful life of an asset, are capitalized. Expenditures for repairs and maintenance are expensed as incurred. Assets in progress include the construction of lab equipment and software to be used in the Company’s facility. The assets will be placed in service when the construction is completed and will be amortized over the useful life of the asset.<br/><br/></span> P20Y Goodwill and Acquired Intangible AssetsGoodwill is calculated as the excess of the purchase consideration paid in a business combination over the fair value of the assets acquired less liabilities assumed. Goodwill is not amortized and is tested for impairment at least annually or when events and circumstances indicate that fair value of a reporting unit may be below its carrying value. The Company has one reporting unit. The Company first assesses qualitative factors to evaluate whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount or elects to bypass such assessment. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying value, or the Company elects to bypass the qualitative assessment, it performs a quantitative test by determining the fair value of the reporting unit. If the carrying value of the reporting unit exceeds the fair value, then an impairment loss is recognized for the difference.Acquired in process R&amp;D, developed technology, and trade names are related to the Merger Transactions. Acquired intangible assets are amortized on a straight-line basis over the estimated period over which the Company expects to realize economic value related to the intangible asset. In process R&amp;D is not amortized until it is determined to be ready for its intended use. The acquired in process R&amp;D will be tested for impairment annually, or more frequently, if an impairment indicator is identified. 1 0 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Leases<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company determines if an arrangement is or contains a lease at inception. For leases with a term greater than one year, lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company excludes short-term leases, if any, having initial terms of 12 months or less at lease commencement as an accounting policy election. In determining the net present value of lease payments, the Company uses its incremental borrowing rate, which represents an estimated rate of interest that the Company would have to pay to borrow equivalent funds on a collateralized basis, at the lease commencement date. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the condensed consolidated statements of operations. Variable lease payments primarily include common area maintenance, utilities, real estate taxes, insurance, and other operating costs that are passed on from the lessor in proportion to the space leased by the Company. The Company has elected the practical expedient to not separate between lease and non-lease components.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Asset Retirement Obligation<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company records an asset retirement obligation (ARO) for the estimated cost of removing constructed leasehold improvement assets and restoring the leased premises back to their original condition, at the time when the contractual obligations are incurred. The ARO represents the present value of the expected cost for the related restoration activities. The ARO assets and liabilities are recorded in property, plant, and equipment, net and other non-current liabilities, respectively, in the Company’s condensed consolidated balance sheets. The Company records accretion expense, which represents the increase in the ARO, over the remaining or operational life of the associated leasehold improvements. Accretion expense is recorded as R&amp;D expense in the condensed consolidated statements of operations using an accretion rate based on the credit adjusted risk-free interest rate. Changes resulting from revisions to the timing or amount of the original estimate of cash flows are recognized as an increase or a decrease in the asset retirement cost, or income when the asset retirement cost is depleted.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>The Company’s revenues represent amounts earned from collaboration agreements related to contract research. The Company recognizes revenues under Topic 606 Revenue from Contracts with Customers (Topic 606) when control of services is transferred to the Company’s customers in an amount that reflects the consideration the Company expects to receive from the Company’s customers in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing the revenue when the performance obligations have been satisfied. The Company recognizes revenue for satisfied performance obligations only when the Company determines there are no uncertainties regarding payment terms or transfer of control. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Contract Liabilities<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company records contract liabilities when cash payments are received or due in advance of performance, primarily related to advances of upfront and milestone payments from contract research and collaboration agreements. Contract liabilities consist of deferred revenue on the accompanying condensed consolidated balance sheets. The Company expects to recognize the amounts included in deferred revenues within one year.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Collaboration Agreements Related to Contract Research</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/><br/>Performance obligations under collaboration arrangements include providing intellectual property licenses, performing R&amp;D consulting services, and providing other materials. To date, the Company has concluded that the licenses of intellectual property in its collaboration arrangements have not been distinct, as intellectual property has not been licensed without related R&amp;D support services. Under Topic 606, milestone fees are variable consideration that is initially constrained and included in the arrangement consideration only when it is probable that the milestones will be achieved. Arrangement consideration, including upfront fees, milestone fees, and fees for research services, is recognized over the period as services are provided using an input method to determine the amount to recognize each reporting period. The Company reviews the inputs each period, such as the Company’s level of effort expended, including the time the Company estimates it will take to complete the activities, or costs incurred relative to the total expected inputs to satisfy the performance obligation. Generally, input measures are labor hours expended or a time-based measure of progress towards the satisfaction of the performance obligation.</span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>The following table represents the deferred revenue activity:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deferred Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">107 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquired from merger with Cibus Global, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consideration earned</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consideration received</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,637</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 107000 1186000 714000 1058000 1637000 500000 100000 Selling, General, and Administrative ExpensesSG&amp;A expense consists primarily of employee-related expenses, such as salaries for its executive, business development, legal, intellectual property, information technology, finance, human resources, and other administrative functions. These costs include legal, professional, and consulting fees for external firms and contractors. All selling and marketing expenses, including advertising expenses and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization, are included in SG&amp;A expense in the accompanying condensed consolidated statements of operations.Beginning in the second quarter of 2023, SG&amp;A expense includes costs related to its intellectual property portfolio and costs to write and support the research for filing patents. Historically, the Company expensed patent application costs and related legal costs for maintenance of such patents as incurred and such costs were included in R&amp;D expense in the accompanying condensed consolidated statements of operations. 400000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Research and Development Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>R&amp;D costs are expensed as incurred in performing R&amp;D activities and include salaries, lab supplies, consultant fees, and allocated facility costs including rent, utilities, maintenance expenses, and depreciation and amortization.<br/><br/>Historically, the Company recognized its intellectual property portfolio and costs to write and support the research for filing patents as R&amp;D expense. Beginning in the second quarter of 2023, these expenses are included in SG&amp;A expense in the accompanying condensed consolidated statements of operations. The amounts in the prior reporting periods are not material and as such no historical amounts have been reclassified.</span></div> Royalty Liability – Related PartiesIn 2014, Cibus Global entered into the warrant exchange agreement (Warrant Exchange Agreement), which remains in place following the Company’s acquisition of Cibus Global in the Merger Transactions, Cibus Global is required to make ongoing quarterly payments equal to a portion of the aggregate amount of certain worldwide revenues received during the applicable quarter. The Company refers to such payment obligations as its Royalty Liability. Management estimates the total amount of royalty payments over the life of the Warrant Exchange Agreement that Cibus Global will be required to make to holders of certain warrants (Royalty Holders) that were exchanged for the rights to future royalty payments pursuant to the Warrant Exchange Agreement. The Royalty Liability is based on the Company’s current estimates of future royalties expected to be paid over the life of the arrangement. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. In order to determine the amortization of the Royalty Liability, the Company is required to estimate the total amount of future royalty payments to the Royalty Holders over the life of the Warrant Exchange Agreement. This estimate contains significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the royalty period. The Company will periodically assess the estimated royalty payments and to the extent the amount or timing of such payments is materially different than the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Non-Operating Income (Expenses)<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Non-operating income (expenses) are income or expenses that are not directly related to ongoing operations and are primarily comprised of gains and losses from the mark-to-market of Common Warrants to purchase Class A Common Stock and foreign exchange transactions.<br/><br/></span> Net Loss Per Share of Class A Common Stock Weighted average shares of Class A Common Stock outstanding excludes unvested Class A Common Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture. Accordingly, unvested shares of Class A Restricted Stock are excluded from the calculation of net loss per share of Class A Common Stock.<br/><br/>For all periods presented, there is no difference in the number of shares used to calculate basic and diluted shares outstanding as inclusion of the common stock equivalent securities would be anti-dilutive.<br/><br/>The Company’s potential dilutive securities, which include Common Warrants, unvested performance stock units, unvested restricted stock units, unvested restricted stock awards, and options to purchase Class A Common Stock, have been excluded from the computation of diluted net loss per share of Class A Common Stock as the effect would be antidilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share of Class A Common Stock is the same. The following potential dilutive securities, presented on an as converted basis, were excluded from the calculation of net loss per share of Class A Common Stock due to their anti-dilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock options outstanding</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">109,551</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,936</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">198,199</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,210</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested performance stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,600</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">945,780</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,483</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,412,013</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">323,229</span></td></tr></table> 109551 116936 198199 25210 0 22600 945780 0 158483 158483 1412013 323229 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Warrants<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company issued pre-funded warrants (Pre-Funded Warrants) to purchase Class A Common Stock in a follow-on offering on February 23, 2022 (the Follow-On Offering). The Pre-Funded Warrants</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">, which were each exercisable for one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">were exercised in full on May 4, 2022, and subsequently settled with the counterparty. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">While outstanding, the Pre-Funded Warrants were considered equity instruments and reported in stockholders’ equity in the Company’s condensed consolidated balance sheets, and the shares issuable upon exercise of the Pre-Funded Warrants were included in the determination of the Company’s net loss per share of Class A Common Stock.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company also issued Common Warrants in the Follow-On Offering. The Common Warrants expire on August 23, 2027, and are each exercisable for one share of the Company’s Class A Common Stock for $69.04 per share</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">, after giving effect to the Reverse Stock Splits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. The Common Warrants have been classified as a liability because they include a put option election available to their holder that is contingently exercisable if the Company enters into a fundamental transaction (Fundamental Transaction). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Pursuant to the terms of the Common Warrants, a Fundamental Transaction occurs if (i) the Company, directly or indirectly, effects any merger or consolidation of the Company with or into another person in which the Company is not the surviving entity, (ii) the Company (and all of its subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer is completed pursuant to which holders of the Company’s Class A Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50 percent or more of the outstanding Class A Common Stock of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization, or recapitalization of the Class A Common Stock or any compulsory share exchange pursuant to which the Class A Common Stock is effectively converted into or exchanged for other securities, cash, or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination with another person or group of persons whereby such other person or group acquires more than 50 percent of the voting power of the outstanding shares of Class A Common Stock (not including any shares of Class A Common Stock held by the other person or other persons making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business combination) (the Fundamental Change Put). If the Fundamental Change Put is exercised by the holder of a Common Warrant, holder may elect to receive either the consideration of the Fundamental Transaction or put the Common Warrants back to the Company in exchange for cash, based on terms and timing specified in the Common Warrant agreement. If the Fundamental Change Put option is exercised, the Company is required to pay cash to the holder in an amount as determined by the Black-Scholes pricing model, with assumptions determined in accordance with the terms of the Common Warrants. The Company believes that the Merger Transactions did not qualify as a Fundamental Transaction.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Common Warrants are reported at fair value with changes in fair value reported in earnings. The Company reports the changes in fair value of the Common Warrants in non-operating income (expenses) in its condensed consolidated statements of operations.<br/><br/></span> 1 0.0001 1 69.04 0.50 0.50 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Employee Retention Credit<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prior to the Merger Transactions, Cibus Global qualified for federal government assistance through the Employee Retention Credit </span>(ERC) provisions of the CARES Act passed in 2020, for the second, third, and fourth fiscal quarters of 2020, as well as the first and second fiscal quarters of 2021. The purpose of the ERC was to encourage employers to keep employees on the payroll, even if they were not working during the covered period because of the coronavirus outbreak. The Company recognizes amounts to be refundable as tax credits if there is a reasonable assurance of compliance with the grant conditions and receipt of credits. 200000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Foreign Currency<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements are presented in United States dollars (USD) as the reporting currency. For those foreign subsidiaries where the Company has determined that the functional currency is the entity’s local currency, the assets and liabilities of such subsidiaries are translated into USD using exchange rates in effect at the balance sheet date. The revenue and expenses of such subsidiaries are translated into USD using average exchange rates in effect during the reporting period. Any translation adjustments are presented as accumulated other comprehensive income (loss), within stockholders' equity in the accompanying condensed consolidated statements of redeemable noncontrolling interest and stockholders' equity. Foreign currency transaction gains and losses are included in non-operating income (expenses) within the accompanying condensed consolidated statements of operations and were immaterial for all periods presented.<br/><br/></span> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Segment Reporting<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Management has determined that the Company has one operating segment, R&amp;D of plant gene editing, which is consistent with the Company's structure and how it manages the business. Furthermore, the Company's Chief Operating Decision Maker, which is the Company's Chief Executive Officer, monitors and reviews financial information at a consolidated level for assessing operating results and the allocation of resources.</span> 1 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time-to-time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective are not expected to have a material impact on the Company’s financial position, results of operations, or cash flows upon adoption.<br/><br/>In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The amendments in ASU No. 2021-08 address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination. The amendments in ASU No. 2021-08 require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. Upon adoption, an acquirer should account for the related revenue contracts of the acquiree as if it has originated the contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">For public business entities, the amendments in ASU No. 2021-08 are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments in ASU No. 2021-08 should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company applied ASU No. 2021-08 to the Merger Transactions.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/><br/></span></div> MERGER WITH CIBUS GLOBALAs described in Note 1, on May 31, 2023, the Company completed the Merger Transactions.<span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Redeemable Noncontrolling Interest</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">All of the issued and outstanding Cibus Global membership units (Common Units) are held solely by the Company and certain members of Cibus Global who elected in connection with the Merger Transactions to receive units (Up-C Units), each consisting of one share of Class B Common Stock and one Common Unit at the closing of the Merger Transactions (Electing Members). The Up-C Units are generally exchangeable for shares of Class A Common Stock on a one-for-one basis, subject to certain restrictions. In accordance with ASC 810, Consolidation, Cibus Global is considered a Variable Interest Entity (VIE) with Cibus as its sole managing member and primary beneficiary. As such, Cibus consolidates Cibus Global, and the remaining Common Unit holders that hold economic interest directly in Cibus Global are presented as redeemable noncontrolling interest on the Company’s financial statements. There are no restrictions on the use of assets of Cibus Global. <br/><br/>Redeemable noncontrolling interest represents the portion of Cibus Global Common Units that are not owned directly by the Company. Redeemable noncontrolling interest is classified as temporary equity because the Common Units contained certain redemption features that were not solely within the control of the Company. As of both May 31, 2023, (the closing date of the Merger Transactions) and September 30, 2023, the Common Unit holders of the redeemable noncontrolling interest owned approximately 22 percent of Cibus Global. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Purchase Price<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The purchase price for Cibus Global was determined as follows:<br/></span><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,150,838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">634,751,397 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1) This share number represents the aggregate number of shares of Common Stock issued to Cibus Global members in the Merger Transactions and comprises: 15,508,202 shares of Class A Common Stock and 4,642,636 shares of Class B Common Stock. This share number excludes 1,019,282 shares of Class A Restricted Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(2) Reflects the purchase price per share of the Company's Class A Common Stock, which was the closing price of the Class A Common Stock on May 31, 2023, the closing date of the Merger Transactions.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Purchase Price Allocation<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The acquisition of Cibus Global was accounted for using the acquisition method, whereby all of the assets acquired and liabilities assumed were recognized at their fair value on the acquisition date, with any excess of the purchase price over the estimated fair value recorded as goodwill. The purchase price allocation is preliminary and subject to change, including completion of the Company's analysis on the deferred tax impact of the acquisition. <br/><br/>Identifiable assets acquired, liabilities assumed, and noncontrolling interest, if applicable, are recorded at their estimated fair values at the acquisition date. Significant judgment is required in determining the acquisition date fair value of the assets acquired and liabilities assumed, predominantly with respect to property, plant, and equipment and intangible assets. Evaluations included numerous inputs, including forecasted cash flows that incorporate the specific attributes of each asset. For property, plant, and equipment, the Company considered the remaining useful life of equipment, current replacement costs for similar assets, and comparable market transactions. The Company evaluated all available information, as well as all appropriate methodologies, when determining the fair value of assets acquired, liabilities assumed, and noncontrolling interest. In addition, the Company determined the remaining useful life for property, plant, and equipment and the amortization period and method of amortization for each finite-lived intangible asset. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The following table sets forth the preliminary allocation of the consideration:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">May 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59,381 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due from related parties, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,588 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use-assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">585,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to related parties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of notes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of operating lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of financing lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notes payable, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease obligations, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financing lease obligations, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Royalty liability - related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(146,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consideration transferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">634,751 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Receivables have been recognized at their fair value, and the Company has not recognized, and it does not expect, any credit losses and therefore expects cash flows to match the recognized receivables.<br/></span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Intangible Assets Acquired<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Intangible assets acquired, and their related estimated average useful lives, are as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"><br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">May 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Estimated Average Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135,429 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The weighted average amortization period for the Company's definite lived intangible assets, including developed technology and trade names, was 20 years.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company incurred expenses of approximately $8.2 million in connection with the completion of the Merger Transactions, of which approximately $0.4 million was recognized in 2022 in the condensed consolidated statements of operations. For the nine months ended September 30, 2023, approximately $3.5 million in legal and professional fees, $1.9 million in severance costs resulting from pre-existing employment agreements, and $1.1 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, were included in SG&amp;A expense in the condensed consolidated statements of operations. Additionally, for the nine months ended September 30, 2023, approximately $1.3 million in stock compensation expense from accelerated share vesting per the individual stock award agreements, was included in R&amp;D expense in the condensed consolidated statements of operations.<br/><br/>The Company's condensed consolidated statements of operations are inclusive of activity relating to the acquired entity, Cibus Global, from the date of acquisition and include $0.7 million in revenue, $35.5 million in net loss attributable to controlling interest, and $9.9 million in net loss attributable to redeemable noncontrolling interest, for the nine months ended September 30, 2023.<br/><br/>These unaudited pro forma figures have been prepared as though the business combination had occurred on January 1, 2022. Pro forma adjustments have been made to reflect non-recurring stock compensation expense, legal and professional fees, severance costs, and amortization of acquired intangible assets, directly attributable to the business combination. </span><span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The unaudited pro forma condensed financial information is not indicative of the results of operations that would have been achieved had the acquisitions reflected herein been consummated on the dates indicated or that will be achieved in the future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Unaudited and in Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">992 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(34,528)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(88,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(61,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma net loss attributable to controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(24,575)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(17,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(70,855)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(53,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma net loss attributable to redeemable noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(9,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(17,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Tax Receivable Agreement<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In conjunction with the Merger Transactions, the Company entered into a Tax Receivable Agreement (TRA) with the Electing Members. Pursuant to the TRA, the Company generally will be required to pay to the Electing Members, in the aggregate, 85 percent of the net income tax savings that the Company actually realizes (or in certain circumstances, is deemed to realize) as a result of (i) certain favorable tax attributes the Company acquired from the blocker entities party to the Merger Agreement in connection with the Merger Transactions (including net operating losses), (ii) increases to the Company's allocatable share of the tax basis of Cibus Global's assets resulting from future redemptions or exchanges of Common Units for shares of Class A Common Stock or cash, (iii) tax attributes resulting from certain payments made under the TRA and (iv) deductions in respect of interest under the TRA. The payment obligations under the TRA are the Company's obligations and not obligations of Cibus Global.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">As of September 30, 2023, no Up-C Units have been exchanged by Electing Members for shares of Class A Common Stock. As of September 30, 2023, the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more-likely-than-not threshold. Since the benefit has not been recorded, the Company determined that the TRA liability is not probable and therefore no TRA liability existed as of September 30, 2023.</span></div> 1 1 1 0.22 0.22 The purchase price for Cibus Global was determined as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,150,838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">634,751,397 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1) This share number represents the aggregate number of shares of Common Stock issued to Cibus Global members in the Merger Transactions and comprises: 15,508,202 shares of Class A Common Stock and 4,642,636 shares of Class B Common Stock. This share number excludes 1,019,282 shares of Class A Restricted Stock, which will be treated as issued and outstanding for financial statement presentation purposes only after such awards have vested and, therefore, have ceased to be subject to a risk of forfeiture.</span>(2) Reflects the purchase price per share of the Company's Class A Common Stock, which was the closing price of the Class A Common Stock on May 31, 2023, the closing date of the Merger Transactions. 20150838 31.50 634751397 15508202 4642636 1019282 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The following table sets forth the preliminary allocation of the consideration:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">May 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59,381 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due from related parties, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,535 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,588 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use-assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,519 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">585,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">457 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,859)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to related parties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of notes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of operating lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion of financing lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Notes payable, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease obligations, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financing lease obligations, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Royalty liability - related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(146,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consideration transferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">634,751 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 59381000 2216000 19000 2500000 2535000 10588000 9519000 585266000 135429000 457000 5582000 3477000 2859000 8000 1186000 517000 4687000 165000 17000 749000 6006000 10000 146360000 1536000 634751000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Intangible assets acquired, and their related estimated average useful lives, are as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"><br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">May 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Estimated Average Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135,429 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Intangible assets acquired, and their related estimated average useful lives, are as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"><br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">May 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Estimated Average Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135,429 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table> 99051000 14148000 P20Y 22230000 P20Y 135429000 P20Y 8200000 400000 3500000 1900000 1100000 1300000 700000 35500000 9900000 These unaudited pro forma figures have been prepared as though the business combination had occurred on January 1, 2022. Pro forma adjustments have been made to reflect non-recurring stock compensation expense, legal and professional fees, severance costs, and amortization of acquired intangible assets, directly attributable to the business combination. <span style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The unaudited pro forma condensed financial information is not indicative of the results of operations that would have been achieved had the acquisitions reflected herein been consummated on the dates indicated or that will be achieved in the future.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Unaudited and in Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">992 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(34,528)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(88,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(61,603)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma net loss attributable to controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(24,575)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(17,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(70,855)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(53,178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pro forma net loss attributable to redeemable noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(9,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(17,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,425)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 475000 307000 1154000 992000 -34528000 -20365000 -88474000 -61603000 -24575000 -17301000 -70855000 -53178000 -9953000 -3064000 -17619000 -8425000 0.85 FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Measured at Fair Value and Financial Statement Presentation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting guidance establishes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as of the measurement date as follows: </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 1: Fair values are based on unadjusted quoted prices in active trading markets for identical assets and liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 2: Fair values are based on observable quoted prices other than those in Level 1, such as quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 3: Fair values are based on at least one significant unobservable input for the asset or liability. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements and Financial Statement Presentation </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company’s financial instruments measured at fair value and their respective levels in the fair value hierarchy as of September 30, 2023, and December 31, 2022, were as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,389 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,389 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br/><br/>(1) Included in cash and cash equivalents on the accompanying condensed consolidated balance sheets<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,512</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,512</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The following table summarizes the Common Warrants activity for the period ended September 30, 2023:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3 Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mark to market adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,221</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,512</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The Company estimates the fair value of the Common Warrants as of the date of issuance and at the end of every fiscal period using a Black-Scholes option pricing model, which requires it to make assumptions regarding future stock price volatility and dividend yield. The Company estimates the risk-free interest rate based on the United States Treasury zero-coupon yield curve for the remaining life of the Common Warrants. The Company estimates its future stock price volatility using a weighted average historical volatility which takes into consideration the Company's historical volatility and historical volatility from a group of guideline companies, over the remaining life of the Common Warrants. The Company does not pay dividends and does not expect to pay dividends in the foreseeable future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair values of the Common Warrants, and the assumptions used for the Black-Scholes option pricing model were as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated fair value of Common Warrants</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assumptions:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">107.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term to liquidation (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.6</span></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, the Company had no other financial instruments measured at fair value.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk </span>The Company invests its cash and cash equivalents in highly liquid securities and interest-bearing deposit accounts. The Company diversifies the risk associated with investing in securities by allocating its investments to a diverse portfolio of short-dated, high investment-grade securities, which it classifies as cash and cash equivalents that are recorded at fair value in its condensed consolidated financial statements. The Company maintains the credit risk in this portfolio in accordance with its internal policies and, if necessary, makes changes to investments to minimize credit risk. The Company has not experienced any counterparty credit losses. As of September 30, 2023, and December 31, 2022, the Company did not hold any short-term investments. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company’s financial instruments measured at fair value and their respective levels in the fair value hierarchy as of September 30, 2023, and December 31, 2022, were as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,389 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,389 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br/><br/>(1) Included in cash and cash equivalents on the accompanying condensed consolidated balance sheets<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,512 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,512</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,512</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 7389000 0 0 7389000 0 0 0 0 7389000 0 0 7389000 0 0 0 0 0 0 1512000 1512000 0 0 291000 291000 0 0 1512000 1512000 0 0 291000 291000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><br/><br/>The following table summarizes the Common Warrants activity for the period ended September 30, 2023:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Level 3 Fair Value of Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">291</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mark to market adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,221</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,512</span></td></tr></table> 291000 1221000 1512000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair values of the Common Warrants, and the assumptions used for the Black-Scholes option pricing model were as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated fair value of Common Warrants</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assumptions:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">107.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term to liquidation (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.6</span></td></tr></table></div> 9.54 1.87 0.047 0.040 1.071 0.850 3.9 4.6 PROPERTY, PLANT, AND EQUIPMENT, NET<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Property, plant, and equipment, net consists of the following:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Useful Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant, and equipment, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Buildings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10 - 20</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">shorter of lease term or - 15</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5 - 10</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13,570</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Office furniture and equipment under financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4 - 20</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computer equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3 - 5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,272</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property, plant, and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">25,258</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(8,061)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,877)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">17,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,516 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br/><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Depreciation and amortization expense is as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,225</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">369 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,208</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,091 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Asset Retirement Obligation<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Certain lease agreements require the Company to return designated areas of leased space to its original condition upon termination of the lease agreement. At the inception of such leases, the Company records an ARO and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. To determine the fair value of the ARO, the Company estimates the cost for a third-party to perform the restoration work. In subsequent periods, for each ARO, the Company records operating expense to accrete the ARO liability to full value and depreciation expense against the ARO, over the term of the associated lease agreement. The Company used a credit-adjusted risk free rate of 5.6 percent to discount the future obligation, and an inflation rate of 5.0 percent to determine the future value of the original estimate of restoration costs. The ARO is expected to be resolved in July 2025.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>The following table presents the changes in the ARO during the nine months ended September 30, 2023.<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Asset Retirement Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquired from merger with Cibus Global, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">264 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Obligations incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accretion expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Property, plant, and equipment, net consists of the following:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except useful life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Useful Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant, and equipment, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Buildings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10 - 20</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">shorter of lease term or - 15</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5 - 10</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13,570</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,803 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Office furniture and equipment under financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4 - 20</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computer equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3 - 5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,272</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property, plant, and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">25,258</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(8,061)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,877)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">17,197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,516 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Depreciation and amortization expense is as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,225</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">369 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,208</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,091 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> P10Y P20Y 900000 900000 P15Y 3879000 364000 P5Y P10Y 13570000 7803000 P4Y P20Y 373000 414000 P3Y P5Y 3264000 912000 3272000 0 25258000 10393000 8061000 5877000 17197000 4516000 1225000 369000 2208000 1091000 0.056 0.05 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>The following table presents the changes in the ARO during the nine months ended September 30, 2023.<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Asset Retirement Obligations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquired from merger with Cibus Global, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">264 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Obligations incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accretion expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">269</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 0 264000 0 5000 269000 GOODWILL AND INTANGIBLE ASSETS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Goodwill<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the Merger Transactions with Cibus Global, the Company recognized goodwill totaling $585.3 million. The company had no goodwill prior to the Merger Transactions. Goodwill represents future economic benefits arising from acquiring Cibus Global, primarily due to its strong market position and its assembled workforce that are not individually identified and separately recognized as intangible assets. None of the goodwill recognized is expected to be deductible for income tax purposes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"><br/><br/>Intangible Assets</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Intangible assets as of September 30, 2023, were as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Intangible Assets, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">135,579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">658</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">134,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/>Total amortization expense is as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:35.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">667</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/>Intangible assets as of December 31, 2022, were immaterial.<br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As of September 30, 2023, amortization expense for each of the next five years is estimated as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:82.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"><br/></span></div> 585300000 0 0 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Intangible assets as of September 30, 2023, were as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Intangible Assets, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">135,579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">658</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">134,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Intangible assets as of September 30, 2023, were as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Intangible Assets, Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99,051 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">236 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,912 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">135,579</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">658</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">134,921</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 99051000 99051000 14148000 236000 13912000 22230000 370000 21860000 150000 52000 98000 135579000 658000 134921000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/>Total amortization expense is as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:35.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">459</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">667</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 459000 5000 667000 16000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As of September 30, 2023, amortization expense for each of the next five years is estimated as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.393%"><tr><td style="width:1.0%"></td><td style="width:82.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">458 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,833 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 458000 1833000 1833000 1833000 1833000 1833000 NOTES PAYABLEThe Company has financed the costs associated with its enterprise science platform annual software license. The financing arrangement for the license has a term of one year and accrues interest at an annual rate of 10.9 percent. The Company makes monthly principal and interest payments. The note related to the annual license matures in July 2024.Additionally, the Company has purchased various fixed assets using notes. The notes on financed equipment are subject to annual interest rates between 7.3 percent and 17.6 percent and have a weighted average remaining term of 2.8 years. Notes used to finance equipment mature between October 2023 and March 2028.<br/><br/>The Company has also financed certain annual insurance premiums using a note. The insurance note is subject to an annual interest rate of 7.5 percent, has a weighted average remaining term of 0.4 years, and matures in February 2024.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>As of September 30, 2023, future minimum payments under notes payable were as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Annual Licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financed Equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Notes Payable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">137 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">290 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">194 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">860 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">309 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,193 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">484 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,986 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,794</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>INTERIM FUNDINGPursuant to the Merger Agreement, beginning at the earlier of March 15, 2023, and the date the Company's unrestricted cash balance first dropped below $1.5 million, the Company could request, and Cibus Global agreed to provide, an unsecured, interest-free revolving line of credit of up to $3.0 million in cash (Interim Funding). Funds could be drawn by the Company in $0.5 million increments and could only be used to fund operating expenses incurred in the ordinary course of business consistent with past practice and consistent with the negative covenants in the Merger Agreement. The Company received $2.5 million of Interim Funding in the aggregate from Cibus Global. The full balance of the Interim Funding was reduced to zero in connection with the closing of the Merger Transactions pursuant to the terms of the Merger Agreement. P1Y 0.109 0.073 0.176 P2Y9M18D 0.075 P0Y4M24D <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>As of September 30, 2023, future minimum payments under notes payable were as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Annual Licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financed Equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Notes Payable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">137 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">290 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">216 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">450 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">194 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">860 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">351 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">151 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">309 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,193 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">484 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,986 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,794</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">294</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">475</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">629</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 93000 137000 290000 520000 216000 450000 194000 860000 0 351000 0 351000 0 151000 0 151000 0 89000 0 89000 0 15000 0 15000 309000 1193000 484000 1986000 15000 168000 9000 192000 294000 1025000 475000 1794000 294000 396000 475000 1165000 0 629000 0 629000 STOCKHOLDERS’ EQUITY <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Follow-On Public Offering</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 23, 2022, the Company completed the Follow-On Offering, in which it issued 77,600 shares of Class A Common Stock, Pre-Funded Warrants to purchase up to 77,600 shares of Class A Common Stock, and Common Warrants to purchase up to 158,483 shares of Class A Common Stock, in each case giving effect to the Reverse Stock Splits. The aggregate offering price for each share of Class A Common Stock and accompanying Common Warrant was $70.50, as adjusted for the Reverse Stock Splits. The aggregate offering price for each Pre-Funded Warrant and accompanying Common Warrant was $70.4999, adjusted for the Reverse Stock Splits. In the aggregate, the Company received net proceeds of $10.0 million, after deducting approximately $0.9 million of underwriting discounts and estimated other offering expenses.<br/><br/>Pre-Funded Warrants </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each Pre-Funded Warrant entitled the holder to purchase one share of the Company’s Class A Common Stock at an exercise price of $0.0001 per share. While outstanding, the Pre-Funded Warrants were recorded as a component of stockholders’ equity within additional paid-in capital. The Pre-Funded Warrants were exercised in full on May 4, 2022, and subsequently settled with the counterparty. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Warrants </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each Common Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $69.04 per share. The Common Warrants became exercisable on August 23, 2022, and expire on August 23, 2027. The Common Warrants are recorded as a liability in the Company’s condensed consolidated balance sheets. Per the terms of the Common Warrants, holders of outstanding Common Warrants are not entitled to exercise any portion of such warrant if, upon exercise, the holder’s ownership of the Company’s Class A Common Stock (together with its affiliates) or the combined voting power of the Company’s securities beneficially owned by such holder (together with its affiliates) would exceed the 4.99 percent after giving effect to the exercise. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Warrant transactions for the nine months ended September 30, 2023, are as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Price Per Share</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69.04 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Outstanding as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">69.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exercisable as of September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">69.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="background-color:#ffff00;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">ATM Facility<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On September 21, 2021, the Company entered into an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> (the ATM Facility) with Jefferies LLC, as sole selling agent. The Company issued approximately 40,000 shares of Class A Common Stock under the ATM Facility in 2022 for net proceeds of $0.1 million. The Company has not issued any additional shares under the ATM Facility during the 2023 fiscal year.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Merger with Cibus Global</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><br/><br/>At the closing of the Merger Transactions, the Company contributed all of its assets and liabilities to Cibus Global, in exchange for Common Units. The Company issued an aggregate of 16,527,484 shares of Class A Common Stock (including 1,019,282 shares of restricted Class A Common Stock) and 4,642,636 shares of Class B Common Stock to Cibus Global equityholders, as consideration in the Merger Transactions, pursuant to the terms of the Merger Agreement.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Class A Common Stock<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Shares of Class A Common Stock have full voting and economic rights. Unvested shares of Class A Restricted Common Stock, which were issued as equity compensation to certain of our employees and executive officers, carry all voting, dividend, distribution, and other rights as apply to shares of Class A Common Stock generally, except that (i) shares of Class A Restricted Common Stock are subject to transfer restrictions and (ii) dividends and distributions are held by the Company until vesting of the underlying shares of Class A Restricted Common Stock and remain subject to the same forfeiture provisions as such shares.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Class B Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon the Closing of the Merger Transactions, the Company issued shares of Class B Common Stock. The Class B Common Stock have full voting rights. The Class B Common Stock have no economic rights and do not participate in dividends or undistributed earnings. However, holders of Class B Common Stock hold a corresponding number of economic, non-voting Common Units through which they would receive </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">pro rata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> distributions from Cibus Global. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Cibus Global Common Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the Merger Transactions, the Company, Cibus Global, and the Electing Members entered into an Exchange Agreement (the Exchange Agreement). The Exchange Agreement sets forth the terms and conditions upon which holders of Up-C Units, comprising an equal number of shares of Class B Common Stock and Cibus Global Common Units, may exchange such Up-C Units for shares of Class A Common Stock. The Up-C Units are generally exchangeable for shares of Class A Common Stock on a one-for-one basis, subject to certain restrictions. The Electing Members’ ownership of Common Units represents the redeemable noncontrolling interest. As of September 30, 2023, there were 21,302,632 Cibus Common Units outstanding. Of the 21,302,632 Cibus Common Units outstanding, 16,659,996 are held by Cibus Inc. and 4,642,636 are held by the Electing Members.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Preferred Stock<br/><br/></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Pursuant to the Amended Certificate of Incorporation, following the consummation of the Merger Transactions, the Company is authorized to issue 10,000,000 shares of preferred stock, par value $0.0001 per share. As of September 30, 2023, the Company has not issued any preferred stock.</span></div> 77600 77600 158483 70.50 70.4999 10000000 900000 1 0.0001 1 69.04 0.0499 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common Warrant transactions for the nine months ended September 30, 2023, are as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Common Warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Price Per Share</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69.04 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Outstanding as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">69.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exercisable as of September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">158,483</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">69.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 158483 69.04 158483 69.04 158483 69.04 40000 100000 0 16527484 1019282 4642636 1 21302632 21302632 16659996 4642636 10000000 0.0001 0 STOCK-BASED COMPENSATION <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses broad-based stock plans to attract and retain highly qualified officers and employees and to help ensure that management’s interests are aligned with those of its shareholders. The Company has also granted equity-based awards to directors, non-employees, and certain employees of Cellectis. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2014, Legacy Calyxt adopted the Calyxt, Inc. Equity Incentive Plan (2014 Plan), which allowed for the grant of stock options, and in June 2017, it adopted the Calyxt, Inc. 2017 Omnibus Plan (2017 Plan), which allowed for the grant of stock options, RSUs, PSUs, and other types of equity awards. As part of the Merger Transactions, the name of the 2017 plan was amended to reflect the name change of the Company. <br/><br/>In July 2021, the Company also adopted the Calyxt, Inc. Employee Inducement Incentive Plan (the Inducement Plan), from which PSUs were granted to Michael A. Carr, the Company's former Chief Executive Officer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, 1,925,024 shares were available for grant in the form of stock options, restricted stock, RSUs, and PSUs under the 2017 Plan. Stock-based awards currently outstanding also include awards granted under the 2014 Plan. No further awards are available for grant or will be granted under either the 2014 Plan or the Inducement Plan. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Stock Options </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair values of stock options granted, and the assumptions used for the Black-Scholes option pricing model were as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated fair values of stock options granted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assumptions:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.9% - 3.5% </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—% </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89.7% - 92.8%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">— </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.50 - 6.89 </span></div></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company estimates the fair value of each stock option on the grant date, or other measurement date if applicable, using a Black-Scholes option pricing model, which requires it to make predictive assumptions regarding employee exercise behavior, future stock price volatility, and dividend yield. The Company estimates the risk-free interest rate based on the United States Treasury zero-coupon yield curve at the date of grant for the expected term of the option. The Company estimates its future stock price volatility using a weighted average historical volatility which takes into consideration the Company's historical volatility and historical volatility from a group of guideline companies, over the expected term of the option. The expected term of stock options is estimated using the average of the vesting tranches and the contractual life of each grant for employee options, or the simplified method, as the Company has limited historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior for its stock option grants. The use of the simplified method is dependent upon the type of equity award granted and the term of the award. The Company has not paid dividends and does not expect to pay dividends in the foreseeable future. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Option strike prices are set at 100 percent or more of the closing share price on the date of grant and generally vest over <span style="-sec-ix-hidden:f-787">three</span> to six years following the grant date. Options generally expire 10 years after the date of grant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Modification of Stock Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On March 1, 2023, the Company’s Board of Directors (Board) approved the modification of the award terms of all outstanding stock options with a 90-day post-separation exercise period from the current 90 days to five years from date of grant. The modification did not affect the vesting or service period of the stock options. These modifications were considered to be Type I and incremental stock compensation expense of $0.2 million was determined for all modified awards, of which $0.1 million was recognized associated with vested awards in the three months ended March 31, 2023. The remaining incremental expenses will be recognized over the remaining service period of the awards. The service period for these awards ended with the close of the Merger Transactions and the remaining expense was recognized in the three months ended June 30, 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information on stock option activity is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Options </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercisable</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercise </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Price Per </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Share </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Options </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Outstanding </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercise </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Price Per </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Share </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67,978</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">496.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,860</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">367.58 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42,195</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited or expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,530)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">441.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7,309)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">369.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">108,643</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">364.57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">109,551</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">367.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock option awards is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,835</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, both options outstanding and options exercisable had nominal aggregate intrinsic value and a weighted average remaining contractual term of 4.0 years. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, unrecognized compensation expense related to non-vested stock options was $0.1 million which has a weighted average remaining recognition period of 1.0 year. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards<br/></span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company granted awards of Class A Restricted Stock (RSAs), in connection with the Merger Transactions, to Cibus Global members who held unvested restricted profits interest units. The Class A Restricted Stock will continue to vest following their original vesting schedules over the remaining life of the awards which is generally 2 months to four years after the date of grant. Information on Class A Restricted Stock award activity is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Restricted Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Awards </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average Grant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Date Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,019,282</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(71,969)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,533)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unvested balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">945,780</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">31.50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total grant-date fair value of RSAs that vested is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,725</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to RSAs is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,631</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7,555</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, unrecognized compensation expense related to RSAs was $24.5 million which has a weighted average remaining recognition period of 2.5 years.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company grants RSUs which generally vest over <span style="-sec-ix-hidden:f-846">three</span> to five years after the date of grant. Information on restricted stock unit activity is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Restricted Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Units </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average Grant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Date Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,575</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99.36 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">272,885</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19.02 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(96,730)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,531)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127.84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">198,199</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total grant-date fair value of RSUs that vested is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,702</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to RSUs is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,550</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">992 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, unrecognized compensation expense related to RSUs was $3.5 million which has a weighted average remaining recognition period of 3.4 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounted for stock-based compensation awards granted to employees of Cellectis as deemed dividends. These awards are fully vested as of December 31, 2022. The Company recorded deemed dividends as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deemed dividends from grants to Cellectis employees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Performance Stock Units </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">From time-to-time, the Company issues PSUs to certain individuals in management in order to align their objectives with stockholders of the Company. Depending upon the type of PSU award, the Company uses a Monte Carlo simulation pricing model when estimating the fair value of these awards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">2023 Grant</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">On May 24, 2023, the Company granted 24,800 PSUs under the 2017 Plan to five employees including four executive officers. The PSUs included an annual performance period (2023) and target performance levels for the period linked to the achievement of Company objectives as determined annually for the respective period by the Compensation Committee of the Board (Compensation Committee). Once the annual objectives are approved, the associated expense will be recognized on a straight-line basis over the period through the determination date, which can be no later than March 15 of the following year. Earned awards are settled in shares of Class A Common Stock no later than the March 15 determination date in the following calendar year. In connection with the closing of the Merger Transactions, the Company’s Board determined the awards would vest at 100 percent.<br/><br/>2022 Grant</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In March 2022, the Company granted 10,600 PSUs under the 2017 Plan to five employees including four executive officers. The PSUs included <span style="-sec-ix-hidden:f-880">three</span> annual performance periods (2022, 2023, and 2024) and target performance levels for each of those periods linked to the achievement of Company objectives as determined annually for the respective period by the Compensation Committee. Once the annual objectives are approved, the associated expense will be recognized on a straight-line basis over the period through the determination date, which can be no later than March 15 of the following year. Earned awards are settled in shares of Class A Common Stock no later than the March 15 determination date in the following calendar year. The grant date for the tranche of awards linked to 2022 performance was May 4, 2022, and on March 1, 2023, the Company’s Board determined the 2022 tranche of PSUs would vest at 100 percent. The grant date for the tranche of awards linked to 2023 performance was May 17, 2023, and on May 31, 2023, in connection with the closing of the Merger Transactions, the Company’s Board determined the 2023 tranche of PSUs would vest at 100 percent. Additionally on May 31, 2023, in connection with the closing of the Merger Transactions, the 2024 tranche of PSUs became fully vested.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 Grant</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In July 2021, the Company granted 12,000 PSUs under the Inducement Plan to Mr. Carr. The PSUs will vest if the Company’s stock remains above three specified price levels for <span style="-sec-ix-hidden:f-884">thirty</span> calendar days over the three-year performance period. The PSUs will be settled in shares of Class A Common Stock on the vesting date. At the close of the Merger Transactions on May 31, 2023, 25 percent of these awards vested per the terms of the award agreement, and the remaining awards were forfeited due to the service period ending with Mr. Carr's termination upon the close of the Merger Transactions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2019 Grant </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">In June 2022, PSUs granted to two executive officers in 2019 were forfeited because the underlying performance criteria were not met. These PSUs contained a market condition and had a five-year service period. At the close of the Merger Transactions, both of these executive officers were terminated. All expense for these awards was reversed in June 2023 due to the service period ending prior to vesting date. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PSU activity for the nine months ended September 30, 2023, is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Performance Stock Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,600</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,800</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9,333)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(38,067)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Outstanding as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to PSUs is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">171 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">478 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, there is no unrecognized compensation expense related to PSUs.</span></div> 1925024 The estimated fair values of stock options granted, and the assumptions used for the Black-Scholes option pricing model were as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimated fair values of stock options granted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assumptions:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.9% - 3.5% </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—% </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89.7% - 92.8%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">— </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.50 - 6.89 </span></div></td></tr></table> 0 42.83 0 0.019 0.035 0 0.897 0.928 P5Y6M P6Y10M20D 1 P6Y P10Y P90D P90D P5Y 200000 100000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information on stock option activity is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Options </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercisable</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercise </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Price Per </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Share </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Options </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Outstanding </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Exercise </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Price Per </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Share </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67,978</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">496.83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,860</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">367.58 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42,195</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited or expired</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,530)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">441.63 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7,309)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">369.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">108,643</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">364.57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">109,551</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">367.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 67978 496.83 116860 367.58 0 0 42195 154.28 0 0 1530 441.63 7309 369.43 108643 364.57 109551 367.46 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock option awards is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,835</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,420 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to RSAs is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,631</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7,555</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to RSUs is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">334 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,550</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">992 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense related to PSUs is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation (benefit) expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">171 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">478 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain statement of operations amounts are as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,853</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">620 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general, and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">6,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,035 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,890 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 40000 530000 1835000 1420000 P4Y 100000 P1Y P2M P4Y Information on Class A Restricted Stock award activity is as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Restricted Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Awards </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average Grant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Date Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,019,282</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(71,969)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,533)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31.50 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unvested balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">945,780</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">31.50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>Information on restricted stock unit activity is as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Restricted Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Units </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Weighted Average Grant </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Date Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,575</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99.36 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">272,885</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19.02 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(96,730)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,531)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127.84 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">198,199</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 0 0 1019282 31.50 71969 31.50 1533 31.50 945780 31.50 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total grant-date fair value of RSAs that vested is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,725</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total grant-date fair value of RSUs that vested is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grant-date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,702</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,686 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1725000 0 2267000 0 5631000 0 7555000 0 24500000 P2Y6M P5Y 24575 99.36 272885 19.02 96730 38.27 2531 127.84 198199 18.19 100000 530000 3702000 1686000 157000 334000 2550000 992000 3500000 P3Y4M24D The Company recorded deemed dividends as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deemed dividends from grants to Cellectis employees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 0 18000 0 82000 24800 5 4 1 10600 5 4 1 1 12000 P3Y 0.25 P5Y <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PSU activity for the nine months ended September 30, 2023, is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Performance Stock Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,600</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,800</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9,333)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(38,067)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Outstanding as of September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span></td></tr></table></div> 22600 24800 9333 38067 0 0 171000 -270000 478000 0 INCOME TAXESThe Company provides for a valuation allowance when it is more likely than not that it will not realize a portion of the deferred tax assets. The Company has established a full valuation allowance for deferred tax assets due to the uncertainty that enough taxable income will be generated in the taxing jurisdiction to utilize the assets. Therefore, the Company has not reflected any benefit of such deferred tax assets in the accompanying condensed consolidated financial statements.<br/><br/>The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates, and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. The Company did not record any income tax provision for the three months ended September 30, 2023, due to its history of net operating losses, and the maintenance of a full valuation allowance against its net deferred tax assets.<br/><br/>As of September 30, 2023, there have been no Up-C Units exchanged by Electing Members for Class A Common Stock. As described in Note 2, the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more-likely-than-not threshold. Since the benefit has not been recorded, the Company determined that the TRA liability is not probable and therefore no TRA liability existed as of September 30, 2023.As of September 30, 2023, there were no material changes to what the Company disclosed regarding tax uncertainties or penalties as of December 31, 2022. 0 LEASES, COMMITMENTS, AND CONTINGENCIES <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%"><br/>The Company had an equipment financing arrangement at the Roseville, Minnesota location that was considered a financing-type lease. This equipment financing arrangement was repaid in full in the first quarter of 2023. The Company was required to deposit cash into a restricted account in an amount equal to the future rent payments required by the lease. As of March 31, 2023, the remaining restricted cash had been returned to the Company.<br/><br/>Upon the completion of the Merger Transactions, the Company assumed financing leases for certain equipment. In the third quarter of 2023, the Company added a financing lease for hardware and software. The ROU asset is included in other non-current assets in the condensed consolidated balance sheets.<br/><br/>The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except remaining term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Roseville, Minnesota lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California laboratory lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California headquarters lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,710</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California greenhouse lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 48.37pt;text-indent:-10pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,541</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0 - 3.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,615 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">The Roseville, Minnesota lease includes four options to extend the lease for five years. These options to extend the lease are not recognized as part of the ROU assets and operating lease liabilities as it is not reasonably certain that the Company will exercise those options. The Company’s lease agreement does not include options to terminate the lease.<br/><br/>Upon the completion of the Merger Transactions, the company assumed additional operating leases. <br/><br/>The lease for the Company's San Diego, California headquarters includes office and laboratory space with terms that expire in May 2025 and August 2025, respectively. The Company has one option to extend the laboratory space lease for one year. As the Company is not </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">reasonably certain to exercise this option at lease commencement, the option was not recognized as part of the associated operating lease ROU asset or liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Additionally, the Company has certain leases for greenhouse and warehouse facilities, with terms that expire in August 2028 and August 2026, respectively. The Company had one option to extend the term of the greenhouse lease, for five years, and executed this right with an amended lease agreement beginning in September 2023 and expiring at the end of August 2028. There are no other options to extend this lease. The Company has one option to extend the warehouse lease, for five years. However, as the Company is not reasonably certain to exercise either of those options at lease commencement, neither option was recognized as part of the associated operating lease ROU asset or liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Certain leases include rent abatement, rent escalations, tenant improvement allowances, and additional charges for common area maintenance and other costs. The Company is required to pay base rent expense as well as its proportionate share of the facilities operating expenses. The non-lease components, consisting primarily of common area maintenance, are paid separately based on actual costs incurred. Therefore, the variable non-lease components were not included in the ROU asset or lease liability and are reflected as expense in the period incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The components of lease expense were as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,830</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">438 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,247 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease costs for short-term leases was not material for the three and nine months ended September 30, 2023, or 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except for lease term and discount rate </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating cash flows (operating leases)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">205 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financing cash flows (finance leases)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 11pt;text-indent:-10pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, future minimum payments under operating and finance leases were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,758 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,901 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">235</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,946</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cibus Non-Profit Foundation<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%"><br/>Litigation and Claims<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In the fourth quarter of 2022, the Company reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, the Company received $0.75 million in the fourth quarter of 2022, and it received the final installment of $0.75 million in the first quarter of 2023.</span></div>The Company is not currently a party to any material pending legal proceeding. LEASES, COMMITMENTS, AND CONTINGENCIES <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%"><br/>The Company had an equipment financing arrangement at the Roseville, Minnesota location that was considered a financing-type lease. This equipment financing arrangement was repaid in full in the first quarter of 2023. The Company was required to deposit cash into a restricted account in an amount equal to the future rent payments required by the lease. As of March 31, 2023, the remaining restricted cash had been returned to the Company.<br/><br/>Upon the completion of the Merger Transactions, the Company assumed financing leases for certain equipment. In the third quarter of 2023, the Company added a financing lease for hardware and software. The ROU asset is included in other non-current assets in the condensed consolidated balance sheets.<br/><br/>The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except remaining term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Roseville, Minnesota lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California laboratory lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California headquarters lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,710</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California greenhouse lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 48.37pt;text-indent:-10pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,541</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0 - 3.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,615 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">The Roseville, Minnesota lease includes four options to extend the lease for five years. These options to extend the lease are not recognized as part of the ROU assets and operating lease liabilities as it is not reasonably certain that the Company will exercise those options. The Company’s lease agreement does not include options to terminate the lease.<br/><br/>Upon the completion of the Merger Transactions, the company assumed additional operating leases. <br/><br/>The lease for the Company's San Diego, California headquarters includes office and laboratory space with terms that expire in May 2025 and August 2025, respectively. The Company has one option to extend the laboratory space lease for one year. As the Company is not </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">reasonably certain to exercise this option at lease commencement, the option was not recognized as part of the associated operating lease ROU asset or liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Additionally, the Company has certain leases for greenhouse and warehouse facilities, with terms that expire in August 2028 and August 2026, respectively. The Company had one option to extend the term of the greenhouse lease, for five years, and executed this right with an amended lease agreement beginning in September 2023 and expiring at the end of August 2028. There are no other options to extend this lease. The Company has one option to extend the warehouse lease, for five years. However, as the Company is not reasonably certain to exercise either of those options at lease commencement, neither option was recognized as part of the associated operating lease ROU asset or liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Certain leases include rent abatement, rent escalations, tenant improvement allowances, and additional charges for common area maintenance and other costs. The Company is required to pay base rent expense as well as its proportionate share of the facilities operating expenses. The non-lease components, consisting primarily of common area maintenance, are paid separately based on actual costs incurred. Therefore, the variable non-lease components were not included in the ROU asset or lease liability and are reflected as expense in the period incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The components of lease expense were as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,830</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">438 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,247 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease costs for short-term leases was not material for the three and nine months ended September 30, 2023, or 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except for lease term and discount rate </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating cash flows (operating leases)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">205 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financing cash flows (finance leases)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 11pt;text-indent:-10pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, future minimum payments under operating and finance leases were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,758 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,901 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">235</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,946</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cibus Non-Profit Foundation<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%"><br/>Litigation and Claims<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In the fourth quarter of 2022, the Company reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, the Company received $0.75 million in the fourth quarter of 2022, and it received the final installment of $0.75 million in the first quarter of 2023.</span></div>The Company is not currently a party to any material pending legal proceeding. LEASES, COMMITMENTS, AND CONTINGENCIES <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%"><br/>The Company had an equipment financing arrangement at the Roseville, Minnesota location that was considered a financing-type lease. This equipment financing arrangement was repaid in full in the first quarter of 2023. The Company was required to deposit cash into a restricted account in an amount equal to the future rent payments required by the lease. As of March 31, 2023, the remaining restricted cash had been returned to the Company.<br/><br/>Upon the completion of the Merger Transactions, the Company assumed financing leases for certain equipment. In the third quarter of 2023, the Company added a financing lease for hardware and software. The ROU asset is included in other non-current assets in the condensed consolidated balance sheets.<br/><br/>The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except remaining term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Roseville, Minnesota lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California laboratory lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California headquarters lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,710</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California greenhouse lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 48.37pt;text-indent:-10pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,541</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0 - 3.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,615 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">The Roseville, Minnesota lease includes four options to extend the lease for five years. These options to extend the lease are not recognized as part of the ROU assets and operating lease liabilities as it is not reasonably certain that the Company will exercise those options. The Company’s lease agreement does not include options to terminate the lease.<br/><br/>Upon the completion of the Merger Transactions, the company assumed additional operating leases. <br/><br/>The lease for the Company's San Diego, California headquarters includes office and laboratory space with terms that expire in May 2025 and August 2025, respectively. The Company has one option to extend the laboratory space lease for one year. As the Company is not </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">reasonably certain to exercise this option at lease commencement, the option was not recognized as part of the associated operating lease ROU asset or liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Additionally, the Company has certain leases for greenhouse and warehouse facilities, with terms that expire in August 2028 and August 2026, respectively. The Company had one option to extend the term of the greenhouse lease, for five years, and executed this right with an amended lease agreement beginning in September 2023 and expiring at the end of August 2028. There are no other options to extend this lease. The Company has one option to extend the warehouse lease, for five years. However, as the Company is not reasonably certain to exercise either of those options at lease commencement, neither option was recognized as part of the associated operating lease ROU asset or liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>Certain leases include rent abatement, rent escalations, tenant improvement allowances, and additional charges for common area maintenance and other costs. The Company is required to pay base rent expense as well as its proportionate share of the facilities operating expenses. The non-lease components, consisting primarily of common area maintenance, are paid separately based on actual costs incurred. Therefore, the variable non-lease components were not included in the ROU asset or lease liability and are reflected as expense in the period incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The components of lease expense were as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,830</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">438 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,247 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease costs for short-term leases was not material for the three and nine months ended September 30, 2023, or 2022. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except for lease term and discount rate </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating cash flows (operating leases)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">205 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financing cash flows (finance leases)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 11pt;text-indent:-10pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, future minimum payments under operating and finance leases were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,758 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,901 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">235</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,946</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cibus Non-Profit Foundation<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, Cibus Global created the Cibus Charitable Foundation, Inc., a nonprofit legal entity (the Cibus Non-Profit Foundation). As of September 30, 2023, the Cibus Non-Profit Foundation has not received any donations or commenced operations. The Company is obligated to make donations to the Cibus Non-Profit Foundation each fiscal year at a rate of 1.0 percent of all net royalty revenue in the applicable fiscal year that is equal to or greater than $100 million up to, and including, $1.0 billion, and then steps up to 2.0 percent in respect of any portion of such net royalty revenue in excess of $1.0 billion. For purposes of this calculation, net royalty revenue refers to all royalty payments received by the Company, net of all taxes (other than income taxes) and all amounts payable pursuant to the Royalty Liability. The donation payable by the Company may be reduced, including to zero, to the extent necessary to comply with any covenant or obligation in any instrument evidencing third-party indebtedness, to permit a financing to occur, to preclude undercapitalization, to satisfy working capital requirements or provide for strategic needs of the Company, to ensure timely payment of the Company's liabilities and debts to third parties as they become due, or to comply with applicable law. The Company has agreed not to enter any change of control transaction unless the surviving entity assumes the obligation to pay such donations to the Cibus Non-Profit Foundation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>This obligation is contingent upon the Cibus Non-Profit Foundation obtaining and maintaining its status as a 501(c)(3) charitable organization, although such registration has not yet been achieved. The Cibus Non-Profit Foundation must use all donations received consistent with its mission statement: to drive sustainable agriculture and sustainable agricultural communities in the developing world. Accordingly, as of September 30, 2023, the Company had not recorded a liability related to its obligations to the Cibus Non-Profit Foundation within the accompanying condensed consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%"><br/>Litigation and Claims<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In the fourth quarter of 2022, the Company reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, the Company received $0.75 million in the fourth quarter of 2022, and it received the final installment of $0.75 million in the first quarter of 2023.</span></div>The Company is not currently a party to any material pending legal proceeding. The Company is obligated under a non-cancellable operating leases, primarily for office, laboratory, greenhouse, and warehouse space, as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except remaining term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Remaining Term (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Right-of-Use-Asset</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Roseville, Minnesota lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13,244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,613 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California laboratory lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California headquarters lease</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,710</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">San Diego, California greenhouse lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 48.37pt;text-indent:-10pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,541</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0 - 3.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">592</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&lt; 1.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,615 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> P14Y7M6D 13244000 P15Y3M18D 13613000 P1Y10M24D 3848000 0 P1Y8M12D 3710000 0 P4Y10M24D 1541000 0 P1Y P1Y P3Y 592000 P1Y P1Y 2000 22935000 13615000 4 P5Y 1 P1Y 1 P5Y 1 P5Y <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The components of lease expense were as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,635</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,830</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">438 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,909</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,247 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands, except for lease term and discount rate </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating cash flows (operating leases)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,297</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">205 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financing cash flows (finance leases)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt 0 11pt;text-indent:-10pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15.3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div> 65000 57000 79000 73000 1635000 381000 2830000 1174000 1700000 438000 2909000 1247000 1297000 70000 1848000 205000 132000 163000 242000 353000 P10Y6M P1Y4M24D P15Y3M18D P0Y4M24D 0.075 0.095 0.079 0.081 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, future minimum payments under operating and finance leases were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,758 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,901 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">235</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,946</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of September 30, 2023, future minimum payments under operating and finance leases were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Operating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Remainder of 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,758 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,798 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,342 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,917 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,863 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,438 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,901 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">370 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,271 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,621)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">235</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Noncurrent portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">102</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18,946</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1758000 40000 1798000 7132000 210000 7342000 4797000 120000 4917000 1993000 0 1993000 1920000 0 1920000 1863000 0 1863000 15438000 0 15438000 34901000 370000 35271000 10621000 33000 10654000 24280000 337000 24617000 5436000 235000 5671000 18844000 102000 18946000 0.01 100000000 1000000000 0.02 1000000000 750000 750000 ROYALTY LIABILITY - RELATED PARTIESThe Royalty Liability was assumed following the Company’s acquisition of Cibus Global in the Merger Transactions. In 2014, Cibus Global entered into the Warrant Exchange Agreement with certain members holding Series A Preferred Units, including members of the <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">board of directors and management of Cibus Global, who were also the holders of warrants to purchase Series A Preferred Units. Under the Warrant Exchange Agreement, the Royalty Holders are entitled to future royalty payments equal to 10 percent of the subject revenues (Subject Revenues), as defined, which includes all royalty revenues earned by Cibus Global, for licensing of plant traits to seed companies that use traits developed by the Company, but excludes specifically, (i) revenues attributable to the Nucelis product line, (ii) amounts received from the sale or disposition of the Company’s assets to the extent the purchaser agrees to be bound by the Warrant Exchange Agreement, (iii) payments for Cibus Global capital stock, and (iv) revenues attributable to collaboration and research projects. Royalty payments will not begin until the first fiscal quarter after which the aggregate Subject Revenues during any consecutive 12-month period equals or exceeds $50.0 million, at which point Cibus Global will be obligated to pay all aggregated but unpaid payments under the Warrant Exchange Agreement. This condition had not occurred as of September 30, 2023. Additionally, Cibus Global granted the Royalty Holders a continuing security interest in certain intellectual property of Cibus Global to secure the payment and performance of obligations of Cibus Global under the Warrant Exchange Agreement. The initial term of the Warrant Exchange Agreement is 30 years and may be extended for an additional 30-year term if the holders provide written notice and make a payment of $100.<br/><br/>For purposes of determining the Royalty Liability, the Company estimates the total amount of future revenues expected to be received from the Company's customers over the life of the agreement. The Company then calculates the amount of future royalty payments required to be paid based upon the estimated future revenues. The Company will periodically assess the expected royalty payments using a combination of internal projections and external sources. Any change in expected future royalty payments is recognized prospectively as an adjustment to the effective yield as interest expense. As of September 30, 2023, the Royalty Liability reflected an effective yield of 23.7 percent.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>As of September 30, 2023, the Royalty Liability activity is as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Royalty Liability - Related Parties</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquired from merger with Cibus Global, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">146,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">157,113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>RELATED-PARTY TRANSACTIONS <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prior to the completion of the Merger Transactions, the Company was party to several agreements that governed its relationship with Cellectis, some of which required the Company to make payments to Cellectis. Pursuant to the Company’s management services agreement with Cellectis, it incurred no management fee expenses for the three and nine months ended September 30, 2023, and 2022. The management services agreement was terminated with respect to the Company upon the closing of the Merger Transactions. <br/><br/>Cellectis has guaranteed the lease agreement for the Company’s Roseville, Minnesota facility. Cellectis’ guarantee of the Company’s obligations under the lease will terminate at the end of the second consecutive calendar year in which the Company’s tangible net worth exceeds $300 million. The Company agreed to indemnify Cellectis for any obligations incurred by Cellectis under its guaranty of the obligations under the lease, effective upon Cellectis’ ownership falling to 50 percent or less of the Company’s outstanding common stock. This indemnification obligation was triggered in October 2022.<br/> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">TALEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> is one of the Company's gene editing technologies. TALEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> technology was invented by researchers at the University of Minnesota and Iowa State University and exclusively licensed to Cellectis. The Company originally obtained an exclusive license for the TALEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> technology for commercial use in plants from Cellectis. Upon the closing of the Merger Transactions, the license agreement was amended (the Amended Cellectis License) to provide exclusive use to certain intellectual property in the field of developing and commercializing microorganism, agricultural, and food products, including, but not limited to traits, seeds, proteins, oils, carbohydrates, food, and food and animal feed ingredients, excluding (i) any application in connection with animals and animal cells and (ii) therapeutic applications (the Calyxt Field). This grant is non-exclusive solely in the non-exclusive fields as described in the Amended Cellectis License. Cellectis also grants to the Company a non-exclusive, worldwide, perpetual, irrevocable, royalty-free, and fully paid-up license (with certain rights to sublicense) under certain licensed plant patents in the Calyxt Field. Cellectis is entitled to royalties on any revenue the Company generates from sales of products less certain amounts as defined in the license agreement, royalties on certain cumulative revenue thresholds, and a percentage of any sublicense revenues. The Company has incurred nominal license and royalty fees for the three and nine months ended September 30, 2023, and 2022. <br/><br/>Prior to the Merger Transactions, amounts payable to Cellectis were reported in the Company's condensed consolidated balance sheets as Due to related parties. Beginning with the three months ended June 30, 2023, any amounts payable to Cellectis are included in accrued </span></div>expenses in the Company's condensed consolidated balance sheets. 0.10 50000000 P30Y P30Y 100 0.237 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><br/>As of September 30, 2023, the Royalty Liability activity is as follows:<br/><br/></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Royalty Liability - Related Parties</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquired from merger with Cibus Global, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">146,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance as of September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">157,113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 0 146360000 10753000 157113000 SUPPLEMENTAL INFORMATION <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain balance sheet amounts are as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued consulting and professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,980</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued field trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,092</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">173 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain statement of operations amounts are as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,853</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">210 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,531</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">620 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general, and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">6,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,270 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,828</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,035 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11,670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,890 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supplemental statement of cash flows information is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">98</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-cash transactions not reported in the condensed consolidated statement of cash flows is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Receivable from Jefferies for shares issued under ATM facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(260)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant, and equipment acquired through assuming liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">419</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares issued for consideration in the merger with Cibus Global</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">634,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forgiveness of interim funding resulting from merger with Cibus Global</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cumulative effect of adoption of lease accounting standard on stockholders’ equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Establishment of financing lease right-of-use assets and associated operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Establishment of operating lease right-of-use assets and associated operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/><br/><br/></span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain balance sheet amounts are as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued consulting and professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,980</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued field trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">396</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5,092</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">173 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2980000 119000 1716000 0 396000 54000 5092000 173000 2853000 210000 5531000 620000 2975000 825000 6139000 2270000 5828000 1035000 11670000 2890000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Supplemental statement of cash flows information is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">98</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-cash transactions not reported in the condensed consolidated statement of cash flows is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">In Thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Receivable from Jefferies for shares issued under ATM facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(260)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant, and equipment acquired through assuming liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">419</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(687)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares issued for consideration in the merger with Cibus Global</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">634,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forgiveness of interim funding resulting from merger with Cibus Global</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cumulative effect of adoption of lease accounting standard on stockholders’ equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Establishment of financing lease right-of-use assets and associated operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Establishment of operating lease right-of-use assets and associated operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1,606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/><br/><br/></span></div> 98000 67000 0 -260000 419000 -687000 634751000 0 2500000 0 832000 307000 0 1606000 14090000 1500000 3000000 500000 2500000 0 COLLABORATION AGREEMENT<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Prior to the Merger Transactions, Cibus Global and Procter &amp; Gamble (P&amp;G), a leading multi-national consumer product company, entered into a collaboration agreement under which P&amp;G will fund a multi-year program to develop sustainable low carbon ingredients or materials that do not negatively impact the environment during production, use, or disposal to help P&amp;G advance its sustainability objectives. As of September 30, 2023, the Company had $1.6 million of deferred revenue from R&amp;D activities under the P&amp;G agreement. The Company has determined the P&amp;G agreement should be accounted for under Topic 606, and it will recognize revenue over time proportional to the R&amp;D activities performed by the Company related to the collaboration agreement. During the nine months ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">September 30, 2023, the Company recognized $0.4 million in revenue in the condensed consolidated statements of operations.</span> 1600000 400000 300000000 0.50 SUBSEQUENT EVENTS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Strategic Realignment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 18, 2023, Cibus implemented a strategic realignment to align with its primary commercial objective of advancing its late-stage activities.<br/><br/>The strategic realignment resulted in a reduction in workforce in full time employees from 242 full-time employees as of October 17, 2023, to approximately 185 full-time employees. The Company estimates that it will incur approximately $0.5 million of one-time costs in connection with the reduction in workforce, primarily related to cash payments for accrued vacation and severance payments. The Company expects the majority of the associated costs to be incurred during the quarter ending December 31, 2023.<br/><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Loan Agreement<br/><br/></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 20, 2023, Cibus entered into a binding term sheet (Binding Term Sheet) with Rory Riggs, the Company’s Chairman and Chief Executive Officer. Pursuant to the Binding Term Sheet, Mr. Riggs has agreed to make available to the Company a line of credit (the Loan) in the aggregate principal amount of $5.0 million (the Loan Amount). Cibus may make draws, in increments of $1.0 million, against the Loan Amount at any time during the period commencing January 1, 2024, and terminating on March 1, 2024. Amounts drawn under the Loan will bear simple interest at a rate of 12 percent per annum and are repayable at maturity on January 1, 2026. The Loan is unsecured and may be prepaid by the Company at any time without penalty. The Binding Term Sheet shall automatically terminate if the Company secures debt and/or equity financing in the aggregate amount of $20.0 million prior to January 1, 2024.</span> 242 185 500000 5000000.0 1000000.0 0.12 20000000.0 false false false false EXCEL 102 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 104 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 105 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 283 457 1 false 85 0 false 10 false false R1.htm 0000001 - Document - COVER PAGE Sheet http://www.cibus.com/role/COVERPAGE COVER PAGE Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Sheet http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITYParenthetical CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 0000010 - Disclosure - MERGER WITH CIBUS GLOBAL Sheet http://www.cibus.com/role/MERGERWITHCIBUSGLOBAL MERGER WITH CIBUS GLOBAL Notes 10 false false R11.htm 0000011 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK Sheet http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISK FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK Notes 11 false false R12.htm 0000012 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET Sheet http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNET PROPERTY, PLANT, AND EQUIPMENT, NET Notes 12 false false R13.htm 0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETS GOODWILL AND INTANGIBLE ASSETS Notes 13 false false R14.htm 0000014 - Disclosure - NOTES PAYABLE Notes http://www.cibus.com/role/NOTESPAYABLE NOTES PAYABLE Notes 14 false false R15.htm 0000015 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS' EQUITY Notes 15 false false R16.htm 0000016 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 16 false false R17.htm 0000017 - Disclosure - INCOME TAXES Sheet http://www.cibus.com/role/INCOMETAXES INCOME TAXES Notes 17 false false R18.htm 0000018 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIES LEASES, COMMITMENTS, AND CONTINGENCIES Notes 18 false false R19.htm 0000019 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES Sheet http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIES ROYALTY LIABILITY - RELATED PARTIES Notes 19 false false R20.htm 0000020 - Disclosure - SUPPLEMENTAL INFORMATION Sheet http://www.cibus.com/role/SUPPLEMENTALINFORMATION SUPPLEMENTAL INFORMATION Notes 20 false false R21.htm 0000021 - Disclosure - INTERIM FUNDING Sheet http://www.cibus.com/role/INTERIMFUNDING INTERIM FUNDING Notes 21 false false R22.htm 0000022 - Disclosure - COLLABORATION AGREEMENT Sheet http://www.cibus.com/role/COLLABORATIONAGREEMENT COLLABORATION AGREEMENT Notes 22 false false R23.htm 0000023 - Disclosure - RELATED-PARTY TRANSACTIONS Sheet http://www.cibus.com/role/RELATEDPARTYTRANSACTIONS RELATED-PARTY TRANSACTIONS Notes 23 false false R24.htm 0000024 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.cibus.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 24 false false R25.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 25 false false R26.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 26 false false R27.htm 9954471 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 27 false false R28.htm 9954472 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 28 false false R29.htm 9954473 - Disclosure - MERGER WITH CIBUS GLOBAL (Tables) Sheet http://www.cibus.com/role/MERGERWITHCIBUSGLOBALTables MERGER WITH CIBUS GLOBAL (Tables) Tables http://www.cibus.com/role/MERGERWITHCIBUSGLOBAL 29 false false R30.htm 9954474 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK (Tables) Sheet http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKTables FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK (Tables) Tables http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISK 30 false false R31.htm 9954475 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET (Tables) Sheet http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETTables PROPERTY, PLANT, AND EQUIPMENT, NET (Tables) Tables http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNET 31 false false R32.htm 9954476 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETS 32 false false R33.htm 9954477 - Disclosure - NOTES PAYABLE (Tables) Notes http://www.cibus.com/role/NOTESPAYABLETables NOTES PAYABLE (Tables) Tables http://www.cibus.com/role/NOTESPAYABLE 33 false false R34.htm 9954478 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.cibus.com/role/STOCKHOLDERSEQUITY 34 false false R35.htm 9954479 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.cibus.com/role/STOCKBASEDCOMPENSATION 35 false false R36.htm 9954480 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES (Tables) Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESTables LEASES, COMMITMENTS, AND CONTINGENCIES (Tables) Tables http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIES 36 false false R37.htm 9954481 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES (Tables) Sheet http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESTables ROYALTY LIABILITY - RELATED PARTIES (Tables) Tables http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIES 37 false false R38.htm 9954482 - Disclosure - SUPPLEMENTAL INFORMATION (Tables) Sheet http://www.cibus.com/role/SUPPLEMENTALINFORMATIONTables SUPPLEMENTAL INFORMATION (Tables) Tables http://www.cibus.com/role/SUPPLEMENTALINFORMATION 38 false false R39.htm 9954483 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 39 false false R40.htm 9954484 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock by Class (Details) Sheet http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock by Class (Details) Details 40 false false R41.htm 9954485 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Deferred Revenue Activity (Details) Sheet http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDeferredRevenueActivityDetails BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Deferred Revenue Activity (Details) Details 41 false false R42.htm 9954486 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 42 false false R43.htm 9954487 - Disclosure - MERGER WITH CIBUS GLOBAL - Narrative (Details) Sheet http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails MERGER WITH CIBUS GLOBAL - Narrative (Details) Details 43 false false R44.htm 9954488 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Purchase Price for Merger Transaction (Details) Sheet http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails MERGER WITH CIBUS GLOBAL - Schedule of Purchase Price for Merger Transaction (Details) Details 44 false false R45.htm 9954489 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Recognized the Preliminary Allocation of the Consideration (Details) Sheet http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails MERGER WITH CIBUS GLOBAL - Schedule of Recognized the Preliminary Allocation of the Consideration (Details) Details 45 false false R46.htm 9954490 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Intangible Assets Acquired in Merger Transaction (Details) Sheet http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails MERGER WITH CIBUS GLOBAL - Schedule of Intangible Assets Acquired in Merger Transaction (Details) Details 46 false false R47.htm 9954491 - Disclosure - MERGER WITH CIBUS GLOBAL - Business Acquisition, Pro Forma Information (Details) Sheet http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails MERGER WITH CIBUS GLOBAL - Business Acquisition, Pro Forma Information (Details) Details 47 false false R48.htm 9954492 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value Measurements and Financial Statement Presentation (Details) Sheet http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value Measurements and Financial Statement Presentation (Details) Details 48 false false R49.htm 9954493 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Common Warrants Activity (Details) Sheet http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Common Warrants Activity (Details) Details 49 false false R50.htm 9954494 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value of the Common Warrants (Details) Sheet http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value of the Common Warrants (Details) Details 50 false false R51.htm 9954495 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Property, Plant, and Equipment (Details) Sheet http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Property, Plant, and Equipment (Details) Details 51 false false R52.htm 9954496 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Narrative (Details) Sheet http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails PROPERTY, PLANT, AND EQUIPMENT, NET - Narrative (Details) Details 52 false false R53.htm 9954497 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Change in Asset Retirement Obligation (Details) Sheet http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofChangeinAssetRetirementObligationDetails PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Change in Asset Retirement Obligation (Details) Details 53 false false R54.htm 9954498 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Details 54 false false R55.htm 9954499 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets (Details) Sheet http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets (Details) Details 55 false false R56.htm 9954500 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Amortization (Details) Sheet http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfAmortizationDetails GOODWILL AND INTANGIBLE ASSETS - Schedule Of Amortization (Details) Details 56 false false R57.htm 9954501 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Sheet http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Details 57 false false R58.htm 9954502 - Disclosure - NOTES PAYABLE - Narrative (Details) Notes http://www.cibus.com/role/NOTESPAYABLENarrativeDetails NOTES PAYABLE - Narrative (Details) Details 58 false false R59.htm 9954503 - Disclosure - NOTES PAYABLE - Schedule of Future Minimum Payments Under Notes Payable (Details) Notes http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails NOTES PAYABLE - Schedule of Future Minimum Payments Under Notes Payable (Details) Details 59 false false R60.htm 9954504 - Disclosure - STOCKHOLDERS' EQUITY - Follow-On Public Offering (Details) Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails STOCKHOLDERS' EQUITY - Follow-On Public Offering (Details) Details 60 false false R61.htm 9954505 - Disclosure - STOCKHOLDERS' EQUITY - Disclosure of Warrants Transactions (Details) Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails STOCKHOLDERS' EQUITY - Disclosure of Warrants Transactions (Details) Details 61 false false R62.htm 9954506 - Disclosure - STOCKHOLDERS' EQUITY - ATM Facility (Details) Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails STOCKHOLDERS' EQUITY - ATM Facility (Details) Details 62 false false R63.htm 9954507 - Disclosure - STOCKHOLDERS' EQUITY - Merger with Cibus Global (Details) Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails STOCKHOLDERS' EQUITY - Merger with Cibus Global (Details) Details 63 false false R64.htm 9954508 - Disclosure - STOCKHOLDERS' EQUITY - Cibus Common Units (Details) Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails STOCKHOLDERS' EQUITY - Cibus Common Units (Details) Details 64 false false R65.htm 9954509 - Disclosure - STOCKHOLDERS' EQUITY - Preferred Stock (Details) Sheet http://www.cibus.com/role/STOCKHOLDERSEQUITYPreferredStockDetails STOCKHOLDERS' EQUITY - Preferred Stock (Details) Details 65 false false R66.htm 9954510 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 66 false false R67.htm 9954511 - Disclosure - STOCK-BASED COMPENSATION - Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails STOCK-BASED COMPENSATION - Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model (Details) Details 67 false false R68.htm 9954512 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details) Details 68 false false R69.htm 9954513 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Expense (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Expense (Details) Details 69 false false R70.htm 9954514 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Nonvested Shares Activity (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails STOCK-BASED COMPENSATION - Schedule of Nonvested Shares Activity (Details) Details 70 false false R71.htm 9954515 - Disclosure - STOCK-BASED COMPENSATION - Summary of Grant Date Fair Value of Awards Vested (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails STOCK-BASED COMPENSATION - Summary of Grant Date Fair Value of Awards Vested (Details) Details 71 false false R72.htm 9954516 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Granted as Deemed Dividends (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Granted as Deemed Dividends (Details) Details 72 false false R73.htm 9954517 - Disclosure - STOCK-BASED COMPENSATION - Share-Based Payment Arrangement, Performance Shares, Outstanding Activity (Details) Sheet http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails STOCK-BASED COMPENSATION - Share-Based Payment Arrangement, Performance Shares, Outstanding Activity (Details) Details 73 false false R74.htm 9954518 - Disclosure - INCOME TAXES (Details) Sheet http://www.cibus.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.cibus.com/role/INCOMETAXES 74 false false R75.htm 9954519 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Schedule of Non-Cancellable Operating Leases (Details) Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails LEASES, COMMITMENTS, AND CONTINGENCIES - Schedule of Non-Cancellable Operating Leases (Details) Details 75 false false R76.htm 9954520 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Narrative (Details) Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails LEASES, COMMITMENTS, AND CONTINGENCIES - Narrative (Details) Details 76 false false R77.htm 9954521 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Lease Cost (Details) Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Lease Cost (Details) Details 77 false false R78.htm 9954522 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Other Information Related to Leases (Details) Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofOtherInformationRelatedtoLeasesDetails LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Other Information Related to Leases (Details) Details 78 false false R79.htm 9954523 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Supplemental Balance Sheet Information Related to Leases (Details) Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails LEASES, COMMITMENTS, AND CONTINGENCIES - Supplemental Balance Sheet Information Related to Leases (Details) Details 79 false false R80.htm 9954524 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details) Sheet http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details) Details 80 false false R81.htm 9954525 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES - Narrative (Details) Sheet http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails ROYALTY LIABILITY - RELATED PARTIES - Narrative (Details) Details 81 false false R82.htm 9954526 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES - Schedule of Royalty Liability (Details) Sheet http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails ROYALTY LIABILITY - RELATED PARTIES - Schedule of Royalty Liability (Details) Details 82 false false R83.htm 9954527 - Disclosure - SUPPLEMENTAL INFORMATION - Accrued Expenses (Details) Sheet http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails SUPPLEMENTAL INFORMATION - Accrued Expenses (Details) Details 83 false false R84.htm 9954528 - Disclosure - SUPPLEMENTAL INFORMATION - Share-based Compensation Expense (Details) Sheet http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails SUPPLEMENTAL INFORMATION - Share-based Compensation Expense (Details) Details 84 false false R85.htm 9954529 - Disclosure - SUPPLEMENTAL INFORMATION - Supplemental Cash Flows Information (Details) Sheet http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails SUPPLEMENTAL INFORMATION - Supplemental Cash Flows Information (Details) Details 85 false false R86.htm 9954530 - Disclosure - INTERIM FUNDING (Details) Sheet http://www.cibus.com/role/INTERIMFUNDINGDetails INTERIM FUNDING (Details) Details http://www.cibus.com/role/INTERIMFUNDING 86 false false R87.htm 9954531 - Disclosure - COLLABORATION AGREEMENT (Details) Sheet http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails COLLABORATION AGREEMENT (Details) Details http://www.cibus.com/role/COLLABORATIONAGREEMENT 87 false false R88.htm 9954532 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) Sheet http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails RELATED-PARTY TRANSACTIONS (Details) Details http://www.cibus.com/role/RELATEDPARTYTRANSACTIONS 88 false false R89.htm 9954533 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.cibus.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://www.cibus.com/role/SUBSEQUENTEVENTS 89 false false R9999.htm Uncategorized Items - cbus-20230930.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - cbus-20230930.htm Cover 90 false false All Reports Book All Reports cbus-20230930.htm cbus-20230930.xsd cbus-20230930_cal.xml cbus-20230930_def.xml cbus-20230930_lab.xml cbus-20230930_pre.xml cbus-20230930_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 108 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cbus-20230930.htm": { "nsprefix": "cbus", "nsuri": "http://www.cibus.com/20230930", "dts": { "inline": { "local": [ "cbus-20230930.htm" ] }, "schema": { "local": [ "cbus-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "cbus-20230930_cal.xml" ] }, "definitionLink": { "local": [ "cbus-20230930_def.xml" ] }, "labelLink": { "local": [ "cbus-20230930_lab.xml" ] }, "presentationLink": { "local": [ "cbus-20230930_pre.xml" ] } }, "keyStandard": 363, "keyCustom": 94, "axisStandard": 32, "axisCustom": 0, "memberStandard": 48, "memberCustom": 30, "hidden": { "total": 13, "http://www.cibus.com/20230930": 2, "http://fasb.org/us-gaap/2023": 6, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 283, "entityCount": 1, "segmentCount": 85, "elementCount": 802, "unitCount": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 885, "http://xbrl.sec.gov/ecd/2023": 4, "http://xbrl.sec.gov/dei/2023": 30 }, "report": { "R1": { "role": "http://www.cibus.com/role/COVERPAGE", "longName": "0000001 - Document - COVER PAGE", "shortName": "COVER PAGE", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:RestrictedCashCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R3": { "role": "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:TreasuryStockCommonShares", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R4": { "role": "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R5": { "role": "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R6": { "role": "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-16", "name": "us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-59", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R7": { "role": "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITYParenthetical", "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-16", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-16", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R9": { "role": "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "longName": "0000009 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.cibus.com/role/MERGERWITHCIBUSGLOBAL", "longName": "0000010 - Disclosure - MERGER WITH CIBUS GLOBAL", "shortName": "MERGER WITH CIBUS GLOBAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISK", "longName": "0000011 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK", "shortName": "FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNET", "longName": "0000012 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET", "shortName": "PROPERTY, PLANT, AND EQUIPMENT, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETS", "longName": "0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.cibus.com/role/NOTESPAYABLE", "longName": "0000014 - Disclosure - NOTES PAYABLE", "shortName": "NOTES PAYABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R15": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITY", "longName": "0000015 - Disclosure - STOCKHOLDERS' EQUITY", "shortName": "STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATION", "longName": "0000016 - Disclosure - STOCK-BASED COMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.cibus.com/role/INCOMETAXES", "longName": "0000017 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIES", "longName": "0000018 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIES", "longName": "0000019 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES", "shortName": "ROYALTY LIABILITY - RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R20": { "role": "http://www.cibus.com/role/SUPPLEMENTALINFORMATION", "longName": "0000020 - Disclosure - SUPPLEMENTAL INFORMATION", "shortName": "SUPPLEMENTAL INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.cibus.com/role/INTERIMFUNDING", "longName": "0000021 - Disclosure - INTERIM FUNDING", "shortName": "INTERIM FUNDING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R22": { "role": "http://www.cibus.com/role/COLLABORATIONAGREEMENT", "longName": "0000022 - Disclosure - COLLABORATION AGREEMENT", "shortName": "COLLABORATION AGREEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONS", "longName": "0000023 - Disclosure - RELATED-PARTY TRANSACTIONS", "shortName": "RELATED-PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R24": { "role": "http://www.cibus.com/role/SUBSEQUENTEVENTS", "longName": "0000024 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-14", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "longName": "9954471 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "longName": "9954472 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALTables", "longName": "9954473 - Disclosure - MERGER WITH CIBUS GLOBAL (Tables)", "shortName": "MERGER WITH CIBUS GLOBAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKTables", "longName": "9954474 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK (Tables)", "shortName": "FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETTables", "longName": "9954475 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET (Tables)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSTables", "longName": "9954476 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.cibus.com/role/NOTESPAYABLETables", "longName": "9954477 - Disclosure - NOTES PAYABLE (Tables)", "shortName": "NOTES PAYABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITYTables", "longName": "9954478 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "cbus:DisclosureOfWarrantsTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cbus:DisclosureOfWarrantsTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables", "longName": "9954479 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "shortName": "STOCK-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESTables", "longName": "9954480 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES (Tables)", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "cbus:AssetsLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "cbus:AssetsLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESTables", "longName": "9954481 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES (Tables)", "shortName": "ROYALTY LIABILITY - RELATED PARTIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONTables", "longName": "9954482 - Disclosure - SUPPLEMENTAL INFORMATION (Tables)", "shortName": "SUPPLEMENTAL INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "longName": "9954483 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "shortName": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-75", "name": "cbus:NumberOfClassesOfStock", "unitRef": "class_of_stock", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-75", "name": "cbus:NumberOfClassesOfStock", "unitRef": "class_of_stock", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "longName": "9954484 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock by Class (Details)", "shortName": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock by Class (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R41": { "role": "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDeferredRevenueActivityDetails", "longName": "9954485 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Deferred Revenue Activity (Details)", "shortName": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Deferred Revenue Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R42": { "role": "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "longName": "9954486 - Disclosure - BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "shortName": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "longName": "9954487 - Disclosure - MERGER WITH CIBUS GLOBAL - Narrative (Details)", "shortName": "MERGER WITH CIBUS GLOBAL - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-101", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-75", "name": "cbus:TaxReceivableAgreementPercentageOfIncomeTaxSavingsRequiredToBePaid", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R44": { "role": "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "longName": "9954488 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Purchase Price for Merger Transaction (Details)", "shortName": "MERGER WITH CIBUS GLOBAL - Schedule of Purchase Price for Merger Transaction (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-103", "name": "us-gaap:BusinessAcquisitionSharePrice", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R45": { "role": "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails", "longName": "9954489 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Recognized the Preliminary Allocation of the Consideration (Details)", "shortName": "MERGER WITH CIBUS GLOBAL - Schedule of Recognized the Preliminary Allocation of the Consideration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-103", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R46": { "role": "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails", "longName": "9954490 - Disclosure - MERGER WITH CIBUS GLOBAL - Schedule of Intangible Assets Acquired in Merger Transaction (Details)", "shortName": "MERGER WITH CIBUS GLOBAL - Schedule of Intangible Assets Acquired in Merger Transaction (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-101", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-110", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R47": { "role": "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails", "longName": "9954491 - Disclosure - MERGER WITH CIBUS GLOBAL - Business Acquisition, Pro Forma Information (Details)", "shortName": "MERGER WITH CIBUS GLOBAL - Business Acquisition, Pro Forma Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-120", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-120", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails", "longName": "9954492 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value Measurements and Financial Statement Presentation (Details)", "shortName": "FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value Measurements and Financial Statement Presentation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails", "longName": "9954493 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Common Warrants Activity (Details)", "shortName": "FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Common Warrants Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-144", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-144", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails", "longName": "9954494 - Disclosure - FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value of the Common Warrants (Details)", "shortName": "FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK - Summary of Fair Value of the Common Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-4", "name": "cbus:EstimatedFairValueOfCommonWarrantsMeasurementInput", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "cbus:EstimatedFairValueOfCommonWarrantsMeasurementInput", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails", "longName": "9954495 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Property, Plant, and Equipment (Details)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Property, Plant, and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R52": { "role": "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails", "longName": "9954496 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Narrative (Details)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT, NET - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-146", "name": "cbus:AssetRetirementObligationMeasurementInput", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-146", "name": "cbus:AssetRetirementObligationMeasurementInput", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofChangeinAssetRetirementObligationDetails", "longName": "9954497 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Change in Asset Retirement Obligation (Details)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT, NET - Schedule of Change in Asset Retirement Obligation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AssetRetirementObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AssetRetirementObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "longName": "9954498 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-101", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-101", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "longName": "9954499 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R56": { "role": "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfAmortizationDetails", "longName": "9954500 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Amortization (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule Of Amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails", "longName": "9954501 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "longName": "9954502 - Disclosure - NOTES PAYABLE - Narrative (Details)", "shortName": "NOTES PAYABLE - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-174", "name": "us-gaap:DebtInstrumentTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-174", "name": "us-gaap:DebtInstrumentTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails", "longName": "9954503 - Disclosure - NOTES PAYABLE - Schedule of Future Minimum Payments Under Notes Payable (Details)", "shortName": "NOTES PAYABLE - Schedule of Future Minimum Payments Under Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails", "longName": "9954504 - Disclosure - STOCKHOLDERS' EQUITY - Follow-On Public Offering (Details)", "shortName": "STOCKHOLDERS' EQUITY - Follow-On Public Offering (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PaymentsOfStockIssuanceCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-187", "name": "us-gaap:SharesIssuedPricePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R61": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails", "longName": "9954505 - Disclosure - STOCKHOLDERS' EQUITY - Disclosure of Warrants Transactions (Details)", "shortName": "STOCKHOLDERS' EQUITY - Disclosure of Warrants Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-190", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "cbus:DisclosureOfWarrantsTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-190", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "cbus:DisclosureOfWarrantsTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails", "longName": "9954506 - Disclosure - STOCKHOLDERS' EQUITY - ATM Facility (Details)", "shortName": "STOCKHOLDERS' EQUITY - ATM Facility (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-192", "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-192", "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails", "longName": "9954507 - Disclosure - STOCKHOLDERS' EQUITY - Merger with Cibus Global (Details)", "shortName": "STOCKHOLDERS' EQUITY - Merger with Cibus Global (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-102", "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R64": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails", "longName": "9954508 - Disclosure - STOCKHOLDERS' EQUITY - Cibus Common Units (Details)", "shortName": "STOCKHOLDERS' EQUITY - Cibus Common Units (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-75", "name": "cbus:CommonUnitConvertibleConversionRatio", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-75", "name": "cbus:CommonUnitConvertibleConversionRatio", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.cibus.com/role/STOCKHOLDERSEQUITYPreferredStockDetails", "longName": "9954509 - Disclosure - STOCKHOLDERS' EQUITY - Preferred Stock (Details)", "shortName": "STOCKHOLDERS' EQUITY - Preferred Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-75", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:PreferredStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R66": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "longName": "9954510 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)", "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-203", "name": "cbus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAwardPostSeparationExercisePeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-203", "name": "cbus:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAwardPostSeparationExercisePeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails", "longName": "9954511 - Disclosure - STOCK-BASED COMPENSATION - Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model (Details)", "shortName": "STOCK-BASED COMPENSATION - Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-196", "name": "cbus:ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedFairValueOfAwardsGranted", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-196", "name": "cbus:ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedFairValueOfAwardsGranted", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails", "longName": "9954512 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details)", "shortName": "STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "longName": "9954513 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Expense (Details)", "shortName": "STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-205", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R70": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails", "longName": "9954514 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Nonvested Shares Activity (Details)", "shortName": "STOCK-BASED COMPENSATION - Schedule of Nonvested Shares Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-209", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-209", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails", "longName": "9954515 - Disclosure - STOCK-BASED COMPENSATION - Summary of Grant Date Fair Value of Awards Vested (Details)", "shortName": "STOCK-BASED COMPENSATION - Summary of Grant Date Fair Value of Awards Vested (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-212", "name": "cbus:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-212", "name": "cbus:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails", "longName": "9954516 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Granted as Deemed Dividends (Details)", "shortName": "STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Granted as Deemed Dividends (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-223", "name": "cbus:DeemedDividendDeficit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-223", "name": "cbus:DeemedDividendDeficit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails", "longName": "9954517 - Disclosure - STOCK-BASED COMPENSATION - Share-Based Payment Arrangement, Performance Shares, Outstanding Activity (Details)", "shortName": "STOCK-BASED COMPENSATION - Share-Based Payment Arrangement, Performance Shares, Outstanding Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-236", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-236", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.cibus.com/role/INCOMETAXESDetails", "longName": "9954518 - Disclosure - INCOME TAXES (Details)", "shortName": "INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": null }, "R75": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails", "longName": "9954519 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Schedule of Non-Cancellable Operating Leases (Details)", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES - Schedule of Non-Cancellable Operating Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-242", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R76": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "longName": "9954520 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Narrative (Details)", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-257", "name": "us-gaap:ProceedsFromLegalSettlements", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-4", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-257", "name": "us-gaap:ProceedsFromLegalSettlements", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-4", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails", "longName": "9954521 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Lease Cost (Details)", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-14", "name": "cbus:FinanceLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "cbus:FinanceLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofOtherInformationRelatedtoLeasesDetails", "longName": "9954522 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Other Information Related to Leases (Details)", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Other Information Related to Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:OperatingLeasePayments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "us-gaap:OperatingLeasePayments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails", "longName": "9954523 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Supplemental Balance Sheet Information Related to Leases (Details)", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES - Supplemental Balance Sheet Information Related to Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails", "longName": "9954524 - Disclosure - LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details)", "shortName": "LEASES, COMMITMENTS, AND CONTINGENCIES - Summary of Future Minimum Rental Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails", "longName": "9954525 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES - Narrative (Details)", "shortName": "ROYALTY LIABILITY - RELATED PARTIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-258", "name": "us-gaap:RelatedPartyTransactionRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-258", "name": "us-gaap:RelatedPartyTransactionRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R82": { "role": "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails", "longName": "9954526 - Disclosure - ROYALTY LIABILITY - RELATED PARTIES - Schedule of Royalty Liability (Details)", "shortName": "ROYALTY LIABILITY - RELATED PARTIES - Schedule of Royalty Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-5", "name": "cbus:AccruedRoyaltiesNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-261", "name": "cbus:AccruedRoyaltiesNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R83": { "role": "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails", "longName": "9954527 - Disclosure - SUPPLEMENTAL INFORMATION - Accrued Expenses (Details)", "shortName": "SUPPLEMENTAL INFORMATION - Accrued Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AccruedProfessionalFeesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AccruedProfessionalFeesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R84": { "role": "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails", "longName": "9954528 - Disclosure - SUPPLEMENTAL INFORMATION - Share-based Compensation Expense (Details)", "shortName": "SUPPLEMENTAL INFORMATION - Share-based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-14", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-264", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R85": { "role": "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails", "longName": "9954529 - Disclosure - SUPPLEMENTAL INFORMATION - Supplemental Cash Flows Information (Details)", "shortName": "SUPPLEMENTAL INFORMATION - Supplemental Cash Flows Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.cibus.com/role/INTERIMFUNDINGDetails", "longName": "9954530 - Disclosure - INTERIM FUNDING (Details)", "shortName": "INTERIM FUNDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LongTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-273", "name": "cbus:DebtInstrumentCovenantUnrestrictedCashBalanceThreshold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R87": { "role": "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails", "longName": "9954531 - Disclosure - COLLABORATION AGREEMENT (Details)", "shortName": "COLLABORATION AGREEMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-276", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "unique": true } }, "R88": { "role": "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "longName": "9954532 - Disclosure - RELATED-PARTY TRANSACTIONS (Details)", "shortName": "RELATED-PARTY TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c-277", "name": "cbus:RelatedPartyTransactionTangibleNetWorthThresholdForTwoConsecutiveYearsWhichTerminatesAgreement", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-277", "name": "cbus:RelatedPartyTransactionTangibleNetWorthThresholdForTwoConsecutiveYearsWhichTerminatesAgreement", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R89": { "role": "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails", "longName": "9954533 - Disclosure - SUBSEQUENT EVENTS (Details)", "shortName": "SUBSEQUENT EVENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c-282", "name": "cbus:LineOfCreditIncrementalDrawAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-282", "name": "cbus:LineOfCreditIncrementalDrawAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "cbus-20230930.htm", "first": true, "unique": true } }, "R9999": { "role": "http://xbrl.sec.gov/role/uncategorizedFacts", "longName": "Uncategorized Items - cbus-20230930.htm", "shortName": "Uncategorized Items - cbus-20230930.htm", "isDefault": "false", "groupType": "", "subGroupType": "", "menuCat": "Cover", "order": "90", "firstAnchor": null, "uniqueAnchor": null } }, "tag": { "cbus_BusinessAcquisitionProFormaNetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessAcquisitionProFormaNetIncomeLossAttributableToRedeemableNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro forma net loss attributable to redeemable noncontrolling interest", "label": "Business Acquisition, Pro Forma Net Income (Loss), Attributable To Redeemable Noncontrolling Interest", "documentation": "Business Acquisition, Pro Forma Net Income (Loss), Attributable To Redeemable Noncontrolling Interest" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Stock Units", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r111" ] }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Performance Shares, Outstanding Activity", "label": "Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares." } } }, "auth_ref": [ "r32" ] }, "cbus_WarrantLiabilityCurrentDeferredFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "WarrantLiabilityCurrentDeferredFinancingCosts", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred financing costs related to common warrants", "label": "Warrant Liability, Current, Deferred Financing Costs", "documentation": "Warrant Liability, Current, Deferred Financing Costs" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r130" ] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "SUPPLEMENTAL INFORMATION", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r942" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets and liabilities, net", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r19", "r129", "r130", "r161", "r489" ] }, "cbus_AtTheMarketOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AtTheMarketOfferingMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "At-The-Market Offering", "label": "At-The-Market Offering [Member]", "documentation": "At-The-Market Offering" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired indefinite-lived intangible assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets", "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "cbus_RelatedPartyTransactionTangibleNetWorthThresholdForTwoConsecutiveYearsWhichTerminatesAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RelatedPartyTransactionTangibleNetWorthThresholdForTwoConsecutiveYearsWhichTerminatesAgreement", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold amount in which the lease will terminate at the end of the second consecutive calendar year in which the Company\u2019s tangible net worth exceeds", "label": "Related Party Transaction, Tangible Net Worth Threshold For Two Consecutive Years Which Terminates Agreement", "documentation": "Related Party Transaction, Tangible Net Worth Threshold For Two Consecutive Years Which Terminates Agreement" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (in shares)", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r19", "r129", "r130", "r161" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/COVERPAGE", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r196", "r213", "r214", "r215", "r239", "r265", "r266", "r268", "r270", "r274", "r275", "r336", "r395", "r397", "r398", "r399", "r402", "r403", "r435", "r436", "r439", "r442", "r449", "r575", "r709", "r710", "r711", "r712", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r741", "r762", "r784", "r797", "r798", "r799", "r800", "r801", "r926", "r951", "r962" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r513", "r514", "r515", "r719", "r957", "r958", "r959", "r1014", "r1039" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of notes payable", "label": "Proceeds from Notes Payable", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r52" ] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesFinanceLeaseLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Financing lease obligations, net of current portion", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Finance Lease, Liability", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Finance Lease, Liability" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r23", "r24" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r199", "r247", "r248", "r249", "r252", "r259", "r261", "r340", "r346", "r513", "r514", "r515", "r524", "r525", "r548", "r550", "r551", "r554", "r565", "r698", "r700", "r719", "r1039" ] }, "cbus_StockholdersEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "StockholdersEquityLineItems", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders Equity [Line Items]", "label": "Stockholders Equity [Line Items]", "documentation": "Stockholders Equity [Line Items]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r111" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of common stock resulting from merger with Cibus Global, LLC (in shares)", "terseLabel": "Stock issued during period for acquisitions (in shares)", "label": "Stock Issued During Period, Shares, Acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r129", "r130", "r161" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r25" ] }, "cbus_BindingTermSheetMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BindingTermSheetMember", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Binding Term Sheet", "label": "Binding Term Sheet [Member]", "documentation": "Binding Term Sheet" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r26" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r19", "r199", "r223", "r224", "r225", "r247", "r248", "r249", "r252", "r259", "r261", "r273", "r340", "r346", "r451", "r513", "r514", "r515", "r524", "r525", "r548", "r549", "r550", "r551", "r552", "r554", "r565", "r582", "r583", "r584", "r585", "r586", "r587", "r612", "r698", "r699", "r700", "r719", "r784" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r5", "r18", "r49", "r549", "r552", "r612", "r698", "r699", "r946", "r947", "r948", "r957", "r958", "r959" ] }, "cbus_CommonStockIssuedAndOutstandingOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CommonStockIssuedAndOutstandingOwnershipPercentage", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued and outstanding, ownership percentage", "label": "Common Stock Issued And Outstanding, Ownership Percentage", "documentation": "Common Stock Issued And Outstanding, Ownership Percentage" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited/canceled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations", "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired." } } }, "auth_ref": [ "r27" ] }, "cbus_IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets and lease liabilities, net", "label": "Increase (Decrease) In Operating Lease Right-Of-Use Asset And Operating Lease Liability", "documentation": "Increase (Decrease) In Operating Lease Right-Of-Use Asset And Operating Lease Liability" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Unvested restricted stock awards", "terseLabel": "Restricted Stock", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r58" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAwardPostSeparationExercisePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAwardPostSeparationExercisePeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option post-separation exercise period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Option, Award Post Separation Exercise Period", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Option, Award Post Separation Exercise Period" } } }, "auth_ref": [] }, "cbus_SanDiegoCaliforniaGreenhouseLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "SanDiegoCaliforniaGreenhouseLeaseMember", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "San Diego, California greenhouse lease", "label": "San Diego, California Greenhouse Lease [Member]", "documentation": "San Diego, California Greenhouse Lease" } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFinanceLeaseLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current portion of financing lease obligations", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Finance Lease, Liability", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Finance Lease, Liability" } } }, "auth_ref": [] }, "cbus_CharitableContributionObligationPercentageOfNetRoyaltyRevenueIfThresholdIsExceeded": { "xbrltype": "decimalItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CharitableContributionObligationPercentageOfNetRoyaltyRevenueIfThresholdIsExceeded", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charitable contribution obligation, percentage of net royalty revenue", "label": "Charitable Contribution Obligation, Percentage Of Net Royalty Revenue If Threshold Is Exceeded", "documentation": "Charitable Contribution Obligation, Percentage Of Net Royalty Revenue If Threshold Is Exceeded" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r243", "r244", "r408", "r437", "r619", "r809", "r811" ] }, "cbus_LeaseGuaranteeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "LeaseGuaranteeMember", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Guarantee", "label": "Lease Guarantee [Member]", "documentation": "Lease Guarantee" } } }, "auth_ref": [] }, "cbus_SanDiegoCaliforniaLaboratoryLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "SanDiegoCaliforniaLaboratoryLeaseMember", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "San Diego, California laboratory lease", "label": "San Diego, California Laboratory Lease [Member]", "documentation": "San Diego, California Laboratory Lease" } } }, "auth_ref": [] }, "cbus_BusinessAcquisitionProFormaNetIncomeLossAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessAcquisitionProFormaNetIncomeLossAttributableToParent", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro forma net loss attributable to controlling interest", "label": "Business Acquisition, Pro Forma Net Income (Loss), Attributable To Parent", "documentation": "Business Acquisition, Pro Forma Net Income (Loss), Attributable To Parent" } } }, "auth_ref": [] }, "cbus_BusinessCombinationNumberOfSharesIssuedToElectiveMembersCommonUnit": { "xbrltype": "sharesItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationNumberOfSharesIssuedToElectiveMembersCommonUnit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Common Units included in Up-C Units (in shares)", "label": "Business Combination, Number Of Shares Issued To Elective Members, Common Unit", "documentation": "Business Combination, Number Of Shares Issued To Elective Members, Common Unit" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r497" ] }, "cbus_WarehouseLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "WarehouseLeaseMember", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warehouse Lease", "label": "Warehouse Lease [Member]", "documentation": "Warehouse Lease" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r11" ] }, "cbus_DisclosureOfWarrantsTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DisclosureOfWarrantsTransactionsLineItems", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of Warrants Transactions [Line Items]", "label": "Disclosure of Warrants Transactions [Line Items]", "documentation": "disclosure of warrants transactions." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "cbus_StockholdersEquityTable": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "StockholdersEquityTable", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders Equity [Table]", "label": "Stockholders Equity [Table]", "documentation": "Stockholders Equity [Table]" } } }, "auth_ref": [] }, "cbus_AssetsLesseeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AssetsLesseeTableTextBlock", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Non-Cancellable Operating Leases", "label": "Assets, Lessee [Table Text Block]", "documentation": "Assets, Lessee" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 21.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accrued expenses", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Expenses", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Expenses" } } }, "auth_ref": [] }, "cbus_AdjustmentsToAdditionalPaidInCapitalChangeInValueOfRedeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalChangeInValueOfRedeemableNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Change in value of redeemable noncontrolling interest", "label": "Adjustments To Additional Paid In Capital, Change In Value Of Redeemable Noncontrolling Interest", "documentation": "Adjustments To Additional Paid In Capital, Change In Value Of Redeemable Noncontrolling Interest" } } }, "auth_ref": [] }, "cbus_ComputerEquipmentAndSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ComputerEquipmentAndSoftwareMember", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computer equipment and software", "label": "Computer Equipment And Software [Member]", "documentation": "Computer Equipment And Software" } } }, "auth_ref": [] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award performance period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period" } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaidYearFive", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 3.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2028", "label": "Operating And Finance Lease, Liability, To Be Paid, Year Five", "documentation": "Operating and finance lease liabilities payments next five years." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r173", "r210", "r239", "r276", "r289", "r293", "r336", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r539", "r543", "r575", "r678", "r753", "r837", "r849", "r979", "r980", "r1025" ] }, "cbus_AssetRetirementObligationMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AssetRetirementObligationMeasurementInput", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset retirement obligation, measurement input", "label": "Asset Retirement Obligation, Measurement Input", "documentation": "Asset Retirement Obligation, Measurement Input" } } }, "auth_ref": [] }, "cbus_FinanceLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "FinanceLeaseCost", "crdr": "debit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease costs", "label": "Finance Lease, Cost", "documentation": "Finance lease cost." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r495" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r497" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r131", "r837", "r1036" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to Cibus, Inc.", "terseLabel": "Net loss", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r138", "r145", "r178", "r202", "r219", "r221", "r225", "r239", "r251", "r254", "r255", "r256", "r257", "r260", "r261", "r267", "r276", "r288", "r292", "r294", "r336", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r567", "r575", "r688", "r761", "r782", "r783", "r814", "r847", "r979" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardThresholdConsecutiveTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardThresholdConsecutiveTradingDays", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, threshold consecutive trading days", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Threshold Consecutive Trading Days", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Vesting Threshold, Consecutive Trading Days" } } }, "auth_ref": [] }, "cbus_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceOfWarrantsOrRightsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceOfWarrantsOrRightsAbstract", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price Per Share", "label": "Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights [Abstract]", "documentation": "Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights" } } }, "auth_ref": [] }, "cbus_EmployeeRetentionCreditCARESActRefundReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "EmployeeRetentionCreditCARESActRefundReceived", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Retention Credit refund received", "label": "Employee Retention Credit, CARES Act, Refund Received", "documentation": "Employee Retention Credit, CARES Act, Refund Received" } } }, "auth_ref": [] }, "cbus_DisclosureOfWarrantsTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DisclosureOfWarrantsTransactionsTableTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of Warrants Transactions", "label": "Disclosure Of Warrants Transactions [Table Text Block]", "documentation": "Disclosure of warrants transactions." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Royalty payment, percentage of subject revenues", "label": "Related Party Transaction, Rate", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r588", "r623" ] }, "cbus_DeemedDividendDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DeemedDividendDeficit", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deemed dividends from grants to Cellectis employees", "label": "Deemed Dividend (Deficit)", "documentation": "Deemed Dividend (Deficit)." } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/COVERPAGE", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class A Common Stock", "label": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r1039" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r120", "r121", "r765", "r766", "r769" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r588", "r623" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONS", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIES" ], "lang": { "en-us": { "role": { "terseLabel": "RELATED-PARTY TRANSACTIONS", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r613", "r614", "r615", "r617", "r620", "r715", "r716", "r717", "r767", "r768", "r769", "r788", "r790" ] }, "cbus_CibusGlobalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CibusGlobalMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cibus Global", "label": "Cibus Global [Member]", "documentation": "Cibus Global" } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r43", "r72" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r588", "r623" ] }, "cbus_ClassOfWarrantOrRightVotingPowerThresholdMaximumBeforeWarrantsCannotBeExercised": { "xbrltype": "percentItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ClassOfWarrantOrRightVotingPowerThresholdMaximumBeforeWarrantsCannotBeExercised", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum voting percentage, before warrants cannot be exercised", "label": "Class Of Warrant Or Right, Voting Power Threshold Maximum Before Warrants Cannot Be Exercised", "documentation": "Class Of Warrant Or Right, Voting Power Threshold Maximum Before Warrants Cannot Be Exercised" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r765", "r766", "r769" ] }, "cbus_AssetRetirementObligationAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AssetRetirementObligationAcquired", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofChangeinAssetRetirementObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired from merger with Cibus Global, LLC", "label": "Asset Retirement Obligation, Acquired", "documentation": "Asset Retirement Obligation, Acquired" } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use-assets", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset" } } }, "auth_ref": [] }, "cbus_BusinessCombinationShareConversionRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationShareConversionRatio", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Up-C Units to Class A Common Stock exchange ratio", "label": "Business Combination, Share Conversion Ratio", "documentation": "Business Combination, Share Conversion Ratio" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary, Sale of Stock [Line Items]", "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cbus_WarrantLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "WarrantLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class A common stock warrants", "verboseLabel": "Common Warrants", "label": "Warrant Liability, Current", "documentation": "Warrant Liability, Current" } } }, "auth_ref": [] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r891" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Consideration transferred", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r99" ] }, "cbus_ContractWithCustomerLiabilityConsiderationReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ContractWithCustomerLiabilityConsiderationReceived", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDeferredRevenueActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consideration received", "label": "Contract With Customer, Liability, Consideration Received", "documentation": "Contract With Customer, Liability, Consideration Received" } } }, "auth_ref": [] }, "cbus_EmployeeRetentionCreditCARESActPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "EmployeeRetentionCreditCARESActPolicyPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Retention Credit", "label": "Employee Retention Credit, CARES Act, Policy [Policy Text Block]", "documentation": "Employee Retention Credit, CARES Act, Policy" } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current portion of operating lease obligations", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Operating Lease, Liability", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Operating Lease, Liability" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock", "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "cbus_TaxReceivableAgreementPercentageOfIncomeTaxSavingsRequiredToBePaid": { "xbrltype": "percentItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "TaxReceivableAgreementPercentageOfIncomeTaxSavingsRequiredToBePaid", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of income tax savings required to be paid under the TRA", "label": "Tax Receivable Agreement, Percentage Of Income Tax Savings Required To Be Paid", "documentation": "Tax Receivable Agreement, Percentage Of Income Tax Savings Required To Be Paid" } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "cbus_OperatingAndFinanceLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Noncurrent portion", "label": "Operating And Finance Lease, Liability, Noncurrent", "documentation": "Operating And Finance Lease, Liability, Noncurrent" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Less: interest", "label": "Operating And Finance Lease, Liability, Undiscounted Excess Amount", "documentation": "Operating and finance lease liability undiscounted excess amount." } } }, "auth_ref": [] }, "cbus_TwoThousandSeventeenOmnibusPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "TwoThousandSeventeenOmnibusPlanMember", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2017 Omnibus Plan", "label": "Two Thousand Seventeen Omnibus Plan [Member]", "documentation": "Two thousand seventeen omnibus plan." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock by Class", "label": "Schedule of Stock by Class [Table Text Block]", "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding." } } }, "auth_ref": [ "r35", "r73", "r79", "r80", "r81", "r82", "r83", "r84", "r129", "r130", "r159", "r160", "r161" ] }, "cbus_ClassOfWarrantOrRightExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ClassOfWarrantOrRightExercisable", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in shares)", "label": "Class Of Warrant Or Right, Exercisable", "documentation": "Class Of Warrant Or Right, Exercisable" } } }, "auth_ref": [] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash acquired from merger with Cibus Global, LLC", "label": "Cash Acquired from Acquisition", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r51" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r56", "r205", "r808" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock by Class [Table]", "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r74", "r79", "r80", "r81", "r82", "r83", "r84", "r159", "r160", "r161", "r213", "r214", "r215", "r274", "r435", "r436", "r437", "r439", "r442", "r447", "r449", "r709", "r710", "r711", "r712", "r824", "r926", "r951" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r213", "r214", "r215", "r274", "r435", "r436", "r437", "r439", "r442", "r447", "r449", "r709", "r710", "r711", "r712", "r824", "r926", "r951" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining Term (years)", "label": "Lessee, Operating Lease, Remaining Lease Term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1017" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Common Warrants Activity", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r22", "r112" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r22", "r112" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Cash", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r57", "r172" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Line Items]", "label": "Class of Warrant or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant activity, Fair Value [Roll Forward]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETS" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL AND INTANGIBLE ASSETS", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r149" ] }, "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances." } } }, "auth_ref": [ "r57" ] }, "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDeferredRevenueActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired from merger with Cibus Global, LLC", "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination." } } }, "auth_ref": [ "r825" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Mark to market adjustment", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r22" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails", "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r241", "r242", "r616", "r617", "r618", "r619", "r734", "r735", "r736", "r737", "r738", "r758", "r760", "r791" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted net loss per share of Class A common stock (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r229", "r254", "r255", "r256", "r257", "r258", "r265", "r268", "r269", "r270", "r272", "r566", "r567", "r676", "r693", "r812" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used) by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r233" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Domain]", "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r233" ] }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBAL" ], "lang": { "en-us": { "role": { "terseLabel": "MERGER WITH CIBUS GLOBAL", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings." } } }, "auth_ref": [ "r126", "r164" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "verboseLabel": "Risk Free Interest Rate", "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r1015" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Notes Payable, Gross", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r34", "r175", "r431" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r13", "r33" ] }, "us-gaap_OtherCommitmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsTable", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Commitments [Table]", "label": "Other Commitments [Table]", "documentation": "Disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeaseTermOfContract1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeFinanceLeaseTermOfContract1", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Useful Life (Years)", "label": "Lessee, Finance Lease, Term of Contract", "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1018" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "verboseLabel": "Offering costs", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration." } } }, "auth_ref": [ "r19", "r161" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r124", "r518", "r1033" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used by operating activities", "negatedTerseLabel": "Net cash used by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r143", "r144", "r145" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)", "label": "Finance Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r605", "r836" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonUnitOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonUnitOutstanding", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common units outstanding (in shares)", "label": "Common Unit, Outstanding", "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC)." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from Class A common stock issuance", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r7" ] }, "us-gaap_FairValueConcentrationOfRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueConcentrationOfRiskTable", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Concentration Of Risk [Table]", "label": "Fair Value, Concentration of Risk [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. Such disclosure may also include quantitative information about the market risks of financial instruments that is consistent with the way the Company manages or adjusts those risks." } } }, "auth_ref": [ "r114", "r115", "r170", "r171" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r488" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingStandardsUpdateExtensibleList", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Standards Update [Extensible Enumeration]", "label": "Accounting Standards Update [Extensible Enumeration]", "documentation": "Indicates amendment to accounting standards." } } }, "auth_ref": [ "r197", "r198", "r199", "r200", "r201", "r251", "r252", "r253", "r304", "r305", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r375", "r513", "r514", "r515", "r524", "r525", "r534", "r535", "r536", "r545", "r546", "r547", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r573", "r574", "r576", "r577", "r578", "r579", "r589", "r590", "r592", "r593", "r594", "r608", "r609", "r610", "r611", "r612", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r960" ] }, "us-gaap_OtherCommitmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsLineItems", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Commitments [Line Items]", "label": "Other Commitments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofOtherInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating cash flows (operating leases)", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r599", "r603" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash transactions not reported in the consolidated statement of cash flows", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable noncontrolling interest", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity." } } }, "auth_ref": [ "r75", "r76", "r77", "r78" ] }, "us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Concentration Of Risk Financial Statement Captions [Line Items]", "label": "Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMeasurementInput", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assumptions:", "label": "Warrants and Rights Outstanding, Measurement Input", "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur." } } }, "auth_ref": [ "r572" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofOtherInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments of financing lease obligations", "terseLabel": "Financing cash flows (finance leases)", "label": "Finance Lease, Principal Payments", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r598", "r603" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility, minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "cbus_RestrictedCommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RestrictedCommonClassAMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Common Class A", "label": "Restricted Common Class A [Member]", "documentation": "Restricted Common Class A" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility, maximum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate, minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r382", "r383", "r386", "r387" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate, maximum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Severance", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r66", "r69", "r658" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate funds received", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r52", "r709" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Establishment of financing lease right-of-use assets and associated operating lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability." } } }, "auth_ref": [ "r604", "r836" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r31", "r153" ] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Renewal term", "label": "Lessee, Operating Lease, Renewal Term", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1018" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r66", "r69" ] }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLongTermLinesOfCredit", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from draws on revolving line of credit from Cibus Global, LLC", "label": "Proceeds from Long-Term Lines of Credit", "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r52" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r605", "r836" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity." } } }, "auth_ref": [ "r31", "r153" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Establishment of operating lease right-of-use assets and associated operating lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r604", "r836" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r19", "r46", "r199", "r223", "r224", "r225", "r247", "r248", "r249", "r252", "r259", "r261", "r273", "r340", "r346", "r451", "r513", "r514", "r515", "r524", "r525", "r548", "r549", "r550", "r551", "r552", "r554", "r565", "r582", "r583", "r584", "r585", "r586", "r587", "r612", "r698", "r699", "r700", "r719", "r784" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r69" ] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Table]", "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r87" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-Lived Intangible Assets [Line Items]", "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-Term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r43", "r81", "r84", "r116", "r117", "r119", "r123", "r159", "r160", "r246", "r405", "r406", "r407", "r408", "r409", "r411", "r416", "r417", "r418", "r419", "r421", "r422", "r423", "r424", "r425", "r426", "r429", "r591", "r819", "r820", "r821", "r822", "r823", "r952" ] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued in transaction (in shares)", "label": "Sale of Stock, Number of Shares Issued in Transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, General and Administrative Expenses", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption." } } }, "auth_ref": [ "r15" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r851" ] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross Carrying Amount", "label": "Intangible Assets, Gross (Excluding Goodwill)", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r207" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Axis]", "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r87" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Domain]", "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds on issuance of common stock", "label": "Sale of Stock, Consideration Received on Transaction", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 }, "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "totalLabel": "Total", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r39", "r239", "r336", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r540", "r543", "r544", "r575", "r739", "r813", "r849", "r979", "r1025", "r1026" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYPreferredStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r129", "r435" ] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued consulting and professional fees", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock", "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual", "label": "Title of Individual [Domain]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Liabilities", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Unvested restricted stock units", "terseLabel": "Restricted Stock Units", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r382", "r383", "r386", "r387" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYPreferredStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r129", "r741" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares of Class A common stock outstanding - diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r264", "r270" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r19", "r129", "r130", "r161", "r719", "r784", "r798", "r848" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities, redeemable noncontrolling interest, and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r135", "r176", "r683", "r837", "r953", "r969", "r1016" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities, redeemable noncontrolling interest, and stockholders\u2019 equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Assets", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares of Class A common stock outstanding - basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r263", "r270" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r21" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fair Value of the Common Warrants", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r21" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYPreferredStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r129", "r435" ] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock resulting from merger with Cibus Global, LLC", "label": "Stock Issued During Period, Value, Acquisitions", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r19", "r46", "r161" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office furniture and equipment", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "totalLabel": "Intangible Assets, Net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r64", "r68" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r247", "r248", "r249", "r273", "r657", "r708", "r730", "r733", "r734", "r735", "r736", "r737", "r738", "r741", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r754", "r755", "r756", "r757", "r758", "r760", "r763", "r764", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r784", "r842" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r19", "r129", "r130", "r161", "r709", "r784", "r798" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r418", "r467", "r468", "r469", "r470", "r471", "r472", "r570", "r628", "r629", "r630", "r820", "r821", "r826", "r827", "r828" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails", "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r429", "r447", "r555", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r689", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r965", "r966", "r967", "r968" ] }, "us-gaap_ScheduleOfChangeInAssetRetirementObligationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfChangeInAssetRetirementObligationTableTextBlock", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Change in Asset Retirement Obligation", "label": "Schedule of Change in Asset Retirement Obligation [Table Text Block]", "documentation": "Tabular disclosure of the changes in carrying amount of a liability for asset retirement obligations, for changes such as new obligations, changes in estimates of existing obligations, spending on existing obligations, property dispositions, and foreign currency translation." } } }, "auth_ref": [ "r975" ] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings", "label": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r155" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwillAbstract", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]", "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Intangible Assets, Net", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r151", "r658" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r888" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r418", "r467", "r472", "r570", "r628", "r826", "r827", "r828" ] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and intangible asset impairment", "label": "Goodwill and Intangible Asset Impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense:", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r418", "r467", "r472", "r570", "r629", "r820", "r821", "r826", "r827", "r828" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r151", "r659" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-Lived Intangible Assets [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r369", "r372" ] }, "us-gaap_TemporaryEquityForeignCurrencyTranslationAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityForeignCurrencyTranslationAdjustments", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Temporary Equity, Foreign Currency Translation Adjustments", "documentation": "Adjustments to temporary equity resulting from foreign currency translation adjustments." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r67", "r153" ] }, "us-gaap_SeveranceCosts1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeveranceCosts1", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Severance costs", "label": "Severance Costs", "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r10" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableRollForward", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options Exercisable", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable [Roll Forward]", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable" } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r863", "r874", "r884", "r909" ] }, "cbus_SanDiegoCaliforniaHeadquartersLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "SanDiegoCaliforniaHeadquartersLeaseMember", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "San Diego, California headquarters lease", "label": "San Diego, California Headquarters Lease [Member]", "documentation": "San Diego, California Headquarters Lease" } } }, "auth_ref": [] }, "cbus_ClassOfWarrantOrRightFundamentalTransactionVotingThresholdPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ClassOfWarrantOrRightFundamentalTransactionVotingThresholdPercent", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fundamental Transaction voting threshold, percent", "label": "Class Of Warrant Or Right, Fundamental Transaction Voting Threshold, Percent", "documentation": "Class Of Warrant Or Right, Fundamental Transaction Voting Threshold, Percent" } } }, "auth_ref": [] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r857", "r868", "r878", "r903" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedFairValueOfAwardsGranted": { "xbrltype": "perShareItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEstimatedFairValueOfAwardsGranted", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair values of stock options granted (USD per share)", "label": "Share Based Compensation Arrangement By Share Based Payment Award Estimated Fair Value Of Awards Granted", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Estimated Fair Value Of Awards Granted" } } }, "auth_ref": [] }, "cbus_RestructuringAndRelatedCostNumberOfFullTimeEmployees": { "xbrltype": "integerItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RestructuringAndRelatedCostNumberOfFullTimeEmployees", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of full time employees", "label": "Restructuring And Related Cost, Number Of Full Time Employees", "documentation": "Restructuring And Related Cost, Number Of Full Time Employees" } } }, "auth_ref": [] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r861", "r872", "r882", "r907" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "lang": { "en-us": { "role": { "terseLabel": "BASIS OF PRESENTATION & SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r125", "r146", "r147", "r168" ] }, "cbus_RelatedPartyTransactionTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RelatedPartyTransactionTerm", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of agreement", "label": "Related Party Transaction, Term", "documentation": "Related Party Transaction, Term" } } }, "auth_ref": [] }, "cbus_DeemedDividendsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DeemedDividendsMember", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Deemed Dividends", "label": "Deemed Dividends [Member]", "documentation": "Non employee restricted stock units." } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r858", "r869", "r879", "r904" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r137", "r177", "r276", "r288", "r292", "r294", "r677", "r686", "r814" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r889" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant-date fair value", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value" } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearOne": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaidYearOne", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 4.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2024", "label": "Operating And Finance Lease, Liability, To Be Paid, Year One", "documentation": "Operating and finance lease liabilities payments next twelve months." } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r858", "r869", "r879", "r904" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r945" ] }, "cbus_RosevilleMnLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RosevilleMnLeaseMember", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Roseville, Minnesota lease", "label": "Roseville, MN Lease [Member]", "documentation": "Roseville, MN lease." } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r859", "r870", "r880", "r905" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r276", "r288", "r292", "r294", "r814" ] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaidRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaidRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 5.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Remainder of 2023", "label": "Operating And Finance Lease, Liability, To Be Paid, Remainder Of Fiscal Year", "documentation": "Operating and finance lease liabilities payments remainder of fiscal year." } } }, "auth_ref": [] }, "cbus_CibusIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CibusIncMember", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cibus, Inc.", "label": "Cibus, Inc. [Member]", "documentation": "Cibus, Inc." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r860", "r871", "r881", "r906" ] }, "cbus_DebtInstrumentWeightedAverageRemainingTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DebtInstrumentWeightedAverageRemainingTerm", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, weighted average remaining term", "label": "Debt Instrument, Weighted Average Remaining Term", "documentation": "Debt Instrument, Weighted Average Remaining Term" } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesRoyaltyLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesRoyaltyLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Royalty liability - related parties", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Royalty Liability", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Royalty Liability" } } }, "auth_ref": [] }, "cbus_NumberOfClassesOfStock": { "xbrltype": "integerItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "NumberOfClassesOfStock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of classes of stock", "label": "Number Of Classes Of Stock", "documentation": "Number Of Classes Of Stock" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r862", "r873", "r883", "r908" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r862", "r873", "r883", "r900", "r908" ] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Thereafter", "label": "Operating And Finance Lease, Liability, To Be Paid, After Year Five", "documentation": "Operating and finance lease liabilities payments after five years." } } }, "auth_ref": [] }, "cbus_CommonWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CommonWarrantsMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails", "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Warrants", "verboseLabel": "Common Warrants", "label": "Common Warrants [Member]", "documentation": "Common warrants." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring cost, expected amount", "label": "Restructuring and Related Cost, Expected Cost", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r382", "r385", "r386", "r388" ] }, "cbus_RelatedPartiesPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RelatedPartiesPolicyPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Royalty Liability - Related Parties", "label": "Related Parties, Policy [Policy Text Block]", "documentation": "Related Parties, Policy" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r91" ] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaidYearThree", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 6.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2026", "label": "Operating And Finance Lease, Liability, To Be Paid, Year Three", "documentation": "Operating and finance lease liabilities payments next three years." } } }, "auth_ref": [] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r864", "r875", "r885", "r910" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r152" ] }, "us-gaap_NumberOfReportingUnits": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportingUnits", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reporting units", "label": "Number of Reporting Units", "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment." } } }, "auth_ref": [] }, "cbus_ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in dollars per share)", "label": "Class Of Warrant Or Right, Exercisable, Weighted Average Exercise Price Of Warrants Or Rights", "documentation": "Class Of Warrant Or Right, Exercisable, Weighted Average Exercise Price Of Warrants Or Rights" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r152" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r862", "r873", "r883", "r908" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r891" ] }, "cbus_ForgivenessOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ForgivenessOfLongTermDebt", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forgiveness of interim funding resulting from merger with Cibus Global", "label": "Forgiveness Of Long-Term Debt", "documentation": "Forgiveness Of Long-Term Debt" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r152" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r152" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award requisite service period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r832" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r862", "r873", "r883", "r908" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r152" ] }, "cbus_FinancedEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "FinancedEquipmentMember", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financed Equipment", "label": "Financed Equipment [Member]", "documentation": "Financed Equipment" } } }, "auth_ref": [] }, "cbus_EstimatedFairValueOfCommonWarrantsMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "EstimatedFairValueOfCommonWarrantsMeasurementInput", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair value of Common Warrants", "label": "Estimated Fair Value of Common Warrants, Measurement Input", "documentation": "Estimated fair value of common warrants, measurement input." } } }, "auth_ref": [] }, "cbus_RelatedPartyTransactionRequiredPaymentToExtendAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RelatedPartyTransactionRequiredPaymentToExtendAgreement", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Required payment to extend agreement", "label": "Related Party Transaction, Required Payment To Extend Agreement", "documentation": "Related Party Transaction, Required Payment To Extend Agreement" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2023", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option, vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r832" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r863", "r874", "r884", "r909" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardStrikePricePercentageOfClosingSharePriceOnTheDateOfGrant": { "xbrltype": "percentItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStrikePricePercentageOfClosingSharePriceOnTheDateOfGrant", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options priced at fair market value, percent", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Strike Price Percentage Of Closing Share Price On The Date Of Grant", "documentation": "Option price at percentage of fair market value." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r862", "r873", "r883", "r908" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r862", "r873", "r883", "r908" ] }, "cbus_CharitableContributionObligationNetRoyaltyRevenueThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CharitableContributionObligationNetRoyaltyRevenueThreshold", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charitable contribution obligation, net royalty revenue threshold", "label": "Charitable Contribution Obligation, Net Royalty Revenue Threshold", "documentation": "Charitable Contribution Obligation, Net Royalty Revenue Threshold" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation expense, expected recognition weighted-average period", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r511" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "label": "Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "documentation": "A table containing detailed information about the characteristics and cost, by total and major class, of indefinite-lived intangible assets acquired as part of a business combination. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. The future benefit is not expected to diminish over a stated period of time. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total." } } }, "auth_ref": [ "r67", "r100" ] }, "cbus_InsuranceNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "InsuranceNotesMember", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance", "label": "Insurance Notes [Member]", "documentation": "Insurance Notes" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired in Merger Transaction", "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period." } } }, "auth_ref": [ "r66" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "cbus_IntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "IntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets Acquired As Part Of Business Combination [Table]", "label": "Intangible Assets Acquired As Part Of Business Combination [Table]", "documentation": "Intangible Assets Acquired As Part Of Business Combination" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets Acquired in Merger Transaction", "label": "Schedule of Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "documentation": "Tabular disclosure of characteristics and cost, by total and major class, of indefinite-lived intangible assets acquired as part of a business combination. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. The future benefit is not expected to diminish over a stated period of time. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total." } } }, "auth_ref": [ "r67", "r100" ] }, "cbus_LineOfCreditIncrementalDrawAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "LineOfCreditIncrementalDrawAmount", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit, incremental draw amount", "label": "Line Of Credit, Incremental Draw Amount", "documentation": "Line Of Credit, Incremental Draw Amount" } } }, "auth_ref": [] }, "cbus_OperatingLeaseAndFinanceLeaseLiabilityToBePaidFiscalYearMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingLeaseAndFinanceLeaseLiabilityToBePaidFiscalYearMaturityAbstract", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Operating Lease And Finance Lease, Liability, To Be Paid, Fiscal Year Maturity [Abstract]", "documentation": "Operating Lease And Finance Lease, Liability, To Be Paid, Fiscal Year Maturity" } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaid", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating and finance lease, liability, to be paid", "label": "Operating And Finance Lease, Liability, To Be Paid", "documentation": "Operating and finance lease liability payment due." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Increase (Decrease) in Employee Related Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r9" ] }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed." } } }, "auth_ref": [ "r66" ] }, "cbus_InducementPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "InducementPlanMember", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inducement Plan [Member]", "label": "Inducement Plan [Member]", "documentation": "Inducement plan." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r40", "r837" ] }, "cbus_AccruedRoyaltiesMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AccruedRoyaltiesMeasurementInput", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Royalty liability, measurement input", "label": "Accrued Royalties, Measurement Input", "documentation": "Accrued Royalties, Measurement Input" } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Shares withheld for net share settlement (in shares)", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Unvested performance stock units", "terseLabel": "Performance Stock Units", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r922" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r921" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "verboseLabel": "Cumulative effect of adoption of lease accounting standard on stockholders\u2019 equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r130", "r133", "r134", "r148", "r743", "r759", "r785", "r786", "r837", "r849", "r953", "r969", "r1016", "r1039" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r537" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r99" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited or expired (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r993" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r537" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited or expired (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r993" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r923" ] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r537" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r854", "r924" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "cbus_ElectingMembersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ElectingMembersMember", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Electing Members", "label": "Electing Members [Member]", "documentation": "Electing Members" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r58" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r58" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r854", "r924" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 16.0 }, "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "totalLabel": "Total", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accounts payable", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred revenue", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r854", "r924" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss Per Share of Class A Common Stock", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r58", "r59" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-operating income (expenses)", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r141" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property, plant, and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r142" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market funds", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r298", "r299" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r37", "r837" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r106", "r169", "r220", "r222", "r226", "r673", "r690" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, acquired during period", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r359", "r818" ] }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/COLLABORATIONAGREEMENT" ], "lang": { "en-us": { "role": { "terseLabel": "COLLABORATION AGREEMENT", "label": "Collaborative Arrangement Disclosure [Text Block]", "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants." } } }, "auth_ref": [ "r183", "r185", "r195" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive loss attributable to redeemable noncontrolling interest", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r8", "r103", "r106", "r220", "r222", "r227", "r674", "r691" ] }, "us-gaap_CollaborativeArrangementAccountingPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementAccountingPolicy", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Agreements Related to Contract Research", "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for collaborative arrangements." } } }, "auth_ref": [ "r187" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r247", "r248", "r249", "r273", "r657", "r708", "r730", "r733", "r734", "r735", "r736", "r737", "r738", "r741", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r754", "r755", "r756", "r757", "r758", "r760", "r763", "r764", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r784", "r842" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities, net of acquisitions:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r9" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r58" ] }, "us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredIndefiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired Indefinite-Lived Intangible Assets [Line Items]", "label": "Acquired Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r853" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Axis]", "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r571" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Domain]", "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price", "verboseLabel": "Shares issued for consideration in the merger with Cibus Global", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r2", "r3", "r16" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "verboseLabel": "Issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r130" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r886" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/INCOMETAXES" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r240", "r519", "r521", "r522", "r523", "r526", "r528", "r529", "r530", "r714" ] }, "cbus_ReceivableRelatedToSharesIssuedViaDebtRelatedArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ReceivableRelatedToSharesIssuedViaDebtRelatedArrangement", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivable from Jefferies for shares issued under ATM facility", "label": "Receivable Related To Shares Issued Via Debt Related Arrangement", "documentation": "Receivable from Jefferies for shares issued under ATM Facility." } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r130", "r680", "r837" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other current liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other non-current liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "verboseLabel": "Authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r130", "r741" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "verboseLabel": "Outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r19", "r130", "r741", "r759", "r1039", "r1040" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current portion of notes payable", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt", "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r925" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r537" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 24.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Notes payable, net of current portion", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt", "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r99" ] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [ "r475", "r961" ] }, "cbus_MinimumThresholdPercentageOfOwnershipInOutstandingCommonStockToEnactIndemnificationAgreement": { "xbrltype": "percentItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "MinimumThresholdPercentageOfOwnershipInOutstandingCommonStockToEnactIndemnificationAgreement", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold percentage of minimum ownership in outstanding common stock to enact indemnification agreement", "label": "Minimum Threshold Percentage Of Ownership In Outstanding Common Stock To Enact Indemnification Agreement", "documentation": "Threshold percentage of ownership in outstanding common stock to enact indemnification agreement." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Axis]", "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r616", "r617", "r1024" ] }, "cbus_OtherLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OtherLeasesMember", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other leases", "label": "Other Leases [Member]", "documentation": "Other Leases" } } }, "auth_ref": [] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash, Current", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r943", "r950" ] }, "cbus_ProctorGambleMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ProctorGambleMember", "presentation": [ "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proctor & Gamble", "label": "Proctor & Gamble [Member]", "documentation": "Proctor & Gamble" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual", "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r964", "r1023" ] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [ "r262", "r475", "r927", "r929", "r961" ] }, "cbus_LesseeOperatingLeaseNumberOfRenewalOptions": { "xbrltype": "integerItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "LesseeOperatingLeaseNumberOfRenewalOptions", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of renewal options", "label": "Lessee, Operating Lease, Number Of Renewal Options", "documentation": "Lessee, Operating Lease, Number Of Renewal Options" } } }, "auth_ref": [] }, "cbus_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateAttributableToRedeemableNoncontrollingInterestActual": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateAttributableToRedeemableNoncontrollingInterestActual", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss of acquiree since acquisition date, attributable to noncontrolling interest", "label": "Business Combination, Pro Forma Information, Earnings Or Loss Of Acquiree Since Acquisition Date, Attributable To Redeemable Noncontrolling Interest, Actual", "documentation": "Business Combination, Pro Forma Information, Earnings Or Loss Of Acquiree Since Acquisition Date, Attributable To Redeemable Noncontrolling Interest, Actual" } } }, "auth_ref": [] }, "cbus_AccruedRoyaltiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AccruedRoyaltiesNoncurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Royalty liability - related parties", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Accrued Royalties, Noncurrent", "documentation": "Accrued Royalties, Noncurrent" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [ "r262", "r475", "r927", "r961" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r418", "r467", "r468", "r469", "r470", "r471", "r472", "r628", "r629", "r630", "r820", "r821", "r826", "r827", "r828" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableForfeituresAndExpirationsInPeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited or expired (in shares)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period" } } }, "auth_ref": [] }, "cbus_AccruedRoyaltiesAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AccruedRoyaltiesAcquiredDuringPeriod", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired from merger with Cibus Global, LLC", "label": "Accrued Royalties, Acquired During Period", "documentation": "Accrued Royalties, Acquired During Period" } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "cbus_OperatingAndFinanceLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Current portion", "label": "Operating And Finance Lease, Liability, Current", "documentation": "Operating And Finance Lease, Liability, Current" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Discount Rate", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r1015" ] }, "cbus_CommonAndPreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CommonAndPreferredStockSharesAuthorized", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common and preferred stock, shares authorized (in shares)", "label": "Common And Preferred Stock, Shares Authorized", "documentation": "Common And Preferred Stock, Shares Authorized" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Lease Expense, Supplemental Cash Flow Information Related to Leases, and Supplemental Balance Sheet Information Related to Leases", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1019" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r143" ] }, "cbus_RelatedPartyTransactionRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RelatedPartyTransactionRenewalTerm", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Renewal term", "label": "Related Party Transaction, Renewal Term", "documentation": "Related Party Transaction, Renewal Term" } } }, "auth_ref": [] }, "cbus_CellectisMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CellectisMember", "presentation": [ "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cellectis", "label": "Cellectis [Member]", "documentation": "Cellectis." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term to liquidation (in years)", "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r1015" ] }, "cbus_CalyxtIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CalyxtIncMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Calyxt, Inc.", "label": "Calyxt, Inc. [Member]", "documentation": "Calyxt, Inc." } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r581" ] }, "cbus_InterimFundingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "InterimFundingAgreementMember", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interim Funding Agreement", "label": "Interim Funding Agreement [Member]", "documentation": "Interim Funding Agreement" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputOptionVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputOptionVolatilityMember", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueoftheCommonWarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Measurement Input, Option Volatility [Member]", "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns." } } }, "auth_ref": [ "r1015" ] }, "cbus_ContractWithCustomerLiabilityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ContractWithCustomerLiabilityRollForward", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDeferredRevenueActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with Customer, Liability [Roll Forward]", "label": "Contract with Customer, Liability [Roll Forward]", "documentation": "Contract with Customer, Liability" } } }, "auth_ref": [] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r890" ] }, "cbus_RelatedPartyTransactionTwelveMonthRevenueThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "RelatedPartyTransactionTwelveMonthRevenueThreshold", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subject revenue threshold, minimum", "label": "Related Party Transaction, Twelve Month Revenue Threshold", "documentation": "Related Party Transaction, Twelve Month Revenue Threshold" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash \u2013 beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash \u2013 end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r56", "r143", "r236" ] }, "cbus_DisclosureOfShareBasedCompensationAwardsRestrictedStockUnitsDeemedDividendsTableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DisclosureOfShareBasedCompensationAwardsRestrictedStockUnitsDeemedDividendsTableTableTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock-Based Compensation Granted As Deemed Dividends", "label": "Disclosure Of Share Based Compensation Awards Restricted Stock Units Deemed Dividends Table [Table Text Block]", "documentation": "Disclosure of share-based compensation awards restricted stock units deemed dividends." } } }, "auth_ref": [] }, "cbus_CommonUnitConvertibleConversionRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "CommonUnitConvertibleConversionRatio", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common unit conversion ratio", "label": "Common Unit, Convertible, Conversion Ratio", "documentation": "Common Unit, Convertible, Conversion Ratio" } } }, "auth_ref": [] }, "cbus_BusinessCombinationNumberOfSharesIssuedToElectiveMembersCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationNumberOfSharesIssuedToElectiveMembersCommonStock", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Common Stock shares included in Up-C Units (in shares)", "label": "Business Combination, Number Of Shares Issued To Elective Members, Common Stock", "documentation": "Business Combination, Number Of Shares Issued To Elective Members, Common Stock" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Revenue Activity", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability." } } }, "auth_ref": [ "r984" ] }, "us-gaap_ProceedsFromLegalSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLegalSettlements", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from legal settlements", "label": "Proceeds from Legal Settlements", "documentation": "Cash received for the settlement of litigation during the current period." } } }, "auth_ref": [ "r55" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r597" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r607" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityCurrent", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Current portion of operating lease obligations", "terseLabel": "Current portion", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r597" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r839", "r840", "r841", "r843", "r844", "r845", "r846", "r957", "r958", "r1014", "r1035", "r1039" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r888" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets in progress", "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r580" ] }, "us-gaap_CashAndCashEquivalentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAxis", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Axis]", "label": "Cash and Cash Equivalents [Axis]", "documentation": "Information by type of cash and cash equivalent balance." } } }, "auth_ref": [ "r205" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining contractual term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r501" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityNoncurrent", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease obligations, net of current portion", "terseLabel": "Noncurrent portion", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r597" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Grant Date Fair Value of Awards Vested", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]", "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r162" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Royalty Liability", "label": "Schedule of Related Party Transactions [Table Text Block]", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r374", "r384", "r769" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Land, buildings, and equipment useful Life", "terseLabel": "Useful Life (Years)", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNET" ], "lang": { "en-us": { "role": { "terseLabel": "PROPERTY, PLANT, AND EQUIPMENT, NET", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r154", "r188", "r191", "r192" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r384", "r769" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r231", "r234", "r235" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r588", "r623" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r502" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r28", "r29", "r89" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fair Values of Stock Options Granted and Assumptions used in Black-Scholes Model", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r163" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2023", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r956" ] }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Nonvested Share Activity", "label": "Schedule of Nonvested Share Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested shares." } } }, "auth_ref": [ "r90" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated stock compensation expense", "label": "Share-Based Payment Arrangement, Accelerated Cost", "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r98", "r99" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r155" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Acquired finite-lived intangibles", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r98", "r99" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r601", "r836" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATION" ], "lang": { "en-us": { "role": { "terseLabel": "STOCK-BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r476", "r480", "r508", "r509", "r512", "r832" ] }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing", "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofLeaseCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease costs", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r602", "r836" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r132", "r161", "r682", "r702", "r707", "r713", "r742", "r837" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average amortization period for definite lived intangible assets", "terseLabel": "Estimated Average Useful Life (Years)", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r150" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails", "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party, Type [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r473", "r616", "r617", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r734", "r735", "r736", "r737", "r738", "r758", "r760", "r791", "r1024" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r600" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "negatedTerseLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r202", "r219", "r221", "r232", "r239", "r251", "r260", "r261", "r276", "r288", "r292", "r294", "r336", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r538", "r541", "r542", "r567", "r575", "r677", "r687", "r718", "r761", "r782", "r783", "r814", "r834", "r835", "r848", "r948", "r979" ] }, "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Redeemable noncontrolling interest resulting from merger with Cibus Global, LLC", "label": "Temporary Equity, Stock Issued During Period, Value, New Issues", "documentation": "Value of new stock classified as temporary equity issued during the period." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r391", "r392", "r393", "r394", "r466", "r474", "r503", "r504", "r505", "r631", "r655", "r695", "r731", "r732", "r792", "r793", "r794", "r795", "r796", "r805", "r806", "r816", "r824", "r831", "r838", "r841", "r976", "r983", "r1028", "r1029", "r1030", "r1031", "r1032" ] }, "us-gaap_LesseeFinanceLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeFinanceLeasesTextBlock", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "terseLabel": "LEASES, COMMITMENTS, AND CONTINGENCIES", "label": "Lessee, Finance Leases [Text Block]", "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability." } } }, "auth_ref": [ "r595" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: interest", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r118", "r416", "r432", "r820", "r821" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses incurred in connection with Merger", "label": "Business Combination, Acquisition Related Costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r94" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r391", "r392", "r393", "r394", "r474", "r655", "r695", "r731", "r732", "r792", "r793", "r794", "r795", "r796", "r805", "r806", "r816", "r824", "r831", "r838", "r983", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r391", "r392", "r393", "r394", "r466", "r474", "r503", "r504", "r505", "r631", "r655", "r695", "r731", "r732", "r792", "r793", "r794", "r795", "r796", "r805", "r806", "r816", "r824", "r831", "r838", "r841", "r976", "r983", "r1028", "r1029", "r1030", "r1031", "r1032" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r892" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets Amortization Expense", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r391", "r392", "r393", "r394", "r474", "r655", "r695", "r731", "r732", "r792", "r793", "r794", "r795", "r796", "r805", "r806", "r816", "r824", "r831", "r838", "r983", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option expiration period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r833" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r40" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r243", "r244", "r408", "r437", "r619", "r810", "r811" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r48", "r49", "r136", "r216", "r681", "r703", "r707" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETTables" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r851" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal Entity [Axis]", "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting rights, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r987" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYCibusCommonUnitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity [Domain]", "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "crdr": "debit", "calculation": { "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease, right-of-use asset, before accumulated amortization", "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r930" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r208", "r371" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "terseLabel": "LEASES, COMMITMENTS, AND CONTINGENCIES", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r595" ] }, "us-gaap_AccruedLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrentAbstract", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Expenses:", "label": "Accrued Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_NotesPayableOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableOtherPayablesMember", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes Payable", "label": "Notes Payable, Other Payables [Member]", "documentation": "A written promise to pay a note to a third party." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r851" ] }, "srt_CondensedCashFlowStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedCashFlowStatementsCaptionsLineItems", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Condensed Cash Flow Statements, Captions [Line Items]", "label": "Condensed Cash Flow Statements, Captions [Line Items]" } } }, "auth_ref": [ "r246", "r928" ] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "crdr": "credit", "calculation": { "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less accumulated depreciation and amortization", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization", "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease." } } }, "auth_ref": [ "r931", "r934", "r974" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total property, plant, and equipment", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization", "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset." } } }, "auth_ref": [ "r930", "r944", "r973" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "terseLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r41", "r204", "r239", "r336", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r540", "r543", "r544", "r575", "r837", "r979", "r1025", "r1026" ] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivable", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Accounts Receivable", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Accounts Receivable" } } }, "auth_ref": [] }, "cbus_FollowOnPublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "FollowOnPublicOfferingMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Follow-on Public Offering", "label": "Follow On Public Offering [Member]", "documentation": "Follow on public offering." } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r246", "r539", "r540", "r543", "r544", "r621", "r804", "r978", "r981", "r982" ] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Table]", "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r38", "r952" ] }, "cbus_StockIssuedDuringPeriodSharesWarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of class A common stock upon exercise of per-funded warrants (in shares)", "label": "Stock Issued During Period, Shares, Warrants Exercised", "documentation": "Stock Issued During Period, Shares, Warrants Exercised" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assumptions:", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r10", "r71" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "cbus_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant, and equipment acquired through assuming liabilities", "label": "Noncash Or Part Noncash Acquisition Fixed Assets Acquired", "documentation": "Noncash Or Part Noncash Acquisition Fixed Assets Acquired" } } }, "auth_ref": [] }, "cbus_MeasurementInputInflationRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "MeasurementInputInflationRateMember", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inflation Rate", "label": "Measurement Input, Inflation Rate [Member]", "documentation": "Measurement Input, Inflation Rate" } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivable", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Notes Receivable", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Notes Receivable" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "cbus_TemporaryEquityChangeInValueOfRedeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "TemporaryEquityChangeInValueOfRedeemableNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Change in value of redeemable noncontrolling interest", "label": "Temporary Equity, Change In Value Of Redeemable Noncontrolling Interest", "documentation": "Temporary Equity, Change In Value Of Redeemable Noncontrolling Interest" } } }, "auth_ref": [] }, "cbus_ClassOfWarrantOrRightOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ClassOfWarrantOrRightOutstandingAbstract", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Warrants", "label": "Class Of Warrant Or Right, Outstanding [Abstract]", "documentation": "Class Of Warrant Or Right, Outstanding" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation (benefit) expense", "verboseLabel": "Total", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r507", "r516" ] }, "cbus_LineOfCreditFinancingThresholdForTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "LineOfCreditFinancingThresholdForTermination", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit, financing threshold for termination", "label": "Line Of Credit, Financing Threshold For Termination", "documentation": "Line Of Credit, Financing Threshold For Termination" } } }, "auth_ref": [] }, "cbus_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePriceOfWarrantsOrRights", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding (in dollars per share)", "label": "Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights", "documentation": "Class Of Warrant Or Right, Outstanding, Weighted Average Exercise Price Of Warrants Or Rights" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cbus_GreenhouseLeaseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "GreenhouseLeaseMember", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Greenhouse Lease", "label": "Greenhouse Lease [Member]", "documentation": "Greenhouse Lease" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments of notes payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r54" ] }, "cbus_AdjustmentsToAdditionalPaidInCapitalRedeemableNoncontrollingInterestsResultingFromMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalRedeemableNoncontrollingInterestsResultingFromMerger", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Redeemable noncontrolling interest resulting from merger with Cibus Global, LLC", "label": "Adjustments To Additional Paid In Capital, Redeemable Noncontrolling Interests Resulting From Merger", "documentation": "Adjustments To Additional Paid In Capital, Redeemable Noncontrolling Interests Resulting From Merger" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity, Primary Beneficiary", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r104", "r539", "r540", "r543", "r544" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableVestedInPeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period" } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Operating And Finance Lease, Liability", "documentation": "Lessee operating and finance lease liability." } } }, "auth_ref": [] }, "us-gaap_UnsecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebtMember", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Debt", "label": "Unsecured Debt [Member]", "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "cbus_ShareBasedCompensationArrangementGrantedSharesNumberOfEmployees": { "xbrltype": "integerItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementGrantedSharesNumberOfEmployees", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of employees", "label": "Share Based Compensation Arrangement, Granted Shares, Number Of Employees", "documentation": "Share Based Compensation Arrangement, Granted Shares, Number Of Employees" } } }, "auth_ref": [] }, "cbus_ContractWithCustomerLiabilityConsiderationEarned": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ContractWithCustomerLiabilityConsiderationEarned", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDeferredRevenueActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Consideration earned", "label": "Contract With Customer, Liability, Consideration Earned", "documentation": "Contract With Customer, Liability, Consideration Earned" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityOwnershipPercentage", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable interest entity, ownership percentage", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)." } } }, "auth_ref": [ "r105" ] }, "cbus_IntangibleAssetsAcquiredAsPartOfBusinessCombinationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "IntangibleAssetsAcquiredAsPartOfBusinessCombinationLineItems", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets Acquired As Part Of Business Combination [Line Items]", "label": "Intangible Assets Acquired As Part Of Business Combination [Line Items]", "documentation": "Intangible Assets Acquired As Part Of Business Combination" } } }, "auth_ref": [] }, "cbus_DisclosureOfWarrantsTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DisclosureOfWarrantsTransactionsTable", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of Warrants Transactions [Table]", "label": "Disclosure of Warrants Transactions [Table]", "documentation": "disclosure of warrants transactions." } } }, "auth_ref": [] }, "cbus_AnnualLicensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AnnualLicensesMember", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual Licenses", "label": "Annual Licenses [Member]", "documentation": "Annual Licenses" } } }, "auth_ref": [] }, "cbus_InterestExpenseRoyaltyLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "InterestExpenseRoyaltyLiability", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Royalty liability interest expense - related parties", "verboseLabel": "Royalty liability interest expense - related parties", "terseLabel": "Interest expense recognized", "label": "Interest Expense, Royalty Liability", "documentation": "Interest Expense, Royalty Liability" } } }, "auth_ref": [] }, "cbus_WarrantExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "WarrantExchangeAgreementMember", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Exchange Agreement", "label": "Warrant Exchange Agreement [Member]", "documentation": "Warrant Exchange Agreement" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price of warrants (in dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r450" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Warrants", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r839", "r840", "r843", "r844", "r845", "r846" ] }, "cbus_AccruedFieldTrialsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AccruedFieldTrialsCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued field trials", "label": "Accrued Field Trials, Current", "documentation": "Accrued Field Trials, Current" } } }, "auth_ref": [] }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionDomain", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Effect, Period of Adoption [Domain]", "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "auth_ref": [ "r199", "r250", "r256", "r262", "r340", "r346", "r513", "r514", "r515", "r524", "r525", "r548", "r549", "r550", "r552", "r553", "r554", "r560", "r563", "r565", "r566", "r610" ] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesEmployeeRelatedLiabilities", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accrued compensation", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Employee-Related Liabilities", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Employee-Related Liabilities" } } }, "auth_ref": [] }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionAxis", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Effect, Period of Adoption [Axis]", "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "auth_ref": [ "r199", "r250", "r256", "r262", "r340", "r346", "r513", "r514", "r515", "r524", "r525", "r548", "r549", "r550", "r552", "r553", "r554", "r560", "r563", "r565", "r566", "r610" ] }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "auth_ref": [ "r199", "r250", "r256", "r262", "r340", "r346", "r513", "r514", "r515", "r524", "r525", "r548", "r549", "r550", "r552", "r553", "r554", "r560", "r563", "r565", "r566", "r610" ] }, "cbus_AccruedRoyaltiesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "AccruedRoyaltiesRollForward", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Royalties [Roll Forward]", "label": "Accrued Royalties [Roll Forward]", "documentation": "Accrued Royalties" } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Operating lease obligations, net of current portion", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Noncurrent Liabilities, Operating Lease, Liability" } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaidYearTwo", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2025", "label": "Operating And Finance Lease, Liability, To Be Paid, Year Two", "documentation": "Operating and finance lease liabilities payments next two years." } } }, "auth_ref": [] }, "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "OperatingAndFinanceLeaseLiabilityToBePaidYearFour", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_2": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 7.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2027", "label": "Operating And Finance Lease, Liability, To Be Paid, Year Four", "documentation": "Operating and finance lease liabilities payments next four years." } } }, "auth_ref": [] }, "cbus_LineOfCreditFacilityMaximumBorrowingIncrements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "LineOfCreditFacilityMaximumBorrowingIncrements", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing increments", "label": "Line Of Credit Facility, Maximum Borrowing Increments", "documentation": "Line Of Credit Facility, Maximum Borrowing Increments" } } }, "auth_ref": [] }, "cbus_PreFundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "PreFundedWarrantsMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-Funded Warrants", "label": "Pre-Funded Warrants [Member]", "documentation": "Pre funded warrants." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenues", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r656", "r949" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited or expired (in dollars per share)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period, Weighted Average Exercise Price", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Forfeitures And Expirations In Period, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Shares withheld for net share settlement", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "cbus_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOtherReceivables", "crdr": "debit", "calculation": { "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due from related parties, net", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Other Receivables", "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Other Receivables" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant, and equipment, net", "totalLabel": "Total", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset." } } }, "auth_ref": [ "r934", "r972" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeasesOperatingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesOperatingAbstract", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating", "label": "Leases, Operating [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition and Contract Liabilities", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r194", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r807" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDING", "http://www.cibus.com/role/NOTESPAYABLE" ], "lang": { "en-us": { "role": { "verboseLabel": "NOTES PAYABLE", "terseLabel": "INTERIM FUNDING", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r157", "r237", "r404", "r410", "r411", "r412", "r413", "r414", "r415", "r420", "r427", "r428", "r430" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r818" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r658" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Acquired Intangible Assets", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r14", "r63" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro forma revenues", "label": "Business Acquisition, Pro Forma Revenue", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r531", "r532" ] }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r818" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pro forma net loss", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r531", "r532" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fair Value Measurements and Financial Statement Presentation", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r111", "r113" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue of acquiree since acquisition date", "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period." } } }, "auth_ref": [ "r96" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r368", "r370", "r371", "r373", "r658", "r659" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of Common Stock received by Cibus Global, LLC equityholders as merger consideration (in shares)", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r167" ] }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss of acquiree since acquisition date, attributable to controlling interest", "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual", "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period." } } }, "auth_ref": [ "r96" ] }, "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]", "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]", "documentation": "Schedule of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information)." } } }, "auth_ref": [ "r30" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails", "http://www.cibus.com/role/RELATEDPARTYTRANSACTIONSDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party, Type [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r473", "r616", "r617", "r734", "r735", "r736", "r737", "r738", "r758", "r760", "r791" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r281", "r282", "r283", "r284", "r285", "r286", "r296", "r815" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r66", "r69" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of securities called by each warrant (in shares)", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r60", "r61", "r62", "r184", "r186", "r189", "r190" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease right-of-use assets", "terseLabel": "Right-of-Use-Asset", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r596" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r279" ] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISK" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE AND CONCENTRATIONS OF CREDIT RISK", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r569" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal and professional fees", "label": "Professional Fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r847", "r1037", "r1038" ] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse stock split conversion ratio", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r36" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating", "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDeferredRevenueActivityDetails", "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "verboseLabel": "Deferred revenue for upfront payments", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r452", "r453", "r464" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r20", "r107", "r108", "r109", "r110", "r245" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Basic net loss per share of Class A common stock (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r229", "r254", "r255", "r256", "r257", "r258", "r263", "r265", "r268", "r269", "r270", "r272", "r566", "r567", "r676", "r693", "r812" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Offering price (in dollars per share)", "label": "Shares Issued, Price Per Share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/COLLABORATIONAGREEMENTDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenue", "verboseLabel": "Revenue from collaboration agreement", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r277", "r278", "r287", "r290", "r291", "r295", "r296", "r297", "r462", "r463", "r657" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Current portion of notes payable", "terseLabel": "Current portion", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r211" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r155" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r911" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r913" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/COVERPAGE", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r196", "r213", "r214", "r215", "r239", "r265", "r266", "r268", "r270", "r274", "r275", "r336", "r395", "r397", "r398", "r399", "r402", "r403", "r435", "r436", "r439", "r442", "r449", "r575", "r709", "r710", "r711", "r712", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r741", "r762", "r784", "r797", "r798", "r799", "r800", "r801", "r926", "r951", "r962" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r217", "r302", "r347" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTS" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r622", "r624" ] }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNonoperatingNet", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Other interest income (expense), net", "label": "Interest Income (Expense), Nonoperating, Net", "documentation": "The net amount of nonoperating interest income (expense)." } } }, "auth_ref": [] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r911" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Statements of Certain Statements of Cash Flows Amounts", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "srt_CondensedCashFlowStatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedCashFlowStatementTable", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSupplementalCashFlowsInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Condensed Cash Flow Statement [Table]", "label": "Condensed Cash Flow Statement [Table]" } } }, "auth_ref": [ "r246", "r928" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r911" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r246", "r422" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r246", "r422" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r246", "r422" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r911" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r246", "r422" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r246", "r422" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Notes payable, net of current portion", "terseLabel": "Noncurrent portion", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r212" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r911" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land, buildings, and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r155", "r206", "r685" ] }, "cbus_NonoperatingIncomeExpensePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "NonoperatingIncomeExpensePolicyPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Operating Income (Expenses)", "label": "Nonoperating Income (Expense), Policy [Policy Text Block]", "documentation": "Nonoperating Income (Expense), Policy" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance as of December 31, 2022", "periodEndLabel": "Balance as of September 30, 2023", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r22" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Shares in Treasury", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r85" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r911" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock, shares (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r85" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Class A common stock in treasury, at cost; 32,660 shares as of September\u00a030, 2023, and 2,007 shares as of December\u00a031, 2022", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r47", "r85", "r86" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r912" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r6" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r588", "r623" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r65", "r70" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant, and Equipment, net", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r11", "r188", "r191", "r684" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r911" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Outstanding debt balance", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r34", "r175", "r417", "r433", "r820", "r821", "r1034" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r912" ] }, "us-gaap_FinanceLeaseLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityAbstract", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing", "label": "Finance Lease, Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r488" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Due to/from related parties", "label": "Increase (Decrease) in Other Current Liabilities", "documentation": "Amount of increase (decrease) in current liabilities classified as other." } } }, "auth_ref": [ "r949" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r489" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r915" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r914" ] }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss attributable to redeemable noncontrolling interest", "verboseLabel": "Net loss", "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest." } } }, "auth_ref": [ "r139" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price Per Share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r597", "r607" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: interest", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r607" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r42", "r406" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r209" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Current portion of financing lease obligations", "terseLabel": "Current portion", "label": "Finance Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r597" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Finance lease, liability, to be paid", "label": "Finance Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r607" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Financing lease obligations, net of current portion", "terseLabel": "Noncurrent portion", "label": "Finance Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r597" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash used by operating activities:", "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, expected tax deductible amount", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes." } } }, "auth_ref": [ "r102" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Finance Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss attributable to Cibus, Inc.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r50", "r220", "r222", "r228", "r675", "r692" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r95", "r97", "r533", "r829", "r830" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYATMFacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "documentation": "Different names of stock transactions and the different attributes of each transaction." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails", "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r43", "r246", "r405", "r406", "r407", "r408", "r409", "r411", "r416", "r417", "r418", "r419", "r421", "r422", "r423", "r424", "r425", "r426", "r591", "r819", "r820", "r821", "r822", "r823", "r952" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearOne", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Finance Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation expense related to non-vested stock options", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1013" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price Per Share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r1013" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearFive", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finance Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALBusinessAcquisitionProFormaInformationDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r533", "r829", "r830" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r203", "r218", "r239", "r336", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r539", "r543", "r575", "r837", "r979", "r980", "r1025" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearFour", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finance Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearThree", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finance Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Awards/Units", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearTwo", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finance Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidRemainderOfFiscalYear", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2023", "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r1020" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r892" ] }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Lease, Liability, to be Paid, Maturity", "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1020" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r95", "r97", "r533" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r533" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALTables" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Pro Forma Information", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r932", "r933" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofCommonWarrantsActivityDetails", "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r429", "r447", "r555", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r689", "r817", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r965", "r966", "r967", "r968" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r850" ] }, "us-gaap_TradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeNamesMember", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade name", "label": "Trade Names [Member]", "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r101" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r246", "r405", "r406", "r407", "r408", "r409", "r411", "r416", "r417", "r418", "r419", "r421", "r422", "r423", "r424", "r425", "r426", "r429", "r591", "r819", "r820", "r821", "r822", "r823", "r952" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/NOTESPAYABLENarrativeDetails", "http://www.cibus.com/role/NOTESPAYABLEScheduleofFutureMinimumPaymentsUnderNotesPayableDetails", "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r34", "r127", "r128", "r174", "r175", "r246", "r405", "r406", "r407", "r408", "r409", "r411", "r416", "r417", "r418", "r419", "r421", "r422", "r423", "r424", "r425", "r426", "r591", "r819", "r820", "r821", "r822", "r823", "r952" ] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Multiplied by the fair value per share of Cibus, Inc. Class A Common Stock (in dollars per share)", "label": "Business Acquisition, Share Price", "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r852" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r271" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money Market Funds", "label": "Money Market Funds [Member]", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r985" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r58" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r900" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized from deferred revenue balance", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r465" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 }, "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r207", "r356", "r672", "r818", "r837", "r970", "r971" ] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonrelatedPartyMember", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofRecognizedthePreliminaryAllocationoftheConsiderationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonrelated Party", "label": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r954", "r955" ] }, "us-gaap_AssetRetirementObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligation", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofChangeinAssetRetirementObligationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Asset Retirement Obligation", "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees." } } }, "auth_ref": [ "r377", "r379" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails_1": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-process research and development", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r153" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Expenses", "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r517" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r890" ] }, "us-gaap_AssetRetirementObligationAccretionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationAccretionExpense", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofChangeinAssetRetirementObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accretion expense", "label": "Asset Retirement Obligation, Accretion Expense", "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability." } } }, "auth_ref": [ "r378", "r381" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetRetirementObligationLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofChangeinAssetRetirementObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Obligations incurred", "label": "Asset Retirement Obligation, Liabilities Incurred", "documentation": "Amount of asset retirement obligations incurred during the period." } } }, "auth_ref": [ "r380" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (See Note 10)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r45", "r122", "r679", "r740" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r856", "r867", "r877", "r902" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of taxes related to vested restricted stock units", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r230" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r179", "r180", "r181", "r300", "r301", "r303" ] }, "us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationRollForwardAnalysisRollForward", "presentation": [ "http://www.cibus.com/role/PROPERTYPLANTANDEQUIPMENTNETScheduleofChangeinAssetRetirementObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]", "label": "Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue:", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r900" ] }, "us-gaap_AssetRetirementObligationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetRetirementObligationsPolicy", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Retirement Obligation", "label": "Asset Retirement Obligation [Policy Text Block]", "documentation": "Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset." } } }, "auth_ref": [ "r376" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r888" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r887" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r900" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r900" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r865", "r873", "r883", "r900", "r908", "r912", "r920" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r865", "r873", "r883", "r900", "r908", "r912", "r920" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r889" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r855", "r866", "r876", "r901" ] }, "us-gaap_OperatingLeasedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasedAssetsLineItems", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leased Assets [Line Items]", "label": "Operating Leased Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r891" ] }, "us-gaap_ScheduleOfOperatingLeasedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOperatingLeasedAssetsTable", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESScheduleofNonCancellableOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Operating Leased Assets [Table]", "label": "Schedule of Operating Leased Assets [Table]", "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r855", "r866", "r876", "r901" ] }, "srt_AffiliatedEntityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AffiliatedEntityMember", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Affiliated Entity", "label": "Affiliated Entity [Member]" } } }, "auth_ref": [ "r760", "r804", "r842", "r986", "r1021", "r1022", "r1024" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche One", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents [Domain]", "label": "Cash and Cash Equivalents [Domain]", "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r205" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearFive", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearFour", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_InProcessResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InProcessResearchAndDevelopmentMember", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-process research and development", "label": "In Process Research and Development [Member]", "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearThree", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearTwo", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r892" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidRemainderOfFiscalYear", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2023", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r1020" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Operating Lease, Liability, to be Paid, Maturity", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1020" ] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche Two", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r892" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r851" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions [Abstract]", "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r140" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.cibus.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "verboseLabel": "Income tax provision", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r182", "r193", "r260", "r261", "r280", "r520", "r527", "r694" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r892" ] }, "cbus_DebtInstrumentCovenantUnrestrictedCashBalanceThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "DebtInstrumentCovenantUnrestrictedCashBalanceThreshold", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrestricted cash balance threshold", "label": "Debt Instrument, Covenant, Unrestricted Cash Balance Threshold", "documentation": "Debt Instrument, Covenant, Unrestricted Cash Balance Threshold" } } }, "auth_ref": [] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r892" ] }, "srt_ManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ManagementMember", "presentation": [ "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESNarrativeDetails", "http://www.cibus.com/role/ROYALTYLIABILITYRELATEDPARTIESScheduleofRoyaltyLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Management", "label": "Management [Member]" } } }, "auth_ref": [ "r964", "r1023" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r893" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.cibus.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofIntangibleAssetsAcquiredinMergerTransactionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r166" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r92", "r93", "r478" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r893" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r963" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r893" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails", "http://www.cibus.com/role/SUBSEQUENTEVENTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r38" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r893" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r893" ] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of liability classified Class A common stock warrants", "label": "Fair Value Adjustment of Warrants", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r1", "r10" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r893" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "srt_ExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExecutiveOfficerMember", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Officer", "label": "Executive Officer [Member]" } } }, "auth_ref": [ "r964" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r851" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r893" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock options outstanding", "terseLabel": "Stock Options", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r894" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r851" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r896" ] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://www.cibus.com/role/INTERIMFUNDINGDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Line Items]", "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r952" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r895" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995", "r996", "r997", "r998", "r999", "r1000", "r1001", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r898" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.cibus.com/role/COVERPAGE" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r851" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r897" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r246", "r539", "r540", "r543", "r544", "r621", "r804", "r978", "r981", "r982" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r898" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r921" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r496" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r918" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unvested beginning balance (in shares)", "periodEndLabel": "Unvested ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r492", "r493" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.cibus.com/role/NOTESPAYABLETables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Minimum Payments Under Notes Payable", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r12" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r919" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.cibus.com/role/FINANCIALINSTRUMENTSMEASUREDATFAIRVALUEANDCONCENTRATIONSOFCREDITRISKSummaryofFairValueMeasurementsandFinancialStatementPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r418", "r467", "r468", "r469", "r470", "r471", "r472", "r570", "r630", "r820", "r821", "r826", "r827", "r828" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r44" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r477", "r479", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r495" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r916" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r492", "r493" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r917" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r496" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "crdr": "debit", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, plan modification, incremental cost", "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost", "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification." } } }, "auth_ref": [ "r510" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r918" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIES" ], "lang": { "en-us": { "role": { "verboseLabel": "LEASES, COMMITMENTS, AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r156", "r389", "r390", "r803", "r977" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r918" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accrued Expenses", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Recognized the Preliminary Allocation of the Consideration", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r165" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "calculation": { "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Costs incurred related to the issuance of Class A common stock", "terseLabel": "Underwriting discounts and estimated other offering expenses", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r53" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation arrangement by share-based payment award, number of shares registered and available for grant (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r88" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Purchase Price for Merger Transaction", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r95", "r97" ] }, "cbus_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableVestedInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.cibus.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableVestedInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in dollars per share)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period, Weighted Average Exercise Price", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Vested In Period, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r919" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r919" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r484", "r485" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYDisclosureofWarrantsTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding (in shares)", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r484", "r485" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r486" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r919" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r486" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r606", "r836" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r919" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r503" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITYFollowOnPublicOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants issued (in shares)", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r450" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r505" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSupplementalBalanceSheetInformationRelatedtoLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r606", "r836" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r920" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONTables", "http://www.cibus.com/role/SUPPLEMENTALINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock-based Compensation Expense", "verboseLabel": "Schedule of Stock-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r91" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.cibus.com/role/STOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "STOCKHOLDERS' EQUITY", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r158", "r238", "r434", "r436", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r448", "r451", "r556", "r787", "r789", "r802" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONScheduleofNonvestedSharesActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONShareBasedPaymentArrangementPerformanceSharesOutstandingActivityDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofFairValuesofStockOptionsGrantedandAssumptionsusedinBlackScholesModelDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofGrantDateFairValueofAwardsVestedDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationExpenseDetails", "http://www.cibus.com/role/STOCKBASEDCOMPENSATIONSummaryofStockBasedCompensationGrantedasDeemedDividendsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r477", "r479", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r920" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaidYearOne", "weight": 1.0, "order": 2.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r607" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r8", "r17", "r169" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails": { "parentTag": "cbus_OperatingAndFinanceLeaseLiabilityToBePaid", "weight": 1.0, "order": 1.0 }, "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.cibus.com/role/LEASESCOMMITMENTSANDCONTINGENCIESSummaryofFutureMinimumRentalPaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating lease, liability, to be paid", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r607" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r920" ] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassBMember", "presentation": [ "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.cibus.com/role/BASISOFPRESENTATIONSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockbyClassDetails", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.cibus.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFREDEEMABLENONCONTROLLINGINTERESTSANDSTOCKHOLDERSEQUITY", "http://www.cibus.com/role/COVERPAGE", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALNarrativeDetails", "http://www.cibus.com/role/MERGERWITHCIBUSGLOBALScheduleofPurchasePriceforMergerTransactionDetails", "http://www.cibus.com/role/STOCKHOLDERSEQUITYMergerwithCibusGlobalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class B Common Stock", "label": "Common Class B [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r1039" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)-(4)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(4)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB TOPIC 4.C)", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(12)(c)", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(16)(c)", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "14", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "15", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-22" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-23" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "808", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "808", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "808", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "808", "Publisher": "FASB", "URI": "https://asc.fasb.org//808/tableOfContent" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//410-20/tableOfContent" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481999/410-20-25-4" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481879/410-20-45-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r839": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r841": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r845": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r846": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r847": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r848": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r849": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r917": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r918": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r926": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r927": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r928": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11" }, "r929": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//210/tableOfContent" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481850/410-20-50-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 109 0001628280-23-038279-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-23-038279-xbrl.zip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

TZ(Y*EO,)A7PYM,B*E+_@R> MM(@GT:)8R26>9Y+P86QA[AB:1_3@Y2C:8L$BNQKDAOQ.#3+--U$&B'[C.T % MIN:L'OEIP2YZ6_]5=71Z1L97VQD3P_/I%_YN/Y$C MAZ+4(K<#R[9DM9#MP#)8KMCH]'G 3L*6DOI.0JY;]0G=%+IY"MT\H(7G?MAP MJXY[%+O@M39/PA'J*]17J.\QM62-C5WZF>W*:C72WOTH-%AHL-#@I-6@*6AP M$_=5=LMU.;U]E4*'A0Z?HP[OI<(;+0A2U]Q6J=EN\$'K?GM-L9M@9 M;C'+"WQHLZN?>,UYO28P/PULC3ZS75J-=>404_6,%[+LB(ZV*?)4H,*UY2/J M"!36][8_LFU\J5E86BZUT\3*V)J](K6DRBHYHO\[<<(!S=1G4ADY1/U94<

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end